{"meta":{"query_hash":"2f253091c182","filters":{"venue":"Current Medical Research and Opinion"},"cohort_total":286,"direct_labels_cover":0,"predictions_cover":286,"exported":286,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/2f253091c182","api":"https://metacan.xera.ac/api/v1/cohort?venue=Current+Medical+Research+and+Opinion"},"results":[{"id":"W1765682497","doi":"10.1185/03007995.2015.1096242","title":"Adherence to non-vitamin-K-antagonist oral anticoagulant medications based on the Pharmacy Quality Alliance measure","year":2015,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Medication Adherence and Compliance","field":"Medicine","cited_by":76,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Apixaban; Medicine; Dabigatran; Rivaroxaban; Medicare Part D; Vitamin K antagonist; Internal medicine; Warfarin; Pharmacy; Medical prescription; Emergency medicine; Atrial fibrillation; Pharmacology; Family medicine; Prescription drug","score_opus":0.532264327907032,"score_gpt":0.5641930501442994,"score_spread":0.03192872223726739,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1765682497","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.2661319,0.009541685,0.04391005,0.64562947,0.0053243125,0.007420174,0.00011486346,0.00030632416,0.021621238],"genre_scores_gemma":[0.99310446,0.0020685191,0.0002202567,0.0029997034,0.00061065366,0.00036630663,0.00009904652,0.000015710402,0.00051535893],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9941924,0.00046347376,0.0004378168,0.00051082706,0.0038355025,0.00055996934],"domain_scores_gemma":[0.9954955,0.00082103565,0.00007933076,0.00063990714,0.0007343109,0.0022299215],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.005819809,0.00017454206,0.00031316144,0.00010817502,0.00028774844,0.00006039454,0.00052165345,0.00008333429,0.00091781176],"category_scores_gemma":[0.007862808,0.000108305096,0.0000532984,0.000702547,0.0006696799,0.00006376738,0.00013331334,0.0010809769,0.0013443672],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009266387,0.0014954797,0.026017332,0.0003722363,0.000043450025,0.0000237341,0.00043866623,0.0000014088446,0.00040827773,0.004693691,0.61402726,0.35155183],"study_design_scores_gemma":[0.007330754,0.0026788423,0.05701828,0.005528414,0.000025270612,0.000030492036,0.0009871969,0.026165577,0.0012511945,0.0011051476,0.8974138,0.0004650218],"about_ca_topic_score_codex":0.000116959265,"about_ca_topic_score_gemma":0.000011191578,"teacher_disagreement_score":0.7269725,"about_ca_system_score_codex":0.000099489764,"about_ca_system_score_gemma":0.0022221429,"threshold_uncertainty_score":0.99999547},"labels":[],"label_agreement":null},{"id":"W1829652422","doi":"10.1185/03007995.2015.1113400","title":"Efficacy and safety of diclofenac sodium 2% topical solution for osteoarthritis of the knee: a randomized, double-blind, vehicle-controlled, 4 week study","year":2015,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Osteoarthritis Treatment and Mechanisms","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"University of Lethbridge; Pfizer","keywords":"Medicine; WOMAC; Osteoarthritis; Diclofenac; Diclofenac Sodium; Randomized controlled trial; Adverse effect; Discontinuation; Anesthesia; Knee pain; Physical therapy; Surgery; Internal medicine; Pharmacology","score_opus":0.12606139898720242,"score_gpt":0.4079615168479793,"score_spread":0.2819001178607769,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1829652422","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9699347,0.01626817,0.00027612137,0.0028469288,0.00092614384,0.009478523,0.000017870592,0.000015527263,0.00023598887],"genre_scores_gemma":[0.9974282,0.0014712242,0.000053114865,0.0000127341045,0.0003595013,0.00050238665,0.000036718124,0.000011820709,0.00012434086],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99697506,0.0004260042,0.0005807172,0.00029729723,0.0013595087,0.00036138814],"domain_scores_gemma":[0.9975565,0.0011331802,0.000108058215,0.00024002555,0.00041669808,0.0005455591],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034548643,0.00014441319,0.0008155577,0.0001306584,0.0001367903,0.000016360955,0.00011218967,0.0001365249,0.000021245358],"category_scores_gemma":[0.0029787102,0.000084883104,0.0001438016,0.00018413374,0.0007080341,0.000059050533,0.00019697317,0.0003830846,0.0000017791574],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6477944,0.0019422479,0.0017407257,0.0002375879,0.00007993847,0.000003898667,0.00068948354,4.2280707e-8,0.00013215099,0.0025478583,0.00031333553,0.3445183],"study_design_scores_gemma":[0.979049,0.013940981,0.00069207716,0.001011932,0.000107812804,0.000016701542,0.0004238213,0.00027326858,0.00042467483,0.00085738656,0.0031179301,0.000084365456],"about_ca_topic_score_codex":0.000038826227,"about_ca_topic_score_gemma":0.000031902742,"teacher_disagreement_score":0.34443393,"about_ca_system_score_codex":0.00003668685,"about_ca_system_score_gemma":0.0003982833,"threshold_uncertainty_score":0.35660094},"labels":[],"label_agreement":null},{"id":"W1834765452","doi":"10.1185/03007990903044374","title":"Projected economic impact of clinical findings of generic entry of topiramate on G4 European countries","year":2009,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Topiramate; Medicine; Demography; Cohort; Pharmacoepidemiology; Pediatrics; Medical prescription; Epilepsy; Psychiatry; Internal medicine","score_opus":0.32516430329213475,"score_gpt":0.5214437338699924,"score_spread":0.19627943057785768,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1834765452","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98698723,0.0023644527,0.00003393912,0.000851693,0.00040601852,0.00019473599,0.0002479334,0.0000061022934,0.008907899],"genre_scores_gemma":[0.97794515,0.021650339,0.000015781976,0.000060653572,0.0002743586,0.0000018703502,0.00002490011,0.000008285678,0.000018653947],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"observational","domain_scores_codex":[0.99791926,0.00012769515,0.0012109457,0.00028924167,0.00011869286,0.000334153],"domain_scores_gemma":[0.99870723,0.00038144548,0.00029862,0.0002139391,0.000058991634,0.00033976685],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0035518424,0.000110600544,0.0005581226,0.00028048892,0.000035563215,0.000017950624,0.00029269632,0.0000863736,0.00046534446],"category_scores_gemma":[0.0009665867,0.000099057426,0.0001635084,0.00013458672,0.00040618214,0.00007131389,0.00007934543,0.0004029169,0.0000753767],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014266545,0.001704871,0.27922228,0.00084219506,0.00023908315,0.000004899126,0.0005298531,0.000053283038,0.00007480089,0.3761495,0.02833694,0.31141564],"study_design_scores_gemma":[0.004375562,0.005708117,0.8048131,0.00054964615,0.0000060103184,0.0000035326054,0.000018495692,0.014072636,0.00077957066,0.017507982,0.15181279,0.00035257856],"about_ca_topic_score_codex":0.000081715174,"about_ca_topic_score_gemma":0.000001423736,"teacher_disagreement_score":0.5255908,"about_ca_system_score_codex":0.00007448733,"about_ca_system_score_gemma":0.00025719518,"threshold_uncertainty_score":0.5095195},"labels":[],"label_agreement":null},{"id":"W1957215797","doi":"10.1185/03007995.2015.1077213","title":"Pharmacy quality alliance measure: adherence to non-warfarin oral anticoagulant medications","year":2015,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Medication Adherence and Compliance","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Dabigatran; Rivaroxaban; Apixaban; Medicine; Warfarin; Medicare Part D; Logistic regression; Internal medicine; Pharmacy; Atrial fibrillation; Medical prescription; Pharmacology; Family medicine","score_opus":0.6288805707270797,"score_gpt":0.599130403391937,"score_spread":0.029750167335142685,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1957215797","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.61709625,0.047520045,0.08339754,0.21405856,0.008358219,0.0076667643,0.00008021458,0.00053641637,0.02128598],"genre_scores_gemma":[0.9865988,0.008588657,0.0008036197,0.0011868892,0.0009829887,0.00037102157,0.00013188484,0.000021393818,0.0013147627],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9943696,0.00030484385,0.00051916257,0.0005662041,0.0036053394,0.0006348173],"domain_scores_gemma":[0.9946377,0.00029476808,0.000074595526,0.000508114,0.0009357891,0.0035490287],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0048844335,0.00016851106,0.00037875897,0.00013818046,0.00016270671,0.000044407083,0.00043145163,0.00009858997,0.0008672098],"category_scores_gemma":[0.0066501135,0.00013188542,0.000047031488,0.00077841297,0.0005082253,0.000118916614,0.00023498677,0.00097403204,0.0018718813],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004617456,0.00093457225,0.037778016,0.0004170376,0.00004370294,0.000020226593,0.0005591113,2.4144947e-7,0.00044381001,0.0021971725,0.29809496,0.6590494],"study_design_scores_gemma":[0.007050293,0.0016515106,0.07955708,0.0036163253,0.000024048077,0.00007405917,0.00069268234,0.003368532,0.0008056899,0.001974985,0.90075403,0.00043078183],"about_ca_topic_score_codex":0.00024069026,"about_ca_topic_score_gemma":0.000017633336,"teacher_disagreement_score":0.6586186,"about_ca_system_score_codex":0.000105041094,"about_ca_system_score_gemma":0.0021623224,"threshold_uncertainty_score":0.9989053},"labels":[],"label_agreement":null},{"id":"W1963836481","doi":"10.1185/030079904x15200","title":"Effects of a fast disintegrating/ rapid release oral formulation of sumatriptan on functional ability in patients with migraine","year":2004,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Migraine and Headache Studies","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"GlaxoSmithKline (Canada)","funders":"GlaxoSmithKline","keywords":"Sumatriptan; Medicine; Migraine; Placebo; Anesthesia; Dosing; Clinical trial; Acute migraine; Randomized controlled trial; Pharmacology; Internal medicine; Agonist","score_opus":0.052612889352196275,"score_gpt":0.38290973408426765,"score_spread":0.3302968447320714,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1963836481","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99730814,0.0011221217,0.00019245918,0.00067730236,0.000039732036,0.0005750683,0.0000080230775,0.000005971481,0.00007120227],"genre_scores_gemma":[0.9992377,0.00048787965,0.00005008842,0.000011822457,0.000068671674,0.000020132045,0.000107945,0.000005448412,0.00001030007],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99795747,0.00008522817,0.00029116584,0.00019905988,0.0012422742,0.00022477726],"domain_scores_gemma":[0.9989194,0.00037586654,0.000052884883,0.000112460664,0.00032023646,0.0002190992],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007074548,0.000096524986,0.00028760204,0.00020797405,0.000050423085,0.0000029832809,0.000039501265,0.00006206386,0.00003754489],"category_scores_gemma":[0.0030796132,0.00005821506,0.000046845245,0.00032048306,0.0002708473,0.000044451033,0.000039255814,0.0004289955,0.0000012506537],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009461727,0.007021614,0.7837825,0.0052917283,0.00007522306,0.000006103845,0.0016576238,0.0000031611958,0.00024295859,0.0040253173,0.0031681838,0.18526386],"study_design_scores_gemma":[0.008131335,0.004905455,0.98265,0.0026640296,0.000007772619,6.3122644e-7,0.00012270428,0.000102661674,0.00043371384,0.00037441743,0.0005533166,0.000053952626],"about_ca_topic_score_codex":0.00013898464,"about_ca_topic_score_gemma":0.000082941515,"teacher_disagreement_score":0.1988675,"about_ca_system_score_codex":0.00007357171,"about_ca_system_score_gemma":0.00023981363,"threshold_uncertainty_score":0.36868072},"labels":[],"label_agreement":null},{"id":"W1966702474","doi":"10.1185/03007995.2011.601733","title":"Effect of transitioning from extended-release methylphenidate onto osmotic, controlled-release methylphenidate in children/adolescents with ADHD: results of a 3-month non-interventional study","year":2011,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Attention Deficit Hyperactivity Disorder","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Child, Adolescent and Family Mental Health","funders":"","keywords":"Tolerability; Methylphenidate; Medicine; Extended release; Rating scale; Pediatrics; Attention deficit hyperactivity disorder; Quality of life (healthcare); Adverse effect; Psychiatry; Anesthesia; Internal medicine; Pharmacology; Psychology","score_opus":0.06560861397264747,"score_gpt":0.4133331308105273,"score_spread":0.34772451683787986,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1966702474","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9935555,0.002009275,0.0013747251,0.0001569065,0.00015327771,0.0025689295,0.000100672485,0.000019238014,0.00006151031],"genre_scores_gemma":[0.9990018,0.00036165997,0.00007403679,0.0000064189035,0.00011510413,0.00013520995,0.00026048967,0.000028945286,0.000016323493],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99396855,0.0014551069,0.0010118028,0.0006799922,0.0023611002,0.0005234356],"domain_scores_gemma":[0.9975691,0.0006701458,0.00026820236,0.0004318782,0.0004261953,0.0006344884],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0040206495,0.00029582903,0.001097532,0.00053268916,0.00008671765,0.000017233055,0.00023408693,0.00015065965,0.0002680895],"category_scores_gemma":[0.0027391375,0.00021163723,0.0002133979,0.00050148286,0.00046698347,0.00020057676,0.00013626176,0.0011026221,0.00001137811],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.14090869,0.03731866,0.66134363,0.0020004234,0.00100103,0.00013333073,0.004385193,0.000007854933,0.0015022618,0.000054883534,0.00019049372,0.15115353],"study_design_scores_gemma":[0.12529461,0.021723555,0.83499664,0.010325601,0.00034428257,0.000022690547,0.0020470791,0.002293308,0.002473713,0.00013378164,0.00001877731,0.00032596264],"about_ca_topic_score_codex":0.0020542417,"about_ca_topic_score_gemma":0.00023601518,"teacher_disagreement_score":0.17365298,"about_ca_system_score_codex":0.000067085966,"about_ca_system_score_gemma":0.00030503757,"threshold_uncertainty_score":0.86303157},"labels":[],"label_agreement":null},{"id":"W1966827685","doi":"10.1185/03007995.2015.1040750","title":"Pregabalin for chronic pain: does one medication fit all?","year":2015,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Opioid Use Disorder Treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; McGill University Health Centre","funders":"","keywords":"Pregabalin; Medicine; Discontinuation; Fibromyalgia; Chronic pain; Medical prescription; Adverse effect; Analgesic; Gabapentin; Quality of life (healthcare); Physical therapy; Anesthesia; Internal medicine; Alternative medicine; Pharmacology; Nursing","score_opus":0.26721175846243683,"score_gpt":0.49362193061705956,"score_spread":0.22641017215462272,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1966827685","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.2600735,0.28163123,0.029642457,0.40255985,0.007881201,0.015035645,0.00019614541,0.0005749277,0.0024050458],"genre_scores_gemma":[0.94404,0.04463928,0.00087070005,0.00051162863,0.004878507,0.001850351,0.002336783,0.0000704097,0.00080232584],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9967165,0.00020818425,0.00027760994,0.00038897176,0.0018836218,0.00052509847],"domain_scores_gemma":[0.99734557,0.00061916176,0.00004052485,0.00028412987,0.00037599876,0.0013346435],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0035198668,0.00013195201,0.0002519702,0.00015524784,0.00009636228,0.000027088045,0.00014357963,0.00015117468,0.00017684237],"category_scores_gemma":[0.0059751202,0.00008181032,0.00005276951,0.00016790899,0.00030659157,0.00006893018,0.00010830832,0.000430926,0.000046591875],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00055529206,0.0020293742,0.0052301916,0.001942741,0.00012301361,0.0000062858826,0.00090850546,1.4316171e-7,0.000054402204,0.0022195359,0.116288714,0.8706418],"study_design_scores_gemma":[0.008353891,0.004771757,0.0061143725,0.0020620031,0.000036204063,0.000007993352,0.000455302,0.0054549426,0.0005170854,0.0052917297,0.9667557,0.00017904774],"about_ca_topic_score_codex":0.000045822686,"about_ca_topic_score_gemma":0.000016364698,"teacher_disagreement_score":0.8704628,"about_ca_system_score_codex":0.00028980072,"about_ca_system_score_gemma":0.001411577,"threshold_uncertainty_score":0.7153209},"labels":[],"label_agreement":null},{"id":"W1970144467","doi":"10.1185/03007995.2012.762903","title":"The long-term clinical benefit and effectiveness of switching to once-daily quetiapine extended release in patients with schizophrenia","year":2013,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University of Ottawa; Université de Montréal; University of Alberta; Université Laval; University of British Columbia; McGill University","funders":"Mylan; Valeant Pharmaceuticals International","keywords":"Tolerability; Medicine; Quetiapine; Discontinuation; Clinical Global Impression; Somnolence; Olanzapine; Adverse effect; Internal medicine; Quetiapine Fumarate; Anticholinergic; Antipsychotic; Clinical endpoint; Extrapyramidal symptoms; Atypical antipsychotic; Schizophrenia (object-oriented programming); Clinical trial; Psychiatry; Placebo","score_opus":0.045520969794869644,"score_gpt":0.41287104708607153,"score_spread":0.3673500772912019,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1970144467","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9924121,0.003951059,0.000053597905,0.001610306,0.00012392325,0.0018166133,0.0000041292283,0.000011708993,0.000016596367],"genre_scores_gemma":[0.9946437,0.0048365314,0.000099622026,0.000014078987,0.00013460523,0.00020382824,0.000042851483,0.000016130685,0.000008669808],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99622107,0.00052545866,0.00043337265,0.00047435026,0.0017416558,0.0006040724],"domain_scores_gemma":[0.99555427,0.002160862,0.00005104106,0.00034594387,0.00047208558,0.0014158195],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002736205,0.00016851538,0.00040225126,0.0002337439,0.00017710372,0.000060366256,0.00017992061,0.00010917829,0.00004035892],"category_scores_gemma":[0.0034064408,0.000090593465,0.000044869044,0.00040158216,0.0004874121,0.00010425616,0.00028582316,0.0009839054,0.000021236316],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015672278,0.0007158808,0.5098071,0.00026430964,0.000036151432,0.000010893284,0.00002150229,5.251276e-8,0.000009965484,0.0005167602,0.000062220235,0.47288287],"study_design_scores_gemma":[0.013158741,0.0043715057,0.97835135,0.0028143818,0.000007303355,0.0000049364644,0.00001588401,0.00009570061,0.000064806685,0.0009548524,0.000073991614,0.000086519656],"about_ca_topic_score_codex":0.0001677975,"about_ca_topic_score_gemma":0.00014853828,"teacher_disagreement_score":0.47279635,"about_ca_system_score_codex":0.00008161115,"about_ca_system_score_gemma":0.0004555487,"threshold_uncertainty_score":0.4274634},"labels":[],"label_agreement":null},{"id":"W1971313899","doi":"10.1185/03007995.2010.522157","title":"Long-term safety of duloxetine during open-label compassionate use treatment of patients who completed previous duloxetine clinical trials","year":2010,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Treatment of Major Depression","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Duloxetine; Medicine; Discontinuation; Adverse effect; Duloxetine Hydrochloride; Major depressive disorder; Fibromyalgia; Internal medicine; Psychiatry; Mood","score_opus":0.43976163016046,"score_gpt":0.570965811539683,"score_spread":0.13120418137922296,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1971313899","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9931597,0.0018690703,0.000035813177,0.0010452459,0.0009782155,0.0026493964,0.00017781675,0.000024232679,0.00006050053],"genre_scores_gemma":[0.97864443,0.019525398,0.00020296437,0.00000920278,0.00041324022,0.000087184235,0.0009360638,0.000030297388,0.00015119248],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9933956,0.0014409354,0.0019233399,0.0006284116,0.002087923,0.00052379095],"domain_scores_gemma":[0.99311024,0.003691649,0.00050448853,0.0006688483,0.00073135836,0.0012934038],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.004525703,0.00027953336,0.0015700475,0.000273856,0.0001757247,0.000037750742,0.00035514872,0.0002853275,0.00066424435],"category_scores_gemma":[0.013531166,0.00017589342,0.0001606625,0.00028592325,0.00082201074,0.00015349485,0.00061505963,0.00083510025,0.000011528791],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008828839,0.013762349,0.6605104,0.0006420113,0.00015062105,0.000023781624,0.000059831724,3.637274e-8,0.00081698503,0.000081660015,0.0010657712,0.31405768],"study_design_scores_gemma":[0.045731865,0.0053078453,0.9369918,0.0029221098,0.00006859536,0.000010249218,0.0000060033713,0.00023072405,0.0015340698,0.000026507872,0.007038047,0.00013215926],"about_ca_topic_score_codex":0.000059854152,"about_ca_topic_score_gemma":0.00002156572,"teacher_disagreement_score":0.3139255,"about_ca_system_score_codex":0.00007644601,"about_ca_system_score_gemma":0.0003675233,"threshold_uncertainty_score":0.9947783},"labels":[],"label_agreement":null},{"id":"W1971336557","doi":"10.1185/03007990802133914","title":"Clinical efficacy and time to symptom resolution of 5-day telithromycin versus 10-day amoxicillin–clavulanate in the treatment of acute bacterial sinusitis","year":2008,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Sinusitis and nasal conditions","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal; McGill University","funders":"","keywords":"Medicine; Telithromycin; Tolerability; Amoxicillin; Regimen; Population; Internal medicine; Adverse effect; Sinusitis; Clinical endpoint; Surgery; Anesthesia; Randomized controlled trial; Antibiotics; Clarithromycin; Helicobacter pylori","score_opus":0.1528621227140363,"score_gpt":0.46754983840954767,"score_spread":0.31468771569551135,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1971336557","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957924,0.0016406476,0.000020596335,0.0011879257,0.00034187172,0.00063609896,0.00008961692,0.000008355475,0.00028250465],"genre_scores_gemma":[0.9852633,0.013644473,0.00003954859,0.000022525073,0.0006032086,0.000025954314,0.00029283037,0.000009682232,0.00009850337],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9973472,0.00059508736,0.00050036225,0.00029617242,0.0009460305,0.00031519245],"domain_scores_gemma":[0.99720025,0.0019138944,0.000057705463,0.00023475838,0.00017926935,0.0004141512],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017928312,0.000117895535,0.00041069448,0.00022271424,0.000112018,0.000008985965,0.000106047315,0.00014294105,0.00053640216],"category_scores_gemma":[0.0013871907,0.00007580937,0.00007019155,0.0003757249,0.0007160118,0.00004138861,0.00006133642,0.0002882648,0.000033876524],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0213322,0.014217744,0.04856656,0.00047939195,0.0007469213,0.00067812775,0.0071075843,9.56052e-7,0.0051291804,0.0013943489,0.08082202,0.81952494],"study_design_scores_gemma":[0.015999166,0.019279376,0.8983973,0.001148181,0.00007274704,0.00006922592,0.000072754025,0.00042534858,0.00039533546,0.000044746477,0.06394043,0.00015539638],"about_ca_topic_score_codex":0.00006849656,"about_ca_topic_score_gemma":0.000011782997,"teacher_disagreement_score":0.84983075,"about_ca_system_score_codex":0.00006565272,"about_ca_system_score_gemma":0.00029297115,"threshold_uncertainty_score":0.5873227},"labels":[],"label_agreement":null},{"id":"W1971352874","doi":"10.1185/030079903125002450","title":"Strategies for continued successful treatment of Alzheimer's disease: switching cholinesterase inhibitors","year":2003,"lang":"en","type":"review","venue":"Current Medical Research and Opinion","topic":"Cholinesterase and Neurodegenerative Diseases","field":"Medicine","cited_by":91,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Novartis Pharma; Novartis","keywords":"Medicine; Cholinesterase; Rivastigmine; Disease; Donepezil; Alzheimer's disease; Pharmacology; Intensive care medicine; Internal medicine; Dementia","score_opus":0.29772167137064165,"score_gpt":0.5340669825974191,"score_spread":0.2363453112267775,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1971352874","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0017369817,0.9942699,0.00006001816,0.00015331026,0.0007848745,0.002662674,0.00027890265,0.000021367276,0.000031991713],"genre_scores_gemma":[0.00069446606,0.99536616,0.000012819244,0.000018387509,0.0016078108,0.00069478294,0.0015191468,0.000052116,0.000034305544],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99634457,0.0004086972,0.00086388475,0.0006902022,0.0011482663,0.00054438564],"domain_scores_gemma":[0.99672025,0.00086647144,0.00020438115,0.00039101523,0.000428667,0.0013892308],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005588975,0.0004510896,0.0016716048,0.00042284833,0.00015642034,0.00008427682,0.00013767234,0.00021098544,0.00006277891],"category_scores_gemma":[0.00080971397,0.0002933713,0.0005167757,0.00034497454,0.00029168432,0.00011928481,0.0000651061,0.00045403346,0.0000052624446],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023309274,0.0012550799,0.00012799415,0.02135227,0.0001792536,0.000041818927,0.000050466082,3.089805e-8,0.0000019834804,0.00032832968,0.0021258232,0.97430384],"study_design_scores_gemma":[0.0021148354,0.00092225656,0.00004626547,0.02751607,0.0005836898,0.000020195295,0.00004776895,0.000027946551,0.000018258172,0.00008421242,0.9683967,0.00022177133],"about_ca_topic_score_codex":0.000011421315,"about_ca_topic_score_gemma":0.0000032001108,"teacher_disagreement_score":0.9740821,"about_ca_system_score_codex":0.00007002907,"about_ca_system_score_gemma":0.0028885165,"threshold_uncertainty_score":0.99995184},"labels":[],"label_agreement":null},{"id":"W1972258960","doi":"10.1185/03007995.2011.585396","title":"Impact of weight gain on outcomes in type 2 diabetes","year":2011,"lang":"en","type":"review","venue":"Current Medical Research and Opinion","topic":"Diabetes, Cardiovascular Risks, and Lipoproteins","field":"Medicine","cited_by":92,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"U.S. National Library of Medicine; Novo Nordisk","keywords":"Medicine; Weight gain; Type 2 diabetes; Weight loss; Internal medicine; Metformin; Glycemic; Type 2 Diabetes Mellitus; Insulin; Insulin resistance; Diabetes mellitus; Endocrinology; Overweight; Liraglutide; Obesity; Body weight","score_opus":0.20904395534938966,"score_gpt":0.49920741509718247,"score_spread":0.2901634597477928,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1972258960","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0020281356,0.99544007,0.0000016659934,0.000036789686,0.00070883817,0.0011373529,0.000033069402,0.000015977748,0.0005980753],"genre_scores_gemma":[0.00077155465,0.998198,0.0000071526347,0.000005532382,0.0005463472,0.00009915521,0.00026682927,0.000041339074,0.000064129235],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99579203,0.0006424175,0.00064935756,0.0005090922,0.0016778082,0.0007292901],"domain_scores_gemma":[0.99751,0.00077610376,0.00011034799,0.00059474056,0.00020081502,0.0008079987],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031163816,0.00034609972,0.002480548,0.00085616653,0.000041584382,0.000015851572,0.0002926764,0.00045673718,0.00044837754],"category_scores_gemma":[0.0044990573,0.00020253067,0.00080217887,0.00065490935,0.00041868375,0.000040823128,0.00019870221,0.0019012801,0.000103056336],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004296271,0.00057607866,0.002078001,0.013371948,0.00033632267,0.0000110875735,0.000025495488,5.892968e-9,1.9967294e-8,0.0000855221,0.002201834,0.98127073],"study_design_scores_gemma":[0.0009793295,0.0020793215,0.009676331,0.049315453,0.00009182677,0.000004319378,0.0000037082582,0.000005986168,0.0000012772044,0.00013367487,0.93752205,0.00018671977],"about_ca_topic_score_codex":0.0004585113,"about_ca_topic_score_gemma":0.000017406184,"teacher_disagreement_score":0.981084,"about_ca_system_score_codex":0.0001652249,"about_ca_system_score_gemma":0.0013159874,"threshold_uncertainty_score":0.82602215},"labels":[],"label_agreement":null},{"id":"W1972386063","doi":"10.1185/03007995.2015.1020365","title":"Effects of desvenlafaxine on blood pressure in patients treated for major depressive disorder: a pooled analysis","year":2015,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Treatment of Major Depression","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pfizer (Canada)","funders":"","keywords":"Medicine; Major depressive disorder; Pooled analysis; Blood pressure; Internal medicine; Psychiatry; Meta-analysis; Mood","score_opus":0.044244870102146276,"score_gpt":0.39600229107197615,"score_spread":0.35175742096982987,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1972386063","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98194677,0.015540565,0.00007929377,0.0004731644,0.00013540575,0.0017167085,0.000032883443,0.000020567746,0.000054616597],"genre_scores_gemma":[0.9982157,0.00092628715,0.000039650997,0.000012097634,0.000088435765,0.00025741986,0.00037459013,0.000015879814,0.00006999163],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969304,0.00022635458,0.0003184164,0.0004282137,0.0016889686,0.00040760954],"domain_scores_gemma":[0.99759966,0.0009870162,0.000077152254,0.00025530162,0.0003675628,0.0007133049],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007143503,0.00016152835,0.00049966533,0.0006257151,0.000053677213,0.0000123637265,0.00014231309,0.00016369077,0.000024763753],"category_scores_gemma":[0.005698684,0.00010998117,0.000101068865,0.0006782425,0.00014993822,0.000052607116,0.000121100995,0.00037350284,0.0000033902384],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005028038,0.008393297,0.88528055,0.0013558129,0.0011849238,0.000020332725,0.00017428269,0.0000032040034,0.00013269162,0.000075876385,0.0022574388,0.09609358],"study_design_scores_gemma":[0.05871162,0.012154995,0.9099458,0.002974895,0.0022345344,0.0000016155109,0.00002800552,0.001881921,0.008147459,0.00031194653,0.0034131545,0.00019406292],"about_ca_topic_score_codex":0.00010249262,"about_ca_topic_score_gemma":0.00002326846,"teacher_disagreement_score":0.095899515,"about_ca_system_score_codex":0.000036770973,"about_ca_system_score_gemma":0.00017915839,"threshold_uncertainty_score":0.6822269},"labels":[],"label_agreement":null},{"id":"W1973651333","doi":"10.1185/03007995.2010.547575","title":"Safety and efficacy of maintenance infliximab therapy for moderate-to-severe Crohn’s disease in children: REACH open-label extension","year":2011,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":109,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Infliximab; Adverse effect; Crohn's disease; Internal medicine; Clinical trial; Randomized controlled trial; Disease; Inflammatory bowel disease; Physical therapy; Pediatrics","score_opus":0.07697412502220531,"score_gpt":0.3890091897877285,"score_spread":0.31203506476552323,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1973651333","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99315566,0.004550705,0.00050820445,0.00018184647,0.00009075383,0.0013774793,0.00006875381,0.000003999241,0.000062624924],"genre_scores_gemma":[0.99102527,0.008283574,0.00014970406,0.00008128995,0.00010968039,0.0001132846,0.00018803074,0.000016254304,0.000032904823],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9984206,0.00015557231,0.00025703682,0.00045448032,0.0003510127,0.0003612787],"domain_scores_gemma":[0.9987901,0.000052331274,0.00003895379,0.0002883174,0.00020516322,0.00062516576],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010590589,0.00012321852,0.00016230944,0.00008134143,0.00009882041,0.00002311785,0.00029156925,0.00010036468,0.000017804612],"category_scores_gemma":[0.0014569324,0.00009949767,0.000023175331,0.00008799094,0.00025738453,0.000012174453,0.00041729488,0.00018563351,0.0000016020534],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.1373522,0.00585933,0.1938613,0.0006396223,0.000108641114,0.000073507304,0.00066582154,0.000008993381,0.003730667,0.0047512334,0.01063385,0.64231485],"study_design_scores_gemma":[0.0104445,0.00057224964,0.98319376,0.0003581014,0.0000024095607,0.0000029625353,0.000015462192,0.0006034526,0.00040483405,0.0007063913,0.0035301233,0.00016573176],"about_ca_topic_score_codex":0.000027343747,"about_ca_topic_score_gemma":0.000008717613,"teacher_disagreement_score":0.78933245,"about_ca_system_score_codex":0.000015163701,"about_ca_system_score_gemma":0.000320965,"threshold_uncertainty_score":0.40573975},"labels":[],"label_agreement":null},{"id":"W1973734746","doi":"10.1185/030079906x132415","title":"Remission, dropouts, and adverse drug reaction rates in major depressive disorder: a meta-analysis of head-to-head trials","year":2006,"lang":"en","type":"review","venue":"Current Medical Research and Opinion","topic":"Treatment of Major Depression","field":"Medicine","cited_by":146,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; PharmIdeas (Canada)","funders":"","keywords":"Medicine; Internal medicine; Meta-analysis; Adverse effect; Rating scale; Confidence interval; Depression (economics); Hamd; Randomized controlled trial; Clinical trial; Psychiatry; Psychology","score_opus":0.36154163991176796,"score_gpt":0.5620345049789328,"score_spread":0.20049286506716485,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1973734746","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0009699248,0.9946879,0.000034227498,0.0010579007,0.0002174755,0.0027671042,0.00015945602,0.000024105631,0.000081899336],"genre_scores_gemma":[0.0007476272,0.9964733,0.00006180306,0.0000097267075,0.00022171912,0.000509739,0.0016196962,0.000040022445,0.00031634324],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9911148,0.002662125,0.0019103889,0.0010975463,0.0026129798,0.00060217996],"domain_scores_gemma":[0.99319106,0.00420899,0.000550738,0.00064744626,0.00030186266,0.0010999123],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0066170287,0.00051535806,0.006203244,0.0024929666,0.00013379121,0.00002970555,0.00023914293,0.0004979814,0.00029427942],"category_scores_gemma":[0.010192024,0.0002999345,0.0012179551,0.0020168102,0.00032879674,0.00010196781,0.00035642387,0.0014398419,0.000011964415],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004107068,0.0010575063,0.0011205022,0.011996437,0.011332244,0.00004549962,0.00007193079,2.6689617e-7,0.0000050274543,0.00002937228,0.0051287287,0.9688018],"study_design_scores_gemma":[0.003204921,0.00040357793,0.0018219112,0.01684584,0.060608353,0.000019519823,0.000045388442,0.000069914815,0.00001134995,0.000100271,0.91658705,0.0002818759],"about_ca_topic_score_codex":0.00085436663,"about_ca_topic_score_gemma":0.00031626038,"teacher_disagreement_score":0.9685199,"about_ca_system_score_codex":0.00017962485,"about_ca_system_score_gemma":0.00072152674,"threshold_uncertainty_score":0.9999453},"labels":[],"label_agreement":null},{"id":"W1974990443","doi":"10.1185/03007995.2014.918028","title":"Assessment of treatment-seeking behavior and healthcare utilization in an international cohort of subjects with overactive bladder","year":2014,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"Allergan","keywords":"Medicine; Overactive bladder; Demographics; Urinary incontinence; Cohort; Health care; Urge incontinence; Internal medicine; Physical therapy; Urinary system; Demography; Urology; Alternative medicine","score_opus":0.16312350381320675,"score_gpt":0.5201605181990953,"score_spread":0.35703701438588853,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1974990443","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99756265,0.00067173515,0.0002113775,0.0004471277,0.00007309917,0.0006147713,0.000014722108,0.0000046095042,0.0003998996],"genre_scores_gemma":[0.9899411,0.009616365,0.00006985796,0.000005431884,0.00007989205,0.000059430793,0.00020983405,0.0000075388093,0.000010502708],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979831,0.00026421086,0.00021288691,0.00024771414,0.0010660082,0.00022607215],"domain_scores_gemma":[0.9988567,0.0002858532,0.000044137414,0.00012901102,0.00034599975,0.0003382792],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010692863,0.0000783487,0.000217831,0.00028313868,0.000043510354,0.0000125566075,0.000059492377,0.00006424353,0.00007453703],"category_scores_gemma":[0.00025132482,0.000055162345,0.000013883436,0.00019226372,0.00027377586,0.00012933259,0.000059083683,0.00032733043,2.3827367e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003608724,0.0007019076,0.83237505,0.00022478767,0.000020875046,0.000005985879,0.00023416846,1.6905383e-7,0.00019222127,0.00060791796,0.000007051161,0.16526897],"study_design_scores_gemma":[0.002294111,0.0069008665,0.98442876,0.00058480585,0.00000779389,0.000016859254,0.00021379007,0.004435416,0.00027287102,0.00007360522,0.0007256227,0.000045523695],"about_ca_topic_score_codex":0.00028547188,"about_ca_topic_score_gemma":0.00009845078,"teacher_disagreement_score":0.16522345,"about_ca_system_score_codex":0.00010486101,"about_ca_system_score_gemma":0.00055380585,"threshold_uncertainty_score":0.22494552},"labels":[],"label_agreement":null},{"id":"W1977273306","doi":"10.1185/03007995.2014.915803","title":"Use of prescription opioids with abuse-deterrent technology to address opioid abuse","year":2014,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Opioid Use Disorder Treatment","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Purdue Pharma (Canada)","funders":"","keywords":"Oxycodone; Medicine; Oxymorphone; Opioid; Medical prescription; Opioid abuse; Chronic pain; Pharmacy; Substance abuse; Psychiatry; Internal medicine; Pharmacology; Family medicine","score_opus":0.08425675245155942,"score_gpt":0.41271037658871584,"score_spread":0.3284536241371564,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1977273306","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9908747,0.0030967265,0.0016647939,0.002300871,0.00050753524,0.0013536635,0.000016351958,0.00009047363,0.000094874624],"genre_scores_gemma":[0.98562497,0.0124959955,0.000862637,0.00008083152,0.00031661766,0.00032652222,0.00014448282,0.000042169595,0.000105747546],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9966173,0.00015494933,0.0003694612,0.00052623753,0.0017280388,0.0006039871],"domain_scores_gemma":[0.99778,0.00027480733,0.00005816445,0.0005568167,0.00045053533,0.0008796577],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00065090513,0.00020385768,0.00041050822,0.00066714396,0.00011113103,0.00003560685,0.00021191269,0.00019429105,0.0000801127],"category_scores_gemma":[0.0011603921,0.00014181783,0.000045466582,0.00064832176,0.00052623684,0.00011171917,0.0001410733,0.00066177483,0.000035453686],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026875834,0.004028079,0.1323239,0.0025080421,0.00017331932,0.000028564393,0.0041571558,0.0000042824427,0.0016409815,0.0039604027,0.012245992,0.83624166],"study_design_scores_gemma":[0.009181112,0.01779421,0.116841495,0.010877983,0.0000806238,0.00007983145,0.0008089081,0.0026118204,0.007957729,0.00071951933,0.83248985,0.000556906],"about_ca_topic_score_codex":0.00007937038,"about_ca_topic_score_gemma":0.000029828116,"teacher_disagreement_score":0.8356848,"about_ca_system_score_codex":0.00008942344,"about_ca_system_score_gemma":0.00025760065,"threshold_uncertainty_score":0.57831633},"labels":[],"label_agreement":null},{"id":"W1977694976","doi":"10.1185/03007995.2013.836078","title":"Health-related quality of life and disease symptoms in postmenopausal women with HR<sup>+</sup>, HER2<sup>−</sup>advanced breast cancer treated with everolimus plus exemestane versus exemestane monotherapy","year":2013,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital du Saint-Sacrement; Sunnybrook Health Science Centre; University of Toronto","funders":"European Society for Medical Oncology; Novartis Pharmaceuticals Corporation","keywords":"Medicine; Exemestane; Discontinuation; Internal medicine; Breast cancer; Quality of life (healthcare); Placebo; Confidence interval; Aromatase inhibitor; Hazard ratio; Oncology; Cancer; Aromatase","score_opus":0.04616009174512354,"score_gpt":0.38911583257544025,"score_spread":0.3429557408303167,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1977694976","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96490365,0.02315901,0.0000878684,0.0095363185,0.00007043043,0.0020046455,0.00014025738,0.0000753813,0.000022443344],"genre_scores_gemma":[0.9839678,0.014505247,0.00010067845,0.00021432825,0.00016451396,0.0007404685,0.00016306776,0.0000763113,0.00006758552],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9942485,0.00054129737,0.00086874823,0.00088323187,0.002143086,0.0013151207],"domain_scores_gemma":[0.99492234,0.000593586,0.00023292302,0.0005159455,0.0005684496,0.003166772],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010587248,0.00046007056,0.0011416029,0.00036454346,0.00017477239,0.0000416088,0.0002233853,0.00017114448,0.0005079255],"category_scores_gemma":[0.00045965106,0.00031647866,0.0000363794,0.0009217344,0.0013646664,0.00038357385,0.00011427269,0.0010494099,0.0000057254497],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.15906431,0.0016688114,0.091959104,0.0022633632,0.00053563307,0.00008261343,0.004328646,0.00043825147,0.00010549658,0.00027775092,0.0002398226,0.7390362],"study_design_scores_gemma":[0.12066018,0.019978782,0.82193995,0.009521037,0.00005086361,0.00016256218,0.0061669266,0.01587536,0.000025980064,0.00078739197,0.0036099765,0.0012209994],"about_ca_topic_score_codex":0.0026803939,"about_ca_topic_score_gemma":0.00008361019,"teacher_disagreement_score":0.7378152,"about_ca_system_score_codex":0.0008861318,"about_ca_system_score_gemma":0.002743139,"threshold_uncertainty_score":0.9999287},"labels":[],"label_agreement":null},{"id":"W1979282053","doi":"10.1185/030079906x115568","title":"Cost-effectiveness of alternative treatments for women with osteoporosis in Canada","year":2006,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Bone health and osteoporosis research","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"St. Joseph’s Healthcare Hamilton; McMaster University; St. Joseph's Hospital; Programs for Assessment of Technology in Health Research Institute","funders":"","keywords":"Medicine; Raloxifene; Osteoporosis; Selective estrogen receptor modulator; Cost effectiveness; Quality-adjusted life year; Etidronic acid; Internal medicine; Breast cancer; Tamoxifen; Risk analysis (engineering); Cancer","score_opus":0.11618627537555021,"score_gpt":0.4527852894941774,"score_spread":0.3365990141186272,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1979282053","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994578,0.0020514284,0.000048384918,0.0005977369,0.00013416739,0.0022627998,0.000061319195,0.000004383717,0.00026175604],"genre_scores_gemma":[0.99683666,0.00177946,0.000030359763,0.000013678211,0.000107662236,0.0010329119,0.00013218723,0.0000123607515,0.00005472771],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9969214,0.00024639114,0.0002783982,0.0002994479,0.0015325774,0.0007217453],"domain_scores_gemma":[0.9974939,0.0012816056,0.000040695395,0.00014157227,0.00036010076,0.00068207795],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018124204,0.00010858591,0.0003571758,0.00020695176,0.000072298724,0.000008117428,0.000091359536,0.000061493345,0.000056785957],"category_scores_gemma":[0.0006140236,0.00007447108,0.00001725458,0.0003698323,0.00023455388,0.000044679153,0.000054430766,0.00040297006,0.0000010897242],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013925134,0.0016228912,0.4874871,0.0056996946,0.000068364134,0.000054573193,0.00035580853,0.0000035908495,0.00024183308,0.0004801153,0.002186326,0.48787454],"study_design_scores_gemma":[0.01618746,0.00534699,0.95551974,0.0029957432,0.000006301128,0.000015824193,0.0009885179,0.0007686175,0.0026736073,0.00096166757,0.014393432,0.00014208352],"about_ca_topic_score_codex":0.45474762,"about_ca_topic_score_gemma":0.2557028,"teacher_disagreement_score":0.48773247,"about_ca_system_score_codex":0.0011124588,"about_ca_system_score_gemma":0.004901578,"threshold_uncertainty_score":0.86951894},"labels":[],"label_agreement":null},{"id":"W1979643646","doi":"10.1185/030079906x148364","title":"Ezetimibe/simvastatin single tablet versus rosuvastatin in patients with hypercholesterolemia","year":2006,"lang":"en","type":"letter","venue":"Current Medical Research and Opinion","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Royal Victoria Hospital","funders":"American Heart Association","keywords":"Rosuvastatin; Ezetimibe; Medicine; Simvastatin; Statin; Atorvastatin; Combination therapy; Pharmacology; Ldl cholesterol; Fixed-dose combination; Cholesterol; Internal medicine; Urology","score_opus":0.07781500923638612,"score_gpt":0.3735728337994214,"score_spread":0.2957578245630353,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1979643646","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5131946,0.021584503,0.0005929579,0.44784656,0.004625769,0.008298183,0.00051648705,0.00019787367,0.0031430288],"genre_scores_gemma":[0.33914417,0.040220503,0.0054482017,0.32597518,0.115641534,0.005451042,0.15926737,0.0028007682,0.0060512363],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99158275,0.0005524963,0.0005473409,0.0008280759,0.0052628024,0.0012265042],"domain_scores_gemma":[0.99778676,0.00045923598,0.00009188073,0.0006013541,0.00043409286,0.00062669715],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0019497179,0.000363717,0.00079487235,0.00051499985,0.00012954058,0.00008518644,0.00022661843,0.0006904387,0.00017142676],"category_scores_gemma":[0.000789655,0.00026318713,0.00011152005,0.0005325854,0.00046903288,0.00009022449,0.0001934735,0.0056187683,0.000040354113],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009899271,0.0006898019,0.011921223,0.002357678,0.0000667219,0.0002410796,0.000054350672,4.107721e-7,7.485539e-7,0.0000069341,0.6905048,0.2931663],"study_design_scores_gemma":[0.013264606,0.0035450999,0.043005325,0.004586679,0.00002598532,0.00001007095,0.000021376021,0.000032614083,0.0000062113563,0.00004188109,0.93515474,0.00030539566],"about_ca_topic_score_codex":0.00041305512,"about_ca_topic_score_gemma":0.00006183085,"teacher_disagreement_score":0.29286093,"about_ca_system_score_codex":0.00038238685,"about_ca_system_score_gemma":0.0010034499,"threshold_uncertainty_score":0.99998206},"labels":[],"label_agreement":null},{"id":"W1981379267","doi":"10.1185/03007995.2010.541433","title":"Tolerability of solifenacin and oxybutynin immediate release in older (&gt;65 years) and younger (≤65 years) patients with overactive bladder: sub-analysis from a Canadian, randomized, double-blind study","year":2010,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Guelph; University of Alberta; University of Calgary; University of Toronto; Dalhousie University; McGill University Health Centre; University of British Columbia Hospital","funders":"","keywords":"Medicine; Overactive bladder; Solifenacin; Oxybutynin; Tolerability; Tolterodine; Urology; Randomized controlled trial; Double blind; Internal medicine; Adverse effect; Placebo","score_opus":0.04259257354233033,"score_gpt":0.38527969621131486,"score_spread":0.34268712266898455,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1981379267","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947958,0.0017387293,0.000008190059,0.0006441419,0.00012748191,0.0024982058,0.00011446896,0.0000070568744,0.000065951506],"genre_scores_gemma":[0.9959803,0.0033675493,0.000017136013,0.000020784408,0.00013747197,0.0001413294,0.0002930702,0.0000182334,0.000024096038],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99562407,0.00061695836,0.0005146463,0.0006814937,0.0019095913,0.0006532156],"domain_scores_gemma":[0.99625015,0.0012719465,0.00008020212,0.00037542352,0.00042264466,0.0015996414],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0035726873,0.00020502813,0.0008811545,0.0008792723,0.00009814823,0.00006383593,0.000136355,0.00019318909,0.0003846304],"category_scores_gemma":[0.0015780528,0.00015140504,0.00007138774,0.00079065375,0.00094309764,0.0001962824,0.000201641,0.0016840097,0.000005661701],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.1176145,0.0023261886,0.844387,0.00017841028,0.0007108687,0.00011906494,0.0033529394,2.8383286e-7,0.000045938872,0.000036419387,0.00030015365,0.030928237],"study_design_scores_gemma":[0.17050025,0.00090194005,0.82661265,0.0001673974,0.00016399554,0.0000036435254,0.00034891488,0.00048436312,0.000038788105,0.00012954455,0.00049207336,0.00015645477],"about_ca_topic_score_codex":0.032636706,"about_ca_topic_score_gemma":0.021103652,"teacher_disagreement_score":0.052885756,"about_ca_system_score_codex":0.000068130044,"about_ca_system_score_gemma":0.00094379607,"threshold_uncertainty_score":0.99675864},"labels":[],"label_agreement":null},{"id":"W1983997227","doi":"10.1185/03007990802333167","title":"Comparison of allergy rates in glaucoma patients receiving brimonidine 0.2% monotherapy versus fixed-combination brimonidine 0.2%–timolol 0.5% therapy","year":2008,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Glaucoma and retinal disorders","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"American Glaucoma Society","keywords":"Brimonidine; Medicine; Timolol; Allergy; Incidence (geometry); Glaucoma; Ophthalmology; Anesthesia; Immunology","score_opus":0.12444064569903891,"score_gpt":0.44489863135242963,"score_spread":0.32045798565339073,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1983997227","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98296165,0.013657137,0.00003945758,0.0016734035,0.0005900188,0.0006201381,0.0000026953048,0.000023753493,0.00043174042],"genre_scores_gemma":[0.9427527,0.05679659,0.00003814858,0.00002556491,0.00011731368,0.000036462163,0.00016879503,0.000021407488,0.000043017415],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99660254,0.00029266204,0.0005817105,0.00038790834,0.0016127401,0.00052246253],"domain_scores_gemma":[0.99825114,0.0006152243,0.00010750179,0.00021971397,0.00038571228,0.0004207154],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008187013,0.00019356047,0.00050389185,0.00040809947,0.00016024637,0.000013154707,0.00019185978,0.00019103756,0.00012775425],"category_scores_gemma":[0.0013198412,0.00015375558,0.0000796903,0.00058567466,0.0005078161,0.00010495564,0.00008694783,0.00078183983,0.000011137352],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034100693,0.0028827037,0.85475945,0.00012694372,0.000041317573,0.000008800827,0.0004902904,1.3326924e-7,0.00027701442,0.00021106303,0.0034848286,0.13430738],"study_design_scores_gemma":[0.013571845,0.004169379,0.96465695,0.0007203511,0.0000023901293,0.0000055157534,0.00016622053,0.0017840718,0.0015570829,0.000104710736,0.013117692,0.00014380287],"about_ca_topic_score_codex":0.0002383899,"about_ca_topic_score_gemma":0.000040390954,"teacher_disagreement_score":0.13416357,"about_ca_system_score_codex":0.000088618515,"about_ca_system_score_gemma":0.00026616652,"threshold_uncertainty_score":0.62699705},"labels":[],"label_agreement":null},{"id":"W1985001841","doi":"10.1185/03007990802417713","title":"A retrospective study of cholinesterase inhibitors for Alzheimer's disease: cerebrovascular disease as a predictor of patient outcomes","year":2008,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Dementia and Cognitive Impairment Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal; Hôtel-Dieu de Montréal","funders":"","keywords":"Medicine; Galantamine; Dementia; Retrospective cohort study; Disease; Internal medicine; Rivastigmine; Cholinesterase; Clinical endpoint; Medical prescription; Cohort study; Donepezil; Clinical trial; Pharmacology","score_opus":0.07044938587892123,"score_gpt":0.42364789333172326,"score_spread":0.353198507452802,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1985001841","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9906141,0.0048584924,0.000040757765,0.0007969726,0.00025040557,0.0033082142,0.00007924151,0.000016649225,0.00003517238],"genre_scores_gemma":[0.9970311,0.0020849402,0.000010471056,0.000025246187,0.00018707437,0.00048811216,0.00011996168,0.000018680823,0.000034415563],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99466664,0.00025831116,0.00052646844,0.00047542964,0.0035890322,0.00048414618],"domain_scores_gemma":[0.9965603,0.00026255084,0.00009152572,0.00034281917,0.0010776785,0.0016651206],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00094731624,0.00017488244,0.00046612075,0.00036201003,0.00016488302,0.000011016959,0.00014857444,0.00005643794,0.00015703228],"category_scores_gemma":[0.004749323,0.00012524713,0.00017896315,0.00038364722,0.00063229376,0.000094462215,0.00024850477,0.00041081297,0.0000042736488],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023444584,0.00769931,0.9719379,0.0005290868,0.00026356388,0.00004702762,0.00061068556,1.1122174e-7,0.0000101568,0.000105299994,0.0013331156,0.015119268],"study_design_scores_gemma":[0.0077525275,0.00629199,0.98131025,0.00081840664,0.0001061263,0.000004822039,0.0005100207,0.00016148738,0.00014376067,0.0002981876,0.0024956346,0.00010678928],"about_ca_topic_score_codex":0.000051707328,"about_ca_topic_score_gemma":0.000002581704,"teacher_disagreement_score":0.0150124775,"about_ca_system_score_codex":0.00005084563,"about_ca_system_score_gemma":0.0008947191,"threshold_uncertainty_score":0.5685726},"labels":[],"label_agreement":null},{"id":"W1985859384","doi":"10.1185/03007995.2014.915801","title":"Weekly risk of venous thromboembolism recurrence in patients receiving oral anticoagulants","year":2014,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Medicine; Venous thromboembolism; Hazard ratio; Medical prescription; Internal medicine; Proportional hazards model; Anticoagulant; Risk assessment; Emergency medicine; Pediatrics; Confidence interval; Thrombosis","score_opus":0.06389392541402902,"score_gpt":0.398267381692557,"score_spread":0.334373456278528,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1985859384","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949625,0.0017658416,0.00013936484,0.00062878005,0.0008518736,0.00061835605,0.000009407859,0.000018749533,0.0010051393],"genre_scores_gemma":[0.978194,0.021374691,0.00007436278,0.00003763511,0.00021282573,0.000025698746,0.00005713431,0.000014405635,0.00000924414],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9964573,0.00043277364,0.00045292894,0.00041017347,0.0016535132,0.00059334975],"domain_scores_gemma":[0.99838954,0.00044601722,0.0001012404,0.0003126919,0.00025151888,0.00049899815],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0032929003,0.00014768426,0.0007138735,0.00034970365,0.00011018898,0.000021774456,0.00020809127,0.00012626573,0.000105687584],"category_scores_gemma":[0.0048207045,0.000117988675,0.000053181193,0.00042173415,0.00035001824,0.00008301362,0.0002732224,0.000794953,0.00002638894],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009265197,0.0028226217,0.3530057,0.00057022827,0.000032779124,0.0000024869682,0.00032258016,4.0792554e-7,0.0000067270403,0.0010191525,0.004638143,0.6374865],"study_design_scores_gemma":[0.0022765908,0.0019259574,0.9794156,0.0023937437,0.00001866069,0.0000012210481,0.000060296643,0.00073398557,0.00004827767,0.0012818909,0.011733441,0.00011033599],"about_ca_topic_score_codex":0.00028681514,"about_ca_topic_score_gemma":0.00004452346,"teacher_disagreement_score":0.6373762,"about_ca_system_score_codex":0.000058328373,"about_ca_system_score_gemma":0.00015146905,"threshold_uncertainty_score":0.57711816},"labels":[],"label_agreement":null},{"id":"W1986062673","doi":"10.1185/03007995.2014.936553","title":"Impact of fatigue on outcome of selective serotonin reuptake inhibitor treatment: secondary analysis of STAR*D","year":2014,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Treatment of Major Depression","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Eli Lilly (Canada)","funders":"Eli Lilly and Company","keywords":"Medicine; Citalopram; Depression (economics); Serotonin reuptake inhibitor; Rating scale; Major depressive disorder; Prospective cohort study; Physical therapy; Quality of life (healthcare); Internal medicine; Psychiatry; Antidepressant; Psychology; Anxiety; Mood","score_opus":0.16244814332232327,"score_gpt":0.5014510710942178,"score_spread":0.33900292777189456,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1986062673","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970718,0.0013878521,0.0000555519,0.00019341418,0.00009933059,0.0005454108,0.00010247477,0.00001089422,0.00053325633],"genre_scores_gemma":[0.9980574,0.0014785335,0.00005510911,0.0000032381172,0.00009240733,0.00002858543,0.00023224176,0.000011526593,0.00004094713],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969709,0.00031588567,0.00053983,0.00032863588,0.0015337229,0.00031104675],"domain_scores_gemma":[0.99771976,0.0008991422,0.0001767073,0.0003689129,0.00035021626,0.0004852449],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009883465,0.0001662602,0.0008031618,0.0008274292,0.000044378314,0.0000045450174,0.000107874715,0.00014432921,0.0003201196],"category_scores_gemma":[0.0018434182,0.00010192335,0.00027501467,0.00083527685,0.00035416518,0.000049636386,0.000072022965,0.00040136423,0.0000025057086],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021074666,0.0032626055,0.71176594,0.00050996104,0.0013385064,0.0000037541106,0.00041337588,0.0000053539297,0.0012888474,0.00019458855,0.0007434714,0.2783661],"study_design_scores_gemma":[0.0054866974,0.017051877,0.9612961,0.0012173003,0.0002487022,0.0000019335298,0.000049265946,0.0019553793,0.011626637,0.00009925635,0.00087664556,0.00009022044],"about_ca_topic_score_codex":0.00029308852,"about_ca_topic_score_gemma":0.000025018098,"teacher_disagreement_score":0.27827588,"about_ca_system_score_codex":0.00017568398,"about_ca_system_score_gemma":0.00036300765,"threshold_uncertainty_score":0.41563135},"labels":[],"label_agreement":null},{"id":"W1986288498","doi":"10.1185/030079902125000246","title":"Lipids and Diabetes Mellitus: A Review of Therapeutic Options","year":2002,"lang":"en","type":"review","venue":"Current Medical Research and Opinion","topic":"Diabetes, Cardiovascular Risks, and Lipoproteins","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Medicine; Diabetes mellitus; Internal medicine; Lipid profile; Disease; Type 2 Diabetes Mellitus; Intensive care medicine; Endocrinology","score_opus":0.19730840211574024,"score_gpt":0.46749184992438086,"score_spread":0.2701834478086406,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1986288498","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000055567807,0.9968743,0.0000156601,0.000447047,0.00044046147,0.0018798223,0.000039520564,0.000024784515,0.00027290056],"genre_scores_gemma":[0.000007382533,0.9981601,0.000028763447,0.000052845644,0.0010323799,0.00032853233,0.00027301855,0.000040455165,0.000076474105],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99497586,0.00086216285,0.0007839933,0.00057638576,0.002182037,0.0006195562],"domain_scores_gemma":[0.9971984,0.0007902899,0.00013652764,0.0006195382,0.00030872584,0.0009465032],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0042424463,0.0003367137,0.0025426734,0.0003895916,0.00011273916,0.000031188534,0.0002402346,0.00036284394,0.00043935239],"category_scores_gemma":[0.0026571883,0.00022373084,0.00060024916,0.00064058206,0.00086120394,0.000055231096,0.00024818766,0.0015690086,0.000040742445],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000023325297,0.00014924043,0.000005542835,0.2734916,0.0002152253,0.0000023497998,0.000008998157,2.9755146e-10,1.3832343e-8,0.00012732024,0.0036784746,0.7223189],"study_design_scores_gemma":[0.00031494035,0.00031981553,0.00003417506,0.32122946,0.0003374489,0.000018968807,0.0000043708733,0.000007524535,3.1116144e-7,0.000073581534,0.67753786,0.00012154708],"about_ca_topic_score_codex":0.000039362836,"about_ca_topic_score_gemma":0.0000020825491,"teacher_disagreement_score":0.72219735,"about_ca_system_score_codex":0.00005773911,"about_ca_system_score_gemma":0.00054982037,"threshold_uncertainty_score":0.91234785},"labels":[],"label_agreement":null},{"id":"W1987970762","doi":"10.1185/03007995.2010.515900","title":"Reasons for discontinuation and continuation of antipsychotics in the treatment of schizophrenia from patient and clinician perspectives","year":2010,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":60,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Institutes of Health; National Institute of Mental Health; Institut National de la Santé et de la Recherche Médicale; Eli Lilly and Company","keywords":"Discontinuation; Medicine; Concordance; Antipsychotic; Adverse effect; Schizophrenia (object-oriented programming); Clinical endpoint; Continuation; Psychiatry; Clinical trial; Antipsychotic drug; Pediatrics; Internal medicine","score_opus":0.08885910751449391,"score_gpt":0.4495784966865421,"score_spread":0.36071938917204815,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1987970762","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9869568,0.008687371,0.000053505744,0.002997913,0.0001239308,0.0010949755,0.00006379042,0.0000032762587,0.000018453607],"genre_scores_gemma":[0.9784769,0.020535845,0.00060590316,0.0000036812987,0.00017516708,0.00008840153,0.00010561577,0.0000057208717,0.0000027709677],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99844474,0.00015161476,0.00027883906,0.00025556443,0.000663813,0.00020541884],"domain_scores_gemma":[0.9978933,0.0014247493,0.000066393695,0.0001730335,0.00021536453,0.00022719837],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000848536,0.00009267507,0.00025292396,0.00016114843,0.000070729526,0.000018977347,0.00005278134,0.00008358036,0.000014015807],"category_scores_gemma":[0.0017239148,0.000054094042,0.00003862295,0.00014438244,0.00054733636,0.00004650901,0.00002451422,0.00026547885,3.4225937e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008110846,0.0023694623,0.067944914,0.00007949859,0.0000488804,0.0000026981886,0.0040068394,1.14025305e-8,0.0004096796,0.005841644,0.00011297516,0.91107255],"study_design_scores_gemma":[0.01389174,0.009024787,0.961244,0.00062403944,0.000035116733,0.000007592945,0.003935573,0.0011023106,0.0009243289,0.006513688,0.0026108257,0.0000859859],"about_ca_topic_score_codex":0.0001326447,"about_ca_topic_score_gemma":0.0005030124,"teacher_disagreement_score":0.91098654,"about_ca_system_score_codex":0.000019404488,"about_ca_system_score_gemma":0.00018848831,"threshold_uncertainty_score":0.2205891},"labels":[],"label_agreement":null},{"id":"W1993235173","doi":"10.1185/03007995.2012.709837","title":"An evaluation of patient and physician satisfaction with controlled-release oxybutynin 15 mg as a one-step daily dose in elderly and non-elderly patients with overactive bladder: results of the STOP study","year":2012,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Purdue Pharma (Canada); Guelph General Hospital; Hôpital Charles-Le Moyne","funders":"","keywords":"Medicine; Overactive bladder; Nocturia; Oxybutynin; Tolterodine; Anticholinergic; Adverse effect; Patient satisfaction; Delirium; Urinary incontinence; Internal medicine; Urology; Urinary system; Surgery; Intensive care medicine","score_opus":0.05188406553823979,"score_gpt":0.4027806970838807,"score_spread":0.3508966315456409,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1993235173","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943495,0.001517458,0.000008871826,0.00026625372,0.000065897584,0.0036041967,0.000030304438,0.0000042975735,0.00015323171],"genre_scores_gemma":[0.99906826,0.0006310612,0.000014326203,0.000010289104,0.00006909472,0.00013674572,0.000052651103,0.0000132842015,0.000004287711],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9942824,0.0010624924,0.0003992669,0.00036184862,0.0034728714,0.00042111365],"domain_scores_gemma":[0.9976423,0.0005337783,0.00016016827,0.0002951695,0.0008341239,0.00053447986],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030171396,0.0001633833,0.00041003225,0.00024155084,0.00013718553,0.000028694736,0.000076197604,0.00008136193,0.000021533951],"category_scores_gemma":[0.000953174,0.000093974675,0.000022776521,0.00038321997,0.00044966303,0.0003769473,0.00009708674,0.00070943614,8.034047e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02246623,0.0045854575,0.44679046,0.00019750929,0.0001095784,0.0000021632043,0.0054088775,0.0000012883706,0.000103249346,0.000015141438,0.00006227492,0.5202578],"study_design_scores_gemma":[0.038386744,0.028506454,0.9263087,0.00091795274,0.000070036236,0.0000035840712,0.004422895,0.0010206786,0.00013890906,0.00006015066,0.000062723375,0.00010116146],"about_ca_topic_score_codex":0.0009812218,"about_ca_topic_score_gemma":0.00035866618,"teacher_disagreement_score":0.5201566,"about_ca_system_score_codex":0.00007752278,"about_ca_system_score_gemma":0.00059209164,"threshold_uncertainty_score":0.3832176},"labels":[],"label_agreement":null},{"id":"W1993770917","doi":"10.1185/03007990903210066","title":"Tadalafil therapy and health-related quality of life in pulmonary arterial hypertension","year":2009,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Pulmonary Hypertension Research and Treatments","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Eli Lilly (Canada)","funders":"Eli Lilly and Company","keywords":"Tadalafil; Medicine; Tolerability; Placebo; Quality of life (healthcare); Pulmonary hypertension; Physical therapy; Internal medicine; Erectile dysfunction; Cardiology; Adverse effect; Alternative medicine","score_opus":0.29839008884754364,"score_gpt":0.4725349696551922,"score_spread":0.17414488080764856,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1993770917","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92818487,0.05111943,0.0000026745026,0.019774156,0.00016304298,0.00056984683,0.000008117352,0.00001538874,0.00016249962],"genre_scores_gemma":[0.9273358,0.072126046,0.000022310507,0.00025342178,0.000111780275,0.000012782914,0.00010497298,0.0000070629785,0.00002579822],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9965437,0.00045030785,0.0005891279,0.00038298828,0.0015006781,0.00053318706],"domain_scores_gemma":[0.99791986,0.00029970478,0.00006228146,0.00021604999,0.00018693408,0.0013151716],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026508875,0.00013346245,0.000562039,0.00030849836,0.00010866158,0.000012608583,0.00008625116,0.00014436053,0.00011543505],"category_scores_gemma":[0.001341534,0.00009232609,0.000044815,0.00036973003,0.0003613865,0.00007959839,0.00007545713,0.00067534554,0.00000662549],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037871858,0.0037754234,0.06731441,0.00028275847,0.000030508954,0.0003005299,0.00006908331,3.1642514e-8,0.0017931388,0.0005392664,0.0027730407,0.91933465],"study_design_scores_gemma":[0.006031269,0.002411981,0.984607,0.0008422192,0.0000011367664,0.00012318845,0.00006647974,0.00068225735,0.000042408992,0.0016297083,0.0034782393,0.00008411366],"about_ca_topic_score_codex":0.00045928863,"about_ca_topic_score_gemma":0.00000945117,"teacher_disagreement_score":0.9192505,"about_ca_system_score_codex":0.000045642202,"about_ca_system_score_gemma":0.00063446845,"threshold_uncertainty_score":0.37649485},"labels":[],"label_agreement":null},{"id":"W1995103418","doi":"10.1185/030079908x280725","title":"In vitro disintegration and dissolution studies of once-weekly copies of alendronate sodium tablets (70  mg) and in vivo implications","year":2008,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Bone health and treatments","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Alendronic acid; Immediate release; Dissolution; Pharmacology; Dosage form; Bisphosphonate; Internal medicine; Chemistry; Osteoporosis","score_opus":0.1915947261061282,"score_gpt":0.4885672652288719,"score_spread":0.2969725391227437,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1995103418","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9679663,0.02523811,0.000019854973,0.0061955536,0.00008799611,0.00040913266,0.000026830447,0.0000036854406,0.000052499425],"genre_scores_gemma":[0.90267605,0.097125165,0.00003926728,0.000011839591,0.000025072175,0.00004670398,0.00003645993,0.0000034942923,0.000035958994],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987303,0.00009354542,0.0003140568,0.00019271551,0.00043016157,0.00023920056],"domain_scores_gemma":[0.99915785,0.0003223531,0.000048411057,0.00009056091,0.00014061976,0.00024018943],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005324413,0.00007520364,0.0002794386,0.0002205785,0.00007658316,0.0000025523177,0.000029102865,0.000066430075,0.0000067946844],"category_scores_gemma":[0.000897491,0.000055549608,0.000012557712,0.00022817634,0.0006562528,0.00008753023,0.000060661438,0.00025843302,4.3125485e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036002558,0.0029472725,0.67442405,0.0045947563,0.000082676655,0.00003537896,0.0044710347,1.8423135e-7,0.013967145,0.0024562108,0.0050591473,0.2883619],"study_design_scores_gemma":[0.005506448,0.0010501372,0.98030806,0.001788529,0.000010318632,0.0000574616,0.0005910898,0.0006463208,0.005171585,0.0016767838,0.0031038162,0.000089440946],"about_ca_topic_score_codex":0.00032889494,"about_ca_topic_score_gemma":0.00018272913,"teacher_disagreement_score":0.30588403,"about_ca_system_score_codex":0.00005986096,"about_ca_system_score_gemma":0.00022269714,"threshold_uncertainty_score":0.24179907},"labels":[],"label_agreement":null},{"id":"W1997452386","doi":"10.1185/03007995.2014.915212","title":"Use of 5% lidocaine medicated plasters for the treatment of pain in routine hospital practice: patient reported pain, functioning and satisfaction","year":2014,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Pain Mechanisms and Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pharma Medica Research (Canada)","funders":"","keywords":"Medicine; Discontinuation; Lidocaine; Physical therapy; Pain relief; Patient satisfaction; Pain score; Anesthesia; Surgery","score_opus":0.10884867224092692,"score_gpt":0.4085421352218908,"score_spread":0.2996934629809639,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1997452386","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97328305,0.003970965,0.014696447,0.005895159,0.00044254842,0.0016782237,0.000009767127,0.0000140812635,0.000009775169],"genre_scores_gemma":[0.988677,0.010594869,0.00035020214,0.000037216407,0.00009820419,0.00013940022,0.00008527514,0.000009246314,0.0000085857755],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99780333,0.0005136371,0.00041764835,0.00024024912,0.0007845339,0.0002406184],"domain_scores_gemma":[0.99397606,0.0051647956,0.00016627664,0.00017234239,0.00026924882,0.00025125602],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0042071156,0.00010530674,0.000259974,0.00014359028,0.00008868986,0.000011816124,0.000026469243,0.00008568104,0.000016346197],"category_scores_gemma":[0.019194301,0.000062160514,0.000038168506,0.00019069409,0.00020190187,0.000073019764,0.000025726578,0.000177087,2.4376357e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000812788,0.0010084604,0.04875255,0.0001870744,0.00011036495,0.0000071606914,0.0005671143,0.000001132528,0.000061212835,0.0001696632,0.00051585265,0.94780666],"study_design_scores_gemma":[0.028673481,0.11721359,0.45818257,0.0062239477,0.00031666495,0.0000895424,0.0051278165,0.1491906,0.0016660388,0.00097317284,0.23191315,0.0004294279],"about_ca_topic_score_codex":0.00037971957,"about_ca_topic_score_gemma":0.000029965828,"teacher_disagreement_score":0.9473772,"about_ca_system_score_codex":0.00007641403,"about_ca_system_score_gemma":0.00011987859,"threshold_uncertainty_score":0.98906744},"labels":[],"label_agreement":null},{"id":"W1999059326","doi":"10.1185/030079904125003467","title":"The multinational Men's Attitudes to Life Events and Sexuality (MALES) study: I. Prevalence oSf erectile dysfunction and related health concerns in the general population","year":2004,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Sexual function and dysfunction studies","field":"Medicine","cited_by":587,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Bayer Corporation","keywords":"Medicine; Erectile dysfunction; Demography; Dyslipidemia; Depression (economics); Population; Gerontology; Prevalence; Disease; Psychiatry; Internal medicine; Environmental health","score_opus":0.15866864211484244,"score_gpt":0.5006145562333871,"score_spread":0.3419459141185447,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1999059326","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96722835,0.003986724,0.000115464725,0.026548339,0.0006948426,0.0012967038,0.000005673058,0.000023597388,0.00010028812],"genre_scores_gemma":[0.99362725,0.0052933935,0.000011030245,0.00030470113,0.0003359345,0.00012595473,0.000038688126,0.0000060610255,0.00025695784],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971631,0.00055119256,0.00033683758,0.0003665411,0.0013023617,0.00027996398],"domain_scores_gemma":[0.9986203,0.00062677223,0.00005253071,0.00014611047,0.00016803849,0.0003862643],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0041807564,0.00010726595,0.00017657717,0.000118759956,0.00067912025,0.000046996538,0.000067008135,0.000059350932,0.000050819228],"category_scores_gemma":[0.0034393105,0.000062058745,0.000014586555,0.00034253232,0.00019802786,0.00008499605,0.00012491626,0.0005268915,0.000010301285],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006626672,0.0009110803,0.8518222,0.00029824197,0.00004752651,0.000002697813,0.003015352,0.0000070969286,0.0000058487517,0.0024853635,0.0051261857,0.13561574],"study_design_scores_gemma":[0.0025939408,0.001028553,0.98481554,0.00020099053,0.0000052333885,0.000016146638,0.0022650168,0.00024981127,5.974855e-7,0.00036869492,0.008397565,0.000057925427],"about_ca_topic_score_codex":0.0005775951,"about_ca_topic_score_gemma":0.00021535839,"teacher_disagreement_score":0.1355578,"about_ca_system_score_codex":0.00012738505,"about_ca_system_score_gemma":0.00021117966,"threshold_uncertainty_score":0.52233124},"labels":[],"label_agreement":null},{"id":"W2000588978","doi":"10.1185/030079907x226087","title":"Health-related quality of life (HRQOL) among patients with Generalised Anxiety Disorder: evaluation conducted alongside an escitalopram relapse prevention trial","year":2007,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes","field":"Psychology","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Escitalopram; Quality of life (healthcare); Visual analogue scale; Anxiety; Placebo; Population; Randomization; Physical therapy; Internal medicine; Randomized controlled trial; Psychiatry; Alternative medicine","score_opus":0.21006950467039445,"score_gpt":0.5130317131532052,"score_spread":0.30296220848281075,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2000588978","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9813171,0.011450921,0.0016861351,0.00027123265,0.0021637883,0.0027398395,0.000052908992,0.000056880774,0.00026121543],"genre_scores_gemma":[0.98916614,0.0080017885,0.00007952293,0.000022017502,0.00035584057,0.00021505436,0.0020800242,0.000031724117,0.00004786298],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99094033,0.0027953486,0.0012145159,0.0008833387,0.003401663,0.00076481124],"domain_scores_gemma":[0.9951618,0.0008632652,0.0006015026,0.0004450153,0.0017803366,0.0011481361],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.012421238,0.0002573243,0.0005153817,0.000599976,0.00032396344,0.000045360914,0.00028457356,0.00033904475,0.0007272389],"category_scores_gemma":[0.008799916,0.00019917333,0.000080217535,0.0015122042,0.0007745575,0.00040146624,0.00010755661,0.0008563113,0.000015251098],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014761885,0.0043854616,0.36665958,0.00012628164,0.0000957205,6.192716e-7,0.0007893729,4.1125844e-7,0.000002022912,0.00027073108,0.0016348411,0.61127305],"study_design_scores_gemma":[0.061159946,0.004218284,0.92868465,0.00036817536,0.000020740486,0.000001349784,0.00065254234,0.000111920366,0.000012365608,0.0016020323,0.0029308384,0.00023713695],"about_ca_topic_score_codex":0.0011904292,"about_ca_topic_score_gemma":0.00047890915,"teacher_disagreement_score":0.61103594,"about_ca_system_score_codex":0.00014783537,"about_ca_system_score_gemma":0.0006950467,"threshold_uncertainty_score":0.9995494},"labels":[],"label_agreement":null},{"id":"W2001583411","doi":"10.1185/03007995.2014.908828","title":"Impact of adherence to treatment with tiotropium and fluticasone propionate/salmeterol in chronic obstructive pulmonary diseases patients","year":2014,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Chronic Obstructive Pulmonary Disease (COPD) Research","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University; GlaxoSmithKline (Canada); McMaster University","funders":"GlaxoSmithKline","keywords":"Medicine; COPD; Salmeterol; Fluticasone propionate; Medical prescription; Internal medicine; Odds ratio; Cohort; Emergency department; Fluticasone; Intensive care medicine; Emergency medicine; Corticosteroid; Pharmacology","score_opus":0.04927786246417121,"score_gpt":0.40540056299820315,"score_spread":0.35612270053403194,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2001583411","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9922991,0.005657286,0.00005402633,0.00022422285,0.00008178664,0.0014783377,0.00008664498,0.000014124284,0.000104479026],"genre_scores_gemma":[0.9964671,0.0028730852,0.0000409076,0.000004923388,0.0002044731,0.0002115593,0.00014570433,0.000021109541,0.000031123014],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99651945,0.00028032414,0.00030269363,0.0006031566,0.0016028197,0.00069158466],"domain_scores_gemma":[0.9973893,0.0003812365,0.000047654878,0.00030724765,0.00038834926,0.0014861852],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003025877,0.00022415961,0.00044052053,0.00041009256,0.00008836708,0.00002251594,0.00013816419,0.00009002333,0.0001578382],"category_scores_gemma":[0.00076773006,0.00014307881,0.000061527215,0.0005079554,0.0007776787,0.000116831405,0.0002276374,0.00043852197,0.000010871672],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013640055,0.0009773863,0.5026315,0.00059124245,0.000038075028,0.00001825829,0.0000663039,9.263477e-7,0.000092606395,0.00007690394,0.00004076,0.49410206],"study_design_scores_gemma":[0.0036648142,0.011682305,0.9789188,0.0013290842,0.000014726482,0.000015752956,0.00004571829,0.0031386155,0.00004984677,0.00024508813,0.0007653307,0.00012992063],"about_ca_topic_score_codex":0.00031821363,"about_ca_topic_score_gemma":0.000028270684,"teacher_disagreement_score":0.49397212,"about_ca_system_score_codex":0.0010500319,"about_ca_system_score_gemma":0.0012541334,"threshold_uncertainty_score":0.5834585},"labels":[],"label_agreement":null},{"id":"W2001783668","doi":"10.1185/030079908x291912","title":"Functionality and health-status benefits associated with reduction of osteoarthritis pain","year":2008,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Osteoarthritis Treatment and Mechanisms","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; WOMAC; Osteoarthritis; Physical therapy; Placebo; Visual analogue scale; Tramadol; Intensity (physics); Randomized controlled trial; Internal medicine; Analgesic; Anesthesia; Alternative medicine","score_opus":0.1429188671685779,"score_gpt":0.39378362470936584,"score_spread":0.25086475754078796,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2001783668","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9571696,0.038773824,0.000055431658,0.0029059502,0.00029075562,0.0005748693,0.000035111858,0.00003060734,0.00016385026],"genre_scores_gemma":[0.97035193,0.028850809,0.00005386733,0.000033821845,0.00019279649,0.00003984958,0.00038790383,0.000010113414,0.000078916484],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99769837,0.00024156642,0.00023460553,0.00026767116,0.0011644603,0.0003933576],"domain_scores_gemma":[0.9986446,0.00019351114,0.00005777658,0.00010911106,0.00026735815,0.0007276552],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017621812,0.00009839919,0.0002654295,0.00013205229,0.00022487309,0.000007210094,0.000026891354,0.000094334115,0.00007996759],"category_scores_gemma":[0.0008823176,0.00007524529,0.000025427755,0.00024186495,0.00049707585,0.00006630076,0.000040650288,0.00035839656,0.000002202481],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038431893,0.00045879747,0.033738125,0.00018032208,0.00001933143,0.000011108729,0.00022805904,3.9906933e-8,0.000055980167,0.0010569794,0.0017438583,0.9621231],"study_design_scores_gemma":[0.04338978,0.09835242,0.77361584,0.01741557,0.000043281503,0.0010663603,0.0012688562,0.00020013818,0.001722214,0.0022457603,0.060092065,0.0005876945],"about_ca_topic_score_codex":0.00006847806,"about_ca_topic_score_gemma":0.000050284652,"teacher_disagreement_score":0.9615354,"about_ca_system_score_codex":0.00007197147,"about_ca_system_score_gemma":0.00051054766,"threshold_uncertainty_score":0.3068414},"labels":[],"label_agreement":null},{"id":"W2001950185","doi":"10.1185/030079906x132749","title":"A large, naturalistic, community-based study of rivastigmine in mild-to-moderate AD:the EXTEND Study","year":2006,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Dementia and Cognitive Impairment Research","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Novartis (Canada); Alberta Hospital Edmonton; University of Alberta Hospital; Douglas Mental Health University Institute","funders":"","keywords":"Rivastigmine; Medicine; Observational study; Clinical Global Impression; Internal medicine; Dementia; Adverse effect; Disease; Donepezil; Alternative medicine","score_opus":0.13386145888034318,"score_gpt":0.4850007915149414,"score_spread":0.35113933263459823,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2001950185","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99386686,0.0011982193,0.00013709448,0.0018218053,0.000115474504,0.0026341348,0.0000118657435,0.000013629262,0.00020088896],"genre_scores_gemma":[0.9991985,0.00012322601,0.000009503804,0.00007747579,0.00011745689,0.00026163808,0.00009779128,0.0000131933275,0.0001012414],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99380666,0.0018711399,0.00047185272,0.00032292138,0.0028592327,0.0006682063],"domain_scores_gemma":[0.99739045,0.0011752323,0.00004030478,0.0004017908,0.00053482637,0.00045742156],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0067309258,0.00015576574,0.00036177534,0.0005355759,0.00035273744,0.00004685433,0.00032114107,0.00006154243,0.00016537338],"category_scores_gemma":[0.0020458282,0.00009953187,0.000039564868,0.00096608495,0.00026408947,0.00004651536,0.00042022922,0.0018467802,0.0000142078625],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0045994986,0.07291723,0.8535588,0.00093512953,0.0001015055,0.00018144552,0.0036694445,0.000002940123,0.00019147102,0.00019528186,0.008114345,0.055532932],"study_design_scores_gemma":[0.011750121,0.009114285,0.96455795,0.0007463453,0.000018919707,0.000003281973,0.006401698,0.0010726412,0.00011180892,0.00026360594,0.005846725,0.00011262277],"about_ca_topic_score_codex":0.0007249682,"about_ca_topic_score_gemma":0.0012012324,"teacher_disagreement_score":0.110999174,"about_ca_system_score_codex":0.00006290173,"about_ca_system_score_gemma":0.00031618206,"threshold_uncertainty_score":0.8023443},"labels":[],"label_agreement":null},{"id":"W2006353383","doi":"10.1185/030079904x4644","title":"Montelukast in asthmatic patients 6 years–14 years old with an FEV<sub>1</sub>&gt; 75%","year":2004,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Asthma and respiratory diseases","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Manitoba","funders":"","keywords":"Montelukast; Medicine; Placebo; Asthma; Leukotriene receptor; Clinical endpoint; Internal medicine; Clinical trial; Leukotriene; Anesthesia; Antagonist; Receptor","score_opus":0.04360183958872483,"score_gpt":0.3726995768612552,"score_spread":0.3290977372725304,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2006353383","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99682796,0.0019749012,0.00004712248,0.0003086937,0.0002128406,0.0005071986,0.000010939122,0.00002957076,0.000080745594],"genre_scores_gemma":[0.99809605,0.0012460317,0.000028361352,0.00010134422,0.00032490195,0.00004682343,0.00012097429,0.000023841896,0.0000116849415],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9967369,0.00015096545,0.00027908458,0.00039211012,0.0018865721,0.00055437733],"domain_scores_gemma":[0.9982369,0.00009315471,0.000038515587,0.0002530609,0.00016186007,0.0012165207],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00064761605,0.0001462838,0.00026826092,0.00030399347,0.00007814251,0.000036313642,0.0001466974,0.00013343645,0.000049233768],"category_scores_gemma":[0.0007345217,0.00010879094,0.000040720017,0.00042231375,0.00042961683,0.00013800392,0.00010464723,0.0007528588,0.00007192269],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00095452147,0.0028598881,0.11095455,0.00050653174,0.000018756615,0.00025969403,0.0005736899,0.000003422481,0.00010659256,0.00028451276,0.0013755125,0.8821023],"study_design_scores_gemma":[0.008200076,0.0048987474,0.9701445,0.0032390219,0.000007649461,0.000016534186,0.00023176528,0.0001585665,0.00016165519,0.0003702543,0.012362328,0.00020886211],"about_ca_topic_score_codex":0.000032671498,"about_ca_topic_score_gemma":0.000057866055,"teacher_disagreement_score":0.88189346,"about_ca_system_score_codex":0.000115698625,"about_ca_system_score_gemma":0.0005327178,"threshold_uncertainty_score":0.44363657},"labels":[],"label_agreement":null},{"id":"W2008055993","doi":"10.1185/030079904125003403","title":"Cost effectiveness of oral triptan therapy: a trans-national comparison based on a meta-analysis of randomised controlled trials","year":2004,"lang":"en","type":"review","venue":"Current Medical Research and Opinion","topic":"Migraine and Headache Studies","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Sumatriptan; Medicine; Triptans; Rizatriptan; Number needed to treat; Migraine; Cost effectiveness; Placebo; Zolmitriptan; Meta-analysis; Randomized controlled trial; Intensive care medicine; Confidence interval; Physical therapy; Relative risk; Anesthesia; Internal medicine; Alternative medicine","score_opus":0.7514765241341359,"score_gpt":0.6330354176853634,"score_spread":0.11844110644877248,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2008055993","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000085169795,0.9906183,0.0008119449,0.00031618326,0.00006837917,0.007673599,0.00026804872,0.0000091076045,0.00022590662],"genre_scores_gemma":[0.003134273,0.99401844,0.000022400467,0.000012585927,0.00011368122,0.0016614092,0.0009949724,0.000019746969,0.000022501124],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98515695,0.0077335625,0.0023396222,0.0005063866,0.0038874159,0.00037606256],"domain_scores_gemma":[0.9689582,0.028631346,0.0006786171,0.00029119255,0.0009962211,0.00044444564],"candidate_categories":["metaresearch","metaepi_broad"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.03971658,0.00041208076,0.018437387,0.0017577158,0.00008872866,0.000014584296,0.00020741195,0.00034466584,0.00084611634],"category_scores_gemma":[0.024706367,0.00020615893,0.006475803,0.0015181134,0.0005491665,0.000020561942,0.0000333406,0.0010832946,0.0000018053728],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06749716,0.0047456683,0.000024241206,0.06793347,0.28196883,0.0000060794982,0.00016713764,0.0000065023974,0.0000021870942,0.00079401594,0.0027739645,0.57408077],"study_design_scores_gemma":[0.19765483,0.0032972554,0.00007631027,0.022626417,0.19074698,0.0000017452937,0.000033861394,0.0011531197,0.000010794493,0.00013056865,0.58398324,0.00028487245],"about_ca_topic_score_codex":0.000049637998,"about_ca_topic_score_gemma":0.000009819711,"teacher_disagreement_score":0.5812093,"about_ca_system_score_codex":0.00013604666,"about_ca_system_score_gemma":0.003273855,"threshold_uncertainty_score":0.99613494},"labels":[],"label_agreement":null},{"id":"W2009077238","doi":"10.1185/030079905x38169","title":"Association between corneal thickness, mean intraocular pressure, disease stability and severity, and cost of treatment in glaucoma: a Canadian analysis","year":2005,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Corneal surgery and disorders","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; PharmIdeas (Canada); Brock University","funders":"","keywords":"Medicine; Glaucoma; Intraocular pressure; Ophthalmology; Disease; Visual field; Severity of illness; Internal medicine","score_opus":0.06771134620846002,"score_gpt":0.3820534541385429,"score_spread":0.3143421079300829,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2009077238","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9860047,0.008983693,0.00002889241,0.004227973,0.00003804889,0.00051731744,0.00011467411,0.0000065458257,0.00007815378],"genre_scores_gemma":[0.9914192,0.008172748,0.0000062031186,0.000021454724,0.000101579404,0.000029423469,0.00022854238,0.000004205474,0.000016620696],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981239,0.00028339078,0.00026156398,0.00029844354,0.0006713749,0.0003613252],"domain_scores_gemma":[0.99774915,0.0005795147,0.000040422623,0.00013962232,0.00012873804,0.0013625466],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017946705,0.00010060395,0.00035313165,0.00030030863,0.00009009476,0.000021368003,0.000043379103,0.00011274465,0.00014741463],"category_scores_gemma":[0.0015167143,0.000081850376,0.000045760746,0.0004682899,0.00024064585,0.000074135074,0.00005921408,0.0003190745,8.669512e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015390992,0.00020346706,0.8680542,0.00018252905,0.0001343095,0.0000043240557,0.00021129905,1.9731424e-7,0.0000014424523,0.000050865376,0.00016903486,0.1308344],"study_design_scores_gemma":[0.0012117763,0.0001659703,0.970163,0.0001193541,0.00016323022,7.9836724e-7,0.00006932353,0.0027399776,0.000012095473,0.00018243224,0.025105014,0.00006701518],"about_ca_topic_score_codex":0.04215531,"about_ca_topic_score_gemma":0.112824835,"teacher_disagreement_score":0.13076738,"about_ca_system_score_codex":0.0002741858,"about_ca_system_score_gemma":0.00080415263,"threshold_uncertainty_score":0.9642231},"labels":[],"label_agreement":null},{"id":"W2010268134","doi":"10.1185/03007995.2014.898140","title":"A network meta-analysis of the efficacy of belatacept, cyclosporine and tacrolimus for immunosuppression therapy in adult renal transplant recipients","year":2014,"lang":"en","type":"review","venue":"Current Medical Research and Opinion","topic":"Renal Transplantation Outcomes and Treatments","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University; Dalhousie University","funders":"","keywords":"Belatacept; Medicine; Tacrolimus; Immunosuppression; Meta-analysis; Renal function; Kidney transplantation; Randomized controlled trial; Transplantation; Internal medicine; Urology; Kidney transplant","score_opus":0.2729114025688503,"score_gpt":0.5037379700726837,"score_spread":0.2308265675038334,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2010268134","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0014429926,0.99599767,0.000089957946,0.00017437138,0.00020539788,0.001792919,0.00027381995,0.0000037364855,0.000019123556],"genre_scores_gemma":[0.006872258,0.99180007,0.000045056746,0.00000943393,0.00010755879,0.00018584437,0.0009329315,0.000017833454,0.00002901338],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9964692,0.0005247206,0.0009921627,0.00041635463,0.0012334152,0.00036417673],"domain_scores_gemma":[0.99659634,0.002289543,0.00029330023,0.0003670032,0.00019047433,0.00026335433],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016009031,0.00026892291,0.0028167525,0.00039544958,0.00009158045,0.0000096263875,0.00022498715,0.00024579224,0.00007706706],"category_scores_gemma":[0.0003758402,0.0001253651,0.0010659661,0.0009010368,0.00028723912,0.000026658676,0.0000586776,0.00063840655,4.6875098e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012126622,0.0007607644,0.0038870552,0.015005449,0.028116535,0.000006773043,0.00017330261,0.0000022695515,7.1625004e-7,0.00032468876,0.000103428945,0.9504064],"study_design_scores_gemma":[0.021895418,0.004171695,0.053358264,0.12897101,0.14332654,0.00007468496,0.000014522931,0.0005124725,0.000024226074,0.00029432637,0.6467272,0.00062963937],"about_ca_topic_score_codex":0.00005208332,"about_ca_topic_score_gemma":0.000017254739,"teacher_disagreement_score":0.9497767,"about_ca_system_score_codex":0.000027889882,"about_ca_system_score_gemma":0.00018479953,"threshold_uncertainty_score":0.51122403},"labels":[],"label_agreement":null},{"id":"W2010436565","doi":"10.1185/03007990802430518","title":"Naturalistic evaluation of entacapone in patients with signs and symptoms of<scp>L</scp>-dopa wearing-off","year":2008,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Novartis (Canada); University of Calgary; Centre Hospitalier de l’Université de Montréal; London Health Sciences Centre","funders":"","keywords":"Entacapone; Medicine; Levodopa; Quality of life (healthcare); Clinical Global Impression; Observational study; Parkinson's disease; Rating scale; Open label; Physical therapy; Internal medicine; Prospective cohort study; Clinical trial; Disease; Psychology; Alternative medicine","score_opus":0.08985375168669918,"score_gpt":0.39372623525140216,"score_spread":0.303872483564703,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2010436565","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9913491,0.0077392347,0.000014776207,0.000034895857,0.0001099995,0.0005684836,0.000019809053,0.0000051375728,0.00015854897],"genre_scores_gemma":[0.9974929,0.0022035711,0.000022306107,0.000005346264,0.000041257976,0.000032560118,0.00018102876,0.000007923593,0.000013089668],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967964,0.00017177637,0.00023016571,0.00025345286,0.002284854,0.0002633241],"domain_scores_gemma":[0.9987718,0.00029491558,0.00005915768,0.00013284867,0.00033184316,0.0004094306],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008865888,0.000102377635,0.00025441183,0.00023977118,0.0000588699,0.0000048158827,0.000057037374,0.000062328334,0.000042887503],"category_scores_gemma":[0.0016756182,0.0000710191,0.000022744225,0.0002562036,0.00031340515,0.000061067236,0.00007071456,0.00028760207,0.0000018978911],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004056684,0.0019580973,0.8363271,0.00044833188,0.00007410558,0.000019791747,0.00033913768,6.274697e-7,0.000052365307,0.0004330005,0.00024312151,0.15969867],"study_design_scores_gemma":[0.00930847,0.0028430417,0.9833552,0.0013269511,0.000039239545,0.000008389116,0.00006371652,0.0012954373,0.00026244833,0.00030972733,0.0011457083,0.00004166323],"about_ca_topic_score_codex":0.00004007132,"about_ca_topic_score_gemma":0.0000043121613,"teacher_disagreement_score":0.159657,"about_ca_system_score_codex":0.00006683514,"about_ca_system_score_gemma":0.00034270974,"threshold_uncertainty_score":0.2896075},"labels":[],"label_agreement":null},{"id":"W2011186711","doi":"10.1185/030079905x75069","title":"Efficacy of etoricoxib 60 mg/day and diclofenac 150 mg/day in reduction of pain and disability in patients with chronic low back pain: results of a 4‐week, multinational, randomized, double-blind study","year":2005,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Etoricoxib; Tolerability; Diclofenac; Low back pain; Discontinuation; Randomized controlled trial; Clinical endpoint; Visual analogue scale; Physical therapy; Analgesic; Anesthesia; Adverse effect; Internal medicine","score_opus":0.05000715325874751,"score_gpt":0.38057945519416736,"score_spread":0.33057230193541987,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2011186711","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99388486,0.0019309225,0.000032079017,0.0004684527,0.00014714351,0.003504978,0.000011809763,0.0000049268424,0.000014811028],"genre_scores_gemma":[0.9982946,0.0012208159,0.000023761973,0.0000032105597,0.00024166533,0.00010330332,0.000094425784,0.000011599393,0.0000066143666],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9943563,0.0022830348,0.0009540559,0.0004487802,0.0015975907,0.0003602462],"domain_scores_gemma":[0.9952016,0.0036565792,0.00020890278,0.00024322899,0.00032288255,0.0003667974],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.021176113,0.00017664538,0.0007700311,0.0003289179,0.000044738634,0.000008240128,0.00009102998,0.00014960625,0.000028054666],"category_scores_gemma":[0.010024405,0.00012105964,0.000044462537,0.0004965712,0.001153776,0.00011895658,0.00010707636,0.00060966506,6.7163074e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.31015685,0.01015477,0.41523445,0.0037861778,0.00007333899,0.0000046134346,0.003690167,0.0000088865945,0.0000817223,0.00005213821,0.00030145326,0.25645545],"study_design_scores_gemma":[0.47566834,0.004572874,0.51171046,0.0033677367,0.000014926263,9.69481e-7,0.00023093003,0.003816483,0.00021631658,0.00002249409,0.00025463663,0.00012381132],"about_ca_topic_score_codex":0.00018314157,"about_ca_topic_score_gemma":0.00013629404,"teacher_disagreement_score":0.25633162,"about_ca_system_score_codex":0.00016976168,"about_ca_system_score_gemma":0.00033360434,"threshold_uncertainty_score":0.99831456},"labels":[],"label_agreement":null},{"id":"W2011227046","doi":"10.1185/03007995.2013.867842","title":"Chronic obstructive pulmonary disease and exacerbations: clinician insights from the global Hidden Depths of COPD survey","year":2013,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Chronic Obstructive Pulmonary Disease (COPD) Research","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Takeda Pharmaceuticals International","keywords":"Medicine; COPD; Exacerbation; Pulmonary rehabilitation; Quality of life (healthcare); Physical therapy; Disease management; Intensive care medicine; Pulmonary disease; Disease; Internal medicine; Nursing","score_opus":0.07687313663596963,"score_gpt":0.40245613765280114,"score_spread":0.3255830010168315,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2011227046","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.86444503,0.12868452,0.000045093595,0.0037080375,0.00047511805,0.0017416469,0.00034022142,0.000026808906,0.0005335121],"genre_scores_gemma":[0.98250276,0.0153839,0.000023252072,0.000047757516,0.0010847837,0.00017922468,0.0006989695,0.000021164096,0.000058215694],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9947338,0.0010300049,0.00051959977,0.00069175154,0.0023799688,0.0006448928],"domain_scores_gemma":[0.9941089,0.0025482343,0.0000913582,0.0005820025,0.0007870818,0.001882388],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010030768,0.00023061725,0.00040730764,0.00012567273,0.0003127769,0.000070262635,0.0003831385,0.00016721238,0.0007994478],"category_scores_gemma":[0.005608206,0.00015462864,0.00008627063,0.0006399465,0.0023811995,0.00024210711,0.0006677511,0.0010097764,0.00007220422],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045141965,0.00038199514,0.5527205,0.0005249206,0.000084320716,0.000029022438,0.000092403294,1.1139169e-7,0.000021019678,0.0014037538,0.0029256693,0.44136488],"study_design_scores_gemma":[0.0013242058,0.00019872517,0.977668,0.0008248532,0.000023571209,0.000008704829,0.00032166752,0.0022546123,0.000009901266,0.011766186,0.005464115,0.00013548644],"about_ca_topic_score_codex":0.002432702,"about_ca_topic_score_gemma":0.00027625333,"teacher_disagreement_score":0.4412294,"about_ca_system_score_codex":0.00042546674,"about_ca_system_score_gemma":0.0021669192,"threshold_uncertainty_score":0.8773629},"labels":[],"label_agreement":null},{"id":"W2013186052","doi":"10.1185/03007995.2011.626760","title":"Blood glucose and subsequent cardiovascular disease: update of a meta-analysis","year":2011,"lang":"en","type":"review","venue":"Current Medical Research and Opinion","topic":"Diabetes, Cardiovascular Risks, and Lipoproteins","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Postprandial; Diabetes mellitus; Myocardial infarction; Stroke (engine); Meta-analysis; Internal medicine; Poisson regression; Relative risk; Confidence interval; Population; Endocrinology; Environmental health","score_opus":0.3009077740967583,"score_gpt":0.44256426945082544,"score_spread":0.14165649535406716,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2013186052","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000080262,0.9975081,0.00012728867,0.000077183715,0.0002050523,0.0017009308,0.00019336815,0.00002678582,0.00008099302],"genre_scores_gemma":[0.00025131172,0.9978307,0.00004517722,0.000008013962,0.00048693042,0.0004607204,0.0008198398,0.00005164161,0.000045673918],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99208176,0.0014189519,0.0009478964,0.0011155638,0.0036818488,0.0007539549],"domain_scores_gemma":[0.9952377,0.00034195557,0.00017205626,0.0015791449,0.00043627855,0.0022328529],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.007150381,0.00052014075,0.0066084545,0.001044549,0.00012289821,0.00004899942,0.00037408384,0.000397297,0.00056468986],"category_scores_gemma":[0.0019188849,0.00033237014,0.00718499,0.0012868913,0.00096338126,0.000072372975,0.00052110374,0.0014873769,0.00002611843],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002614489,0.00029630345,0.000010094878,0.025302162,0.20943753,0.00006456025,0.00001582146,3.7637065e-8,6.8036012e-9,0.00018951278,0.00018956026,0.76446825],"study_design_scores_gemma":[0.00054288533,0.00016095268,0.00008711895,0.002688884,0.2939757,0.000026317226,0.000004633795,0.0000067379824,0.0000012155574,0.00009052118,0.7022212,0.00019379015],"about_ca_topic_score_codex":0.0008029504,"about_ca_topic_score_gemma":0.000020806516,"teacher_disagreement_score":0.7642745,"about_ca_system_score_codex":0.00004470625,"about_ca_system_score_gemma":0.0010533422,"threshold_uncertainty_score":0.99991286},"labels":[],"label_agreement":null},{"id":"W2014301715","doi":"10.1185/03007990212500093","title":"Cardiovascular Properties of the Kallikrein-Kinin System","year":2002,"lang":"en","type":"review","venue":"Current Medical Research and Opinion","topic":"Coagulation, Bradykinin, Polyphosphates, and Angioedema","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"","keywords":"Medicine; Kinin; Myocardial infarction; Kallikrein; Heart failure; Cardiology; Diabetes mellitus; Left ventricular hypertrophy; Internal medicine; Infarction; Bradykinin; Endocrinology; Blood pressure; Receptor","score_opus":0.29251122512116917,"score_gpt":0.4267279343491331,"score_spread":0.13421670922796392,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2014301715","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000054646007,0.9966119,0.000013657643,0.00018009367,0.0012384822,0.0014077232,0.000015097867,0.000035017718,0.00044341682],"genre_scores_gemma":[0.0019215692,0.9962069,0.000004431419,0.000005406628,0.0012967712,0.00013067164,0.000051819894,0.000038898048,0.00034353085],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99433434,0.0006664269,0.0007863238,0.0005092405,0.0031691613,0.0005345059],"domain_scores_gemma":[0.9979424,0.00027885212,0.0001516357,0.00075952103,0.0003121235,0.0005554994],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023468172,0.00030618053,0.0017056596,0.00024985912,0.00021166624,0.000034042663,0.00042015954,0.0003974554,0.00009440821],"category_scores_gemma":[0.0015334589,0.00015883242,0.0009109473,0.0006230765,0.0007500584,0.0000435282,0.00036464137,0.0012088161,0.00004495812],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000012046946,0.00010215357,0.000075008014,0.068717025,0.00026523008,0.0000071156146,0.00007118316,3.1088607e-8,1.08697584e-7,0.0006238688,0.0027447282,0.9273815],"study_design_scores_gemma":[0.0004335349,0.00012255296,0.00007493796,0.12618908,0.00022583103,0.0001125095,0.000038518694,0.000079721685,0.000004946003,0.000009618879,0.87258196,0.00012680735],"about_ca_topic_score_codex":0.000056283065,"about_ca_topic_score_gemma":0.000001726088,"teacher_disagreement_score":0.9272547,"about_ca_system_score_codex":0.00014408292,"about_ca_system_score_gemma":0.0010349968,"threshold_uncertainty_score":0.64769983},"labels":[],"label_agreement":null},{"id":"W2014337472","doi":"10.1185/030079906x148265","title":"Budgetary impact of treating acute bipolar mania in hospitalized patients with quetiapine: an economic analysis of clinical trials","year":2006,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Bipolar Disorder and Treatment","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"AstraZeneca","keywords":"Quetiapine; Medicine; Bipolar disorder; Olanzapine; Mania; Clinical trial; Psychiatry; Emergency medicine; Lithium (medication); Internal medicine; Schizophrenia (object-oriented programming)","score_opus":0.11719718238809285,"score_gpt":0.5276035133286752,"score_spread":0.4104063309405823,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2014337472","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9906598,0.008424344,0.000033854707,0.00010545581,0.000065199056,0.00052764075,0.00011398164,0.00000674438,0.00006299782],"genre_scores_gemma":[0.9924146,0.0061823786,0.00006448867,0.0000017727316,0.000106339365,0.000017183533,0.0011984709,0.0000102626755,0.0000045187376],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9966991,0.0007729982,0.0011162171,0.00033642325,0.00077012734,0.0003051383],"domain_scores_gemma":[0.9982852,0.0006654469,0.0002235424,0.0002601438,0.00015682,0.0004088589],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0040068673,0.00014111075,0.0011677254,0.00060681533,0.000034297133,0.000009695884,0.00009972431,0.000137197,0.0001992114],"category_scores_gemma":[0.00081514096,0.00008502502,0.00028608684,0.0005005508,0.00030110986,0.00008252989,0.00005215969,0.00037002214,0.0000017926487],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014122007,0.0021671515,0.8834009,0.00007318549,0.00095315237,0.0000024324897,0.00004266125,0.000002951893,0.0000051176876,0.000062353494,0.00007290421,0.11180499],"study_design_scores_gemma":[0.008215446,0.0040935,0.9842212,0.00024347003,0.00038794382,7.62192e-7,0.000013750973,0.002464578,0.000018168284,0.000080345286,0.00019102947,0.00006977276],"about_ca_topic_score_codex":0.0037275096,"about_ca_topic_score_gemma":0.00059193844,"teacher_disagreement_score":0.11173522,"about_ca_system_score_codex":0.00007844341,"about_ca_system_score_gemma":0.00046533364,"threshold_uncertainty_score":0.56349045},"labels":[],"label_agreement":null},{"id":"W2014755596","doi":"10.1185/03007995.2013.838154","title":"The impact of knowledge, attitudes and beliefs on the engagement of primary and community-based healthcare professionals in cancer care: a literature review","year":2013,"lang":"en","type":"review","venue":"Current Medical Research and Opinion","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Cancer Australia","keywords":"Medicine; Grey literature; Intervention (counseling); Primary care; Health professionals; Health care; Family medicine; Nursing; MEDLINE","score_opus":0.4713188435233936,"score_gpt":0.6194994241723552,"score_spread":0.14818058064896156,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2014755596","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0004981211,0.9942902,2.9175857e-7,0.0026607637,0.000100217665,0.002308555,0.00007049172,0.0000029459354,0.00006846194],"genre_scores_gemma":[0.0015259794,0.9975299,0.0000041111716,0.00012514464,0.00012806889,0.00047353745,0.00019125077,0.000010812063,0.000011178814],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.99442106,0.0033872079,0.00056615565,0.00022854337,0.0010691938,0.00032780477],"domain_scores_gemma":[0.99483347,0.0037656329,0.00018011115,0.00037296003,0.00051712594,0.0003306966],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.006456425,0.00021479739,0.0010421111,0.00014791136,0.0003337494,0.00002429445,0.00027629593,0.00018429698,0.00002578111],"category_scores_gemma":[0.0022775081,0.00008804524,0.00012414133,0.0005014167,0.00059014774,0.000033827073,0.00034217324,0.0036049837,7.2502183e-7],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000039914055,0.00014823141,0.00042210336,0.21990049,0.000033778604,0.0000014517989,0.00041038395,5.1081024e-9,8.125345e-8,0.000106887295,0.007060647,0.77187604],"study_design_scores_gemma":[0.00033635416,0.0009537115,0.0026680266,0.67129827,0.00002292371,0.0000054422694,0.000114363946,0.0000023846633,4.1359922e-7,0.000020670357,0.32451224,0.00006522619],"about_ca_topic_score_codex":0.00045744784,"about_ca_topic_score_gemma":0.000085560634,"teacher_disagreement_score":0.77181077,"about_ca_system_score_codex":0.00022909085,"about_ca_system_score_gemma":0.0026711682,"threshold_uncertainty_score":0.99869376},"labels":[],"label_agreement":null},{"id":"W2016190330","doi":"10.1185/03007995.2010.525475","title":"Meta-analysis of a partially hydrolysed 100%-whey infant formula vs. extensively hydrolysed infant formulas in the prevention of atopic dermatitis","year":2010,"lang":"en","type":"review","venue":"Current Medical Research and Opinion","topic":"Food Allergy and Anaphylaxis Research","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"PharmIdeas (Canada)","funders":"","keywords":"Medicine; Atopic dermatitis; Incidence (geometry); Infant formula; Milk allergy; Casein; Relative risk; Randomized controlled trial; Meta-analysis; Cumulative incidence; Pediatrics; Internal medicine; Allergy; Confidence interval; Food allergy; Food science; Dermatology; Immunology; Mathematics","score_opus":0.26968374150559316,"score_gpt":0.4874502259053778,"score_spread":0.21776648439978463,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2016190330","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.002803206,0.9938158,0.00007961289,0.0008612134,0.00013360701,0.002039331,0.000074587646,0.00001051912,0.00018212869],"genre_scores_gemma":[0.053030346,0.94559443,0.000026825928,0.00003947416,0.00015292256,0.00039720934,0.0006796305,0.00002573469,0.000053452735],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99105424,0.0015094255,0.0018669723,0.0006442727,0.004119346,0.0008057507],"domain_scores_gemma":[0.9956538,0.0017386265,0.0005031393,0.00089795183,0.00062986126,0.00057660654],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.006680373,0.00042163752,0.004074246,0.0021269158,0.00013486418,0.000042562122,0.0007497482,0.00067275774,0.0005604969],"category_scores_gemma":[0.003579398,0.00023397923,0.0021147602,0.0029338922,0.0007621177,0.00012939367,0.00035688313,0.0030677589,0.000010098995],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014709299,0.0011680884,0.000095294745,0.019852601,0.023565479,0.000050951177,0.000443161,8.1882797e-7,0.0000086547325,0.0010543746,0.00063557434,0.9529779],"study_design_scores_gemma":[0.0015748331,0.0017872037,0.0012515537,0.0070356587,0.01218831,0.00004193568,0.00004685541,0.0016140522,0.000037433172,0.0004449999,0.97369343,0.0002837369],"about_ca_topic_score_codex":0.0002938396,"about_ca_topic_score_gemma":0.0006608385,"teacher_disagreement_score":0.97305787,"about_ca_system_score_codex":0.00005490585,"about_ca_system_score_gemma":0.0017041557,"threshold_uncertainty_score":0.99923223},"labels":[],"label_agreement":null},{"id":"W2017304854","doi":"10.1185/030079906x80242","title":"Efficacy and safety of rofecoxib 12.5 mg and celecoxib 200 mg in two similarly designed osteoarthritis studies","year":2005,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Rofecoxib; Celecoxib; Medicine; Placebo; WOMAC; Osteoarthritis; Clinical endpoint; Internal medicine; Adverse effect; Anesthesia; Randomized controlled trial; Cyclooxygenase","score_opus":0.09109603477984789,"score_gpt":0.4542389730617358,"score_spread":0.3631429382818879,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2017304854","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.918518,0.07850083,0.000027636217,0.0016388661,0.0002811109,0.0008290024,0.0000068344943,0.00001635092,0.00018138676],"genre_scores_gemma":[0.93076473,0.068352334,0.00007772681,0.00005571873,0.0006201477,0.00004778885,0.000022434155,0.000015870808,0.00004324058],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9972484,0.0003425785,0.00045722717,0.00038217107,0.0010078312,0.0005617541],"domain_scores_gemma":[0.99765396,0.0012122421,0.000053837684,0.00017228663,0.00017385159,0.0007338008],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029021208,0.00017624746,0.0005178092,0.00029781065,0.0001349608,0.000018610237,0.00007959124,0.00012320736,0.00007292036],"category_scores_gemma":[0.0032514564,0.00013768308,0.000031100593,0.00021875718,0.00076287007,0.00012139751,0.00018035207,0.0007321003,0.0000069839434],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020283733,0.0003669844,0.03155777,0.0013321687,0.00003276962,0.000062397805,0.0012832239,3.5081473e-7,0.0011432148,0.00034200013,0.0033898233,0.9584609],"study_design_scores_gemma":[0.11378144,0.014053495,0.5880662,0.022166723,0.00009676398,0.00029770785,0.0018241969,0.003487415,0.0065119625,0.001080007,0.247472,0.0011620693],"about_ca_topic_score_codex":0.000017945402,"about_ca_topic_score_gemma":0.00017246869,"teacher_disagreement_score":0.9572989,"about_ca_system_score_codex":0.00006456944,"about_ca_system_score_gemma":0.00024610572,"threshold_uncertainty_score":0.5614553},"labels":[],"label_agreement":null},{"id":"W2018780010","doi":"10.1185/030079902125001029","title":"Functional, Cognitive and Behavioral Effects of Donepezil in Patients with Moderate Alzheimer's Disease","year":2002,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Dementia and Cognitive Impairment Research","field":"Medicine","cited_by":85,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia Hospital; McGill University","funders":"Pfizer","keywords":"Donepezil; Medicine; Alzheimer's disease; Disease; Cognition; Dementia; Psychiatry; Internal medicine","score_opus":0.09042586568861398,"score_gpt":0.4050831020880094,"score_spread":0.3146572363993954,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2018780010","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98996,0.008447749,0.000061194034,0.0004173567,0.00008051659,0.00090207247,0.000012491506,0.000007636647,0.00011094292],"genre_scores_gemma":[0.99606395,0.003587447,0.0000057103493,0.00002526184,0.000061279046,0.00010200957,0.00011280566,0.000009532718,0.000032005442],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997249,0.00017463189,0.00017884205,0.00030676444,0.0017094612,0.00038126484],"domain_scores_gemma":[0.99832183,0.00035121868,0.000024779214,0.000083801155,0.0003997349,0.00081860536],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044230878,0.00011021571,0.0002013535,0.0002656339,0.000084171996,0.000021907788,0.000042271957,0.00005295097,0.00032036117],"category_scores_gemma":[0.0005478993,0.00007812221,0.000021963142,0.00026512577,0.000572962,0.00010673968,0.00011108929,0.0004905524,0.000010215562],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002577339,0.0027078982,0.747874,0.0003889035,0.000034645076,0.000034800865,0.00008162627,1.9934447e-8,0.0000037769214,0.00004959996,0.0005685499,0.24567884],"study_design_scores_gemma":[0.009989522,0.0028501053,0.98430115,0.0017866243,0.000038060392,0.000001635835,0.000043374137,0.00046180695,0.00012801852,0.00009252232,0.00022661283,0.00008055991],"about_ca_topic_score_codex":0.000017179624,"about_ca_topic_score_gemma":0.0000028559803,"teacher_disagreement_score":0.24559829,"about_ca_system_score_codex":0.00001957453,"about_ca_system_score_gemma":0.00011613274,"threshold_uncertainty_score":0.350773},"labels":[],"label_agreement":null},{"id":"W2019045699","doi":"10.1185/03007995.2014.901941","title":"US practitioner prescribing practices and patient characteristics of those newly treated with a buprenorphine transdermal patch system","year":2014,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Opioid Use Disorder Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Purdue Pharma (Canada)","funders":"American Pain Society","keywords":"Medicine; Dosing; Medical prescription; Pharmacy; Buprenorphine; Opioid; Emergency medicine; Family medicine; Internal medicine; Pharmacology","score_opus":0.06090701486458457,"score_gpt":0.375056298115606,"score_spread":0.3141492832510214,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2019045699","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.993081,0.0035168799,0.0003300464,0.001806625,0.00012852518,0.0007858318,0.000032270673,0.000035419704,0.0002834366],"genre_scores_gemma":[0.9942455,0.005101977,0.000162146,0.00002204095,0.00015518798,0.0000883322,0.00019389625,0.000018753519,0.000012126891],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9973526,0.00029286457,0.00035039496,0.00036339276,0.0012865774,0.0003541532],"domain_scores_gemma":[0.9981364,0.0004933646,0.0002092723,0.00022901704,0.00035050517,0.00058142195],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006672711,0.00016494474,0.0003635525,0.00015289949,0.00013533165,0.000038849666,0.0000638168,0.000104221865,0.000038216724],"category_scores_gemma":[0.0012658787,0.000107174645,0.00002828364,0.00019962472,0.00029057337,0.0001468023,0.00006399355,0.00048746864,0.000003977536],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0039656595,0.0033724704,0.30166787,0.0067943837,0.00024088085,0.00008595036,0.0031481048,4.3778076e-7,0.000552681,0.0010879162,0.00083018583,0.6782535],"study_design_scores_gemma":[0.020227749,0.02243656,0.81853,0.022675104,0.00038877418,0.000608387,0.0044852244,0.015466214,0.0027355808,0.000069782174,0.091706604,0.0006699656],"about_ca_topic_score_codex":0.00043121254,"about_ca_topic_score_gemma":0.00001690361,"teacher_disagreement_score":0.6775835,"about_ca_system_score_codex":0.00005132313,"about_ca_system_score_gemma":0.00025100328,"threshold_uncertainty_score":0.4370455},"labels":[],"label_agreement":null},{"id":"W2020989669","doi":"10.1185/03007991003771338","title":"Omalizumab in children with inadequately controlled severe allergic (IgE-mediated) asthma","year":2010,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Asthma and respiratory diseases","field":"Medicine","cited_by":92,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Research in Astrophysics of Québec","funders":"","keywords":"Omalizumab; Medicine; Placebo; Asthma; Exacerbation; Adverse effect; Immunoglobulin E; Randomized controlled trial; Rate ratio; Internal medicine; Corticosteroid; Anesthesia; Gastroenterology; Confidence interval; Immunology; Antibody","score_opus":0.03495446278182664,"score_gpt":0.372221480296493,"score_spread":0.33726701751466637,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2020989669","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9904029,0.0054734177,0.000022303422,0.0020382123,0.00027641773,0.0010514557,0.000013251709,0.000041500367,0.000680582],"genre_scores_gemma":[0.99638534,0.0024487951,0.000019266316,0.000109481225,0.00065626495,0.00012011092,0.0001545643,0.000021630045,0.000084525294],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9965306,0.0002099179,0.00034028656,0.00044109262,0.0018140653,0.0006640564],"domain_scores_gemma":[0.9977242,0.00036879515,0.00004970601,0.00026427186,0.0002062555,0.00138682],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011961549,0.00019229893,0.00045496784,0.00034266908,0.00014134325,0.000039363003,0.00018554277,0.00022723238,0.000697631],"category_scores_gemma":[0.0023053114,0.00011795379,0.00006344304,0.0003345708,0.0006637628,0.00009240571,0.0001235116,0.0017703661,0.000076914315],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0063276696,0.0019283346,0.5291196,0.00028108145,0.000103503,0.00020875604,0.0001953866,6.147444e-7,0.000121822995,0.000847905,0.0053885602,0.45547673],"study_design_scores_gemma":[0.0398825,0.0028401667,0.8413759,0.0011357536,0.000013138379,0.0003638273,0.00017252403,0.0011399077,0.000043797787,0.00022472664,0.11248318,0.00032456932],"about_ca_topic_score_codex":0.00005509951,"about_ca_topic_score_gemma":0.00012335373,"teacher_disagreement_score":0.45515215,"about_ca_system_score_codex":0.000037111742,"about_ca_system_score_gemma":0.0010611791,"threshold_uncertainty_score":0.76914585},"labels":[],"label_agreement":null},{"id":"W2021278088","doi":"10.1185/030079902125001128","title":"A Double-blind, Randomised Comparative Trial of Amisulpride Versus Olanzapine in the Treatment of Schizophrenia: Short-term Results at Two Months","year":2002,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alzheimer Society of Canada","funders":"","keywords":"Amisulpride; Olanzapine; Medicine; Brief Psychiatric Rating Scale; Extrapyramidal symptoms; Schizophrenia (object-oriented programming); Adverse effect; Internal medicine; Psychiatry; Psychosis; Antipsychotic","score_opus":0.33400150161970055,"score_gpt":0.48912254988820697,"score_spread":0.15512104826850642,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2021278088","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.981332,0.011296396,0.0000036351246,0.0022153724,0.00035003253,0.0039852564,0.00005099736,0.000011310489,0.0007549672],"genre_scores_gemma":[0.9650059,0.033638213,0.000042089323,0.0000028625548,0.0004976877,0.00049786514,0.00023927592,0.000010564982,0.00006558683],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9950393,0.0005745433,0.0007888626,0.00046082336,0.0025404065,0.0005961095],"domain_scores_gemma":[0.9960162,0.002491646,0.0000977677,0.0005091782,0.00024986523,0.00063531345],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017342236,0.00023417242,0.0007766114,0.00040548766,0.00013090337,0.000021393653,0.0002474863,0.000120154014,0.00019007444],"category_scores_gemma":[0.0008716286,0.00012005037,0.00018585652,0.0005982652,0.0007584567,0.00005710305,0.000098060525,0.00053916604,0.000020746776],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8981657,0.0054208976,0.00048366017,0.00009682767,0.00016648514,0.00006780369,0.0012890535,4.7919025e-7,0.000043560827,0.00023801331,0.00084886776,0.09317862],"study_design_scores_gemma":[0.9727514,0.017907187,0.003066945,0.00050441327,0.00004443858,0.000015059652,0.0001906193,0.00087997643,0.001380714,0.0000685469,0.0030855911,0.000105114574],"about_ca_topic_score_codex":0.00017701763,"about_ca_topic_score_gemma":0.00046701566,"teacher_disagreement_score":0.09307351,"about_ca_system_score_codex":0.00024043302,"about_ca_system_score_gemma":0.0003127205,"threshold_uncertainty_score":0.4895512},"labels":[],"label_agreement":null},{"id":"W2021917132","doi":"10.1185/030079904x15165","title":"Measuring symptom response to pharmacological interventions in patients with COPD: a review of instruments used in clinical trials","year":2004,"lang":"en","type":"review","venue":"Current Medical Research and Opinion","topic":"Chronic Obstructive Pulmonary Disease (COPD) Research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Social Innovation; Centre for Global Health Research","funders":"","keywords":"Medicine; COPD; Psychological intervention; Clinical trial; Intensive care medicine; Physical therapy; Internal medicine; Psychiatry","score_opus":0.4908715463316888,"score_gpt":0.5965045688036081,"score_spread":0.10563302247191936,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2021917132","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.013838294,0.97639066,0.000008795153,0.00059953216,0.0004464375,0.008522007,0.00014964055,0.000014983367,0.000029667104],"genre_scores_gemma":[0.001885452,0.99651253,0.000029561503,0.00003103355,0.00019947717,0.00084477797,0.0004334789,0.000043242435,0.000020470297],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9788067,0.011064659,0.0037530272,0.0010911046,0.0042999424,0.0009846073],"domain_scores_gemma":[0.99153584,0.0048388927,0.0004770729,0.00054159825,0.0006021422,0.0020044472],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.037148885,0.000438468,0.004080965,0.001565839,0.00006445698,0.000026617368,0.00057992217,0.00044628207,0.00069548603],"category_scores_gemma":[0.050749175,0.00029101188,0.00071841176,0.0020431129,0.00075713976,0.000102055004,0.0008058211,0.0035995753,0.00004814771],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028646588,0.0032087285,0.011263993,0.21594748,0.00013727433,0.000060454022,0.00001589865,2.6260132e-8,7.055666e-8,0.000019837455,0.00034237062,0.7661392],"study_design_scores_gemma":[0.009829325,0.0019351343,0.059934836,0.75817806,0.0001822623,0.000008842973,0.000012934024,0.0000046864343,2.9064458e-7,0.00002486152,0.16965838,0.00023037894],"about_ca_topic_score_codex":0.000027504751,"about_ca_topic_score_gemma":0.000009544952,"teacher_disagreement_score":0.76590884,"about_ca_system_score_codex":0.0015144135,"about_ca_system_score_gemma":0.0061949794,"threshold_uncertainty_score":0.9999542},"labels":[],"label_agreement":null},{"id":"W2022069934","doi":"10.1185/03007995.2011.621416","title":"Barriers to effective insulin treatment: the persistence of poor glycemic control in type 2 diabetes","year":2011,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Diabetes Management and Education","field":"Medicine","cited_by":153,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia; University of Calgary","funders":"Novo Nordisk Canada","keywords":"Medicine; Glycemic; Hypoglycemia; Intensive care medicine; Insulin; Type 2 diabetes; Diabetes mellitus; Diabetes management; Internal medicine; Endocrinology","score_opus":0.09655757236718554,"score_gpt":0.39005797805382925,"score_spread":0.2935004056866437,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2022069934","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9904882,0.004918773,0.000010184594,0.0022874922,0.0004422904,0.00093853934,0.0000027973847,0.0000071321065,0.00090459717],"genre_scores_gemma":[0.9975169,0.0020861696,0.0000086344735,0.00011242079,0.0001181954,0.00010710508,0.000012027731,0.0000050388517,0.000033514265],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9987882,0.00014241158,0.00014265564,0.00017628381,0.00045719708,0.00029325805],"domain_scores_gemma":[0.998918,0.00034657243,0.000021428734,0.00013505854,0.00012188813,0.00045706646],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00091506704,0.0000714876,0.00016582022,0.00018213401,0.000056071996,0.000007532523,0.00010661652,0.00004442274,0.00024072498],"category_scores_gemma":[0.0028483204,0.000042831223,0.000027916036,0.00039490426,0.00023949347,0.000039718834,0.000046380093,0.00020502774,0.000025965624],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019405417,0.000515617,0.2580014,0.00031815734,0.00007037759,0.000002277775,0.0038806389,1.296868e-7,0.00018621262,0.0005539346,0.0026015625,0.7319292],"study_design_scores_gemma":[0.011752108,0.019382656,0.8815456,0.0029794532,0.00007702533,0.0000016256326,0.0039294995,0.0027559157,0.0020593598,0.0013353741,0.07391528,0.0002661084],"about_ca_topic_score_codex":0.000056127894,"about_ca_topic_score_gemma":0.000008933149,"teacher_disagreement_score":0.73166305,"about_ca_system_score_codex":0.000073902906,"about_ca_system_score_gemma":0.00020830473,"threshold_uncertainty_score":0.34099114},"labels":[],"label_agreement":null},{"id":"W2024791905","doi":"10.1185/03007995.2015.1019608","title":"Developing an Atrial Fibrillation Guideline Support Tool (AFGuST) for shared decision making","year":2015,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Patient-Provider Communication in Healthcare","field":"Health Professions","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Center for Advancing Translational Sciences; European Society of Cardiology; University of Cincinnati","keywords":"Medicine; Atrial fibrillation; Guideline; Warfarin; Antithrombotic; Stroke (engine); Intensive care medicine; Anticoagulant therapy; Anticoagulant; Decision analysis; Psychological intervention; Surgery; Internal medicine; Nursing","score_opus":0.7270205726613163,"score_gpt":0.6477190679370661,"score_spread":0.07930150472425013,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2024791905","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.34791166,0.07698954,0.40696377,0.091985516,0.044815917,0.027979229,0.0007903231,0.0010908245,0.0014732145],"genre_scores_gemma":[0.8750413,0.010373744,0.08540972,0.0012965897,0.019538421,0.0009997643,0.007011106,0.00015650377,0.00017282444],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.994684,0.0009873813,0.0011844174,0.00045780704,0.0018785354,0.0008078851],"domain_scores_gemma":[0.9920961,0.0039763763,0.00020715028,0.0005524239,0.0023173834,0.0008505492],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.00619985,0.00014483958,0.00027341093,0.00027570684,0.0010826593,0.000038766935,0.0004663595,0.0003251676,0.0002904583],"category_scores_gemma":[0.032442603,0.0001243638,0.000054559267,0.00036642345,0.00013212654,0.00035224424,0.00067089294,0.0009848867,0.000080420636],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011626614,0.000027977881,0.019951709,0.00060697645,0.000008847312,8.6916685e-7,0.003835124,0.000006215436,0.0000015136815,0.007432699,0.110300206,0.8566652],"study_design_scores_gemma":[0.0037999894,0.0007975663,0.0030486616,0.002766734,0.000003854833,0.0000028882612,0.0031507963,0.027983526,0.0000021750009,0.03404329,0.9241687,0.0002318265],"about_ca_topic_score_codex":0.000074830175,"about_ca_topic_score_gemma":0.00008566567,"teacher_disagreement_score":0.8564334,"about_ca_system_score_codex":0.0005334971,"about_ca_system_score_gemma":0.004638239,"threshold_uncertainty_score":0.97570753},"labels":[],"label_agreement":null},{"id":"W2026240770","doi":"10.1185/03007990802426813","title":"Comparison of morning versus evening dosing and 24-h post-dose efficacy of travoprost compared with latanoprost in patients with open-angle glaucoma","year":2008,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Glaucoma and retinal disorders","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; University of Toronto","funders":"","keywords":"Medicine; Travoprost; Latanoprost; Evening; Morning; Dosing; Glaucoma; Open angle glaucoma; Ophthalmology; Internal medicine","score_opus":0.10709904824102029,"score_gpt":0.4203581562258453,"score_spread":0.31325910798482504,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2026240770","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99674594,0.001961954,0.000022254751,0.00021258573,0.00010327407,0.000797075,0.000010808724,0.0000071883996,0.00013890398],"genre_scores_gemma":[0.9992337,0.0003278852,0.00020085102,0.0000050093927,0.000027307253,0.00001045477,0.00017509371,0.000014382448,0.000005295851],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99754256,0.00012567715,0.00037987554,0.0003061888,0.0012764032,0.0003693223],"domain_scores_gemma":[0.99862725,0.0004053588,0.000104728926,0.00016868953,0.00031161055,0.00038235844],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004987902,0.00014185665,0.00051779876,0.00021923833,0.00015150248,0.000015582647,0.00015704375,0.000078834695,0.000023534081],"category_scores_gemma":[0.00064631604,0.00009437745,0.000021030133,0.00042811522,0.00088240724,0.00010119127,0.00018490353,0.0006224173,8.234147e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014471853,0.0015153473,0.9662893,0.00041592008,0.000028008079,0.000012283234,0.0013776808,2.616146e-7,0.00017774626,0.000040335697,0.00007768329,0.015593619],"study_design_scores_gemma":[0.022169923,0.006050858,0.96678007,0.0031030108,0.000012795486,0.000010717728,0.00072659476,0.00038392097,0.00037868757,0.000005011011,0.00027562233,0.000102799124],"about_ca_topic_score_codex":0.00014633179,"about_ca_topic_score_gemma":0.000059990765,"teacher_disagreement_score":0.01549082,"about_ca_system_score_codex":0.00003182829,"about_ca_system_score_gemma":0.00029244766,"threshold_uncertainty_score":0.38486007},"labels":[],"label_agreement":null},{"id":"W2026341154","doi":"10.1185/03007995.2014.916159","title":"Is rivaroxaban associated with lower inpatient costs compared to warfarin among patients with non-valvular atrial fibrillation?","year":2014,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Rivaroxaban; Medicine; Warfarin; Atrial fibrillation; Propensity score matching; Internal medicine; Stroke (engine); Emergency medicine","score_opus":0.08631108257162853,"score_gpt":0.4082514394110455,"score_spread":0.321940356839417,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2026341154","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939717,0.00009987503,0.00089708297,0.0024263072,0.00055197184,0.001491087,0.00001114237,0.000046203877,0.00050459744],"genre_scores_gemma":[0.99797696,0.00010935065,0.00006205177,0.000075942364,0.0011447511,0.000005928891,0.00042742857,0.000024547458,0.00017304785],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9957749,0.00019057521,0.0003611343,0.00045548906,0.00270074,0.0005171481],"domain_scores_gemma":[0.9976868,0.0004461946,0.000098495446,0.00028072257,0.0005718671,0.00091593823],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011056981,0.00019877976,0.00041222828,0.0002965332,0.00023103062,0.00007040312,0.00012458739,0.00011901499,0.00024077548],"category_scores_gemma":[0.0021202154,0.0001315181,0.00007922606,0.00063197315,0.00024662627,0.00012708442,0.00019027972,0.00038575943,0.000047161953],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015651825,0.000046450175,0.9614111,0.00006595341,0.00009215539,0.000001810386,0.00016608139,0.00001282633,8.073102e-7,0.00011010443,0.005223862,0.031303618],"study_design_scores_gemma":[0.008116527,0.0025444191,0.92629,0.0011134539,0.000032232147,3.8625032e-7,0.000028664035,0.0046988158,0.000009580365,0.000039449536,0.05693858,0.0001879068],"about_ca_topic_score_codex":0.00006254184,"about_ca_topic_score_gemma":0.000029294099,"teacher_disagreement_score":0.051714722,"about_ca_system_score_codex":0.00015746805,"about_ca_system_score_gemma":0.00015131917,"threshold_uncertainty_score":0.5363152},"labels":[],"label_agreement":null},{"id":"W2026692964","doi":"10.1185/030079904x12951","title":"Lidocaine patch 5% and its positive impact on pain qualities in osteoarthritis: results of a pilot 2-week, open-label study using the Neuropathic Pain Scale","year":2004,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Pain Mechanisms and Treatments","field":"Medicine","cited_by":81,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Lidocaine; Neuropathic pain; Analgesic; Adverse effect; Osteoarthritis; Anesthesia; Visual analogue scale; Population; Randomized controlled trial; Surgery; Internal medicine","score_opus":0.23042993751117313,"score_gpt":0.48560950754814897,"score_spread":0.25517957003697583,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2026692964","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9911518,0.004688303,0.00016607481,0.0019226555,0.00010179931,0.0018511264,0.00006307958,0.0000094072775,0.000045738267],"genre_scores_gemma":[0.9975531,0.002064028,0.000026180058,0.00010457912,0.00011038656,0.00006655236,0.000045333847,0.000015681062,0.000014140282],"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9934036,0.003947539,0.0004319361,0.0004277527,0.001315597,0.0004735471],"domain_scores_gemma":[0.99673843,0.002305824,0.00007105958,0.0002447012,0.00018990577,0.0004500939],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.020974958,0.00018051952,0.00038750083,0.00020261471,0.0002042427,0.000057174715,0.00018143037,0.00007138983,0.0000088555735],"category_scores_gemma":[0.0078054615,0.0001076535,0.00002432405,0.00039114617,0.00023949222,0.00009238993,0.00027050968,0.0007357118,0.0000019424476],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017760275,0.038923472,0.01644849,0.00079536956,0.00018311472,0.000998737,0.0126651535,0.0000054786638,0.0010174367,0.0015249087,0.0002589163,0.90941864],"study_design_scores_gemma":[0.2396668,0.5043717,0.1348772,0.051773556,0.000121095516,0.00031437245,0.02515838,0.02665398,0.002307069,0.01319246,0.00046349433,0.0010999116],"about_ca_topic_score_codex":0.0018157661,"about_ca_topic_score_gemma":0.00020786801,"teacher_disagreement_score":0.90831876,"about_ca_system_score_codex":0.00011671209,"about_ca_system_score_gemma":0.0004294964,"threshold_uncertainty_score":0.934443},"labels":[],"label_agreement":null},{"id":"W2029158492","doi":"10.1185/03007995.2014.952367","title":"Re: Marchington JM, Burd GP. Author attitudes to professional medical writing support. Curr Med Res Opin 2014 Jul 9:1-6","year":2014,"lang":"en","type":"letter","venue":"Current Medical Research and Opinion","topic":"Academic integrity and plagiarism","field":"Social Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Montreal General Hospital","funders":"","keywords":"Medicine; Medical writing; Medical education; Family medicine; Nursing","score_opus":0.15935537919502707,"score_gpt":0.5178399436591414,"score_spread":0.35848456446411436,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2029158492","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00029026423,0.002920874,0.0010267013,0.9821161,0.0074041556,0.0010937988,0.00008572569,0.00012888206,0.004933509],"genre_scores_gemma":[0.018306557,0.08451305,0.0009557787,0.5925557,0.2604159,0.0014002415,0.008191178,0.00037241334,0.03328915],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9733039,0.0070410348,0.0011748872,0.0013658692,0.014624094,0.0024901903],"domain_scores_gemma":[0.9863219,0.009268533,0.00023458105,0.00048840005,0.0007245601,0.0029620214],"candidate_categories":["metaresearch","metaepi_narrow","sts","research_integrity","insufficient_payload"],"consensus_categories":["metaresearch","research_integrity"],"category_scores_codex":[0.043968808,0.00049099786,0.0008612435,0.0006704687,0.002006881,0.00032869048,0.0024349901,0.005813515,0.008536788],"category_scores_gemma":[0.05207651,0.00039723236,0.00019599026,0.0005756669,0.002615085,0.00024435957,0.001331674,0.030370595,0.000756194],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005411236,0.00009144219,0.0005962868,0.00081754074,0.000025459016,0.000088740126,0.0019091103,3.2493368e-8,6.8467665e-7,0.0032639988,0.8599794,0.1331732],"study_design_scores_gemma":[0.00042216943,0.0002661795,0.0002201475,0.0065954635,0.000008228939,0.000010432272,0.000589819,0.0001432597,0.000003532513,0.0042814133,0.98700786,0.00045146857],"about_ca_topic_score_codex":0.0017683334,"about_ca_topic_score_gemma":0.0005747738,"teacher_disagreement_score":0.38956037,"about_ca_system_score_codex":0.0003170473,"about_ca_system_score_gemma":0.0050978535,"threshold_uncertainty_score":0.99984795},"labels":[],"label_agreement":null},{"id":"W2030138403","doi":"10.1185/03007995.2011.633989","title":"Indirect comparison of the efficacy of cetuximab and cisplatin in squamous cell carcinoma of the head and neck","year":2011,"lang":"en","type":"review","venue":"Current Medical Research and Opinion","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; Dalhousie University","funders":"","keywords":"Cetuximab; Medicine; Radiation therapy; Head and neck cancer; Oncology; Cisplatin; Internal medicine; Hazard ratio; Head and neck squamous-cell carcinoma; Dosing; Randomized controlled trial; Meta-analysis; Confidence interval; Cancer; Chemotherapy; Colorectal cancer","score_opus":0.26108924597764915,"score_gpt":0.49318848902548784,"score_spread":0.2320992430478387,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2030138403","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.11923014,0.87915355,3.570649e-7,0.000116309835,0.00024028649,0.0008554122,0.000023018805,0.0000017659659,0.0003791401],"genre_scores_gemma":[0.31260344,0.68728226,0.0000032029186,0.0000023517302,0.000063287676,0.000017888497,0.000006697919,0.000008441749,0.0000124411545],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9973607,0.00046362405,0.0006968476,0.000284033,0.00089734787,0.00029743867],"domain_scores_gemma":[0.99789476,0.001242231,0.00022494423,0.0003075747,0.00011361034,0.00021684894],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011641905,0.00018217583,0.0015844675,0.0001739225,0.000073374125,0.0000039220413,0.00022140238,0.00020253668,0.000019537858],"category_scores_gemma":[0.0017826312,0.00008790554,0.00012123109,0.0004456578,0.0010748522,0.000014931327,0.00051537907,0.0011482147,4.0510255e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010495614,0.00054288795,0.0420221,0.03843649,0.000016885224,8.533339e-7,0.0009400653,2.712365e-9,0.0000013331628,0.000057974317,0.00092717644,0.9169493],"study_design_scores_gemma":[0.0065426286,0.0027615062,0.25919017,0.10734616,0.00018813311,0.000021632777,0.00023833798,0.00004543291,0.0001796239,0.00006009289,0.6232026,0.00022364006],"about_ca_topic_score_codex":0.00018006454,"about_ca_topic_score_gemma":0.00006300915,"teacher_disagreement_score":0.91672564,"about_ca_system_score_codex":0.000035543453,"about_ca_system_score_gemma":0.00071032764,"threshold_uncertainty_score":0.49884853},"labels":[],"label_agreement":null},{"id":"W2030898895","doi":"10.1185/030079905x38123","title":"Quality of structured abstracts of original research articles in the British Medical Journal, the Canadian Medical Association Journal and the Journal of the American Medical Association: a 10-year follow-up study","year":2005,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Meta-analysis and systematic reviews","field":"Decision Sciences","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Family medicine; Medical journal; Consistency (knowledge bases); MEDLINE; Quality Score","score_opus":0.6294144850314811,"score_gpt":0.6092852695994536,"score_spread":0.020129215432027503,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2030898895","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.89957184,0.0059668203,0.000047326692,0.09260646,0.0007332279,0.0007199124,0.000009698581,7.255488e-7,0.00034400666],"genre_scores_gemma":[0.99134016,0.0068198927,0.000018077773,0.00026767267,0.0013946884,0.000011613872,8.2910907e-7,0.0000064991086,0.00014053819],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.75031084,0.11625414,0.010984632,0.00052481395,0.120755024,0.0011705445],"domain_scores_gemma":[0.884434,0.089334615,0.008462763,0.0015950428,0.013132933,0.003040668],"candidate_categories":["metaresearch","sts","scholarly_communication","research_integrity","insufficient_payload"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.69658095,0.00017140753,0.0017076381,0.0004331341,0.0013974862,0.0014303959,0.0043640714,0.00031193258,0.007728176],"category_scores_gemma":[0.59275293,0.000059951282,0.00052991626,0.0025488434,0.0020384595,0.00021488364,0.00038503113,0.0060436265,0.000023921797],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032057427,0.000532471,0.26737982,0.00005884107,0.00040105334,0.000042865133,0.0057102027,0.0000020134084,0.0000017309338,0.000980698,0.33498818,0.38958156],"study_design_scores_gemma":[0.0058084372,0.00061521115,0.7664477,0.0009899046,0.00008228692,0.0007668058,0.0225661,0.0014719408,0.0000045487495,0.0058930763,0.19521293,0.0001410084],"about_ca_topic_score_codex":0.0057132468,"about_ca_topic_score_gemma":0.14999388,"teacher_disagreement_score":0.49906793,"about_ca_system_score_codex":0.00033992325,"about_ca_system_score_gemma":0.007268618,"threshold_uncertainty_score":0.99990255},"labels":[],"label_agreement":null},{"id":"W2031040803","doi":"10.1185/03007995.2013.779876","title":"The fundamental role of inflammation in tendon injury","year":2013,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Tendon Structure and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Inflammation; Tendon; Ultimate tensile strength; Inflammatory response; Surgery; Immunology; Composite material","score_opus":0.045199280963502994,"score_gpt":0.4247034206302917,"score_spread":0.3795041396667887,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2031040803","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98769027,0.007455086,0.0000034512746,0.0034783366,0.00017224983,0.00051297306,0.0000025432248,0.0000073162096,0.0006777771],"genre_scores_gemma":[0.9935972,0.006074699,0.000010033545,0.000007921121,0.00017777616,0.0000704621,0.000026965565,0.000003876647,0.00003106795],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99854296,0.00007940229,0.00020761808,0.00012246941,0.0008106581,0.00023689971],"domain_scores_gemma":[0.99928427,0.00023893398,0.000026359812,0.00012274102,0.00009881124,0.00022886925],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048531682,0.000058019363,0.00011801469,0.000102282,0.00006955543,0.000017254088,0.00006456998,0.00005277788,0.00016044799],"category_scores_gemma":[0.00043034495,0.000031198266,0.000022892349,0.00015916748,0.00025591234,0.000054927983,0.0000765658,0.00034527766,0.000024515266],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011544172,0.00009728408,0.048417076,0.000059150985,0.000010112166,0.0000014620302,0.00014459988,8.512047e-9,0.0013478262,0.0020442498,0.0010348363,0.94672793],"study_design_scores_gemma":[0.003630407,0.001859299,0.7866754,0.0009414545,0.000006892395,0.000027126809,0.0012281503,0.0006766582,0.011754764,0.016404517,0.17668894,0.00010637768],"about_ca_topic_score_codex":0.00014650162,"about_ca_topic_score_gemma":0.000017133783,"teacher_disagreement_score":0.9466216,"about_ca_system_score_codex":0.000045151915,"about_ca_system_score_gemma":0.00012803898,"threshold_uncertainty_score":0.1756793},"labels":[],"label_agreement":null},{"id":"W2036440924","doi":"10.1185/03007995.2013.856287","title":"Statin–fibrate combination therapy is safe and effective in normalizing lipid profile and in keeping cardiovascular event rates low","year":2013,"lang":"en","type":"letter","venue":"Current Medical Research and Opinion","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Fibrate; Medicine; Cardiovascular event; Statin; Lipid profile; Dyslipidemia; Cardiology; Internal medicine; Intensive care medicine; Pharmacology; Cholesterol; Disease","score_opus":0.05354596407779159,"score_gpt":0.3889355457778891,"score_spread":0.33538958170009747,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2036440924","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.52092195,0.30181295,0.0003493429,0.16450664,0.0011086678,0.010974887,0.000040311912,0.000041984313,0.00024329122],"genre_scores_gemma":[0.24272391,0.71896744,0.000116940304,0.02600973,0.007127006,0.003191712,0.001562945,0.00017134355,0.00012894756],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.994367,0.001315215,0.0004880813,0.00075805065,0.0022933218,0.0007783382],"domain_scores_gemma":[0.99839073,0.0005019123,0.000072699106,0.000366407,0.0002453601,0.0004228975],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0054861936,0.000298276,0.00093249045,0.00058902975,0.00013832035,0.0000924448,0.000105656116,0.00056806573,0.0000719383],"category_scores_gemma":[0.00066272845,0.00023304053,0.00014928599,0.0003998682,0.000327214,0.00016478055,0.00019510619,0.0033670259,0.000008755891],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001999309,0.00017831809,0.0054203477,0.007217305,0.00024345862,0.00013721101,0.0007035081,3.642059e-7,0.000014054244,0.000024664128,0.028528273,0.95733255],"study_design_scores_gemma":[0.016161345,0.0022431514,0.1276254,0.021415683,0.00004245447,0.000139969,0.0002640539,0.00416903,0.0005498659,0.00050982187,0.8261583,0.00072094647],"about_ca_topic_score_codex":0.0012248966,"about_ca_topic_score_gemma":0.000015247848,"teacher_disagreement_score":0.95661163,"about_ca_system_score_codex":0.00019189178,"about_ca_system_score_gemma":0.00044001642,"threshold_uncertainty_score":0.99893224},"labels":[],"label_agreement":null},{"id":"W2036471103","doi":"10.1185/030079905x56402","title":"Efficacy and safety of mometasone furoate administered once-daily in the evening in patients with persistent asthma dependent on inhaled corticosteroids","year":2005,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Asthma and respiratory diseases","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CARE Canada","funders":"","keywords":"Medicine; Mometasone furoate; Evening; Placebo; Asthma; Inhalation; Morning; Corticosteroid; Inhaler; Dry-powder inhaler; Clinical endpoint; Dosing; Anesthesia; Internal medicine; Randomized controlled trial","score_opus":0.05810863186133086,"score_gpt":0.37454886046167923,"score_spread":0.31644022860034837,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2036471103","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943955,0.003313682,0.000008757684,0.0014102919,0.000054630687,0.0007163437,0.000009534283,0.000004767313,0.00008649097],"genre_scores_gemma":[0.9987515,0.00097112753,0.0000111263635,0.00008678292,0.00008917216,0.000027426957,0.000041774878,0.000008660075,0.000012418084],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99708235,0.00033810444,0.00036205654,0.00029560865,0.0015734432,0.00034842684],"domain_scores_gemma":[0.99886554,0.00038386197,0.000056924,0.00019185318,0.00009857211,0.00040324123],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010720406,0.00012468317,0.00027380255,0.00024440905,0.00007156057,0.000017523207,0.0001179292,0.00007027031,0.00004493617],"category_scores_gemma":[0.0008088208,0.00007056352,0.000034145887,0.00027812022,0.00033236685,0.00005630968,0.00009152367,0.0006033939,0.0000040190216],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00977186,0.0031110079,0.27406803,0.00033135852,0.000026864516,0.00006139855,0.0010592195,0.0000047497074,0.000017565695,0.000051157996,0.00014156927,0.7113552],"study_design_scores_gemma":[0.013070287,0.005423335,0.9727204,0.0021867692,0.00000851259,0.000013503545,0.0004650626,0.000276413,0.000025723313,0.0000037763862,0.005717795,0.00008846646],"about_ca_topic_score_codex":0.0000073809706,"about_ca_topic_score_gemma":0.000019066114,"teacher_disagreement_score":0.71126676,"about_ca_system_score_codex":0.000065591994,"about_ca_system_score_gemma":0.00021012136,"threshold_uncertainty_score":0.28774968},"labels":[],"label_agreement":null},{"id":"W2040005083","doi":"10.1185/03007995.2012.657302","title":"Daily and intermittent rosuvastatin 5 mg therapy in statin intolerant patients: an observational study","year":2012,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":52,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Rosuvastatin; Medicine; Tolerability; Internal medicine; Statin; Adverse effect; Simvastatin; Atorvastatin; Rosuvastatin Calcium; Gastroenterology; Diabetes mellitus; Endocrinology","score_opus":0.33369323085718666,"score_gpt":0.49896020723159556,"score_spread":0.1652669763744089,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2040005083","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9912951,0.006332997,0.00009918134,0.0007902796,0.00030742056,0.0011279971,0.000007766849,0.000011791024,0.000027489517],"genre_scores_gemma":[0.9933078,0.0056879176,0.0000705348,0.0001402642,0.00048059048,0.00014032586,0.00015215269,0.000012493349,0.000007916274],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9965096,0.00051481515,0.00033855304,0.00028927156,0.0018584278,0.000489328],"domain_scores_gemma":[0.99848264,0.00015570193,0.00003194161,0.00022127664,0.00022088437,0.0008875517],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0041435286,0.00011684072,0.00027103123,0.00017181772,0.0001054982,0.000031897223,0.000080268976,0.00006508615,0.000091751775],"category_scores_gemma":[0.0008543574,0.00008182904,0.000031180774,0.00022723581,0.0001572376,0.00019862373,0.00011415522,0.0006522139,0.0000046974596],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019245467,0.0017737374,0.47241154,0.000088754256,0.0000135964465,0.0000026546427,0.00145315,1.813342e-8,0.0000051141396,0.000082967126,0.00027689093,0.5236991],"study_design_scores_gemma":[0.0052429833,0.0026970892,0.9795051,0.00030784617,0.0000025830432,0.000004580735,0.0011415101,0.0002624553,0.000007532245,0.00007829153,0.010669845,0.00008018243],"about_ca_topic_score_codex":0.0003025779,"about_ca_topic_score_gemma":0.00004131368,"teacher_disagreement_score":0.52361894,"about_ca_system_score_codex":0.0000713971,"about_ca_system_score_gemma":0.00024635455,"threshold_uncertainty_score":0.33368915},"labels":[],"label_agreement":null},{"id":"W2041031356","doi":"10.1185/030079906x112561","title":"Quetiapine in patients with comorbid schizophrenia-spectrum and substance use disorders: an open-label trial","year":2006,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":68,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université Laval; Hôpital Louis-H Lafontaine; AstraZeneca (Canada); Université de Montréal","funders":"","keywords":"Quetiapine; Medicine; Psychiatry; Schizophrenia (object-oriented programming); Extrapyramidal symptoms; Craving; Substance abuse; Clozapine; Cannabis; Psychosis; Addiction; Antipsychotic","score_opus":0.10499089369123789,"score_gpt":0.4098819037209551,"score_spread":0.30489101002971725,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2041031356","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9911479,0.003392003,0.000029951965,0.003054378,0.00013739409,0.002128402,0.000021586588,0.000025533001,0.0000629007],"genre_scores_gemma":[0.9939964,0.0045368457,0.00035366483,0.000018613911,0.00031151416,0.00018252656,0.00052692025,0.000026603231,0.000046916084],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9960553,0.00030902144,0.00035465253,0.00063728774,0.0018931391,0.00075058907],"domain_scores_gemma":[0.9980938,0.00034396772,0.000046113695,0.00036005507,0.00015165866,0.0010044249],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011181846,0.00020981526,0.000383903,0.00033157234,0.00019990624,0.00020676611,0.00024112214,0.00011862436,0.00007932657],"category_scores_gemma":[0.00059564813,0.00014278991,0.000015109014,0.000527866,0.0006018278,0.00040672172,0.00022232284,0.0009081525,0.000009019863],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.39257178,0.012853071,0.39398724,0.00016980284,0.000041115567,0.00005979928,0.00005930231,1.1415927e-7,0.0000040442255,0.008915118,0.0017057533,0.18963286],"study_design_scores_gemma":[0.2741035,0.013986116,0.70296746,0.000874958,0.000007776051,0.000006118648,0.000017758146,0.0002892046,0.000015013379,0.0045605362,0.0029757756,0.00019578515],"about_ca_topic_score_codex":0.0012515135,"about_ca_topic_score_gemma":0.0066375025,"teacher_disagreement_score":0.30898023,"about_ca_system_score_codex":0.00011236255,"about_ca_system_score_gemma":0.0005139271,"threshold_uncertainty_score":0.58228034},"labels":[],"label_agreement":null},{"id":"W2041216910","doi":"10.1185/03007995.2013.786692","title":"Predictors of achieving HbA<sub>1c</sub> &lt;7% and no hypoglycaemia 6 months after initiation of biphasic insulin aspart 30 in patients with type 2 diabetes in the IMPROVE study","year":2013,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Diabetes Management and Research","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Windsor Regional Hospital","funders":"Novo Nordisk; Bristol-Myers Squibb","keywords":"Medicine; Insulin aspart; Postprandial; Internal medicine; Diabetes mellitus; Insulin; Type 2 diabetes; Hypoglycemia; Observational study; Incidence (geometry); Regimen; Cohort; Endocrinology","score_opus":0.02573497210367938,"score_gpt":0.3233318535809332,"score_spread":0.2975968814772538,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2041216910","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99563813,0.0018398055,0.000001027454,0.00021707159,0.0001511185,0.0019754013,0.0000047749095,0.000005118935,0.00016757348],"genre_scores_gemma":[0.9984533,0.0011916992,0.0000040142513,0.000015687885,0.000101120204,0.00017179194,0.00004552267,0.000010993156,0.00000582684],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968761,0.00034568223,0.00037988194,0.00027751926,0.0016992143,0.0004215619],"domain_scores_gemma":[0.9986515,0.00047621276,0.00006628902,0.00021398245,0.00037716876,0.00021483588],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021459782,0.00012208203,0.00029276477,0.00043647643,0.000038862032,0.000029131596,0.00015708173,0.00008375431,0.00005464705],"category_scores_gemma":[0.0019069657,0.000070979215,0.000018732626,0.00060661085,0.0003777436,0.000169027,0.00022456859,0.0006349457,0.000009156913],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038150128,0.0011462776,0.8934131,0.0005739395,0.000028870461,0.0000016837571,0.00042099218,1.2280157e-7,0.0001420176,0.000007574073,0.0004345691,0.10344931],"study_design_scores_gemma":[0.003781389,0.004369458,0.98965865,0.0009811291,0.000009780238,4.1506485e-8,0.00021675843,0.0005462425,0.00012378438,0.000040888972,0.00020635308,0.00006554009],"about_ca_topic_score_codex":0.000026845008,"about_ca_topic_score_gemma":0.000020115864,"teacher_disagreement_score":0.103383765,"about_ca_system_score_codex":0.00003334669,"about_ca_system_score_gemma":0.00012658545,"threshold_uncertainty_score":0.28944483},"labels":[],"label_agreement":null},{"id":"W2044581275","doi":"10.1185/03007995.2013.795139","title":"Comparison of gastrointestinal safety and tolerability of aceclofenac with diclofenac: a multicenter, randomized, double-blind study in patients with knee osteoarthritis","year":2013,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Diclofenac; Tolerability; Aceclofenac; Osteoarthritis; Adverse effect; Discontinuation; Internal medicine; Placebo; Anesthesia; Gastroenterology","score_opus":0.053062289657115694,"score_gpt":0.3960141481509415,"score_spread":0.3429518584938258,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2044581275","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939531,0.0008190427,0.00007035505,0.00012761845,0.000086070286,0.0048857434,0.000005175764,0.00000771586,0.000045167257],"genre_scores_gemma":[0.9995067,0.0001252848,0.00008699552,0.0000033308067,0.000055738234,0.00017195601,0.00003438324,0.000011598273,0.000004001155],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9964977,0.000474044,0.0006918013,0.0003412279,0.0015945765,0.0004006751],"domain_scores_gemma":[0.99754864,0.0009449646,0.00015113199,0.00022679636,0.00056252227,0.0005659278],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002148808,0.00017260438,0.00097470474,0.00022222789,0.00006179458,0.000014018277,0.00008382358,0.00006265038,0.00008401606],"category_scores_gemma":[0.0012297258,0.0001023174,0.00003406203,0.00026066313,0.0011329934,0.00010694189,0.00012595505,0.00069791265,0.0000020307662],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.24808724,0.002174931,0.7123707,0.0006377796,0.000020357464,0.000004343621,0.00058675255,3.0747955e-7,0.0000054316715,0.000015265829,0.000020228917,0.036076646],"study_design_scores_gemma":[0.4303266,0.011313007,0.553848,0.003185562,0.00001811268,0.000005620435,0.0005007914,0.0006105177,0.00005860711,0.000007658466,0.000042391282,0.00008308453],"about_ca_topic_score_codex":0.00025385534,"about_ca_topic_score_gemma":0.00010409553,"teacher_disagreement_score":0.18223937,"about_ca_system_score_codex":0.00004016932,"about_ca_system_score_gemma":0.00022542283,"threshold_uncertainty_score":0.41745612},"labels":[],"label_agreement":null},{"id":"W2047601746","doi":"10.1185/03007990903512396","title":"Undertreatment of hypercholesterolemia","year":2009,"lang":"en","type":"letter","venue":"Current Medical Research and Opinion","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Intensive care medicine; Internal medicine; Pharmacology","score_opus":0.1455126765897489,"score_gpt":0.4490897593131414,"score_spread":0.30357708272339246,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2047601746","genre_codex":"commentary","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0048455163,0.082557864,0.00012694893,0.9080226,0.00088229036,0.0015389128,0.00003211034,0.000039806524,0.0019539949],"genre_scores_gemma":[0.03573057,0.5596209,0.00037999524,0.33712915,0.05840054,0.00044845915,0.0055781924,0.00023761002,0.0024745837],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99424595,0.00033300486,0.00039529364,0.00047306623,0.0039293505,0.00062334724],"domain_scores_gemma":[0.9982456,0.00020714101,0.00005832496,0.0005968274,0.00029266428,0.00059944694],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0018229,0.0002090473,0.0006922169,0.00029493112,0.00008274114,0.000019275258,0.0001659587,0.00075468613,0.0001516834],"category_scores_gemma":[0.0005832,0.00014504096,0.00021346282,0.00021827329,0.00037746163,0.000027610185,0.00012229985,0.0037613753,0.000027493952],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000047222187,0.00014739555,0.00012022508,0.0018382604,0.000067203364,0.00012549569,0.000022885077,4.2656954e-9,0.0000024947888,0.000039012546,0.51232713,0.4852627],"study_design_scores_gemma":[0.0014739261,0.001455613,0.0019407682,0.0037851078,0.000031243264,0.00013326068,0.0000124362405,0.000011610136,0.00004001022,0.00048255714,0.990529,0.0001044655],"about_ca_topic_score_codex":0.00009929119,"about_ca_topic_score_gemma":0.000002222314,"teacher_disagreement_score":0.5708934,"about_ca_system_score_codex":0.00016038708,"about_ca_system_score_gemma":0.0011481692,"threshold_uncertainty_score":0.998537},"labels":[],"label_agreement":null},{"id":"W2048088264","doi":"10.1185/03007995.2014.919908","title":"Influence of a genomic classifier on post-operative treatment decisions in high-risk prostate cancer patients: results from the PRO-ACT study","year":2014,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Genome British Columbia","funders":"","keywords":"Medicine; Prostate cancer; Oncology; Classifier (UML); Internal medicine; Prostatectomy; Cancer; Artificial intelligence","score_opus":0.08400146609774921,"score_gpt":0.44386760837072586,"score_spread":0.35986614227297664,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2048088264","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99192065,0.0017385429,0.0000010794548,0.0031120444,0.00017281002,0.0024756063,0.000547946,0.0000072165635,0.000024083809],"genre_scores_gemma":[0.96103305,0.037744746,0.000007651083,0.00006988822,0.00013713683,0.0007460166,0.00023777997,0.0000113947235,0.00001232011],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99701977,0.0005379742,0.00049108313,0.000497382,0.0010976976,0.0003561204],"domain_scores_gemma":[0.9961908,0.0026089726,0.00010902308,0.00035364626,0.00037084156,0.00036673376],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010476426,0.00017081034,0.00034237656,0.00011862861,0.00015250046,0.000025509278,0.00013312737,0.00006349274,0.000028679147],"category_scores_gemma":[0.0044081407,0.00008553804,0.0000400179,0.00022066433,0.00027015028,0.000056554545,0.00011531631,0.00048189898,0.000014579309],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026898535,0.0040825084,0.57773876,0.000012300003,0.00007049519,0.000005268053,0.0033691954,0.000020434889,0.000016793296,0.00003840672,0.0004374048,0.41151857],"study_design_scores_gemma":[0.01219305,0.013316963,0.9651475,0.001344341,0.000021327895,1.9343788e-7,0.0003221356,0.00016852903,0.00017798494,0.0001352767,0.0070974273,0.000075256816],"about_ca_topic_score_codex":0.005589797,"about_ca_topic_score_gemma":0.0012404966,"teacher_disagreement_score":0.41144332,"about_ca_system_score_codex":0.0003736185,"about_ca_system_score_gemma":0.0005639867,"threshold_uncertainty_score":0.84501386},"labels":[],"label_agreement":null},{"id":"W2048521093","doi":"10.1185/030079906x120968","title":"Dosing patterns, treatment costs, and frequency of physician visits in adults with cancer receiving erythropoietic agents in managed care organizations","year":2006,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Erythropoietin and Anemia Treatment","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Medicine; Epoetin alfa; Dosing; Darbepoetin alfa; Cumulative dose; Erythropoietin; Internal medicine; Cancer","score_opus":0.034716047231888626,"score_gpt":0.38251526016441106,"score_spread":0.3477992129325224,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2048521093","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9810111,0.016469859,0.000019495224,0.0015443475,0.00008602731,0.00060953124,0.000020912259,0.000010802948,0.00022791907],"genre_scores_gemma":[0.96990603,0.029589474,0.00005866098,0.000015477775,0.00012452748,0.000054010223,0.00021973962,0.000015163955,0.000016891376],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983669,0.00011032561,0.0002495485,0.00032115958,0.0006200973,0.00033194956],"domain_scores_gemma":[0.9993689,0.00010833381,0.00004134972,0.00012960506,0.00015020474,0.00020157761],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016624045,0.0001361296,0.0002630577,0.00022074464,0.00008284913,0.000015422409,0.00004788785,0.00007180289,0.00006701083],"category_scores_gemma":[0.00009466687,0.000096591975,0.000015302909,0.0005040251,0.00018625097,0.00005207585,0.000046799876,0.00027676718,0.0000013523793],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009565871,0.0006701552,0.8228753,0.0009234785,0.000012994647,0.000057101282,0.0012613724,9.2401285e-7,0.000041540745,0.000098195116,0.00011524555,0.17384802],"study_design_scores_gemma":[0.007848985,0.0011101621,0.9689593,0.017972847,0.000016342292,0.000009696571,0.002875358,0.00021069076,0.00047372436,0.000057863257,0.00032873394,0.00013632792],"about_ca_topic_score_codex":0.0062254136,"about_ca_topic_score_gemma":0.0053951126,"teacher_disagreement_score":0.17371169,"about_ca_system_score_codex":0.00043262873,"about_ca_system_score_gemma":0.00024083797,"threshold_uncertainty_score":0.9411005},"labels":[],"label_agreement":null},{"id":"W2050347354","doi":"10.1185/030079904125004006","title":"Triple nucleoside treatment with abacavir plus the lamivudine/ zidovudine combination tablet (COM) compared to indinavir/COM in antiretroviral therapy-naïve adults: results of a 48-week open-label, equivalence trial (CNA3014)","year":2004,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University Medical Centre","funders":"","keywords":"Medicine; Abacavir; Lamivudine; Indinavir; Zidovudine; Regimen; Tolerability; Population; Internal medicine; Viral load; Intention-to-treat analysis; Gastroenterology; Randomized controlled trial; Immunology; Adverse effect; Human immunodeficiency virus (HIV); Antiretroviral therapy; Viral disease; Virus","score_opus":0.18496230111015938,"score_gpt":0.4390745304334409,"score_spread":0.25411222932328154,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2050347354","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9729119,0.0023398125,0.00012725039,0.018508587,0.00038222907,0.0052855667,0.00008655847,0.000030706586,0.00032740412],"genre_scores_gemma":[0.98957664,0.008430676,0.00018840676,0.000057990477,0.00015765107,0.00051285303,0.0005379099,0.000027136392,0.00051076553],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9956035,0.00033176062,0.0007715808,0.00065793685,0.0019058043,0.0007294164],"domain_scores_gemma":[0.9980227,0.00048037665,0.00016242791,0.00043751768,0.00029497905,0.00060199917],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00195171,0.00032298156,0.0007575366,0.00042179227,0.0002542614,0.00009506188,0.00046771506,0.00013337035,0.00003946366],"category_scores_gemma":[0.0007463697,0.00018524096,0.00004956789,0.0011764473,0.00046098419,0.00021769234,0.00030068718,0.00060043397,0.000029107252],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.41341522,0.03195945,0.013083032,0.0005091488,0.00045280805,0.0002892919,0.009002827,0.0000075819294,0.0003825647,0.0016343064,0.010183743,0.51908],"study_design_scores_gemma":[0.87590456,0.055523008,0.020075964,0.008994119,0.00005775275,0.00004106234,0.0019073023,0.0014734897,0.0026432334,0.00070834294,0.03207128,0.0005998771],"about_ca_topic_score_codex":0.0009989588,"about_ca_topic_score_gemma":0.00021440908,"teacher_disagreement_score":0.5184801,"about_ca_system_score_codex":0.0006751559,"about_ca_system_score_gemma":0.0012563296,"threshold_uncertainty_score":0.7553907},"labels":[],"label_agreement":null},{"id":"W2052628556","doi":"10.1185/03007995.2013.874992","title":"Efficacy and safety of the adjustable gastric band – pooled interim analysis of the APEX and HERO studies at 48 weeks","year":2013,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Bariatric Surgery and Outcomes","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; HERO; Apex (geometry); Adjustable gastric band; Interim analysis; Internal medicine; Surgery; Clinical trial; Weight loss; Anatomy; Obesity; Gastric bypass","score_opus":0.10793692970021856,"score_gpt":0.4211310819086208,"score_spread":0.31319415220840224,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2052628556","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96763957,0.026143022,0.000011240163,0.0052644527,0.00036310244,0.00044846535,0.000008166683,0.000004481527,0.00011750652],"genre_scores_gemma":[0.97769576,0.021864384,0.000005553934,0.000043060438,0.00008414278,0.000013000686,0.0000069823877,0.0000047344715,0.00028240052],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980088,0.0003063965,0.00034628803,0.00021585614,0.00085271435,0.00026996553],"domain_scores_gemma":[0.997504,0.0016679153,0.00008544423,0.00025703944,0.00022239723,0.0002632127],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013977521,0.00010168003,0.0004601733,0.00018732302,0.0001750438,0.000011272536,0.00012798146,0.000076657525,0.0002447398],"category_scores_gemma":[0.0038905798,0.000046955978,0.00008978077,0.00091121695,0.0008790005,0.00004559632,0.0004946779,0.00039524861,0.000001492726],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009240756,0.0004299115,0.71452177,0.0012489341,0.0014240043,0.0000017872054,0.0013278573,6.0733464e-7,0.0006303994,0.00029379592,0.020558791,0.25863805],"study_design_scores_gemma":[0.0019165801,0.00019264156,0.9889612,0.00066033716,0.00027789827,0.0000085210695,0.00054869725,0.000378876,0.00034783632,0.0001045921,0.0065449104,0.00005789449],"about_ca_topic_score_codex":0.00007371928,"about_ca_topic_score_gemma":0.000016931894,"teacher_disagreement_score":0.27443942,"about_ca_system_score_codex":0.000033628592,"about_ca_system_score_gemma":0.00011648252,"threshold_uncertainty_score":0.46576685},"labels":[],"label_agreement":null},{"id":"W2054439906","doi":"10.1185/030079902125000651","title":"GABA Agonist: Clomethiazole","year":2002,"lang":"en","type":"review","venue":"Current Medical Research and Opinion","topic":"Neurological Disease Mechanisms and Treatments","field":"Neuroscience","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Agonist; Glutamate receptor; Neuroprotection; Pharmacology; Anesthesia; Depolarization; Neurotransmitter; Neuroscience; NMDA receptor; Central nervous system; Internal medicine; Receptor; Biology","score_opus":0.4875499766340358,"score_gpt":0.5270043245140522,"score_spread":0.039454347880016394,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2054439906","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000006424039,0.9961801,0.000018390803,0.00018903936,0.0012600172,0.00077445956,0.00014244711,0.00006198919,0.0013671337],"genre_scores_gemma":[0.000039812443,0.99876815,0.0000050364997,0.00006443175,0.0004936533,0.00024566927,0.00006845566,0.000032589287,0.00028219985],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99403745,0.0011837892,0.00045422875,0.0010633448,0.0023785934,0.00088257785],"domain_scores_gemma":[0.99613047,0.0018986175,0.00009563231,0.00039105248,0.000049828788,0.001434404],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0008035173,0.0003607322,0.00087356404,0.0003128675,0.0004049088,0.00015049486,0.0006473412,0.00037644987,0.0014943741],"category_scores_gemma":[0.0049348553,0.00022822764,0.0002541189,0.00067674037,0.0005775019,0.00007158293,0.0006500002,0.0020428973,0.0012264914],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000067745846,0.00044760536,4.6539083e-7,0.004037019,0.0000059719787,0.00014383924,0.0000042797365,1.2541598e-9,5.317221e-7,0.0056451866,0.0035375415,0.98617077],"study_design_scores_gemma":[0.00027001675,0.00036973812,0.0000014188385,0.0048124036,0.00002066923,0.000046875273,8.7385826e-7,0.000024592586,0.0000060441293,0.002431553,0.9918326,0.00018322258],"about_ca_topic_score_codex":0.000002431636,"about_ca_topic_score_gemma":3.2918936e-7,"teacher_disagreement_score":0.9882951,"about_ca_system_score_codex":0.000061969564,"about_ca_system_score_gemma":0.00028586027,"threshold_uncertainty_score":0.9995512},"labels":[],"label_agreement":null},{"id":"W2056290188","doi":"10.1185/030079904125004051","title":"Predictors of adherence and virologic outcome in HIV-infected patients treated with abacavir- or indinavir-based triple combination HAART also containing lamivudine/zidovudine","year":2004,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University Medical Centre","funders":"","keywords":"Medicine; Abacavir; Regimen; Lamivudine; Internal medicine; Zidovudine; Indinavir; Randomized controlled trial; Population; Viral load; Dosing; Immunology; Human immunodeficiency virus (HIV); Antiretroviral therapy; Viral disease; Virus","score_opus":0.08232951022776082,"score_gpt":0.39161202277814156,"score_spread":0.30928251255038075,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2056290188","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971337,0.00043363162,0.00009584814,0.0011020057,0.000084161125,0.0010081709,0.000020946445,0.00003273372,0.000088828456],"genre_scores_gemma":[0.9982585,0.0007905158,0.00008888892,0.000018998015,0.000030010382,0.000101695165,0.0006090854,0.0000131672805,0.00008918971],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99745464,0.00015060291,0.000472768,0.00037565138,0.0011252344,0.0004210731],"domain_scores_gemma":[0.9987523,0.00034486727,0.00009997711,0.00013458211,0.00023896116,0.00042930426],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00080227474,0.00019668201,0.0004683369,0.0004473997,0.000097522265,0.000016930024,0.00008242379,0.00014667449,0.00006357454],"category_scores_gemma":[0.0013524978,0.000121278295,0.000026517859,0.0006415091,0.00039682077,0.000097419834,0.00007163616,0.0004958618,0.000006390405],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016624597,0.0016749926,0.9829713,0.00022611715,0.000037123726,0.0000392718,0.0002273269,4.375122e-7,0.000024302193,0.000121041136,0.00012781737,0.0128878],"study_design_scores_gemma":[0.030194513,0.0069826017,0.95909053,0.0019083839,0.00002384143,0.0000072617154,0.00011962838,0.00035449042,0.0004187964,0.00006423064,0.00068995595,0.00014576348],"about_ca_topic_score_codex":0.00007031244,"about_ca_topic_score_gemma":0.000035199275,"teacher_disagreement_score":0.028532052,"about_ca_system_score_codex":0.00017668183,"about_ca_system_score_gemma":0.0004176081,"threshold_uncertainty_score":0.4945585},"labels":[],"label_agreement":null},{"id":"W2057332288","doi":"10.1185/03007995.2013.837817","title":"Early use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) in Type 2 diabetes","year":2013,"lang":"en","type":"review","venue":"Current Medical Research and Opinion","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary","funders":"Canadian Diabetes Association","keywords":"Medicine; Exenatide; Liraglutide; Metformin; Type 2 diabetes; Incretin; Hypoglycemia; Glucagon-like peptide 1 receptor; Diabetes mellitus; Internal medicine; Glycemic; Clinical trial; Pharmacology; Endocrinology; Agonist; Receptor","score_opus":0.22692591207380713,"score_gpt":0.45767175723437686,"score_spread":0.23074584516056973,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2057332288","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0033496348,0.99259245,0.0000015412332,0.00020063804,0.0013908911,0.0021769514,0.00002411795,0.000025729865,0.00023804804],"genre_scores_gemma":[0.00008339648,0.9968753,0.00007032239,0.000017153223,0.00040813923,0.0003235328,0.0009648315,0.000047194957,0.001210167],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9955902,0.00042817186,0.00078956876,0.00062163506,0.0017250647,0.00084535446],"domain_scores_gemma":[0.9971874,0.0010325509,0.00016375304,0.0004975445,0.00028272366,0.0008360584],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0014465932,0.00038150544,0.001650082,0.0007680125,0.00006116565,0.00008198334,0.00028663946,0.00038555695,0.00066349836],"category_scores_gemma":[0.0020975578,0.0002614882,0.00021441883,0.00082764163,0.00047310212,0.00015402233,0.0004738585,0.0012159953,0.0003718637],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000028373603,0.00056640554,0.00090956554,0.023341654,0.00016102708,0.000007565419,0.00003138043,3.4822494e-9,5.3905563e-7,0.00016580486,0.049828265,0.9249594],"study_design_scores_gemma":[0.0008209501,0.0010279105,0.00054396054,0.047707375,0.00009706641,9.2596673e-7,0.000007793792,0.000011951123,0.0000020856207,0.000038260125,0.9495579,0.00018381946],"about_ca_topic_score_codex":0.00007269972,"about_ca_topic_score_gemma":0.0000050581,"teacher_disagreement_score":0.9247756,"about_ca_system_score_codex":0.00019065663,"about_ca_system_score_gemma":0.00067641126,"threshold_uncertainty_score":0.9999837},"labels":[],"label_agreement":null},{"id":"W2058758881","doi":"10.1185/03007990802484234","title":"The cost-effectiveness of palivizumab for respiratory syncytial virus prophylaxis in premature infants with a gestational age of 32–35 weeks: a Canadian-based analysis","year":2008,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Respiratory viral infections research","field":"Medicine","cited_by":75,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Children's Hospital of Eastern Ontario; University of Manitoba; St. Joseph’s Healthcare Hamilton; McMaster University; McMaster Children's Hospital; Toronto Rehabilitation Institute; Sunnybrook Health Science Centre; Health Sciences Centre; University of Toronto","funders":"Abbott Laboratories","keywords":"Palivizumab; Medicine; Gestational age; Respiratory system; Pediatrics; Bronchopulmonary dysplasia; Pregnancy; Internal medicine","score_opus":0.14225546417479512,"score_gpt":0.45932642881124514,"score_spread":0.31707096463645,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2058758881","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99186397,0.003532779,0.0009207401,0.00024932058,0.00009528328,0.0030499676,0.000156616,0.000008936715,0.00012240397],"genre_scores_gemma":[0.998424,0.0006312483,0.00003052065,0.000016559368,0.000082911596,0.00066254917,0.0001295838,0.000013865631,0.000008768039],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99610704,0.00088558416,0.00042748937,0.00033831823,0.0017176219,0.0005239176],"domain_scores_gemma":[0.99521255,0.0028732368,0.00007683115,0.00032184075,0.0009137871,0.0006017452],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0035522792,0.00013322372,0.0004435766,0.0011809523,0.00027073338,0.000017618851,0.00019530497,0.00018324055,0.000043517266],"category_scores_gemma":[0.005577757,0.000083224,0.000094130075,0.002032298,0.0013473652,0.00006871919,0.000046325207,0.0008621802,0.0000013312348],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.031712767,0.0033077437,0.695791,0.007901341,0.0012005856,0.00033652858,0.00072178926,0.00025341834,0.006322318,0.0024690062,0.001967576,0.24801596],"study_design_scores_gemma":[0.007372174,0.007315656,0.95201504,0.0023252186,0.000046216155,0.000012270479,0.000072427945,0.0031464605,0.0040068324,0.00018756068,0.023315964,0.00018416632],"about_ca_topic_score_codex":0.005652421,"about_ca_topic_score_gemma":0.020767713,"teacher_disagreement_score":0.25622407,"about_ca_system_score_codex":0.00028371383,"about_ca_system_score_gemma":0.0052240086,"threshold_uncertainty_score":0.9971007},"labels":[],"label_agreement":null},{"id":"W2058810731","doi":"10.1185/03007995.2013.867843","title":"Hospital length of stay: is rivaroxaban associated with shorter inpatient stay compared to warfarin among patients with non-valvular atrial fibrillation?","year":2013,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Medicine; Rivaroxaban; Warfarin; Atrial fibrillation; Propensity score matching; Internal medicine; Cohort; Stroke (engine); Retrospective cohort study; Emergency medicine","score_opus":0.0679400469636449,"score_gpt":0.38356245780021464,"score_spread":0.3156224108365697,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2058810731","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950052,0.00013070359,0.000334184,0.0016399857,0.00032018044,0.0023804603,0.000026520029,0.000027959695,0.00013482831],"genre_scores_gemma":[0.9985744,0.0001544979,0.00011342681,0.000024290492,0.0005532674,0.000010987053,0.00043935474,0.000023260087,0.00010654281],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99580824,0.00013098255,0.00047177367,0.0004061701,0.0026937055,0.00048914325],"domain_scores_gemma":[0.9977117,0.00031965467,0.00013640978,0.00026648585,0.0008334787,0.00073222746],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006280176,0.00020015429,0.0004696117,0.00030534784,0.00013791256,0.000055384124,0.00012781406,0.00011288935,0.00047538197],"category_scores_gemma":[0.00092391984,0.00013020597,0.0000863453,0.00055837596,0.00029927367,0.00021486635,0.00020218459,0.0003453634,0.000025764697],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00058372004,0.00007398551,0.9701451,0.00009011178,0.00018599008,0.0000012931064,0.00055701466,0.0000063588564,0.0000015365414,0.00003753583,0.004473498,0.02384382],"study_design_scores_gemma":[0.005633133,0.0031419357,0.9818687,0.0007014214,0.00003550591,1.6370497e-7,0.0001535923,0.0019736178,0.000026761909,0.000048676244,0.0062425616,0.0001739355],"about_ca_topic_score_codex":0.00015737933,"about_ca_topic_score_gemma":0.000015493353,"teacher_disagreement_score":0.023669884,"about_ca_system_score_codex":0.0001027535,"about_ca_system_score_gemma":0.00017485171,"threshold_uncertainty_score":0.5309645},"labels":[],"label_agreement":null},{"id":"W2059079195","doi":"10.1185/03007995.2015.1027185","title":"Single-pill combination therapy for type 2 diabetes mellitus: linagliptin plus empagliflozin","year":2015,"lang":"en","type":"review","venue":"Current Medical Research and Opinion","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"LMC Diabetes & Endocrinology (Canada)","funders":"","keywords":"Linagliptin; Empagliflozin; Medicine; Metformin; Type 2 diabetes; Type 2 Diabetes Mellitus; Pill; Glycemic; Diabetes mellitus; Dipeptidyl peptidase-4 inhibitor; Pharmacology; Internal medicine; Endocrinology","score_opus":0.36926063485675414,"score_gpt":0.5114607009127419,"score_spread":0.14220006605598773,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2059079195","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000108334454,0.9929258,0.000022636073,0.00064420426,0.0017791253,0.003851594,0.000027451331,0.0000630602,0.000577773],"genre_scores_gemma":[0.00003363945,0.99419034,0.00005739104,0.00003705136,0.0011394417,0.0006616702,0.0031082027,0.000059386253,0.0007128696],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9959161,0.00033308656,0.0005620841,0.00063067116,0.0017694989,0.0007885545],"domain_scores_gemma":[0.9970094,0.0008869194,0.00013791499,0.0003894091,0.0006525339,0.00092381943],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.003090975,0.00038739838,0.001429219,0.00051868457,0.0001366005,0.00009752356,0.00027090497,0.00038421596,0.00012929241],"category_scores_gemma":[0.001897369,0.0002602713,0.0002339074,0.0005526721,0.00030109263,0.000080984995,0.0002208368,0.00076435116,0.00011384989],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000089256384,0.000905407,0.00001531169,0.01540312,0.00021134756,0.0000034246302,0.000039122122,4.4160267e-9,1.0968589e-7,0.0007996341,0.0466337,0.93589956],"study_design_scores_gemma":[0.0029928281,0.0041660047,0.000006908806,0.019234292,0.00015891346,0.0000013525479,0.00001763863,0.00009559265,0.0000023755094,0.00070937036,0.9724023,0.00021244932],"about_ca_topic_score_codex":0.0000026887335,"about_ca_topic_score_gemma":0.0000010548808,"teacher_disagreement_score":0.9356871,"about_ca_system_score_codex":0.00041801244,"about_ca_system_score_gemma":0.001044564,"threshold_uncertainty_score":0.999985},"labels":[],"label_agreement":null},{"id":"W2059142294","doi":"10.1185/03007995.2012.748654","title":"Major depressive disorder severity and the frequency of painful physical symptoms: a pooled analysis of observational studies","year":2012,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Treatment of Major Depression","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Eli Lilly (Canada)","funders":"","keywords":"Observational study; Medicine; Depression (economics); Major depressive disorder; Anxiety; Logistic regression; Physical therapy; Longitudinal study; Odds ratio; Post-hoc analysis; Internal medicine; Psychiatry; Mood","score_opus":0.13270354148571759,"score_gpt":0.4601563853263587,"score_spread":0.3274528438406411,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2059142294","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94490755,0.051922906,0.00008453718,0.0025251359,0.00010228207,0.0003759681,0.000024982859,0.000007833858,0.00004881508],"genre_scores_gemma":[0.9934848,0.0061034407,0.000040321473,0.00001958076,0.00018603304,0.00006438565,0.0000808293,0.0000055910677,0.000015003488],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973727,0.00038089565,0.0002864102,0.0001992373,0.0014813571,0.00027944148],"domain_scores_gemma":[0.9967067,0.0023258768,0.000096334865,0.00021514167,0.00035405875,0.00030184252],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014734198,0.000110271154,0.0005258603,0.00018906858,0.00011081617,0.000005767144,0.0000970712,0.00006680152,0.00005408445],"category_scores_gemma":[0.0047450266,0.00005780761,0.00010581818,0.00052238104,0.0013186662,0.000101092395,0.0002232234,0.00033499597,0.0000010531769],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046346383,0.0011332472,0.9220658,0.00049354654,0.0018140188,0.0000012221936,0.0014821818,2.3185322e-7,0.000099967154,0.0050664237,0.0004615525,0.06691838],"study_design_scores_gemma":[0.0042473334,0.00023358341,0.98966944,0.0005902333,0.0007145868,0.0000029156422,0.00033683103,0.0016375724,0.00015681669,0.0019278972,0.0004201052,0.00006268387],"about_ca_topic_score_codex":0.000059769038,"about_ca_topic_score_gemma":0.0000097628135,"teacher_disagreement_score":0.06760368,"about_ca_system_score_codex":0.000028414504,"about_ca_system_score_gemma":0.00010939308,"threshold_uncertainty_score":0.56805825},"labels":[],"label_agreement":null},{"id":"W2062448901","doi":"10.1185/03007995.2014.944973","title":"Impact of low-grade adverse events on health-related quality of life in adult patients receiving imatinib or nilotinib for newly diagnosed Philadelphia chromosome positive chronic myelogenous leukemia in chronic phase","year":2014,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":70,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Medicine; Nilotinib; Imatinib; Internal medicine; Adverse effect; Incidence (geometry); Imatinib mesylate; Quality of life (healthcare); Chronic myelogenous leukemia; Philadelphia chromosome; Bosutinib; Tyrosine-kinase inhibitor; Myeloid leukemia; Gastroenterology; Leukemia; Cancer","score_opus":0.09152452362728754,"score_gpt":0.45543503688559417,"score_spread":0.36391051325830664,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2062448901","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9933808,0.0020172573,0.00004479814,0.00068757526,0.0002869749,0.0033059653,0.00023629141,0.000020821986,0.000019512894],"genre_scores_gemma":[0.99208915,0.006213161,0.000034939414,0.000034432484,0.0002459089,0.00023229142,0.0011005347,0.000043434153,0.000006117594],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9933997,0.001022089,0.0018753791,0.00072412274,0.0018308245,0.0011478754],"domain_scores_gemma":[0.9945451,0.0029126958,0.0005704781,0.00047478548,0.000418944,0.0010779973],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.003054628,0.0003648636,0.0013211723,0.0006497792,0.0001038297,0.0000054256575,0.00028444242,0.00031696257,0.00017382327],"category_scores_gemma":[0.013927859,0.00027595455,0.00021702594,0.00083412055,0.00040634003,0.00012831138,0.00015058774,0.0011581389,0.000009615326],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.03567862,0.02287272,0.24012706,0.021242617,0.0006992878,0.000050570197,0.004743189,0.00036812844,0.0019144185,0.00036677194,0.0023319,0.6696047],"study_design_scores_gemma":[0.14620647,0.03814866,0.77394164,0.021985628,0.00001887158,0.000006909671,0.00010872016,0.018546835,0.00038852193,0.00020676623,0.000078743135,0.000362241],"about_ca_topic_score_codex":0.0032984598,"about_ca_topic_score_gemma":0.0009647705,"teacher_disagreement_score":0.6692425,"about_ca_system_score_codex":0.010607484,"about_ca_system_score_gemma":0.012125456,"threshold_uncertainty_score":0.99996924},"labels":[],"label_agreement":null},{"id":"W2062482109","doi":"10.1185/030079908x297231","title":"Chondroitin sulphate for symptomatic osteoarthritis: critical appraisal of meta-analyses","year":2008,"lang":"en","type":"review","venue":"Current Medical Research and Opinion","topic":"Proteoglycans and glycosaminoglycans research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Hôpital Notre-Dame","funders":"Pfizer","keywords":"Medicine; Tolerability; Placebo; Meta-analysis; Osteoarthritis; Acetaminophen; Internal medicine; Clinical trial; Analgesic; Chondroitin sulphate; Randomized controlled trial; Dosing; Physical therapy; Adverse effect; Anesthesia; Alternative medicine; Pathology","score_opus":0.3959808938835189,"score_gpt":0.581649663551936,"score_spread":0.1856687696684171,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2062482109","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000063972206,0.996511,0.0009936953,0.00012444759,0.0004978924,0.0012306116,0.0004943173,0.000008844162,0.00007526216],"genre_scores_gemma":[0.00017414542,0.99597126,0.00017673222,0.0000054859643,0.0008862405,0.0012740617,0.0013719745,0.000052423242,0.000087659355],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9945699,0.0008905658,0.00095752964,0.00087346515,0.0017872194,0.00092132523],"domain_scores_gemma":[0.995507,0.002350114,0.00014732173,0.0005922048,0.0005958695,0.00080751575],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0019062371,0.00042181212,0.001878492,0.00038157855,0.0002198183,0.000056327637,0.00072526117,0.0006092314,0.00013331187],"category_scores_gemma":[0.016108017,0.00029543525,0.0009460805,0.0003856968,0.001427193,0.000009293684,0.00054669066,0.00089592795,0.000012194101],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006910458,0.00024350965,0.0000012521878,0.01834105,0.00075330894,0.000010541203,0.00001054065,3.5884565e-8,0.00002844784,0.00043548585,0.007925657,0.9721811],"study_design_scores_gemma":[0.0005951282,0.0014457261,0.0000010893045,0.0039540315,0.00034448018,0.00013092706,0.00001250543,0.00002428561,0.0002010832,0.00011632097,0.992906,0.00026843778],"about_ca_topic_score_codex":0.000020925945,"about_ca_topic_score_gemma":0.000009489339,"teacher_disagreement_score":0.98498034,"about_ca_system_score_codex":0.000024989105,"about_ca_system_score_gemma":0.0015495335,"threshold_uncertainty_score":0.99994975},"labels":[],"label_agreement":null},{"id":"W2063443588","doi":"10.1185/03007995.2013.802230","title":"Real-life effectiveness and tolerability of the rivastigmine transdermal patch in patients with mild-to-moderate Alzheimer’s disease: the EMBRACE study","year":2013,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Dementia and Cognitive Impairment Research","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Novartis (Canada); University of Toronto; Université de Montréal; McGill University","funders":"","keywords":"Medicine; Tolerability; Rivastigmine; Internal medicine; Transdermal patch; Quality of life (healthcare); Adverse effect; Dementia; Disease; Transdermal; Donepezil; Pharmacology","score_opus":0.055553451928397106,"score_gpt":0.3999487300846192,"score_spread":0.34439527815622206,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2063443588","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9910508,0.0008772236,0.000034537406,0.0034393894,0.00007950378,0.0044523138,0.000011084556,0.000006258619,0.00004888012],"genre_scores_gemma":[0.9990545,0.0003814183,0.0000025538272,0.00004441029,0.000052848252,0.00043442874,0.000012687801,0.000010077262,0.0000070936903],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9954612,0.0011202012,0.0002795966,0.00039688186,0.002288922,0.00045316634],"domain_scores_gemma":[0.99748105,0.0007064836,0.00003059277,0.00030731005,0.0005300798,0.0009444797],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024177476,0.0001399034,0.00028646566,0.000108002016,0.00018724274,0.000041504296,0.00019209285,0.000045863686,0.000155116],"category_scores_gemma":[0.0013497227,0.00006564611,0.000032716664,0.0004653021,0.00062787946,0.00009374025,0.00025707186,0.0006678172,0.0000050627987],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021635313,0.0022169405,0.93638724,0.00029155117,0.000049370163,0.000002161682,0.000341011,3.4118491e-7,0.000011937714,0.000025027952,0.00015819535,0.05835267],"study_design_scores_gemma":[0.004721034,0.0018647856,0.9917737,0.00069596624,0.000023766175,4.4697518e-7,0.0002547928,0.00035261206,0.0000666692,0.000075299795,0.000101807134,0.00006911747],"about_ca_topic_score_codex":0.00044103584,"about_ca_topic_score_gemma":0.00004784799,"teacher_disagreement_score":0.058283553,"about_ca_system_score_codex":0.000028040125,"about_ca_system_score_gemma":0.0004702867,"threshold_uncertainty_score":0.29013705},"labels":[],"label_agreement":null},{"id":"W2063984158","doi":"10.1185/030079908x280545","title":"Efficacy and tolerability of intramuscular interferon beta-1a compared with subcutaneous interferon beta-1a in relapsing MS: results from PROOF","year":2008,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre","funders":"","keywords":"Medicine; Tolerability; Interferon beta-1a; Intramuscular injection; BETA (programming language); Interferon; Adverse effect; Interferon beta; Pharmacology; Internal medicine; Immunology","score_opus":0.17177108392703672,"score_gpt":0.4099728827756343,"score_spread":0.2382017988485976,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2063984158","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9865158,0.008627526,0.00016527576,0.0027922844,0.00018459959,0.0014294966,0.00006132814,0.000030268728,0.00019340168],"genre_scores_gemma":[0.98583734,0.013382266,0.00019616654,0.000012522698,0.00023675979,0.000059934442,0.00023639457,0.000023896962,0.000014727579],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99409497,0.00069892197,0.00096323114,0.0009074656,0.002511894,0.00082349643],"domain_scores_gemma":[0.9956871,0.0022254249,0.00012211977,0.0005628286,0.00049406063,0.0009084383],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026413794,0.0002911399,0.0009684963,0.00039185825,0.00020578827,0.000034633395,0.00028000202,0.00019711317,0.00008726222],"category_scores_gemma":[0.0046983454,0.0002041371,0.00006653502,0.00050497585,0.0024667322,0.00012952715,0.00058232364,0.0018921326,0.000005084009],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.14995481,0.007479634,0.1150186,0.003913982,0.0006558531,0.0006191296,0.017842093,0.000012619228,0.0049990797,0.00009904497,0.0069583547,0.6924468],"study_design_scores_gemma":[0.06052627,0.045580376,0.81810653,0.03434974,0.000091968126,0.00032968962,0.002384013,0.013828322,0.006483743,0.00029454258,0.016927991,0.0010967931],"about_ca_topic_score_codex":0.0008510071,"about_ca_topic_score_gemma":0.0003590158,"teacher_disagreement_score":0.7030879,"about_ca_system_score_codex":0.00022079248,"about_ca_system_score_gemma":0.0004221338,"threshold_uncertainty_score":0.90887773},"labels":[],"label_agreement":null},{"id":"W2064266976","doi":"10.1185/03007995.2015.1013625","title":"Six-minute walk test in Chinese adults with clinically stable bronchiectasis: association with clinical indices and determinants","year":2015,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Cystic Fibrosis Research Advances","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute of Infection and Immunity","keywords":"Bronchiectasis; Medicine; Spirometry; DLCO; Internal medicine; Quality of life (healthcare); Diffusing capacity; Physical therapy; Pediatrics; Lung; Lung function; Asthma","score_opus":0.08031396074731945,"score_gpt":0.4720257132296111,"score_spread":0.3917117524822917,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2064266976","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9925191,0.0040699397,0.000033339275,0.002090923,0.0001897197,0.0008325306,0.000022876991,0.000029714292,0.00021190253],"genre_scores_gemma":[0.98692775,0.011594886,0.0006317775,0.00004610225,0.0005270909,0.00009015535,0.00006670763,0.000024457206,0.00009104887],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.993862,0.00046293484,0.0007154972,0.0006780416,0.003418754,0.0008627979],"domain_scores_gemma":[0.9917203,0.00512083,0.00017157903,0.00028998413,0.0006555849,0.002041727],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.007373165,0.00021250435,0.00061285164,0.00029765753,0.00011336965,0.000088681474,0.00020197582,0.00023767843,0.0000312118],"category_scores_gemma":[0.039574504,0.0001261505,0.00003140109,0.0006991619,0.0007960726,0.00028441584,0.0002612763,0.0018054217,0.000017797003],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004908571,0.0007775088,0.82413435,0.00036813036,0.000020475125,0.000080056845,0.00022975859,1.1810302e-7,0.000003872486,0.0000048754537,0.0012707176,0.1682016],"study_design_scores_gemma":[0.013912279,0.015366458,0.95324236,0.0048269136,0.000012879478,0.00006517027,0.0004918302,0.002024161,0.000019297713,0.00018960316,0.009643051,0.00020597306],"about_ca_topic_score_codex":0.00020424434,"about_ca_topic_score_gemma":0.0008723527,"teacher_disagreement_score":0.16799562,"about_ca_system_score_codex":0.0001959628,"about_ca_system_score_gemma":0.0015260427,"threshold_uncertainty_score":0.9685156},"labels":[],"label_agreement":null},{"id":"W2064799289","doi":"10.1185/030079905x75087","title":"The economic burden of schizophrenia in Canada in 2004","year":2005,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":176,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"St. Joseph’s Healthcare Hamilton; McMaster University","funders":"National Institute of Mental Health","keywords":"Medicine; Schizophrenia (object-oriented programming); Government (linguistics); Productivity; Indirect costs; Health care; Unemployment; Economic cost; Psychiatry; MEDLINE; Environmental health; Gerontology; Demography; Economic growth; Business; Accounting","score_opus":0.0509386803591048,"score_gpt":0.3887010100075109,"score_spread":0.3377623296484061,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2064799289","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9559248,0.02721323,0.0000014725263,0.015939038,0.00019762205,0.00043292466,0.000009513702,0.0000035427763,0.00027786675],"genre_scores_gemma":[0.98008335,0.019405412,0.00003226371,0.000009359792,0.0003566322,0.000049744718,0.000019080388,0.000006552913,0.00003759088],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9976873,0.0001488126,0.00033272855,0.00022309377,0.0010644468,0.00054364215],"domain_scores_gemma":[0.99844795,0.00070168637,0.000024873934,0.00020897211,0.000058425223,0.0005580719],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013729077,0.00008674641,0.00021118834,0.00019664786,0.00006621814,0.000013937694,0.00017449158,0.000050736173,0.0001701698],"category_scores_gemma":[0.0009551224,0.000054665474,0.000024421392,0.00022102764,0.0002519842,0.00004326198,0.0001183269,0.00073526363,0.000021960977],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035290818,0.00012286476,0.027697882,0.000090407266,0.000016479707,0.000039569728,0.00006425811,0.000010177252,0.0000070363826,0.0021012907,0.0058237445,0.9604972],"study_design_scores_gemma":[0.038454473,0.001763019,0.64239335,0.0038352823,0.000008625643,0.000089473186,0.0010969274,0.034010258,0.00091461046,0.005301239,0.27174187,0.00039089166],"about_ca_topic_score_codex":0.39648968,"about_ca_topic_score_gemma":0.8704254,"teacher_disagreement_score":0.9601063,"about_ca_system_score_codex":0.0011754913,"about_ca_system_score_gemma":0.009326124,"threshold_uncertainty_score":0.9962901},"labels":[],"label_agreement":null},{"id":"W2067585939","doi":"10.1185/03007995.2015.1027183","title":"Comments on the discordant recommendations for the use of symptomatic slow-acting drugs in knee osteoarthritis","year":2015,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Osteoarthritis Treatment and Mechanisms","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"Medical Research Council; National Institute for Health and Care Research","keywords":"Osteoarthritis; Medicine; Rheumatology; Drug class; Interpretation (philosophy); Physical therapy; Alternative medicine; Osteoporosis; Intensive care medicine; Internal medicine; Drug; Pathology; Psychiatry","score_opus":0.2891479671736384,"score_gpt":0.4439503389713015,"score_spread":0.1548023717976631,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2067585939","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8864106,0.006024705,0.0004665937,0.09918455,0.002314999,0.005100042,0.000096490636,0.000034188055,0.0003678358],"genre_scores_gemma":[0.9962493,0.002235618,0.0001800808,0.00023651625,0.00023560958,0.0005462006,0.00016322875,0.000016426235,0.0001370099],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99818087,0.00021272982,0.00027993816,0.00017101884,0.0008399881,0.0003154331],"domain_scores_gemma":[0.99624026,0.0030585737,0.000050883125,0.00022635351,0.00013779773,0.0002861221],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016601371,0.00009401992,0.00018428288,0.000109710076,0.00017206291,0.00003724937,0.00010329791,0.00004213597,0.000045697972],"category_scores_gemma":[0.0032310183,0.000049232352,0.000045432334,0.0002023519,0.00020508957,0.00008089889,0.00010256638,0.00040164465,0.0000077787145],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003476826,0.0003983747,0.0014071641,0.000090058864,0.000014881459,0.0000026738749,0.0009833714,1.4384078e-7,0.000021083903,0.00389525,0.0113315685,0.9815077],"study_design_scores_gemma":[0.035603035,0.030765615,0.0028433066,0.020543978,0.00007202172,0.00005971873,0.0153867835,0.006674806,0.0017959912,0.0071239034,0.87871784,0.00041297468],"about_ca_topic_score_codex":0.000041285282,"about_ca_topic_score_gemma":0.00003181099,"teacher_disagreement_score":0.9810948,"about_ca_system_score_codex":0.00006121805,"about_ca_system_score_gemma":0.00018362943,"threshold_uncertainty_score":0.38680643},"labels":[],"label_agreement":null},{"id":"W2070555238","doi":"10.1185/030079907x182202","title":"Pharmacotherapy of generalized anxiety disorder: results of duloxetine treatment from a pooled analysis of three clinical trials","year":2007,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes","field":"Psychology","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Eli Lilly (Canada)","funders":"Otsuka Pharmaceutical; Otsuka America; Otsuka America Pharmaceutical","keywords":"Duloxetine; Duloxetine Hydrochloride; Medicine; Placebo; Nausea; Internal medicine; Adverse effect; Clinical endpoint; Anxiety; Clinical trial; Generalized anxiety disorder; Randomized controlled trial; Escitalopram; Psychiatry; Antidepressant","score_opus":0.382866705017147,"score_gpt":0.6069214512962262,"score_spread":0.22405474627907923,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2070555238","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88597536,0.09945842,0.009881295,0.00048355226,0.001616107,0.00096164126,0.0010966231,0.000022859926,0.0005041302],"genre_scores_gemma":[0.69061667,0.30802605,0.00017711827,0.0000129421405,0.00050372514,0.000047030346,0.00056466,0.000015599358,0.000036247704],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9925186,0.0021492324,0.0023741766,0.0007773161,0.0016498809,0.00053078827],"domain_scores_gemma":[0.9873265,0.009851471,0.00086079515,0.00051958946,0.0008171728,0.0006244887],"candidate_categories":["metaresearch","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.014942058,0.00025211636,0.001507831,0.0011865738,0.000074481286,0.000010529246,0.00036614027,0.00030543006,0.001746697],"category_scores_gemma":[0.010198223,0.00017160246,0.000524049,0.0025646745,0.0008610364,0.00005422601,0.000112118694,0.0004312003,0.000007071776],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008791514,0.0045849704,0.24499574,0.00004625216,0.0031569728,0.0000020822877,0.00044175217,3.419638e-7,0.0002295268,0.00013317222,0.0019286489,0.73568904],"study_design_scores_gemma":[0.058356818,0.0056327446,0.73232675,0.0005879342,0.0019981463,0.0000015296755,0.0007668377,0.00085461745,0.006312021,0.002408629,0.19033006,0.00042391862],"about_ca_topic_score_codex":0.0014742794,"about_ca_topic_score_gemma":0.00022691148,"teacher_disagreement_score":0.7352651,"about_ca_system_score_codex":0.000042741256,"about_ca_system_score_gemma":0.00021191365,"threshold_uncertainty_score":0.99916583},"labels":[],"label_agreement":null},{"id":"W2071657833","doi":"10.1185/03007995.2013.835715","title":"Real-world use patterns of olanzapine long-acting injection in the United States: comparison to the recommended dosing strategy","year":2013,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Newfoundland and Labrador Centre for Applied Health Research; Memorial University of Newfoundland; Waypoint Centre for Mental Health Care","funders":"","keywords":"Medicine; Dosing; Olanzapine; Confidence interval; Anesthesia; Internal medicine; Schizophrenia (object-oriented programming)","score_opus":0.24317243608566128,"score_gpt":0.48304835078294195,"score_spread":0.23987591469728067,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2071657833","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98218995,0.00043236406,0.00031227473,0.015549262,0.00016124017,0.0012682253,0.00001099968,0.0000151221475,0.000060553615],"genre_scores_gemma":[0.994725,0.0043649334,0.000039425304,0.000095201234,0.0002220836,0.00015114159,0.0003592862,0.000010687873,0.000032225642],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9966216,0.0007248074,0.0003929655,0.0002601469,0.0014683619,0.00053213007],"domain_scores_gemma":[0.997249,0.0016318065,0.000056261208,0.000305538,0.00027864575,0.00047873575],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022048724,0.00012569778,0.00023911444,0.0005082321,0.00017976949,0.000119801334,0.00020600035,0.000058365167,0.000227229],"category_scores_gemma":[0.0014033495,0.000064071035,0.000037419053,0.0010538889,0.000117143405,0.000112817026,0.0001385701,0.0011057549,0.000022129978],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024816492,0.0011986126,0.39219052,0.0003649628,0.00006140838,0.000021768237,0.0019159538,0.000024284367,0.000025552858,0.00058484834,0.011144702,0.5899857],"study_design_scores_gemma":[0.0041312324,0.0027064593,0.9624085,0.0020652083,0.0000103517,0.000020626774,0.0040794173,0.013695192,0.00018573823,0.0004251331,0.010149207,0.00012294721],"about_ca_topic_score_codex":0.014903897,"about_ca_topic_score_gemma":0.004841284,"teacher_disagreement_score":0.58986276,"about_ca_system_score_codex":0.0001286088,"about_ca_system_score_gemma":0.00022871893,"threshold_uncertainty_score":0.99165595},"labels":[],"label_agreement":null},{"id":"W2072117854","doi":"10.1185/03007995.2012.681035","title":"Extended-release tramadol/paracetamol in moderate-to-severe pain: a randomized, placebo-controlled study in patients with acute low back pain","year":2012,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Veterinary Pharmacology and Anesthesia","field":"Veterinary","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lakeshore General Hospital; McGill University; Manna Research","funders":"","keywords":"Medicine; Placebo; Anesthesia; Tramadol; Double blind; Randomized controlled trial; Clinical endpoint; Clinical trial; Placebo-controlled study; Low back pain; Analgesic; Surgery; Internal medicine","score_opus":0.07394208201321233,"score_gpt":0.4115539855001807,"score_spread":0.33761190348696835,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2072117854","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99239075,0.00085950847,0.0003143209,0.0007214934,0.00024077072,0.0053635864,0.000007385689,0.000024320674,0.00007789002],"genre_scores_gemma":[0.9978144,0.00028318856,0.000027019394,0.00016339321,0.00018744524,0.0013693488,0.00005028508,0.000027760298,0.00007713484],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.98626786,0.010171114,0.0006288137,0.00054315565,0.0012529622,0.00113609],"domain_scores_gemma":[0.99549574,0.0030579309,0.00007439733,0.00025165052,0.00010973388,0.0010105639],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.020563455,0.00030954566,0.00094803504,0.00043903216,0.00014878804,0.000050126022,0.0003193266,0.00018656047,0.0007649595],"category_scores_gemma":[0.002358154,0.00021321895,0.00008049685,0.00040548915,0.00029747788,0.00029684388,0.00018524814,0.0012888849,0.000117605996],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8656679,0.008777871,0.073223636,0.00026478872,0.0001318027,0.00032320924,0.00129337,0.000006378527,0.0000062894014,0.00003886358,0.0018779964,0.048387893],"study_design_scores_gemma":[0.86117303,0.011500978,0.10313503,0.0014153582,0.00003030235,0.00006735836,0.00049650355,0.019775912,0.0000026894552,0.00016668608,0.0016196178,0.0006165284],"about_ca_topic_score_codex":0.000034346493,"about_ca_topic_score_gemma":0.000013823734,"teacher_disagreement_score":0.047771364,"about_ca_system_score_codex":0.00010304683,"about_ca_system_score_gemma":0.00019812105,"threshold_uncertainty_score":0.8694817},"labels":[],"label_agreement":null},{"id":"W2073695555","doi":"10.1185/03007995.2013.812961","title":"Attention deficit hyperactivity disorder in the European adult population: prevalence, disease awareness, and treatment guidelines","year":2013,"lang":"en","type":"review","venue":"Current Medical Research and Opinion","topic":"Attention Deficit Hyperactivity Disorder","field":"Medicine","cited_by":109,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Eli Lilly (Canada)","funders":"","keywords":"Atomoxetine; Medicine; Methylphenidate; Attention deficit hyperactivity disorder; Psychiatry; Stimulant; MEDLINE; Population; European union; Epidemiology; Pediatrics; Pathology","score_opus":0.3117459813348096,"score_gpt":0.5198673718540309,"score_spread":0.2081213905192213,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2073695555","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.03097302,0.9631646,0.00003668595,0.0028591298,0.00031364648,0.0024518685,0.000040374543,0.00002990095,0.0001307721],"genre_scores_gemma":[0.005794165,0.99179083,0.000012530646,0.000018180786,0.00068892405,0.00050309335,0.0009603017,0.0000452811,0.00018669796],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99409723,0.0021418983,0.0007536752,0.0007830841,0.0017221397,0.0005019939],"domain_scores_gemma":[0.99751526,0.00080443034,0.00017198698,0.00052453537,0.00039982135,0.0005839717],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021567596,0.00041267768,0.0009156317,0.00037989765,0.00031635468,0.00013442311,0.00021544742,0.0001903422,0.000140975],"category_scores_gemma":[0.00416557,0.00023509249,0.00020823254,0.0005098966,0.00024090632,0.00022341436,0.00021304736,0.0010996405,0.00009131643],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000022693272,0.00075339415,0.07882997,0.0103149805,0.000028570395,0.000022430542,0.000014430958,5.9075237e-8,4.7492605e-8,0.000108673245,0.00034258878,0.9095622],"study_design_scores_gemma":[0.0013622161,0.00027016288,0.1706462,0.028575623,0.00022543776,0.00008875426,0.00019997156,0.00025744815,2.105833e-9,0.00004767103,0.79803455,0.00029197897],"about_ca_topic_score_codex":0.00028973934,"about_ca_topic_score_gemma":0.00007212406,"teacher_disagreement_score":0.90927017,"about_ca_system_score_codex":0.00014321994,"about_ca_system_score_gemma":0.00047234588,"threshold_uncertainty_score":0.9586793},"labels":[],"label_agreement":null},{"id":"W2074206824","doi":"10.1185/03007995.2014.907140","title":"Real-world comparative effectiveness and safety of rivaroxaban and warfarin in nonvalvular atrial fibrillation patients","year":2014,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":185,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Medicine; Rivaroxaban; Warfarin; Atrial fibrillation; Hazard ratio; Propensity score matching; Internal medicine; Stroke (engine); Confidence interval; Pulmonary embolism; Cardiology","score_opus":0.14760869087517217,"score_gpt":0.47262164088784175,"score_spread":0.3250129500126696,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2074206824","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99700207,0.0008426277,0.00017434174,0.00047480964,0.00025231807,0.0007778223,0.0000037989475,0.000009623022,0.00046261254],"genre_scores_gemma":[0.9945257,0.0048132516,0.000035356978,0.0000028871975,0.0005252701,0.0000015528894,0.000072451505,0.0000056538925,0.000017879622],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99802995,0.0004453829,0.0003110067,0.0002562861,0.00075029465,0.00020707207],"domain_scores_gemma":[0.99807173,0.0013872734,0.000058787096,0.00010133846,0.00012899112,0.0002518601],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00205788,0.00009841614,0.0003780905,0.00030024207,0.00007852538,0.00001527011,0.000037775473,0.000070094444,0.000023247083],"category_scores_gemma":[0.0013550435,0.00007677991,0.00003821679,0.00029769342,0.00027498917,0.000083679006,0.00015636819,0.0002307716,0.0000020682226],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013017273,0.000012054497,0.8672453,0.00043740746,0.000018118271,3.547563e-7,0.00014596057,0.0000021219748,0.000016068827,0.003774289,0.0000597908,0.12698679],"study_design_scores_gemma":[0.005342601,0.0005310156,0.97516763,0.0006613863,0.000009343118,4.13524e-7,0.000026658076,0.003190745,0.00004339631,0.0008044856,0.01415406,0.00006826883],"about_ca_topic_score_codex":0.00012261713,"about_ca_topic_score_gemma":0.00003286162,"teacher_disagreement_score":0.12691852,"about_ca_system_score_codex":0.000039910316,"about_ca_system_score_gemma":0.00005435455,"threshold_uncertainty_score":0.31309938},"labels":[],"label_agreement":null},{"id":"W2076944326","doi":"10.1185/030079908x260853","title":"An economic evaluation of sevelamer in patients new to dialysis","year":2008,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Parathyroid Disorders and Treatments","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Medicine; Sevelamer; Dialysis; Intensive care medicine; Internal medicine; Kidney disease; Hyperphosphatemia","score_opus":0.21261200673001632,"score_gpt":0.5082672745175829,"score_spread":0.29565526778756657,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2076944326","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99587864,0.0028025545,0.000028075006,0.000445055,0.00013427684,0.00042240624,0.000004453679,0.000003477943,0.00028104885],"genre_scores_gemma":[0.99707484,0.0026178602,0.000026701617,0.0000156301,0.00009671635,0.000024892532,0.00011807638,0.0000046993077,0.000020573945],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981267,0.00013703259,0.00019686429,0.00020872342,0.0011267464,0.00020396894],"domain_scores_gemma":[0.9990494,0.00005882969,0.00002089909,0.00014283234,0.00014366827,0.00058436225],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00087274564,0.00006112369,0.00017171878,0.00023948244,0.00003957536,0.000003958864,0.00005964472,0.000051610954,0.00013468112],"category_scores_gemma":[0.0006652153,0.000048328333,0.000022618073,0.0001813002,0.00008130807,0.000060945353,0.0000356151,0.00014587183,0.000046596186],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032754807,0.0012197857,0.6539206,0.000012833655,0.000018527708,0.000001629122,0.00051223,0.0000048798374,0.000010582259,0.000055587097,0.011147637,0.33276814],"study_design_scores_gemma":[0.0065359944,0.00121417,0.986017,0.000078404104,0.000009423198,0.0000011562909,0.000033237116,0.0023983351,0.0000665014,0.000247683,0.0033453666,0.000052747862],"about_ca_topic_score_codex":0.0002576446,"about_ca_topic_score_gemma":0.000046059333,"teacher_disagreement_score":0.3327154,"about_ca_system_score_codex":0.00011018389,"about_ca_system_score_gemma":0.00071994105,"threshold_uncertainty_score":0.19707721},"labels":[],"label_agreement":null},{"id":"W2079424502","doi":"10.1185/030079908x273011","title":"The impact of a medical food containing gammalinolenic and eicosapentaenoic acids on asthma management and the quality of life of adult asthma patients","year":2008,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Asthma and respiratory diseases","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Moncton","funders":"","keywords":"Medicine; Asthma; Placebo; Quality of life (healthcare); Eicosapentaenoic acid; Internal medicine; Randomized controlled trial; Gastroenterology; Fatty acid; Polyunsaturated fatty acid","score_opus":0.08993296323244858,"score_gpt":0.43529647497093354,"score_spread":0.34536351173848495,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2079424502","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98598003,0.012148619,0.000029036937,0.001001193,0.00009652539,0.0005976247,0.000023947296,0.000005453941,0.00011757108],"genre_scores_gemma":[0.9732555,0.026526826,0.0000036889369,0.000045421624,0.00010812558,0.000026404077,0.000019648638,0.000008390944,0.000005960519],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9950939,0.0006411789,0.0006497554,0.0002557739,0.003020178,0.0003392278],"domain_scores_gemma":[0.99700505,0.0013945315,0.00017893492,0.00026683148,0.00034681958,0.0008078537],"candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.002526478,0.00014278255,0.00046891623,0.00012637097,0.00020876947,0.000009902124,0.0002119746,0.000114310336,0.000052032283],"category_scores_gemma":[0.005052462,0.00006666499,0.00012326092,0.00020066206,0.0027623742,0.00003653148,0.0003192615,0.00051764975,8.922029e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011832009,0.0016193,0.43535393,0.0014610243,0.000315238,0.000009881432,0.0008180875,2.7451514e-7,0.000007334374,0.00789014,0.0015051835,0.5391876],"study_design_scores_gemma":[0.013670859,0.0065852534,0.9747019,0.0018114721,0.000011238635,0.0000087520975,0.00075972587,0.0004003429,0.000044671444,0.00019168505,0.0017290761,0.000085057414],"about_ca_topic_score_codex":0.00007633771,"about_ca_topic_score_gemma":0.000008855784,"teacher_disagreement_score":0.53934795,"about_ca_system_score_codex":0.000025069841,"about_ca_system_score_gemma":0.0004611357,"threshold_uncertainty_score":0.99995154},"labels":[],"label_agreement":null},{"id":"W2081028045","doi":"10.1185/03007995.2012.728524","title":"Comparison of quetiapine and risperidone in Chinese Han patients with schizophrenia: results of a single-blind, randomized study","year":2012,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"AstraZeneca","keywords":"Quetiapine; Risperidone; Tolerability; Extrapyramidal symptoms; Medicine; Positive and Negative Syndrome Scale; Clinical Global Impression; Internal medicine; Adverse effect; Quetiapine Fumarate; Somnolence; Psychiatry; Schizophrenia (object-oriented programming); Atypical antipsychotic; Antipsychotic; Psychosis; Placebo","score_opus":0.09370925198373438,"score_gpt":0.448551174275721,"score_spread":0.35484192229198663,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2081028045","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9861442,0.010900928,0.000018772513,0.0005228024,0.00010120373,0.002232318,0.00001613022,0.000008740112,0.000054897966],"genre_scores_gemma":[0.9979447,0.0014745375,0.00018035148,0.0000020394657,0.00014137708,0.00010765079,0.00012947722,0.000013709297,0.000006119458],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99550235,0.0006569412,0.00072578964,0.0003273653,0.0022500074,0.00053755986],"domain_scores_gemma":[0.9971138,0.0012504292,0.00013340371,0.00027847136,0.00031275864,0.0009111365],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0033327509,0.00018896422,0.0010257422,0.000546997,0.00006395114,0.000013802832,0.00010954032,0.000096040785,0.000027544893],"category_scores_gemma":[0.005569427,0.00010792364,0.000052194096,0.00063290936,0.00088857126,0.00010958254,0.00019657392,0.000672545,0.000002376484],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.44171345,0.009249995,0.5071466,0.00021156507,0.000084000014,0.0000034140207,0.00083283946,4.8001834e-8,0.000016317998,0.00005791169,0.00005843454,0.04062544],"study_design_scores_gemma":[0.48994222,0.005620737,0.50262535,0.00095329265,0.000025347184,0.0000033664232,0.00023639761,0.00018722448,0.00015505914,0.000086230626,0.00007887571,0.000085881016],"about_ca_topic_score_codex":0.00023628787,"about_ca_topic_score_gemma":0.00019421236,"teacher_disagreement_score":0.048228763,"about_ca_system_score_codex":0.00005270561,"about_ca_system_score_gemma":0.00023120623,"threshold_uncertainty_score":0.66675264},"labels":[],"label_agreement":null},{"id":"W2081208043","doi":"10.1185/0300799009117014","title":"Dose Response and Safety of Cizolirtine Citrate (E-4018) in Patients with Pain Following Extraction of Third Molars","year":2000,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Pain Management and Opioid Use","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Molar; Extraction (chemistry); Dentistry; Anesthesia; Chromatography","score_opus":0.03720159257238333,"score_gpt":0.3832386857286012,"score_spread":0.3460370931562179,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2081208043","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99713445,0.0013610341,0.00007695786,0.0006619855,0.00006047236,0.00048292812,0.000003663831,0.000008291091,0.0002102441],"genre_scores_gemma":[0.99637884,0.0033466236,0.00006803626,0.000023445053,0.000041679745,0.000010977756,0.000042000367,0.000008146294,0.000080251695],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974708,0.0005368095,0.0003448492,0.00022585514,0.001139113,0.00028258303],"domain_scores_gemma":[0.99871737,0.0007094494,0.000048819555,0.00015531796,0.000095331765,0.00027368622],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005799326,0.000094260155,0.00025525177,0.00028268198,0.00005023832,0.000008171607,0.00006989475,0.00008018907,0.00012052633],"category_scores_gemma":[0.002010105,0.00006895815,0.000031065247,0.00038856492,0.00021886919,0.00009412268,0.000045759087,0.00042621014,0.0000017079653],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019110445,0.0006696177,0.6622454,0.0005232572,0.000031817533,0.000014658861,0.00030578222,6.155402e-7,0.00014217252,0.000058288526,0.0005010893,0.31639683],"study_design_scores_gemma":[0.0059008347,0.0016229423,0.98311216,0.0019129517,0.000008273097,4.3606698e-7,0.00009428806,0.000763338,0.000069945476,0.00011730354,0.006329473,0.000068062545],"about_ca_topic_score_codex":0.000026982745,"about_ca_topic_score_gemma":0.0000074342634,"teacher_disagreement_score":0.32086673,"about_ca_system_score_codex":0.000034448924,"about_ca_system_score_gemma":0.00014338805,"threshold_uncertainty_score":0.28120318},"labels":[],"label_agreement":null},{"id":"W2082548427","doi":"10.1185/030079905x36396","title":"Safety, effectiveness, and duration of effect of BOTOX after switching from Dysport for blepharospasm, cervical dystonia, and hemifacial spasm","year":2005,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Botulinum Toxin and Related Neurological Disorders","field":"Medicine","cited_by":86,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Blepharospasm; Cervical dystonia; Medicine; Hemifacial spasm; Botulinum toxin; Anesthesia; Dystonia; Focal dystonia; Visual analogue scale; Surgery; Facial nerve","score_opus":0.02722865630179253,"score_gpt":0.3876719189177403,"score_spread":0.3604432626159477,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2082548427","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9879229,0.008222186,0.0005680401,0.0021969068,0.00015540452,0.0008600769,0.000022738594,0.000012169974,0.000039595947],"genre_scores_gemma":[0.98750716,0.012080144,0.000055201315,0.000032435353,0.00020817807,0.000054643955,0.00004791525,0.000010285871,0.000004056894],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99818945,0.00021020633,0.00034877678,0.0003365569,0.00064394873,0.00027105323],"domain_scores_gemma":[0.99794453,0.0014154874,0.000056510493,0.00010669004,0.00009087256,0.0003859258],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013974273,0.00013206297,0.0004176661,0.00009241536,0.00008527582,0.000009916371,0.000056176938,0.00025865383,0.0000747574],"category_scores_gemma":[0.0011443157,0.000087516055,0.000054337863,0.000118471726,0.0004131684,0.000063345535,0.000111897796,0.0005758848,0.0000014131942],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01729162,0.0005922683,0.154653,0.0034298967,0.00010732836,0.000014382228,0.00022947058,6.989033e-7,0.011626122,0.00041384928,0.0002257439,0.8114156],"study_design_scores_gemma":[0.01673519,0.007798509,0.9375661,0.0028317426,0.00009758291,0.000032309385,0.000025340729,0.005404471,0.015287034,0.0024771632,0.011505854,0.00023867788],"about_ca_topic_score_codex":0.000029636101,"about_ca_topic_score_gemma":0.000007816887,"teacher_disagreement_score":0.81117696,"about_ca_system_score_codex":0.000017793725,"about_ca_system_score_gemma":0.00007326048,"threshold_uncertainty_score":0.35688013},"labels":[],"label_agreement":null},{"id":"W2084667022","doi":"10.1185/030079906x112642","title":"Single-day famciclovir therapy for recurrent genital herpes","year":2006,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Herpesvirus Infections and Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"National Institutes of Health; GlaxoSmithKline","keywords":"Medicine; Famciclovir; Clinical trial; Internal medicine; Pediatrics; Placebo; Immunology; Virus; Pathology; Alternative medicine","score_opus":0.14092265418949607,"score_gpt":0.44978677706090353,"score_spread":0.30886412287140746,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2084667022","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9379044,0.047179457,0.0024215067,0.0036949846,0.0023707447,0.002236219,0.00007213635,0.00013150793,0.0039890315],"genre_scores_gemma":[0.98779327,0.009249203,0.00015124545,0.00004728091,0.0017996219,0.0002714247,0.00029784942,0.000025719019,0.00036439206],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99790424,0.000114610164,0.0002516009,0.00033819187,0.000889652,0.00050171546],"domain_scores_gemma":[0.9987171,0.00043443148,0.000028127759,0.00017304123,0.00018383785,0.00046340763],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000933768,0.00013925915,0.00021245771,0.00017952186,0.00025197145,0.000047562025,0.000074277996,0.00012942628,0.00021111158],"category_scores_gemma":[0.0004815241,0.0000979863,0.000089448804,0.0002376985,0.00027710176,0.00006376714,0.00005097786,0.00032079822,0.000037996084],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031028505,0.002144833,0.0023432197,0.000085971435,0.000029646902,0.0000067554383,0.000033685374,2.9033384e-8,0.00006005865,0.0009914379,0.013167413,0.9808267],"study_design_scores_gemma":[0.0036955515,0.0024344756,0.006676265,0.00029932262,0.00000653272,0.000017241267,0.00002192738,0.00024037423,0.00075385685,0.0018044183,0.9839491,0.000100887824],"about_ca_topic_score_codex":0.00006712805,"about_ca_topic_score_gemma":0.000022942279,"teacher_disagreement_score":0.98072577,"about_ca_system_score_codex":0.00010963591,"about_ca_system_score_gemma":0.00022689461,"threshold_uncertainty_score":0.39957654},"labels":[],"label_agreement":null},{"id":"W2088551446","doi":"10.1185/03007990902784459","title":"Effectiveness and safety of recombinant human erythropoietin beta in maintaining common haemoglobin targets in routine clinical practice in Europe: the GAIN study","year":2009,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Erythropoietin and Anemia Treatment","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"University of Manitoba","keywords":"Medicine; Erythropoietin; Epoetin alfa; Observational study; Clinical trial; Anemia; Erythropoiesis; Clinical Practice; Internal medicine; Physical therapy","score_opus":0.08632463025427674,"score_gpt":0.494633193862878,"score_spread":0.4083085636086013,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2088551446","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9768313,0.006917323,0.000011858077,0.013885749,0.0002376777,0.0016731583,0.0000018667583,0.000009754301,0.00043128218],"genre_scores_gemma":[0.98389125,0.015835892,0.000041521194,0.00005640818,0.000089554895,0.000032378426,0.000032630644,0.0000110195315,0.000009344766],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9934479,0.0036061606,0.0009133287,0.00049837027,0.0010168402,0.0005173992],"domain_scores_gemma":[0.99558973,0.0035440484,0.00010597243,0.0002845067,0.00015789321,0.00031782236],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0180414,0.00017609203,0.0006329646,0.00024537384,0.00011912946,0.000019695422,0.0001628049,0.00013301997,0.000022537006],"category_scores_gemma":[0.007065532,0.0001139593,0.000036407248,0.0007477754,0.00058565615,0.00007465864,0.00023697739,0.0018115367,0.00000222279],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023363042,0.008530921,0.68130475,0.00024997137,0.000021197755,0.0004561056,0.0015061698,9.888395e-7,0.000027240803,0.0013591999,0.00034420236,0.30386293],"study_design_scores_gemma":[0.012601267,0.006223787,0.971465,0.003751166,0.000010161128,0.000040069797,0.002618945,0.0001733768,0.000038198657,0.00045776588,0.0025142562,0.00010600997],"about_ca_topic_score_codex":0.00046427344,"about_ca_topic_score_gemma":0.00021078928,"teacher_disagreement_score":0.30375692,"about_ca_system_score_codex":0.00013562967,"about_ca_system_score_gemma":0.00024910946,"threshold_uncertainty_score":0.8458612},"labels":[],"label_agreement":null},{"id":"W2091516800","doi":"10.1185/030079905x75104","title":"Cost-minimization analysis of treprostinil vs. epoprostenol as an alternate to oral therapy non-responders for the treatment of pulmonary arterial hypertension","year":2005,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Pulmonary Hypertension Research and Treatments","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; PharmIdeas (Canada); Brock University","funders":"United Therapeutics Corporation","keywords":"Treprostinil; Medicine; Dosing; Adverse effect; Bosentan; Pulmonary hypertension; Emergency medicine; Intensive care medicine; Internal medicine","score_opus":0.20181207033086745,"score_gpt":0.47038349871434565,"score_spread":0.2685714283834782,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2091516800","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98820084,0.0030901185,0.00028227214,0.0054809623,0.00022321225,0.0025870644,0.0000915529,0.000013362525,0.000030617633],"genre_scores_gemma":[0.9729849,0.025329709,0.00016055482,0.00012854836,0.0003162927,0.00035041748,0.00058946584,0.000019170982,0.0001209026],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9969183,0.0001832474,0.00044198235,0.00047713507,0.0014966025,0.00048273368],"domain_scores_gemma":[0.99725175,0.00073896075,0.00007975174,0.00045761824,0.00064982346,0.0008220714],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00083889364,0.00018211246,0.0005731339,0.00059937744,0.00018189449,0.000021948095,0.00017494483,0.000111793575,0.00017607467],"category_scores_gemma":[0.000697264,0.00010163047,0.00017873124,0.00078518444,0.00031648,0.000097942444,0.000058004513,0.00015830314,0.00000840515],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01716125,0.0058262404,0.008218545,0.000058543716,0.0006457028,0.000071880706,0.00031554865,0.000016233123,0.0034268703,0.00003093459,0.0005644168,0.9636638],"study_design_scores_gemma":[0.031014362,0.055023253,0.33683679,0.00088738085,0.0008648726,0.00026294508,0.0010153423,0.3657602,0.019866489,0.0002900865,0.18765815,0.0005201429],"about_ca_topic_score_codex":0.00023509482,"about_ca_topic_score_gemma":0.000026714972,"teacher_disagreement_score":0.9631437,"about_ca_system_score_codex":0.00008213198,"about_ca_system_score_gemma":0.00034915138,"threshold_uncertainty_score":0.414437},"labels":[],"label_agreement":null},{"id":"W2093173165","doi":"10.1185/03007995.2013.784191","title":"Comparison of safety outcomes among Caucasian, Hispanic, Black, and Asian patients in duloxetine studies of chronic painful conditions","year":2013,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Fibromyalgia and Chronic Fatigue Syndrome Research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"inVentiv Health Clinical","funders":"","keywords":"Medicine; Duloxetine; Placebo; Adverse effect; Internal medicine; Discontinuation; Nausea; Subgroup analysis; Physical therapy; Confidence interval","score_opus":0.10204924964318275,"score_gpt":0.4715952761652065,"score_spread":0.3695460265220238,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2093173165","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9898949,0.0063378247,0.000009829713,0.002552223,0.00013270462,0.0008920064,0.000018396404,0.000008451835,0.00015363742],"genre_scores_gemma":[0.9895641,0.010144974,0.000014341234,0.0000018744616,0.000031574546,0.000053779033,0.00012525005,0.000011420742,0.00005266791],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99671394,0.00028854824,0.0006741593,0.00030105692,0.0014977424,0.00052456016],"domain_scores_gemma":[0.9978347,0.00077818026,0.000097052856,0.0002342711,0.00051993085,0.0005358921],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011612774,0.00014722583,0.0006771254,0.0003743703,0.00008662772,0.000010542734,0.00013092246,0.00013794316,0.00049110636],"category_scores_gemma":[0.0030773014,0.00010757282,0.000053991076,0.00037086205,0.0020880916,0.000103507045,0.00026167944,0.0007824638,0.0000125744245],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006624032,0.0009370593,0.96273655,0.0066608367,0.000073897994,0.0000032246453,0.00083848543,2.0532295e-7,0.000051543255,0.00037919218,0.0040362705,0.024216512],"study_design_scores_gemma":[0.0033499894,0.0020913412,0.9867471,0.004276625,0.000008072906,0.000002275474,0.0014848883,0.0011968118,0.00008811066,0.00026205438,0.00040731183,0.00008545504],"about_ca_topic_score_codex":0.000333734,"about_ca_topic_score_gemma":0.00006618868,"teacher_disagreement_score":0.024131058,"about_ca_system_score_codex":0.0001810894,"about_ca_system_score_gemma":0.0004398633,"threshold_uncertainty_score":0.7693661},"labels":[],"label_agreement":null},{"id":"W2094364524","doi":"10.1185/03007995.2014.973939","title":"A multiplicity of targets: evaluating composite endpoint studies of the GLP-1 receptor agonists in type 2 diabetes","year":2014,"lang":"en","type":"review","venue":"Current Medical Research and Opinion","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Novo Nordisk Canada","keywords":"Medicine; Liraglutide; Metformin; Type 2 diabetes; Clinical endpoint; Exenatide; Glycemic; Clinical trial; Internal medicine; Glucagon-like peptide 1 receptor; Hypoglycemia; Diabetes mellitus; Endocrinology; Insulin; Agonist; Receptor","score_opus":0.29486009570304916,"score_gpt":0.5409420813016502,"score_spread":0.24608198559860106,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2094364524","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004053336,0.9932869,0.0000016539773,0.0002487885,0.00074223115,0.0015593346,0.000018663373,0.0000076270776,0.000081486265],"genre_scores_gemma":[0.0013414724,0.99801624,0.00006966474,0.0000092981845,0.00019901407,0.00013579073,0.00016781848,0.00001708879,0.000043616583],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9961236,0.00079019944,0.00076818577,0.0003572027,0.0015432421,0.00041758298],"domain_scores_gemma":[0.99727726,0.0015468063,0.0002604893,0.0003603327,0.0003387078,0.00021641525],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0039469535,0.00023133402,0.0016108113,0.00027518783,0.00007086419,0.000009213211,0.00026174256,0.0001506213,0.000053322197],"category_scores_gemma":[0.0058359327,0.00012550793,0.00020066982,0.0005357913,0.0006354122,0.000024514355,0.0006575783,0.0007359631,0.000009446437],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003722714,0.00040164206,0.0012604519,0.05747295,0.00024862232,5.944239e-7,0.00010394472,2.8739116e-8,0.000004630892,0.00012191371,0.0018531338,0.93849486],"study_design_scores_gemma":[0.0011915351,0.0011689799,0.0008196466,0.11221516,0.00018977202,4.1948374e-7,0.00004639499,0.00013372472,0.00004117243,0.00013577909,0.88393027,0.00012712237],"about_ca_topic_score_codex":0.000011684096,"about_ca_topic_score_gemma":0.000005153116,"teacher_disagreement_score":0.9383677,"about_ca_system_score_codex":0.000153753,"about_ca_system_score_gemma":0.00035831114,"threshold_uncertainty_score":0.6986578},"labels":[],"label_agreement":null},{"id":"W2095313483","doi":"10.1185/03007995.2014.915211","title":"Systematic review of long-acting injectables versus oral atypical antipsychotics on hospitalization in schizophrenia","year":2014,"lang":"en","type":"review","venue":"Current Medical Research and Opinion","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Medicine; Meta-analysis; Schizophrenia (object-oriented programming); Pediatrics; Random effects model; Internal medicine; Emergency medicine; Psychiatry","score_opus":0.17038784938800458,"score_gpt":0.507362570092788,"score_spread":0.3369747207047834,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2095313483","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000116072,0.99537337,0.000057471676,0.00017801578,0.0005825414,0.0035862736,0.000018343952,0.000022487608,0.000065414475],"genre_scores_gemma":[0.0004114286,0.99804807,0.00006552296,0.000012798983,0.00033495636,0.00031294365,0.0007557172,0.000045478715,0.000013075608],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99258894,0.0014893686,0.0014476955,0.00066486915,0.003084536,0.00072460115],"domain_scores_gemma":[0.9951699,0.0025740415,0.00032568353,0.0006407935,0.00036919964,0.000920386],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0043528494,0.00041786744,0.0031644606,0.00080558273,0.00009398907,0.000041844243,0.00034463964,0.0003998043,0.00014219711],"category_scores_gemma":[0.019952066,0.00026909204,0.00032627344,0.0012085116,0.00035127153,0.0000597858,0.00020517186,0.001905599,0.00008942279],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025971653,0.0003934244,0.000022736089,0.6077179,0.00011023115,0.000032065596,0.0000050938447,5.6742215e-9,4.5921316e-9,0.0007606361,0.00048323238,0.38787752],"study_design_scores_gemma":[0.003630204,0.0022233631,0.00014840801,0.9705624,0.0002636389,0.00003492032,0.000008164764,0.00005666088,4.4660234e-7,0.00006640292,0.022817284,0.00018811144],"about_ca_topic_score_codex":0.00000837214,"about_ca_topic_score_gemma":0.000015981781,"teacher_disagreement_score":0.3876894,"about_ca_system_score_codex":0.0003067886,"about_ca_system_score_gemma":0.0015472089,"threshold_uncertainty_score":0.9999761},"labels":[],"label_agreement":null},{"id":"W2097410402","doi":"10.1185/030079903125002955","title":"Preliminary evaluation of a new controlled-release oxybutynin in urinary incontinence","year":2004,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Purdue Pharma (Canada); University Health Network","funders":"Purdue Pharma","keywords":"Oxybutynin; Medicine; Urination; Urinary incontinence; Adverse effect; Urology; Anesthesia; Urinary system; Internal medicine; Overactive bladder","score_opus":0.1711520587863129,"score_gpt":0.486737151901993,"score_spread":0.3155850931156801,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2097410402","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9467777,0.042840037,0.0001500545,0.0068928353,0.00019978207,0.0019230586,0.000005465054,0.000016267993,0.0011947866],"genre_scores_gemma":[0.98704183,0.01231046,0.000059664053,0.00001890591,0.0002843761,0.00011730672,0.000059200265,0.000011146182,0.00009710967],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9945928,0.00046378054,0.00046206865,0.00036148477,0.0035884348,0.0005314203],"domain_scores_gemma":[0.99776584,0.00047665605,0.000048146998,0.00024823897,0.0005527228,0.0009084177],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006712187,0.00012629777,0.0003930403,0.00050073507,0.000070113194,0.000015755648,0.00016262975,0.00013271524,0.00038023476],"category_scores_gemma":[0.0057753758,0.000097114345,0.000061752835,0.00057427015,0.00038641068,0.000121453115,0.00021205455,0.0009938123,0.000023118728],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017892204,0.004694341,0.03171403,0.0013361175,0.000057722154,0.00018862165,0.0013431609,0.000015110918,0.00035180364,0.0011689427,0.004635244,0.9366027],"study_design_scores_gemma":[0.21000974,0.039573047,0.64043564,0.016946003,0.00011246898,0.00046554714,0.0015250883,0.02424058,0.0024988903,0.043163847,0.02037243,0.0006567332],"about_ca_topic_score_codex":0.0003126725,"about_ca_topic_score_gemma":0.00001747205,"teacher_disagreement_score":0.935946,"about_ca_system_score_codex":0.00014934105,"about_ca_system_score_gemma":0.0035647827,"threshold_uncertainty_score":0.69140816},"labels":[],"label_agreement":null},{"id":"W2097411741","doi":"10.1185/030079906x80314","title":"Assessment of Canadian provincial expenditures in depressed patients treated with venlafaxine XR versus SSRIs: the APEX Study","year":2005,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Treatment of Major Depression","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hôpital du Sacré-Cœur de Montréal; Montreal General Hospital; McGill University","funders":"","keywords":"Medicine; Apex (geometry); Venlafaxine; Depression (economics); Internal medicine; Gerontology; Psychiatry; Physical therapy; Antidepressant; Anxiety","score_opus":0.09141584852667184,"score_gpt":0.4406190705037754,"score_spread":0.3492032219771036,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2097411741","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949114,0.0011207438,0.0000026165167,0.0013044426,0.00017397448,0.0016441235,0.000015543965,0.000012640038,0.00081453624],"genre_scores_gemma":[0.99882233,0.0005611457,0.00002307517,0.000011658964,0.00024862352,0.0001634892,0.00013656635,0.000013121383,0.000019972136],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967667,0.0002798791,0.0002738068,0.00032555958,0.0018998268,0.00045422761],"domain_scores_gemma":[0.998564,0.00033943853,0.00005067361,0.0002852018,0.00014686443,0.0006137916],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007847533,0.00014199564,0.00025578117,0.0005484874,0.00012918154,0.000019793357,0.00017972777,0.0000887461,0.00012842729],"category_scores_gemma":[0.00055408117,0.00007643773,0.00002508765,0.00038801122,0.00021969837,0.00007422677,0.00009556562,0.000643996,0.000004240791],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013184668,0.0031705857,0.8648298,0.00007049744,0.000050217794,0.000032134823,0.0003070019,0.0000013693042,0.000011149755,0.0000411704,0.0019851883,0.12818241],"study_design_scores_gemma":[0.013400373,0.0042084428,0.9706759,0.0005316477,0.000018751907,0.000001951376,0.0003164892,0.00029782444,0.000097557815,0.000004015904,0.01037339,0.000073671385],"about_ca_topic_score_codex":0.019426983,"about_ca_topic_score_gemma":0.06607727,"teacher_disagreement_score":0.12810874,"about_ca_system_score_codex":0.000258102,"about_ca_system_score_gemma":0.00087208836,"threshold_uncertainty_score":0.98710275},"labels":[],"label_agreement":null},{"id":"W2097624585","doi":"10.1185/03007995.2013.803057","title":"Effects of demographics on the antihypertensive efficacy of triple therapy with amlodipine, valsartan, and hydrochlorothiazide for moderate to severe hypertension","year":2013,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Blood Pressure and Hypertension Studies","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; Omron Healthcare; Novartis Pharmaceuticals Corporation","keywords":"Medicine; Hydrochlorothiazide; Amlodipine; Valsartan; Blood pressure; Internal medicine; Placebo; Combination therapy; Randomized controlled trial; Urology; Cardiology","score_opus":0.09806040910206085,"score_gpt":0.37090220348313224,"score_spread":0.27284179438107137,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2097624585","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95546377,0.027916048,0.00014170313,0.013449155,0.0001731721,0.0027864322,0.000006754923,0.000013102631,0.000049837025],"genre_scores_gemma":[0.97467536,0.023668885,0.000109056746,0.001167829,0.00014967627,0.00017034648,0.000008807345,0.000017500757,0.000032518066],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9980277,0.00013791573,0.0002558655,0.00031278265,0.0009425727,0.0003231849],"domain_scores_gemma":[0.9955128,0.0027875628,0.00005744334,0.00022050478,0.0010617063,0.00036000172],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000666483,0.00015619677,0.00060616585,0.00018366647,0.00018372072,0.000015623167,0.00009600575,0.00010340808,0.000012485877],"category_scores_gemma":[0.002070959,0.00007521526,0.00005784372,0.0003006253,0.00046396302,0.00004223904,0.000089836336,0.0003757251,0.0000024980695],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.023914581,0.004975266,0.008903241,0.0055485982,0.0017938116,0.000039753148,0.0022115943,0.000002426336,0.04146455,0.004434821,0.27244967,0.63426167],"study_design_scores_gemma":[0.0934266,0.06680894,0.43643215,0.032311127,0.00094972097,0.0004144389,0.0021199984,0.012462345,0.14063613,0.006155293,0.20669459,0.001588676],"about_ca_topic_score_codex":0.00004128623,"about_ca_topic_score_gemma":0.0000032108906,"teacher_disagreement_score":0.632673,"about_ca_system_score_codex":0.000003227992,"about_ca_system_score_gemma":0.00010554302,"threshold_uncertainty_score":0.30671895},"labels":[],"label_agreement":null},{"id":"W2097933001","doi":"10.1185/030079903125003125","title":"Efficacy of risedronate on clinical vertebral fractures within six months","year":2004,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Bone health and osteoporosis research","field":"Medicine","cited_by":184,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"Procter and Gamble","keywords":"Medicine; Osteoporosis; Placebo; Incidence (geometry); Surgery; Internal medicine","score_opus":0.16601880925933565,"score_gpt":0.5405479117058117,"score_spread":0.3745291024464761,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2097933001","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97923845,0.007132583,0.000044048054,0.010666014,0.0009775473,0.00096723274,0.000012387276,0.000035128305,0.0009266086],"genre_scores_gemma":[0.98765177,0.011000482,0.000082306884,0.00029476985,0.0007976758,0.000030030555,0.00007315026,0.000019464984,0.000050378705],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99456495,0.0003548406,0.00074640545,0.00048979325,0.0030923306,0.0007516828],"domain_scores_gemma":[0.9957217,0.0013293826,0.0000827479,0.00038394847,0.00032910935,0.0021530925],"candidate_categories":["metaresearch","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.004313527,0.00015769675,0.00048417467,0.00029599934,0.00017507221,0.000020697404,0.00022370603,0.0003121169,0.00030011556],"category_scores_gemma":[0.011194492,0.000109049586,0.00011790016,0.00038262372,0.0010109176,0.000059245656,0.00017690171,0.00257259,0.00010610465],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010129067,0.006052474,0.04333474,0.0015062361,0.00007950672,0.00010046523,0.0004750063,0.0000050004655,0.00010224211,0.006902459,0.022341365,0.9089714],"study_design_scores_gemma":[0.03253205,0.01968063,0.8336315,0.005977681,0.000018921848,0.00004501292,0.00019383557,0.0007029546,0.0018105238,0.0037342855,0.10135543,0.00031713827],"about_ca_topic_score_codex":0.00015849224,"about_ca_topic_score_gemma":0.00002728245,"teacher_disagreement_score":0.9086543,"about_ca_system_score_codex":0.00009071044,"about_ca_system_score_gemma":0.0018408252,"threshold_uncertainty_score":0.9997285},"labels":[],"label_agreement":null},{"id":"W2097938982","doi":"10.1185/030079903125002090","title":"An open-label study of a second course of hylan G-F 20 for the treatment of pain associated with knee osteoarthritis","year":2003,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Osteoarthritis Treatment and Mechanisms","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"UCB Pharma","keywords":"Medicine; WOMAC; Osteoarthritis; Tolerability; Visual analogue scale; Physical therapy; Knee pain; Analgesic; Randomized controlled trial; Surgery; Anesthesia; Adverse effect; Internal medicine","score_opus":0.11669649382085101,"score_gpt":0.43189280560074567,"score_spread":0.31519631177989466,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2097938982","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.987944,0.008065256,0.000048072943,0.00012622302,0.00014288259,0.0034409922,0.00012331523,0.0000062704876,0.00010298598],"genre_scores_gemma":[0.9981796,0.0011031645,0.00004254327,0.000006080977,0.00004756383,0.00034806327,0.00015357115,0.000014683123,0.000104689934],"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9978821,0.0004390068,0.00032723707,0.0002471955,0.0008024642,0.0003019552],"domain_scores_gemma":[0.99782354,0.0010707375,0.00010931088,0.00028892336,0.00038232832,0.00032513912],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018264754,0.00013008046,0.00045844264,0.00008644884,0.000106744264,0.000013192245,0.00013310504,0.000079221,0.00012045822],"category_scores_gemma":[0.0006493063,0.000072823306,0.000029618135,0.00022178337,0.00025030106,0.00005452796,0.000027012566,0.00014303709,3.4811092e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020796992,0.03640115,0.014290144,0.00020736454,0.00023700335,0.000013247373,0.00200369,7.2584555e-8,0.0009537311,0.00075073086,0.0003546364,0.94270855],"study_design_scores_gemma":[0.1368529,0.81678873,0.0066026803,0.0027007866,0.00019182252,0.000017533454,0.010095587,0.00030004274,0.008245405,0.00055461243,0.017429516,0.00022037816],"about_ca_topic_score_codex":0.000029605979,"about_ca_topic_score_gemma":0.00070719066,"teacher_disagreement_score":0.94248813,"about_ca_system_score_codex":0.000036237172,"about_ca_system_score_gemma":0.00042431103,"threshold_uncertainty_score":0.29696482},"labels":[],"label_agreement":null},{"id":"W2099652899","doi":"10.1185/030079904x2051","title":"Efficacy and safety of budesonide/formoterol single inhaler therapy versus a higher dose of budesonide in moderate to severe asthma","year":2004,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Asthma and respiratory diseases","field":"Medicine","cited_by":234,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"AstraZeneca","keywords":"Budesonide; Formoterol; Medicine; Budesonide/formoterol; Inhaler; Exacerbation; Asthma; Corticosteroid; Anesthesia; Terbutaline; Internal medicine","score_opus":0.10602572009709625,"score_gpt":0.41532322922396603,"score_spread":0.30929750912686976,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2099652899","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9903795,0.0069944127,0.00008542599,0.0014787525,0.00021123004,0.00062773156,0.000014047567,0.000011535113,0.00019735083],"genre_scores_gemma":[0.995006,0.004608057,0.0000665589,0.000064833606,0.000176866,0.000020043122,0.000020028881,0.000014449843,0.000023126997],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9976873,0.00012344157,0.00039159486,0.00031269487,0.0010856232,0.00039938607],"domain_scores_gemma":[0.99851716,0.00029332002,0.000048998045,0.0002009319,0.00017465878,0.0007649287],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00068748015,0.00014524859,0.0003698759,0.00026515912,0.00006257847,0.000013580489,0.00011088208,0.00013222436,0.00012564556],"category_scores_gemma":[0.0007023032,0.00010397288,0.00004698814,0.0003584388,0.00040627585,0.00007439757,0.00013343246,0.0004270816,0.000005710829],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02791635,0.002349792,0.0054386286,0.00065588154,0.000044975048,0.000045971825,0.0007465529,0.000019473431,0.0017811507,0.0005472985,0.0002486511,0.96020526],"study_design_scores_gemma":[0.11325012,0.024261305,0.72151804,0.012814506,0.000021367889,0.00004615583,0.00059449987,0.00041831832,0.0050399248,0.00078632304,0.120609656,0.00063977006],"about_ca_topic_score_codex":0.00006123433,"about_ca_topic_score_gemma":0.000026468555,"teacher_disagreement_score":0.9595655,"about_ca_system_score_codex":0.0000783284,"about_ca_system_score_gemma":0.0004514645,"threshold_uncertainty_score":0.4239891},"labels":[],"label_agreement":null},{"id":"W2099955896","doi":"10.1185/030079904125003566","title":"Two-year efficacy and tolerability of risedronate once a week for the treatment of women with postmenopausal osteoporosis","year":2004,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Bone health and osteoporosis research","field":"Medicine","cited_by":86,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier de l'Université Laval; University of Calgary","funders":"Procter and Gamble","keywords":"Medicine; Tolerability; Osteoporosis; Postmenopausal women; Postmenopausal osteoporosis; Internal medicine; Bone mineral; Adverse effect","score_opus":0.09070662429593646,"score_gpt":0.4395590446284275,"score_spread":0.34885242033249103,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2099955896","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9821678,0.011451568,0.000050195442,0.0042778724,0.00008002466,0.0018710927,0.000035992165,0.000008465414,0.000056979334],"genre_scores_gemma":[0.978222,0.021112267,0.00019739688,0.000021304197,0.00013129228,0.00026550895,0.000024538502,0.000012213365,0.000013442403],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.997252,0.000122029385,0.00036678836,0.00032575586,0.0012682789,0.0006651837],"domain_scores_gemma":[0.99687076,0.0014345798,0.000065536115,0.00028230587,0.00039039235,0.0009564277],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019532894,0.0001270047,0.00042793073,0.000117122145,0.00017340308,0.0000130545095,0.00010451944,0.00007624017,0.000051108258],"category_scores_gemma":[0.0010233622,0.00006789861,0.000029874658,0.00027529005,0.0011101435,0.000041997013,0.00006203611,0.00032092343,0.0000015262984],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0239221,0.0074740676,0.020717805,0.0030321511,0.0001522622,0.00000818027,0.005730843,0.0000026367156,0.0008951741,0.0023877202,0.00017802595,0.935499],"study_design_scores_gemma":[0.100141324,0.23905914,0.5728701,0.0041404804,0.00009719228,0.00008000823,0.0074226875,0.00051670725,0.006896171,0.002715452,0.06563576,0.0004250134],"about_ca_topic_score_codex":0.00044086092,"about_ca_topic_score_gemma":0.000045032986,"teacher_disagreement_score":0.93507403,"about_ca_system_score_codex":0.00025526367,"about_ca_system_score_gemma":0.0012035938,"threshold_uncertainty_score":0.409037},"labels":[],"label_agreement":null},{"id":"W2101407866","doi":"10.1185/030079906x104722","title":"Efficacy and safety of aceclofenac in the treatment of osteoarthritis: a randomized double-blind comparative clinical trial versus diclofenac – an Indian experience","year":2006,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Aceclofenac; Tolerability; Diclofenac; Osteoarthritis; Adverse effect; WOMAC; Randomized controlled trial; Population; Visual analogue scale; Internal medicine; Anesthesia; Alternative medicine","score_opus":0.27134232502661093,"score_gpt":0.5309749352035308,"score_spread":0.25963261017691985,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2101407866","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9877065,0.007694826,0.0000075908797,0.0002521447,0.00070653425,0.003454768,0.0000071898626,0.0000063890748,0.00016404607],"genre_scores_gemma":[0.9878276,0.011005359,0.0000133779595,0.0000051806755,0.00078270596,0.00027222012,0.0000823284,0.000006350478,0.0000048733095],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99584925,0.0014169057,0.00086258573,0.000326718,0.0011931437,0.0003514063],"domain_scores_gemma":[0.99466443,0.0044242376,0.00013393859,0.00025240786,0.00012896881,0.00039604126],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0046799784,0.00015368346,0.00090398494,0.00018895029,0.00009351987,0.000014402158,0.00012984649,0.00016968478,0.000030874144],"category_scores_gemma":[0.0011270738,0.00008722976,0.00010260609,0.00028652934,0.0019174576,0.00007114857,0.000042788735,0.00045338343,0.0000015135574],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.91237026,0.0024345415,0.0016860353,0.00011020276,0.000025910245,0.000025091525,0.0049937586,1.2577664e-7,0.000012423616,0.0006964784,0.00007865836,0.07756649],"study_design_scores_gemma":[0.97217345,0.014680079,0.0063464837,0.00059894845,0.000022548898,0.0000073444844,0.0009866034,0.00012906578,0.00028543666,0.00006386691,0.004623538,0.000082602965],"about_ca_topic_score_codex":0.00021137981,"about_ca_topic_score_gemma":0.00013404038,"teacher_disagreement_score":0.077483885,"about_ca_system_score_codex":0.000037279766,"about_ca_system_score_gemma":0.0003413767,"threshold_uncertainty_score":0.7064952},"labels":[],"label_agreement":null},{"id":"W2101760942","doi":"10.1185/030079906x80341","title":"Real-world utilization of DMARDs and biologics in rheumatoid arthritis: the RADIUS (Rheumatoid Arthritis Disease-Modifying Anti-Rheumatic Drug Intervention and Utilization Study) study","year":2005,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Etanercept; Rheumatoid arthritis; Internal medicine; Infliximab; Discontinuation; Rheumatology; Combination therapy; Physical therapy; Disease","score_opus":0.11525694431924108,"score_gpt":0.4334376229740263,"score_spread":0.3181806786547853,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2101760942","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8443452,0.15213203,0.00011215774,0.0009891421,0.00016475799,0.0021627948,0.000016025091,0.000038327726,0.000039532115],"genre_scores_gemma":[0.53835374,0.46140483,0.000012827637,0.000005188124,0.000038646856,0.00010956339,0.0000555004,0.000013706441,0.0000060067814],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99479216,0.0012769781,0.0009968973,0.0006147934,0.001704617,0.0006145518],"domain_scores_gemma":[0.99777067,0.00072764076,0.00015580586,0.0003674678,0.00031373295,0.00066468085],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005332756,0.00026114506,0.0006382263,0.00071114243,0.00039856392,0.00014677134,0.00020028357,0.00008267769,0.0001117447],"category_scores_gemma":[0.0028656446,0.00019036561,0.00006182767,0.00078882294,0.0009425508,0.00032554838,0.0003598575,0.00079385604,0.000004692698],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037118894,0.0020702858,0.35259324,0.0002579393,0.000047173045,0.000016195654,0.0024387112,7.141596e-7,0.0000141933215,0.00063852203,0.00026586957,0.64128596],"study_design_scores_gemma":[0.01647473,0.0024164645,0.93866813,0.013762264,0.0000042434926,0.00006410877,0.011172293,0.009966401,0.00008380186,0.0017260584,0.005329807,0.00033172316],"about_ca_topic_score_codex":0.00062463374,"about_ca_topic_score_gemma":0.0021789984,"teacher_disagreement_score":0.64095426,"about_ca_system_score_codex":0.00007731475,"about_ca_system_score_gemma":0.0002442176,"threshold_uncertainty_score":0.7762884},"labels":[],"label_agreement":null},{"id":"W2103796156","doi":"10.1185/030079902125000282","title":"Efficacy and Tolerability Profile of Etoricoxib in Patients with Osteoarthritis: A Randomized, Double-blind, Placebo and Active-comparator Controlled 12-Week Efficacy Trial","year":2002,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":118,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Tolerability; Etoricoxib; Osteoarthritis; Placebo; Randomized controlled trial; Clinical trial; Internal medicine; Anesthesia; Adverse effect; Alternative medicine","score_opus":0.08160137811245635,"score_gpt":0.37390564270905796,"score_spread":0.29230426459660164,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2103796156","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98548025,0.0043722596,0.000007736377,0.00024884424,0.0003860113,0.009300507,0.000009368556,0.000016676173,0.00017834795],"genre_scores_gemma":[0.9974621,0.0014930493,0.000014536697,0.000008968776,0.00035317946,0.00059080886,0.00004329534,0.000015480515,0.00001859609],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99600786,0.0008297372,0.00067358057,0.00048553865,0.0014971389,0.00050614116],"domain_scores_gemma":[0.9955294,0.0030394373,0.00013704946,0.00021763494,0.0002482297,0.0008282508],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0032365448,0.00022906958,0.0013620243,0.00029335104,0.00011313604,0.00003325465,0.00008612757,0.00019275262,0.00016366728],"category_scores_gemma":[0.0043704803,0.00014749164,0.0000662244,0.00025678801,0.0009829366,0.000114033355,0.000098184864,0.00088553934,0.000005608615],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9168375,0.0023842293,0.00712724,0.0004475163,0.00005225122,0.0000084688445,0.0005252979,6.996776e-8,0.000006013935,0.000072990486,0.00026258075,0.072275795],"study_design_scores_gemma":[0.9733962,0.006533018,0.017435363,0.0012452346,0.000032934888,0.000004438708,0.000038414477,0.00049829116,0.00007490827,0.00001587951,0.0005869329,0.00013840606],"about_ca_topic_score_codex":0.000019384504,"about_ca_topic_score_gemma":0.000008881505,"teacher_disagreement_score":0.07213739,"about_ca_system_score_codex":0.000052910134,"about_ca_system_score_gemma":0.00019538398,"threshold_uncertainty_score":0.6014534},"labels":[],"label_agreement":null},{"id":"W2104243240","doi":"10.1185/03007995.2012.689956","title":"Effect of canagliflozin, a sodium glucose co-transporter 2 (SGLT2) inhibitor, on bacteriuria and urinary tract infection in subjects with type 2 diabetes enrolled in a 12-week, phase 2 study","year":2012,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":78,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"American Diabetes Association","keywords":"Medicine; Canagliflozin; Sitagliptin; Metformin; Internal medicine; Placebo; Type 2 diabetes; Sitagliptin Phosphate; Urinary system; Creatinine; Gastroenterology; Glycemic; Diabetes mellitus; Renal function; Endocrinology; Urology","score_opus":0.04561111091520502,"score_gpt":0.39865473916015326,"score_spread":0.3530436282449482,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2104243240","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952054,0.0024072656,6.642062e-7,0.000114033384,0.00026474855,0.0018032406,0.0000037680843,0.000014393469,0.00018648792],"genre_scores_gemma":[0.996981,0.002529929,0.0000019674433,0.000012843198,0.000172963,0.00017026535,0.000099215096,0.000015272906,0.00001649176],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976306,0.00040436359,0.00028841733,0.0002985612,0.0008335837,0.00054448517],"domain_scores_gemma":[0.9988357,0.00043611403,0.000045393295,0.0001645803,0.000047641446,0.000470561],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024095827,0.00018896692,0.0004534192,0.000558843,0.000043074186,0.000015949758,0.000048473623,0.000087120134,0.00006269911],"category_scores_gemma":[0.00033774128,0.00012415224,0.00002840684,0.00036440237,0.00016235636,0.00014064675,0.000044238626,0.00049425033,0.000004715132],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005130551,0.0140515035,0.9015643,0.0009490024,0.00006101486,0.000062501815,0.0005491905,4.9406697e-8,0.00013566323,0.000006777617,0.00017292223,0.07731652],"study_design_scores_gemma":[0.026611708,0.06066542,0.9069517,0.0017128834,0.00004811657,0.0000039539855,0.000070397306,0.00006462797,0.0016985934,0.000006088991,0.0020352637,0.00013119972],"about_ca_topic_score_codex":0.00018503984,"about_ca_topic_score_gemma":0.00011323286,"teacher_disagreement_score":0.077185325,"about_ca_system_score_codex":0.000094254254,"about_ca_system_score_gemma":0.00010213824,"threshold_uncertainty_score":0.50627816},"labels":[],"label_agreement":null},{"id":"W2104819398","doi":"10.1185/03007990152005405","title":"Eprosartan Provides Safe and Effective Long-term Maintenance of Blood Pressure Control in Patients with Mild to Moderate Essential Hypertension","year":2001,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Blood Pressure and Hypertension Studies","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Hydrochlorothiazide; Blood pressure; Adverse effect; Candesartan; Incidence (geometry); Placebo; Internal medicine; Diuretic; Peripheral edema; Essential hypertension; Angiotensin II; Cardiology","score_opus":0.037067750166443134,"score_gpt":0.3484559406893169,"score_spread":0.31138819052287375,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2104819398","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97065276,0.024861185,0.00011838458,0.0024016295,0.0001242385,0.0017655843,0.0000145499325,0.000011373585,0.000050290782],"genre_scores_gemma":[0.9956549,0.0038356066,0.00002679493,0.00020111083,0.00013290292,0.00008427446,0.000018712764,0.000011933313,0.00003375989],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99771094,0.00016283366,0.00025642483,0.0004213833,0.0010355515,0.00041287622],"domain_scores_gemma":[0.99839014,0.00035337463,0.000041377323,0.0001773798,0.00058845594,0.00044927828],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00064168224,0.00014985398,0.00054329366,0.00018636674,0.00010584227,0.00001800297,0.00006893323,0.00010086963,0.000017665898],"category_scores_gemma":[0.00077069,0.00009311526,0.000025348363,0.00022826914,0.00035274134,0.0000760657,0.00013836907,0.0004761359,0.0000019149143],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011157051,0.0019803098,0.8810223,0.0011745916,0.00038976778,0.000098042394,0.00034264394,8.3181476e-7,0.00046694957,0.00008080996,0.002324651,0.1009621],"study_design_scores_gemma":[0.015252706,0.003391167,0.9727245,0.0040169195,0.00025044873,0.00003255515,0.000034663317,0.0004243637,0.00039678664,0.000056397137,0.003273053,0.00014646258],"about_ca_topic_score_codex":0.00004606671,"about_ca_topic_score_gemma":0.00003558006,"teacher_disagreement_score":0.10081564,"about_ca_system_score_codex":0.0000051090788,"about_ca_system_score_gemma":0.00009165624,"threshold_uncertainty_score":0.37971303},"labels":[],"label_agreement":null},{"id":"W2106728901","doi":"10.1185/030079905x65547","title":"Overall tolerability and analgesic activity of intra-articular sodium hyaluronate in the treatment of knee osteoarthritis","year":2005,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Osteoarthritis Treatment and Mechanisms","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Tolerability; Viscosupplementation; Osteoarthritis; WOMAC; Sodium hyaluronate; Adverse effect; Clinical endpoint; Hyaluronic acid; Knee pain; Surgery; Internal medicine; Anesthesia; Randomized controlled trial; Intra articular","score_opus":0.061442415981732376,"score_gpt":0.38317129679134504,"score_spread":0.32172888080961265,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2106728901","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98196787,0.014885151,0.000011035431,0.0021538446,0.0000957385,0.0007170825,0.000012060922,0.0000056028275,0.00015160629],"genre_scores_gemma":[0.99041176,0.009298714,0.00003953488,0.000015223361,0.00013927008,0.000050908264,0.000023029315,0.0000055358314,0.000016000971],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.998052,0.00025703385,0.0002746513,0.00025150413,0.0008561422,0.0003086545],"domain_scores_gemma":[0.99905443,0.0003355631,0.000042377116,0.00021758105,0.00009051741,0.00025954656],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009066815,0.00011509829,0.00034204862,0.00012295922,0.000049873543,0.000010561116,0.000058131354,0.00008615992,0.000084882195],"category_scores_gemma":[0.00026655121,0.00007245964,0.00005632077,0.00015934289,0.0004035297,0.0000701689,0.00003728207,0.00024071203,0.0000027720887],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005537722,0.0018896557,0.008182843,0.00015697144,0.000012200965,0.000014833172,0.00069768756,7.172355e-8,0.0011195902,0.00063909247,0.000038585513,0.9866947],"study_design_scores_gemma":[0.080923244,0.1878052,0.50402004,0.005246847,0.00017816108,0.00026963768,0.001328066,0.002012934,0.09645322,0.007665655,0.11337763,0.00071934814],"about_ca_topic_score_codex":0.000059024755,"about_ca_topic_score_gemma":0.00010263437,"teacher_disagreement_score":0.9859753,"about_ca_system_score_codex":0.000059401467,"about_ca_system_score_gemma":0.00014288352,"threshold_uncertainty_score":0.29548183},"labels":[],"label_agreement":null},{"id":"W2108680897","doi":"10.1185/030079904125004376","title":"Nursing home-acquired pneumonia: an emergency department treatment algorithm","year":2004,"lang":"en","type":"review","venue":"Current Medical Research and Opinion","topic":"Pneumonia and Respiratory Infections","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Hamilton Health Sciences","funders":"","keywords":"Medicine; Emergency department; Pneumonia; Emergency medicine; Intensive care medicine; Algorithm; Medical emergency; Nursing; Internal medicine","score_opus":0.23041544399512015,"score_gpt":0.533487597536195,"score_spread":0.30307215354107486,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2108680897","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00006460942,0.9939641,0.00024597725,0.00046908177,0.0030605604,0.0017893495,0.00009095752,0.00009271252,0.00022266104],"genre_scores_gemma":[0.00003344976,0.99607015,0.00003182767,0.000007884422,0.0020146964,0.00055994606,0.0010868715,0.000063051004,0.000132128],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99499816,0.0005198499,0.0008150368,0.0008776579,0.0018123175,0.0009769604],"domain_scores_gemma":[0.99662596,0.00015991679,0.00012820789,0.00056511967,0.00021673135,0.0023040802],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008113372,0.0005259316,0.0014845202,0.000634846,0.0004990033,0.000051531504,0.00022155912,0.0005733827,0.00042458356],"category_scores_gemma":[0.00026507143,0.00034654708,0.0004115275,0.0006997823,0.0005354225,0.000102753955,0.0001002756,0.0010245624,0.0001540198],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000011245254,0.0021778042,0.000025717258,0.0066944314,0.00012225576,0.00008729837,0.00006454237,1.9949084e-8,9.959531e-7,0.00014163258,0.000452585,0.9902215],"study_design_scores_gemma":[0.0009546312,0.0032788594,0.00013825203,0.041426506,0.0002133393,0.00038630862,0.00002306875,0.000031779753,8.5341907e-7,0.0002917342,0.9529691,0.0002855939],"about_ca_topic_score_codex":0.000020149126,"about_ca_topic_score_gemma":0.0000048946445,"teacher_disagreement_score":0.9899359,"about_ca_system_score_codex":0.0012230554,"about_ca_system_score_gemma":0.003281316,"threshold_uncertainty_score":0.9998987},"labels":[],"label_agreement":null},{"id":"W2109156797","doi":"10.1185/030079903125002469","title":"A comparison of the therapeutic efficacy and tolerability of etoricoxib and diclofenac in patients with osteoarthritis","year":2003,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":64,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Etoricoxib; Medicine; Tolerability; Diclofenac; Osteoarthritis; WOMAC; Clinical endpoint; Anesthesia; Clinical trial; Physical therapy; Adverse effect; Internal medicine","score_opus":0.059623230907279924,"score_gpt":0.4094679379635202,"score_spread":0.34984470705624027,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2109156797","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9912912,0.007732416,0.000006132411,0.00015303234,0.00015742115,0.0006041033,0.0000025964262,0.0000025783045,0.000050475293],"genre_scores_gemma":[0.999231,0.00070370716,0.000006388263,0.00000733999,0.000028589078,0.000012234122,0.0000038254952,0.000004932517,0.0000019909785],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982009,0.0003165897,0.0002539735,0.00017416838,0.0008456645,0.00020870833],"domain_scores_gemma":[0.9989389,0.0004950698,0.000050216957,0.0001494306,0.00012459586,0.00024177018],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001144333,0.00007781368,0.00030119694,0.000074560514,0.000052685944,0.000005008449,0.00004752762,0.00007307267,0.000017273447],"category_scores_gemma":[0.00134261,0.000043417258,0.0000145721815,0.00021211439,0.0006433284,0.000028413051,0.000053380674,0.00042922347,2.382115e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037721606,0.00045844578,0.8608312,0.000475754,0.0000056505055,4.860955e-7,0.00039768784,3.1387117e-8,0.000034794055,0.00031204397,0.000036633053,0.13707006],"study_design_scores_gemma":[0.0055018095,0.0021305066,0.98842144,0.0011750798,0.000005558414,0.0000017178901,0.00007274844,0.000050295053,0.00063180237,0.00010199993,0.0018620854,0.000044949018],"about_ca_topic_score_codex":0.00001259993,"about_ca_topic_score_gemma":0.00001045273,"teacher_disagreement_score":0.13702512,"about_ca_system_score_codex":0.00001888733,"about_ca_system_score_gemma":0.00015283225,"threshold_uncertainty_score":0.23703703},"labels":[],"label_agreement":null},{"id":"W2109883415","doi":"10.1185/030079906x80279","title":"Response to rivastigmine or donepezil in Alzheimer's patients with symptoms suggestive of concomitant Lewy body pathology","year":2005,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Dementia and Cognitive Impairment Research","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Donepezil; Rivastigmine; Medicine; Concomitant; Internal medicine; Lewy body; Dementia with Lewy bodies; Adverse effect; Dementia; Population; Alzheimer's disease; Disease","score_opus":0.05331040456414979,"score_gpt":0.4222077054324689,"score_spread":0.36889730086831907,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2109883415","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99146914,0.0015153401,0.00012076308,0.0053334534,0.00010065752,0.0011752591,0.000029406021,0.000013263987,0.00024273018],"genre_scores_gemma":[0.9984956,0.0008581886,0.00010424777,0.000120923585,0.00013231598,0.00012520824,0.000077002034,0.000016011887,0.00007050147],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99567556,0.0006143097,0.0004094881,0.00044902824,0.0021365313,0.0007150623],"domain_scores_gemma":[0.9968354,0.0012233554,0.000047291072,0.00022091593,0.00066667184,0.0010063392],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030420155,0.00016247449,0.0003941272,0.0006167397,0.00007430498,0.000016294209,0.00017264367,0.00011525666,0.0005382622],"category_scores_gemma":[0.0045261174,0.000102820166,0.000032698645,0.00068379514,0.0006984024,0.000089321984,0.0002659216,0.0007308876,0.000041959556],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04816022,0.0030266612,0.5020662,0.00014993598,0.000096966076,0.00017612037,0.0004598136,2.3895603e-7,0.0004420273,0.00014596841,0.0026081037,0.44266775],"study_design_scores_gemma":[0.011884106,0.01385718,0.94396406,0.0016186616,0.000018107654,0.00002521928,0.0001605921,0.00013739141,0.0011843229,0.00003072534,0.02697869,0.00014092399],"about_ca_topic_score_codex":0.000023705155,"about_ca_topic_score_gemma":0.00003197178,"teacher_disagreement_score":0.44252685,"about_ca_system_score_codex":0.000093459406,"about_ca_system_score_gemma":0.00079824234,"threshold_uncertainty_score":0.58935934},"labels":[],"label_agreement":null},{"id":"W2110411269","doi":"10.1185/03007990802695037","title":"Cost-benefit analysis of primary prevention of sudden cardiac death with an implantable cardioverter defibrillator versus amiodarone in Canada","year":2009,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Cardiac pacing and defibrillation studies","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Medtronic (Canada); McGill University","funders":"","keywords":"Medicine; Amiodarone; Implantable cardioverter-defibrillator; Sudden cardiac death; Primary prevention; Cardiology; Internal medicine; Intensive care medicine; Ventricular fibrillation; Sudden death; Atrial fibrillation; Disease","score_opus":0.13160721765674607,"score_gpt":0.4207621936664989,"score_spread":0.2891549760097528,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2110411269","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97412765,0.009344737,0.00006667853,0.000041283118,0.0001953358,0.00034437096,0.0000842537,0.0000070566475,0.015788632],"genre_scores_gemma":[0.9939851,0.005632637,0.00003521757,0.0000069877415,0.00009532778,0.0000073017513,0.00021889842,0.0000051948705,0.000013313109],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99743986,0.00011670204,0.00032860742,0.00025964386,0.0015438979,0.0003112914],"domain_scores_gemma":[0.9987759,0.00031153456,0.00006669245,0.00023126553,0.0002773901,0.00033721415],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007456954,0.00010561887,0.0009556637,0.0003670169,0.00004644737,0.0000072626717,0.00002854326,0.000057730664,0.0000043898463],"category_scores_gemma":[0.00021144947,0.00008036446,0.00010317985,0.00079177506,0.00009345404,0.00006614702,0.000042448177,0.00020305853,3.8643515e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0060557625,0.00022420552,0.68569314,0.0004978186,0.0018954257,0.000003114834,0.00039562504,0.00009857457,0.00013229327,0.00043846338,0.0082930755,0.29627252],"study_design_scores_gemma":[0.0027686257,0.0014874996,0.97909313,0.0006362053,0.0003069705,0.000014517191,0.00048445564,0.0001996139,0.00017578916,0.000043550084,0.014660483,0.00012914898],"about_ca_topic_score_codex":0.095547184,"about_ca_topic_score_gemma":0.044986375,"teacher_disagreement_score":0.29614338,"about_ca_system_score_codex":0.00027343823,"about_ca_system_score_gemma":0.0012931984,"threshold_uncertainty_score":0.9724401},"labels":[],"label_agreement":null},{"id":"W2112485792","doi":"10.1185/030079907x233269","title":"Reviewing CATIE for clinicians:balancing benefit and risk using evidence-based medicine tools","year":2007,"lang":"en","type":"review","venue":"Current Medical Research and Opinion","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto East General Hospital; Eli Lilly (Canada); Memorial University of Newfoundland","funders":"","keywords":"Medicine; Intensive care medicine; Evidence-based medicine; Alternative medicine; MEDLINE; Pathology","score_opus":0.6920178167274026,"score_gpt":0.6105946113727778,"score_spread":0.08142320535462477,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2112485792","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00019138624,0.9926362,0.0010285696,0.0011145931,0.00067561626,0.0042058397,0.00009023478,0.00003615525,0.000021378954],"genre_scores_gemma":[0.000031991192,0.9947498,0.0011716243,0.00005781249,0.0029678666,0.00038259907,0.00054286944,0.00006898852,0.000026447444],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9924621,0.00070176425,0.001411015,0.0011252608,0.002996184,0.0013036899],"domain_scores_gemma":[0.9808464,0.015208672,0.0003483539,0.0006277014,0.0007036296,0.002265229],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.013878229,0.0005589607,0.0025769232,0.00093333056,0.0005197319,0.0000987711,0.00031876538,0.00057133957,0.00013637355],"category_scores_gemma":[0.03910111,0.00035282262,0.00036426005,0.00087459694,0.00091499207,0.00016195692,0.00027477185,0.0025792976,0.000016055608],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007270169,0.00014680852,0.00036471445,0.05230282,0.00015838465,0.000037252736,0.000019447645,2.4827282e-8,1.14535986e-7,0.00023383809,0.0011885896,0.944821],"study_design_scores_gemma":[0.0025048363,0.0016542776,0.0001770358,0.28735858,0.00046601126,0.000067377114,0.000017730812,0.00042569794,7.373911e-7,0.00028293373,0.7068254,0.00021939824],"about_ca_topic_score_codex":0.0002147543,"about_ca_topic_score_gemma":0.000041758176,"teacher_disagreement_score":0.9446016,"about_ca_system_score_codex":0.00049291214,"about_ca_system_score_gemma":0.0033985332,"threshold_uncertainty_score":0.99989235},"labels":[],"label_agreement":null},{"id":"W2112514785","doi":"10.1185/030079905x56484","title":"Cost effectiveness of duloxetine compared with venlafaxine‐XR in the treatment of major depressive disorder","year":2005,"lang":"en","type":"review","venue":"Current Medical Research and Opinion","topic":"Treatment of Major Depression","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto","funders":"","keywords":"Venlafaxine; Duloxetine; Medicine; Liberian dollar; Major depressive disorder; Internal medicine; Psychiatry; Antidepressant; Economics; Finance; Anxiety; Mood","score_opus":0.2201016283113629,"score_gpt":0.5184016880465453,"score_spread":0.29830005973518237,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2112514785","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0033052585,0.99188316,0.000032418142,0.00014699835,0.00013199095,0.0043236385,0.00007078749,0.0000091556585,0.0000966084],"genre_scores_gemma":[0.006749114,0.9912157,0.000022729957,0.0000014461099,0.00022796656,0.00093145936,0.0008074461,0.000030493049,0.000013611891],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99510264,0.0014141934,0.00061837916,0.0004962453,0.001927159,0.00044134993],"domain_scores_gemma":[0.995407,0.0033141414,0.00022017691,0.00052863534,0.00019556041,0.000334495],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001352551,0.00035896478,0.0018038615,0.00041247575,0.00006865722,0.000011677206,0.00027859543,0.00024583365,0.00007877758],"category_scores_gemma":[0.0005950345,0.00016494073,0.00018910629,0.0005853683,0.0006370887,0.0000377596,0.00009198369,0.000700792,0.000006450928],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00093827234,0.004514386,0.002945475,0.023444118,0.00015454854,0.000049438655,0.00012932443,2.5205628e-7,4.783941e-7,0.0000439222,0.00013042791,0.96764934],"study_design_scores_gemma":[0.0102860425,0.00437399,0.00801414,0.111107856,0.00030239974,0.000080340564,0.000055467095,0.000025161384,0.000016361435,0.000018664217,0.8655607,0.00015884217],"about_ca_topic_score_codex":0.00009854989,"about_ca_topic_score_gemma":0.00003402227,"teacher_disagreement_score":0.9674905,"about_ca_system_score_codex":0.00019780236,"about_ca_system_score_gemma":0.0006864059,"threshold_uncertainty_score":0.6726088},"labels":[],"label_agreement":null},{"id":"W2115498839","doi":"10.1185/03007995.2013.874988","title":"Asenapine treatment and health-related quality of life in patients experiencing bipolar I disorder with mixed episodes: post-hoc analyses of pivotal trials","year":2013,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Bipolar Disorder and Treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Asenapine; Medicine; Olanzapine; Placebo; Bipolar I disorder; Post-hoc analysis; Quality of life (healthcare); Population; Internal medicine; Atypical antipsychotic; Clinical trial; Randomized controlled trial; Bipolar disorder; Antipsychotic; Psychiatry; Schizophrenia (object-oriented programming); Mania; Lithium (medication)","score_opus":0.272580436939632,"score_gpt":0.5029290711515391,"score_spread":0.23034863421190704,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2115498839","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9016626,0.09606404,0.000016066511,0.0010654776,0.000059924365,0.0010824443,0.000030836894,0.000007547231,0.000011066978],"genre_scores_gemma":[0.980027,0.019551579,0.000042167536,0.000008344612,0.000024746614,0.00008995433,0.00024033595,0.000010505598,0.0000053277577],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99660236,0.00076499546,0.0010112355,0.00032261596,0.0009150624,0.00038373136],"domain_scores_gemma":[0.9980664,0.0005363473,0.00021469787,0.00020463791,0.00030670717,0.000671183],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019229804,0.0001701915,0.0009833347,0.00031451747,0.0000723846,0.000010701791,0.00005760865,0.00009989561,0.00016210905],"category_scores_gemma":[0.0018163543,0.0000977418,0.00008430569,0.00037229946,0.00040482468,0.000082332735,0.00006564291,0.00025056853,0.0000020680282],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00082525774,0.0027475778,0.7043789,0.00047023027,0.00016789552,3.7650102e-7,0.0009391965,1.9471415e-7,0.000094294155,0.00006373047,0.000046152934,0.2902662],"study_design_scores_gemma":[0.014039064,0.011842017,0.9717955,0.0008318132,0.000017317721,0.0000011695879,0.00078896026,0.00014338607,0.0001548161,0.000044739718,0.00025225116,0.00008894333],"about_ca_topic_score_codex":0.010754038,"about_ca_topic_score_gemma":0.00069183344,"teacher_disagreement_score":0.29017723,"about_ca_system_score_codex":0.00009904056,"about_ca_system_score_gemma":0.0005509426,"threshold_uncertainty_score":0.99583346},"labels":[],"label_agreement":null},{"id":"W2116370794","doi":"10.1185/03007995.2011.604672","title":"A practical, evidence-based guide to the use of adalimumab in Crohn’s disease","year":2011,"lang":"en","type":"review","venue":"Current Medical Research and Opinion","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Adalimumab; Infliximab; Internal medicine; Maintenance therapy; Crohn's disease; Disease; Inflammatory bowel disease; Randomized controlled trial; MEDLINE; Intensive care medicine; Chemotherapy","score_opus":0.4129539309395999,"score_gpt":0.5245469099389666,"score_spread":0.11159297899936665,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2116370794","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00018456313,0.9972071,0.00032462052,0.000528149,0.00031487786,0.0013396567,0.00008471154,0.0000043862765,0.000011903421],"genre_scores_gemma":[0.00009669911,0.99863327,0.00009177494,0.00007690335,0.0004165965,0.0004075689,0.00019953334,0.00002618886,0.000051463405],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9960107,0.0013327384,0.0005934175,0.0005649878,0.0010089851,0.00048915297],"domain_scores_gemma":[0.99711215,0.0006740953,0.0001217383,0.0007511585,0.00028308723,0.0010577415],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0023125182,0.00023833752,0.00043197104,0.0002081381,0.000079944126,0.000050284296,0.00051085866,0.0002527902,0.00010013854],"category_scores_gemma":[0.02435524,0.00015102258,0.00018527865,0.0002707992,0.00045873213,0.000012082089,0.0005859009,0.00069835957,0.00003645821],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00057564833,0.00033152287,0.00019762288,0.011090429,0.000029419454,0.00014295967,0.000011749607,5.061283e-7,5.335447e-7,0.00028570837,0.094490424,0.8928435],"study_design_scores_gemma":[0.00023372436,0.0001270762,0.001393064,0.022779921,0.000028620163,0.0000026587084,0.000003519441,0.00003683853,0.0000012146281,0.000011101636,0.9752313,0.00015097165],"about_ca_topic_score_codex":0.000037305,"about_ca_topic_score_gemma":0.00004640014,"teacher_disagreement_score":0.8926925,"about_ca_system_score_codex":0.00005257072,"about_ca_system_score_gemma":0.004689471,"threshold_uncertainty_score":0.98386306},"labels":[],"label_agreement":null},{"id":"W2117216433","doi":"10.1185/030079905x59102","title":"Statins and LDL‐cholesterol lowering: an overview","year":2005,"lang":"en","type":"review","venue":"Current Medical Research and Opinion","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"European Society of Cardiology; University of Waterloo; Merck KGaA","keywords":"Medicine; Ldl cholesterol; Cholesterol; Cholesterol lowering; Ezetimibe; Pharmacology; Atorvastatin; Statin; Internal medicine","score_opus":0.4106502170329484,"score_gpt":0.5698913529223524,"score_spread":0.15924113588940397,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2117216433","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007416317,0.9973798,0.00004968795,0.00037458623,0.00041788872,0.0015014155,0.000030850133,0.000025914896,0.00014572994],"genre_scores_gemma":[0.000020784886,0.99648327,0.000036393198,0.000048746155,0.0027548033,0.00017000764,0.0003742765,0.00004718186,0.00006451053],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99483925,0.0005520947,0.000590163,0.000732124,0.0025652868,0.0007210521],"domain_scores_gemma":[0.9966877,0.00022915729,0.00008185736,0.00059817545,0.0001652088,0.0022379088],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0040976596,0.00032983336,0.001543142,0.00030400185,0.00018095272,0.00008682888,0.00020194358,0.00041615072,0.00027236147],"category_scores_gemma":[0.0009027829,0.0002235218,0.00024450617,0.00033062795,0.0003629225,0.000106673535,0.00031330687,0.0022005176,0.000053308897],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000013840602,0.00019565334,0.000008617588,0.04120529,0.00006331667,0.000020503725,0.00003545636,1.3731476e-9,2.0450804e-8,0.00018863729,0.0007237546,0.9575449],"study_design_scores_gemma":[0.0007913074,0.00074857636,0.00012855373,0.048659418,0.00008254467,0.00026095365,0.000015358599,0.000014561228,1.1681865e-7,0.00003490875,0.94909036,0.000173317],"about_ca_topic_score_codex":0.00006040617,"about_ca_topic_score_gemma":0.000016505242,"teacher_disagreement_score":0.9573716,"about_ca_system_score_codex":0.00013111791,"about_ca_system_score_gemma":0.0014954244,"threshold_uncertainty_score":0.9560276},"labels":[],"label_agreement":null},{"id":"W2118328023","doi":"10.1185/03007995.2012.756808","title":"Impact of sevelamer versus calcium-based binders on hospitalizations and missed in-center dialysis treatments among CKD patients on dialysis: a modeled analysis","year":2012,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Parathyroid Disorders and Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Humber River Regional Hospital","funders":"","keywords":"Medicine; Dialysis; Sevelamer; Dialysis adequacy; End stage renal disease; Intensive care medicine; Hemodialysis; Emergency medicine; Internal medicine; Kidney disease; Hyperphosphatemia","score_opus":0.12389662635742724,"score_gpt":0.4597669767169544,"score_spread":0.33587035035952717,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2118328023","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971934,0.0016556153,0.00010944423,0.00016217785,0.00010981136,0.0005083398,0.000057060755,0.000008792919,0.00019535457],"genre_scores_gemma":[0.9974671,0.0014619797,0.000008457499,0.000018087518,0.000042317693,0.00008377457,0.0008907658,0.00001368964,0.000013841349],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99735075,0.00021602571,0.00032987824,0.0003646285,0.0012088009,0.00052988617],"domain_scores_gemma":[0.9983204,0.0003493362,0.00007880138,0.00025701476,0.00015311771,0.0008413185],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035304928,0.00021382404,0.0004999491,0.0010071589,0.00010010621,0.00001818707,0.00007069639,0.00013127213,0.000076198754],"category_scores_gemma":[0.00072009437,0.00014530818,0.00021776684,0.0011891805,0.0002428627,0.00009699993,0.00004149744,0.0002656692,0.0000067936066],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016361868,0.0074614016,0.98083645,0.000022360015,0.0011383311,0.000002943475,0.00028390018,0.00003214324,0.000002993039,0.000016315134,0.0004956347,0.008071361],"study_design_scores_gemma":[0.016205119,0.0024641305,0.97217906,0.00013709132,0.00033984613,1.03564524e-7,0.000048673086,0.00842423,0.000024557887,0.0000119152155,0.000053461124,0.000111795765],"about_ca_topic_score_codex":0.00046897773,"about_ca_topic_score_gemma":0.00004051494,"teacher_disagreement_score":0.014568932,"about_ca_system_score_codex":0.00022110886,"about_ca_system_score_gemma":0.00015563173,"threshold_uncertainty_score":0.59254956},"labels":[],"label_agreement":null},{"id":"W2120807296","doi":"10.1185/030079907x233160","title":"Long-term darifenacin treatment for overactive bladder in patients aged 65 years and older: analysis of results from a 2-year, open-label extension study","year":2007,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Novartis Pharma; Novartis","keywords":"Medicine; Tolerability; Overactive bladder; Discontinuation; Placebo; Adverse effect; Constipation; Solifenacin; Internal medicine; Anesthesia","score_opus":0.17753468286716914,"score_gpt":0.5006003412852479,"score_spread":0.32306565841807877,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2120807296","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99511415,0.0015864196,0.000059982587,0.00022246876,0.00010434119,0.0026473915,0.00020382147,0.0000061240016,0.00005533299],"genre_scores_gemma":[0.99473256,0.0038625055,0.00006114779,0.000010042154,0.00008201587,0.0000647149,0.0011085997,0.000013684169,0.000064710075],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.996615,0.0002962027,0.0005098873,0.00063140516,0.0014278525,0.000519656],"domain_scores_gemma":[0.99699306,0.0016552365,0.00007297875,0.00033059655,0.00031882044,0.0006293249],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031628846,0.00015038502,0.00053837814,0.0007514333,0.000105881176,0.000047607973,0.00015170484,0.00012006274,0.00006988932],"category_scores_gemma":[0.0016200821,0.00011345528,0.000045456934,0.00080379983,0.00022368936,0.0001225346,0.0003178839,0.00049312814,0.000002192455],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016942736,0.009537068,0.679263,0.00007371123,0.0005200625,0.00006485574,0.0022804693,8.850135e-8,0.00005499045,0.0000065839113,0.0005507153,0.2907057],"study_design_scores_gemma":[0.033385582,0.008623493,0.9563239,0.00037861874,0.00011030395,7.2737095e-7,0.00046177654,0.00023731808,0.00007375583,0.000042961783,0.00026824514,0.00009332076],"about_ca_topic_score_codex":0.00086108746,"about_ca_topic_score_gemma":0.0005487581,"teacher_disagreement_score":0.2906124,"about_ca_system_score_codex":0.00013262422,"about_ca_system_score_gemma":0.00026824608,"threshold_uncertainty_score":0.46265718},"labels":[],"label_agreement":null},{"id":"W2122016047","doi":"10.1185/030079906x162809","title":"Quetiapine augmentation of treatment-resistant depression: a comparison with lithium","year":2007,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Treatment of Major Depression","field":"Medicine","cited_by":83,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Louis-H Lafontaine; AstraZeneca (Canada)","funders":"","keywords":"Quetiapine; Lithium (medication); Medicine; Antidepressant; Rating scale; Quetiapine Fumarate; Depression (economics); Internal medicine; Bipolar disorder; Lithium carbonate; Anesthesia; Psychiatry; Antipsychotic; Atypical antipsychotic; Psychology; Schizophrenia (object-oriented programming)","score_opus":0.1272281207290876,"score_gpt":0.48260314132262894,"score_spread":0.3553750205935413,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2122016047","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97308564,0.020738438,0.0018559303,0.0014174854,0.00026924085,0.0010251839,0.000008920597,0.000057517133,0.0015416549],"genre_scores_gemma":[0.995551,0.0033791156,0.00040949756,0.000010412354,0.00026143878,0.000035677884,0.00016470751,0.000015903477,0.00017225952],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9970627,0.000114582464,0.00038325458,0.0003513915,0.0016696923,0.00041838942],"domain_scores_gemma":[0.99821156,0.00046313176,0.00008864688,0.0002633448,0.00023616775,0.00073712954],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010395279,0.00015522583,0.00034429115,0.00026773862,0.000120241944,0.000014771968,0.0000840164,0.00012120999,0.0001667441],"category_scores_gemma":[0.0003802031,0.0000915149,0.000043341883,0.00030780223,0.000381022,0.00007246374,0.00007176476,0.00035480838,0.000010158435],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009157358,0.002807023,0.30032283,0.0005964989,0.00009768338,0.000065245615,0.0005133793,3.8880907e-7,0.0038937705,0.00045217,0.0033675584,0.6787261],"study_design_scores_gemma":[0.030016478,0.025472768,0.72904426,0.009222832,0.00011604283,0.00013121303,0.0008732872,0.0008558303,0.061818056,0.00030787152,0.14178456,0.00035678336],"about_ca_topic_score_codex":0.00013059123,"about_ca_topic_score_gemma":0.0000570747,"teacher_disagreement_score":0.6783693,"about_ca_system_score_codex":0.00018593347,"about_ca_system_score_gemma":0.0003462775,"threshold_uncertainty_score":0.37318695},"labels":[],"label_agreement":null},{"id":"W2123003746","doi":"10.1185/030079904125003430","title":"Managing acute exacerbations of schizophrenia: focus on quetiapine","year":2004,"lang":"en","type":"review","venue":"Current Medical Research and Opinion","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"AstraZeneca","keywords":"Medicine; Quetiapine; Schizophrenia (object-oriented programming); Psychiatry; Quetiapine Fumarate; Focus (optics); Intensive care medicine; Atypical antipsychotic; Antipsychotic","score_opus":0.15210424749362153,"score_gpt":0.4848616602917703,"score_spread":0.33275741279814874,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2123003746","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000023738925,0.9945608,0.00007862667,0.0024711376,0.00034177385,0.0017991043,0.00007695102,0.00004381931,0.0006040725],"genre_scores_gemma":[0.00022718874,0.99771106,0.00018451738,0.0000051879965,0.00071063614,0.0003449755,0.0006339647,0.000055800807,0.00012666223],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9938271,0.00040316992,0.0007644825,0.0007716247,0.0033672997,0.00086629007],"domain_scores_gemma":[0.9962878,0.00096047635,0.00014170805,0.00067003217,0.00032475192,0.001615225],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0014216116,0.000435893,0.0016410354,0.0012315181,0.00021583054,0.000047217385,0.0003652779,0.0004107925,0.0003415118],"category_scores_gemma":[0.0015594016,0.0002898176,0.00039547667,0.0010451983,0.00070424436,0.000060362334,0.00038231845,0.0026483946,0.000232689],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010072123,0.0007542516,0.000003858429,0.019968443,0.0003899408,0.0001384829,0.0000149928155,2.7127863e-8,1.0093638e-7,0.015632555,0.0015723446,0.96051776],"study_design_scores_gemma":[0.0064425752,0.0038192018,0.000072131086,0.1802177,0.00037901348,0.00024017028,0.000013064728,0.00002739425,0.000011012331,0.013326715,0.79512155,0.00032945912],"about_ca_topic_score_codex":0.000052956737,"about_ca_topic_score_gemma":0.000013187561,"teacher_disagreement_score":0.9601883,"about_ca_system_score_codex":0.000433996,"about_ca_system_score_gemma":0.0043549705,"threshold_uncertainty_score":0.9999554},"labels":[],"label_agreement":null},{"id":"W2124466636","doi":"10.1185/030079907x188198","title":"Prescriptions for vitamin Damong patients taking antiresorptive agents in Canada","year":2007,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Vitamin D Research Studies","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Merck Canada Inc. (Canada); University of Calgary","funders":"","keywords":"Medicine; Vitamin D and neurology; Medical prescription; Raloxifene; Alfacalcidol; Calcitriol receptor; Ergocalciferol; Internal medicine; Denosumab; Osteoporosis; Cholecalciferol; Pharmacology; Breast cancer; Bone mineral; Cancer","score_opus":0.164496793056832,"score_gpt":0.46485279143798475,"score_spread":0.30035599838115273,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2124466636","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.990936,0.0028941513,0.00035806888,0.0025996102,0.00073731574,0.0016364766,0.00004932656,0.000013985052,0.0007750648],"genre_scores_gemma":[0.9963817,0.0028587685,0.00006893997,0.00008045717,0.00029226017,0.000106678235,0.00011654195,0.000014571289,0.00008006224],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9960524,0.00011890273,0.0003451175,0.00037213444,0.0021519954,0.0009594362],"domain_scores_gemma":[0.997241,0.001222386,0.000047616046,0.00014826706,0.00044572874,0.00089501153],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0025664263,0.00012524497,0.00025466125,0.00035967285,0.0002674194,0.000018906681,0.00015695438,0.00007796509,0.00006030758],"category_scores_gemma":[0.015999936,0.00009963205,0.000034624256,0.00044025676,0.00038111414,0.00007295714,0.00026955642,0.00076457567,0.0000038420867],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024804054,0.00053862407,0.7238901,0.0006677043,0.000034718298,0.000039662646,0.00021611157,2.1643541e-7,0.000028388118,0.0003877553,0.06616944,0.20777921],"study_design_scores_gemma":[0.0031914024,0.0006625466,0.9474206,0.0014199489,0.000003615813,0.0000024000556,0.0005144675,0.0008309785,0.000107130334,0.00011218153,0.04563524,0.000099517616],"about_ca_topic_score_codex":0.086207,"about_ca_topic_score_gemma":0.17402297,"teacher_disagreement_score":0.22353046,"about_ca_system_score_codex":0.0006767966,"about_ca_system_score_gemma":0.0020729366,"threshold_uncertainty_score":0.9922887},"labels":[],"label_agreement":null},{"id":"W2127101106","doi":"10.1185/030079906x80323","title":"Treatment patterns for women with new episodes of uterine myomas in an insured population in the US","year":2005,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Uterine Myomas and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"University of Waterloo","keywords":"Medicine; Population; Gynecology; Obstetrics; Environmental health","score_opus":0.12372607828550747,"score_gpt":0.4669350017645471,"score_spread":0.34320892347903964,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2127101106","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99594957,0.0004728588,0.00005420792,0.002742792,0.00003974914,0.00069124554,0.000015314403,0.0000049506875,0.000029300109],"genre_scores_gemma":[0.9977604,0.0015222599,0.00009060413,0.00001875684,0.0002255729,0.00017181018,0.00015479374,0.000007299148,0.000048497706],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987132,0.00007923622,0.00020651639,0.00018896867,0.0005185947,0.0002934998],"domain_scores_gemma":[0.9994119,0.00011502745,0.000026463062,0.00015388957,0.000039632643,0.00025311537],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004209401,0.000089849,0.00020248405,0.00015844783,0.000029458091,0.000012670086,0.00006865373,0.000045911613,0.00004989272],"category_scores_gemma":[0.000091651804,0.00004744432,0.0000156216,0.00015761738,0.000052082985,0.00007283146,0.000024722052,0.00013394986,7.9416395e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008104056,0.0009672586,0.5226519,0.00013040655,0.000010343141,0.0000086271175,0.000736713,5.524833e-7,0.000011448609,0.00010291356,0.000023426162,0.474546],"study_design_scores_gemma":[0.0065240157,0.006025988,0.9704791,0.00029854293,0.0000024849678,0.000014356814,0.000120820376,0.000591938,0.000052021453,0.00017111033,0.015674744,0.00004489621],"about_ca_topic_score_codex":0.0008869678,"about_ca_topic_score_gemma":0.0016234213,"teacher_disagreement_score":0.47450107,"about_ca_system_score_codex":0.00013771876,"about_ca_system_score_gemma":0.00011922232,"threshold_uncertainty_score":0.19347233},"labels":[],"label_agreement":null},{"id":"W2128057975","doi":"10.1185/03007995.2013.763779","title":"Denosumab, a new pharmacotherapy option for postmenopausal osteoporosis","year":2013,"lang":"en","type":"review","venue":"Current Medical Research and Opinion","topic":"Bone health and osteoporosis research","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia; McMaster University; University of Toronto; St. Michael's Hospital","funders":"","keywords":"Denosumab; Medicine; Teriparatide; Osteoporosis; Discontinuation; Raloxifene; Adverse effect; Osteonecrosis of the jaw; Bisphosphonate; Internal medicine; Placebo; Bone mineral; Tamoxifen; Breast cancer; Alternative medicine; Cancer","score_opus":0.35256512639565313,"score_gpt":0.5813298030249506,"score_spread":0.2287646766292975,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2128057975","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000032584874,0.98853606,0.00017154883,0.0023881851,0.0012072842,0.007403447,0.0000749686,0.000063937565,0.0001219606],"genre_scores_gemma":[0.000004092616,0.99133146,0.0003113561,0.00012427887,0.0036019883,0.0017955168,0.0014584485,0.00010880851,0.0012640328],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9927592,0.0005321899,0.0010507589,0.0009934037,0.0030376946,0.0016267146],"domain_scores_gemma":[0.99253285,0.0017518427,0.00018183306,0.00049855205,0.00064958364,0.0043853414],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.003096043,0.00050894805,0.0018527115,0.0008263835,0.00037749176,0.0001461658,0.00041726066,0.00081215287,0.0013886059],"category_scores_gemma":[0.002255985,0.0003552729,0.00033498844,0.00073019817,0.00043917334,0.00013660666,0.00025535258,0.002814657,0.00040376396],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021728636,0.00032875128,0.000005272857,0.036003508,0.00006725905,0.0000052436067,0.000038957984,1.2934962e-9,0.0000037012626,0.00024173922,0.10504369,0.8580446],"study_design_scores_gemma":[0.003033571,0.0029436427,0.00001323667,0.024397276,0.00008769546,0.0001048855,0.00002181743,0.000060210565,0.0000061239793,0.0002755097,0.9687872,0.0002688082],"about_ca_topic_score_codex":0.00015759436,"about_ca_topic_score_gemma":0.0000072365324,"teacher_disagreement_score":0.86374354,"about_ca_system_score_codex":0.00037519485,"about_ca_system_score_gemma":0.0071169776,"threshold_uncertainty_score":0.9998899},"labels":[],"label_agreement":null},{"id":"W2128667657","doi":"10.1185/03007995.2015.1082989","title":"A primer on the hormone-free interval for combined oral contraceptives","year":2015,"lang":"en","type":"review","venue":"Current Medical Research and Opinion","topic":"Reproductive Health and Contraception","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Calgary General Hospital; Foothills Medical Centre","funders":"","keywords":"Medicine; Dosing; Discontinuation; Estrogen; Follicular phase; Family planning; Progestin; Population; Gynecology; Internal medicine; Environmental health","score_opus":0.4227601636236631,"score_gpt":0.558261526390508,"score_spread":0.13550136276684488,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2128667657","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00004680031,0.9825198,0.0001335034,0.0106746415,0.0010453828,0.005187539,0.000058717873,0.000030874286,0.00030274125],"genre_scores_gemma":[0.000054687796,0.9953538,0.000019890329,0.00010470703,0.0024553193,0.0012623931,0.00037678095,0.00003797192,0.0003344184],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99526525,0.00082995876,0.0006048174,0.00069383247,0.001880637,0.0007254837],"domain_scores_gemma":[0.9955476,0.0017673541,0.00015224823,0.00072105683,0.00072524004,0.0010865238],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.006903292,0.00031481523,0.001298181,0.00023936681,0.00022907015,0.00005082407,0.0004045977,0.0003677887,0.0000967265],"category_scores_gemma":[0.015273031,0.00016217507,0.0002654516,0.00029879902,0.000699379,0.00005371913,0.00023007841,0.002158256,0.000079284466],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008645361,0.0003307471,0.0000026569762,0.0055533187,0.000060793547,0.0000025146003,0.00005017367,7.147285e-10,1.7873603e-7,0.002963931,0.16442026,0.8257509],"study_design_scores_gemma":[0.0024349783,0.004248838,0.000056597986,0.0147194015,0.000069195055,0.00002121767,0.000058800873,0.00003581901,3.9033395e-7,0.0013910689,0.9768246,0.00013908443],"about_ca_topic_score_codex":0.000012047958,"about_ca_topic_score_gemma":0.0000022784777,"teacher_disagreement_score":0.82561177,"about_ca_system_score_codex":0.00020284839,"about_ca_system_score_gemma":0.0019941414,"threshold_uncertainty_score":0.9930217},"labels":[],"label_agreement":null},{"id":"W2129869980","doi":"10.1185/030079904x2754","title":"Topical lidocaine patch 5% may target a novel underlying pain mechanism in osteoarthritis","year":2004,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Pain Mechanisms and Treatments","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Osteoarthritis; Analgesic; WOMAC; Tramadol; Lidocaine; Adverse effect; Anesthesia; Hyperalgesia; Duloxetine; Brief Pain Inventory; Physical therapy; Chronic pain; Internal medicine; Nociception","score_opus":0.1506651205344753,"score_gpt":0.44258410425849315,"score_spread":0.2919189837240178,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2129869980","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7663135,0.017788729,0.1572245,0.052029844,0.0021170778,0.0032231843,0.000043675485,0.00018339658,0.0010761189],"genre_scores_gemma":[0.994061,0.0033585418,0.001742311,0.00024024243,0.0002992195,0.000107920874,0.000111621695,0.000018025154,0.00006110657],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9970577,0.00020281055,0.0003018648,0.00042010137,0.0013568897,0.00066067354],"domain_scores_gemma":[0.99853426,0.00034356842,0.000024686562,0.00019509863,0.00009574106,0.00080666324],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028266779,0.00015407734,0.00030110584,0.0002362152,0.0001335435,0.000032264154,0.00011208662,0.00019094028,0.00020266524],"category_scores_gemma":[0.0021432382,0.00012203363,0.000052699485,0.0003327685,0.00015056274,0.000068612404,0.0001347768,0.0008708971,0.000028374237],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041123162,0.0031132377,0.008379784,0.00063790294,0.00004177053,0.0009269947,0.00060215424,7.078883e-7,0.00094208296,0.10370709,0.00043460587,0.88080245],"study_design_scores_gemma":[0.116795346,0.032858547,0.0560071,0.02984585,0.000048423633,0.0011175883,0.002981865,0.008926431,0.0063830954,0.58939683,0.1538889,0.0017500496],"about_ca_topic_score_codex":0.00022700171,"about_ca_topic_score_gemma":0.000086903216,"teacher_disagreement_score":0.8790524,"about_ca_system_score_codex":0.00017939786,"about_ca_system_score_gemma":0.00043440502,"threshold_uncertainty_score":0.4976387},"labels":[],"label_agreement":null},{"id":"W2129945276","doi":"10.1185/030079905x43677","title":"Nicotinic acid in the management of dyslipidaemia associated with diabetes and metabolic syndrome: a position paper developed by a European Consensus Panel","year":2005,"lang":"en","type":"review","venue":"Current Medical Research and Opinion","topic":"Diabetes, Cardiovascular Risks, and Lipoproteins","field":"Medicine","cited_by":101,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"McMaster University","keywords":"Medicine; Metabolic syndrome; Position paper; Diabetes mellitus; Type 2 diabetes; Position (finance); Consensus conference; Intensive care medicine; Internal medicine; Endocrinology; Pathology","score_opus":0.11074684889550147,"score_gpt":0.39118636971840426,"score_spread":0.2804395208229028,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2129945276","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.008752227,0.98848486,0.000004801883,0.00031757922,0.000106234154,0.0018557167,0.000049846523,0.00001855009,0.00041017114],"genre_scores_gemma":[0.008827508,0.9899703,0.000033963122,0.00004087029,0.00015823563,0.0002058203,0.0006848768,0.000043502587,0.000034894398],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9942046,0.0019411405,0.00067521166,0.0005500758,0.001985834,0.00064317806],"domain_scores_gemma":[0.9983341,0.00055365986,0.00017077239,0.00039827495,0.00014446606,0.00039872064],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0067526735,0.0003349997,0.0015588076,0.00030131414,0.00010909221,0.00005179578,0.00027411908,0.00021511299,0.000041314317],"category_scores_gemma":[0.00075638614,0.00019270435,0.00019037173,0.0007602662,0.0005543363,0.00004587904,0.00022235472,0.0014056256,0.000011408415],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000021071353,0.00028929365,0.000064601634,0.009621778,0.0007164974,0.000068028006,0.00007606214,6.0653136e-9,2.5702167e-7,0.00004237259,0.0010171552,0.9880829],"study_design_scores_gemma":[0.002358144,0.00050164876,0.011270963,0.06982383,0.00065973017,0.00009439406,0.000114075774,0.0000070387637,0.0000015307859,0.00001431989,0.9149079,0.0002464829],"about_ca_topic_score_codex":0.00003181766,"about_ca_topic_score_gemma":0.000019536363,"teacher_disagreement_score":0.9878364,"about_ca_system_score_codex":0.00007459768,"about_ca_system_score_gemma":0.00034289103,"threshold_uncertainty_score":0.7858255},"labels":[],"label_agreement":null},{"id":"W2129953844","doi":"10.1185/03007990802622726","title":"Escitalopram in the treatment of major depressive disorder: A meta-analysis","year":2008,"lang":"en","type":"review","venue":"Current Medical Research and Opinion","topic":"Treatment of Major Depression","field":"Medicine","cited_by":146,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Eli Lilly and Company","keywords":"Escitalopram; Citalopram; Duloxetine; Venlafaxine; Major depressive disorder; Sertraline; Medicine; Internal medicine; Antidepressant; Paroxetine; Fluoxetine; Rating scale; Meta-analysis; Hamilton Rating Scale for Depression; Depression (economics); Psychiatry; Psychology; Serotonin","score_opus":0.37284286152732893,"score_gpt":0.5338162859527834,"score_spread":0.16097342442545448,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2129953844","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000077900964,0.99664885,0.000025321775,0.00059797516,0.000116396404,0.002280123,0.00008657558,0.000013081358,0.00015380235],"genre_scores_gemma":[0.0002561739,0.9973814,0.000024605322,0.000005918605,0.00019539703,0.0011286765,0.0008808819,0.000025499132,0.00010147351],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99358296,0.0012637682,0.00086698134,0.00072603236,0.0030042639,0.00055601844],"domain_scores_gemma":[0.99570507,0.0025940726,0.00022358174,0.000840313,0.00014870877,0.00048827592],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00094080664,0.0004427801,0.0036478306,0.0011233607,0.00014297054,0.000026358668,0.00039282432,0.00037453655,0.00034672854],"category_scores_gemma":[0.0009629555,0.00019283709,0.0019277356,0.0017159139,0.0005837458,0.000048494843,0.00013217781,0.0009056101,0.000024053377],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000053432206,0.0033145072,0.0003098099,0.0038805208,0.020245437,0.00013562545,0.0002082173,4.8847486e-8,1.3892532e-8,0.000052575608,0.00095125666,0.97084856],"study_design_scores_gemma":[0.0015755744,0.0013576391,0.0002734066,0.0023700711,0.04303292,0.000082113664,0.000033328437,0.00001617371,4.998714e-7,0.00004979457,0.95107317,0.00013531822],"about_ca_topic_score_codex":0.0001843309,"about_ca_topic_score_gemma":0.00006724907,"teacher_disagreement_score":0.97071326,"about_ca_system_score_codex":0.00015359858,"about_ca_system_score_gemma":0.0006892921,"threshold_uncertainty_score":0.7863668},"labels":[],"label_agreement":null},{"id":"W2131442583","doi":"10.1185/03007990802381364","title":"Review of the pharmaceutical properties and clinical effects of the topical NSAID formulation, diclofenac epolamine","year":2008,"lang":"en","type":"review","venue":"Current Medical Research and Opinion","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":73,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Diclofenac; Intensive care medicine; Pharmacology; Traditional medicine","score_opus":0.27508731710275125,"score_gpt":0.5253570267360547,"score_spread":0.2502697096333034,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2131442583","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0011052621,0.9937018,0.0000041046965,0.0008448879,0.0014758955,0.0028078305,0.000005884725,0.000007680414,0.000046647267],"genre_scores_gemma":[0.00048633092,0.99827105,0.000003953791,0.00014063291,0.0009375925,0.00008890205,0.000016540303,0.000020129139,0.000034868168],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9946367,0.0016095563,0.0011661556,0.00036539053,0.0018284533,0.0003937095],"domain_scores_gemma":[0.9960354,0.0023372257,0.00027178033,0.00051421917,0.00029467136,0.0005467358],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.002528635,0.00025984505,0.0015682451,0.00009130448,0.00015877515,0.0000065713266,0.0003459707,0.00037168548,0.000024326715],"category_scores_gemma":[0.015400958,0.00010663583,0.00046650338,0.0004207576,0.0016867906,0.000036475518,0.0005834888,0.002076814,0.0000036422146],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000029345754,0.00017707841,0.0007174304,0.2901732,0.000054421125,0.0000036449096,0.000015129856,3.2489295e-10,6.4413655e-7,0.00015280073,0.0050074207,0.7036689],"study_design_scores_gemma":[0.00065047515,0.0003091793,0.0010779477,0.31090063,0.0001504621,0.00007486246,0.0000011587184,0.000022955066,0.000024596991,0.000013267554,0.6867015,0.00007296769],"about_ca_topic_score_codex":0.000004572444,"about_ca_topic_score_gemma":7.5079834e-7,"teacher_disagreement_score":0.70359594,"about_ca_system_score_codex":0.000049982136,"about_ca_system_score_gemma":0.0013106292,"threshold_uncertainty_score":0.99289274},"labels":[],"label_agreement":null},{"id":"W2131806746","doi":"10.1185/030079904125004178","title":"Impact of migraine on patients and their families: the Migraine And Zolmitriptan Evaluation (MAZE) survey – Phase III","year":2004,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Migraine and Headache Studies","field":"Medicine","cited_by":97,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"St. Joseph’s Healthcare Hamilton","funders":"AstraZeneca","keywords":"Migraine; Medicine; Zolmitriptan; Menstruation; Physical therapy; Migraine treatment; Pediatrics; Psychiatry; Internal medicine","score_opus":0.194414882329176,"score_gpt":0.5139342092231748,"score_spread":0.31951932689399876,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2131806746","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9823175,0.014299472,0.00003139081,0.0021953988,0.000054006876,0.00087498745,0.00007580329,0.0000087641865,0.00014267056],"genre_scores_gemma":[0.97752434,0.021894744,0.0000043974014,0.000050168495,0.00017927414,0.00003384534,0.0002743022,0.000009646024,0.000029290473],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99734014,0.00033836116,0.00032480908,0.00031425967,0.0013127706,0.00036964464],"domain_scores_gemma":[0.9977782,0.00091301335,0.0000620148,0.00020491294,0.00058349996,0.00045836298],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004001263,0.0001733114,0.00036418976,0.00021037417,0.00019412834,0.00001816377,0.000083608786,0.00009055211,0.000055361546],"category_scores_gemma":[0.006767815,0.00008750506,0.00007238345,0.0003442042,0.00077291543,0.000048178885,0.0001263559,0.00054215954,0.000001747426],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004332596,0.003877774,0.17436868,0.00067185896,0.00034926774,0.000003515193,0.010786836,4.5751187e-7,0.00028156355,0.00043715848,0.046605606,0.7582847],"study_design_scores_gemma":[0.020646645,0.008657442,0.95901024,0.0010713404,0.000026661945,0.000008148159,0.00088397256,0.0008103566,0.00008869201,0.00084291626,0.007814737,0.00013885566],"about_ca_topic_score_codex":0.0011110785,"about_ca_topic_score_gemma":0.00037144063,"teacher_disagreement_score":0.78464156,"about_ca_system_score_codex":0.00007440338,"about_ca_system_score_gemma":0.00038740598,"threshold_uncertainty_score":0.8102196},"labels":[],"label_agreement":null},{"id":"W2133195352","doi":"10.1185/030079907x219643","title":"Modeling the economic and health consequences of managing chronic osteoarthritis pain with opioids in Germany: comparison of extended-release oxycodone and OROS hydromorphone","year":2007,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Opioid Use Disorder Treatment","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Hydromorphone; Oxycodone; Medicine; Opioid; Anesthesia; Morphine; Chronic pain; Adverse effect; Osteoarthritis; Extended release; Physical therapy; Pharmacology; Internal medicine","score_opus":0.07536041559794104,"score_gpt":0.4218867078261125,"score_spread":0.34652629222817144,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2133195352","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.882102,0.11297282,0.0008776622,0.0033316738,0.000056542754,0.0006191544,0.000008608394,0.00000634223,0.000025168649],"genre_scores_gemma":[0.9548563,0.04493882,0.00006929368,0.00002225063,0.000053718293,0.000019486473,0.000028738892,0.000008759399,0.0000026532412],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99815565,0.00018652933,0.0004439559,0.00026926765,0.00056088803,0.00038369655],"domain_scores_gemma":[0.99898225,0.00036564883,0.00007212554,0.00015634298,0.000052968124,0.00037068757],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0033940687,0.00011338954,0.0003948302,0.00019513653,0.00009899115,0.000011875257,0.0000717254,0.000053891137,0.000020534637],"category_scores_gemma":[0.00014238036,0.000075629105,0.000016667856,0.00013917801,0.00094035495,0.00004737421,0.00008870448,0.00041055135,6.42634e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00059627974,0.0004613324,0.044696514,0.002368645,0.00003968612,0.000025580594,0.0022316296,0.00005008014,0.00020206178,0.0008122976,0.00012750024,0.9483884],"study_design_scores_gemma":[0.041033436,0.036484044,0.2485445,0.03945192,0.00007824572,0.00036948436,0.021667248,0.60116905,0.002931545,0.004870586,0.0025483612,0.0008516069],"about_ca_topic_score_codex":0.0014528421,"about_ca_topic_score_gemma":0.00080640597,"teacher_disagreement_score":0.94753677,"about_ca_system_score_codex":0.0001498967,"about_ca_system_score_gemma":0.0007647142,"threshold_uncertainty_score":0.34647772},"labels":[],"label_agreement":null},{"id":"W2135648839","doi":"10.1185/030079903125002405","title":"Comparison of the efficacy of rosuvastatin versus atorvastatin, simvastatin, and pravastatin in achieving lipid goals: results from the STELLAR trial","year":2003,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":158,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"AstraZeneca","keywords":"Rosuvastatin; Medicine; Pravastatin; Atorvastatin; Simvastatin; Pharmacology; Statin; Rosuvastatin Calcium; Internal medicine; Cholesterol","score_opus":0.17612580238412012,"score_gpt":0.47144030552235,"score_spread":0.2953145031382299,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2135648839","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98454046,0.0114361225,0.00015013061,0.0014008959,0.0006935757,0.0015442533,0.00006720264,0.000006636962,0.00016073161],"genre_scores_gemma":[0.99497616,0.004340578,0.00020984143,0.000018232044,0.00035606287,0.000027022548,0.00005040919,0.000014776565,0.0000069354896],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.994148,0.0018341461,0.00090573274,0.00038047743,0.0023082031,0.00042343317],"domain_scores_gemma":[0.9926787,0.0059773135,0.0002280454,0.0005268216,0.00023549638,0.00035364248],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.007508124,0.00014991204,0.0005730429,0.00008861449,0.00015477953,0.000023521805,0.00019578297,0.000110955676,0.000029516485],"category_scores_gemma":[0.027347367,0.00008371905,0.00011042998,0.0005046825,0.000653847,0.00004324728,0.00017290223,0.0010506471,0.0000014003001],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.045311727,0.0016609684,0.037724648,0.00093552377,0.00017920462,0.0000062084196,0.0067137307,0.0000070356677,0.00023716195,0.0013402014,0.0037530633,0.90213054],"study_design_scores_gemma":[0.43403497,0.01173767,0.35972458,0.012185828,0.00017630644,0.00001613329,0.016065098,0.0029331935,0.0053228154,0.00060158974,0.15658098,0.0006208248],"about_ca_topic_score_codex":0.00047202993,"about_ca_topic_score_gemma":0.000111109286,"teacher_disagreement_score":0.9015097,"about_ca_system_score_codex":0.000043393455,"about_ca_system_score_gemma":0.00079958414,"threshold_uncertainty_score":0.9808457},"labels":[],"label_agreement":null},{"id":"W2136459019","doi":"10.1185/03007995.2013.803462","title":"Venous thromboembolism management: where do novel anticoagulants fit?","year":2013,"lang":"en","type":"review","venue":"Current Medical Research and Opinion","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton General Hospital; Hamilton Health Sciences; McMaster University","funders":"","keywords":"Medicine; Venous thromboembolism; Dabigatran; Intensive care medicine; Rivaroxaban; Warfarin; Atrial fibrillation; Internal medicine; Thrombosis","score_opus":0.28757096000421317,"score_gpt":0.5060240680105191,"score_spread":0.21845310800630596,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2136459019","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000032472137,0.98929423,0.00006675052,0.00050763646,0.0020127364,0.003920821,0.000044492666,0.000086348446,0.004034494],"genre_scores_gemma":[0.000034943874,0.996501,0.00011296206,0.00004911098,0.00169604,0.0007292077,0.0003120066,0.00010629757,0.0004583979],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99290645,0.00027059345,0.0009482799,0.0011914473,0.00326326,0.0014199401],"domain_scores_gemma":[0.9965988,0.00042922754,0.00019846989,0.0009270182,0.00026153782,0.0015849466],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0019117711,0.0006451887,0.0033402895,0.0008279587,0.00035061728,0.00024253987,0.000686906,0.00061281817,0.001648113],"category_scores_gemma":[0.00044155406,0.00045970333,0.00038219072,0.0007482832,0.0005782924,0.00012927383,0.0012566542,0.0021958617,0.0010939204],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000007599686,0.0023073973,0.0000056016966,0.07333937,0.0004667102,0.00007264015,0.00005075238,1.0013346e-8,7.331779e-8,0.004848364,0.079730816,0.83917063],"study_design_scores_gemma":[0.00096057996,0.0005264447,0.0002448836,0.09064566,0.00042340384,0.00008384808,0.00006205618,0.000018663346,1.411819e-7,0.00025764492,0.9064153,0.0003613857],"about_ca_topic_score_codex":0.00006785763,"about_ca_topic_score_gemma":0.0000037356813,"teacher_disagreement_score":0.83880925,"about_ca_system_score_codex":0.00020980286,"about_ca_system_score_gemma":0.0005561851,"threshold_uncertainty_score":0.9997855},"labels":[],"label_agreement":null},{"id":"W2136897350","doi":"10.1185/03007995.2015.1092127","title":"Two placebo-controlled, randomized withdrawal studies to evaluate the fentanyl 1 day patch in opioid-naïve patients with chronic pain","year":2015,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Opioid Use Disorder Treatment","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Placebo; Fentanyl; Discontinuation; Visual analogue scale; Adverse effect; Anesthesia; Opioid; Chronic pain; Clinical endpoint; Randomized controlled trial; McGill Pain Questionnaire; Physical therapy; Internal medicine","score_opus":0.07340315948754632,"score_gpt":0.4373179433196166,"score_spread":0.36391478383207027,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2136897350","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92818767,0.04595717,0.00023946972,0.014821117,0.0009151714,0.009612194,0.000011381103,0.00003798446,0.00021782277],"genre_scores_gemma":[0.9893842,0.0073161437,0.000051973,0.00018696574,0.00045263942,0.0023518498,0.0001318877,0.00003060774,0.00009377455],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9922727,0.0025267482,0.00054117636,0.00053354626,0.0033453961,0.00078046654],"domain_scores_gemma":[0.99469227,0.00311138,0.000059914095,0.00039434506,0.0007261362,0.0010159751],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.014460237,0.0002815441,0.0010506677,0.00027508513,0.00017251249,0.00004905616,0.00022426384,0.000078272,0.00005706264],"category_scores_gemma":[0.014768853,0.0001328117,0.00008557254,0.00051322917,0.0007172806,0.00007690495,0.00026994915,0.0007883347,0.00005273138],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.46085826,0.0034336778,0.19057244,0.00074023905,0.0009651082,0.00006326855,0.013000019,0.000013154112,0.0000028045563,0.00062618736,0.022415295,0.30730954],"study_design_scores_gemma":[0.96215594,0.0052328603,0.01290756,0.0036083222,0.0001128767,0.000004656725,0.0025162,0.004507373,0.000011823254,0.0011152046,0.007551857,0.000275302],"about_ca_topic_score_codex":0.00032324615,"about_ca_topic_score_gemma":0.0004279291,"teacher_disagreement_score":0.5012977,"about_ca_system_score_codex":0.00059714814,"about_ca_system_score_gemma":0.0015407618,"threshold_uncertainty_score":0.99353015},"labels":[],"label_agreement":null},{"id":"W2137919051","doi":"10.1185/030079906x89685","title":"Effect of age on response to rivastigmine or donepezil in patients with Alzheimer's disease","year":2006,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Dementia and Cognitive Impairment Research","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Donepezil; Tolerability; Rivastigmine; Internal medicine; Butyrylcholinesterase; Acetylcholinesterase; Population; Adverse effect; Cholinesterase; Oncology; Dementia; Disease; Aché","score_opus":0.04012341822008597,"score_gpt":0.4254921382347489,"score_spread":0.38536872001466294,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2137919051","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963245,0.0005850039,0.000022425425,0.0012802221,0.000080991165,0.001417314,0.000019089133,0.000011122811,0.00025933975],"genre_scores_gemma":[0.9992946,0.0001541028,0.0000105982035,0.000033230026,0.00011996407,0.00013267412,0.0001328756,0.000013697717,0.00010830139],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9954952,0.000689967,0.00025340338,0.00036135633,0.0026688003,0.0005312772],"domain_scores_gemma":[0.9972363,0.0013157768,0.00002486035,0.00021072975,0.00021811177,0.0009942132],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029262244,0.00014176033,0.0002828978,0.00054856634,0.00006327449,0.000019566985,0.00011982204,0.00005392976,0.0002557306],"category_scores_gemma":[0.003423754,0.00008092119,0.000033922042,0.0006238574,0.0003365055,0.000045575045,0.00014037114,0.00048864837,0.00002954688],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.16915947,0.0022668068,0.60342115,0.00042129803,0.0000249513,0.0002015012,0.000027037255,3.1493116e-7,0.000043875738,0.000053061118,0.003285421,0.22109513],"study_design_scores_gemma":[0.010204958,0.021895206,0.9582492,0.0021596255,0.00001471794,9.582088e-7,0.0000067334768,0.000032974523,0.00062217424,0.000028681345,0.0067004818,0.00008430139],"about_ca_topic_score_codex":0.000040993575,"about_ca_topic_score_gemma":0.0000104983055,"teacher_disagreement_score":0.35482806,"about_ca_system_score_codex":0.000052842723,"about_ca_system_score_gemma":0.00034231483,"threshold_uncertainty_score":0.40988004},"labels":[],"label_agreement":null},{"id":"W2138234348","doi":"10.1080/03007995.2017.1292446","title":"Corrections to: Once-daily controlled-release pregabalin in the treatment of patients with fibromyalgia: a phase III, double-blind, randomized withdrawal, placebo-controlled study","year":2017,"lang":"en","type":"erratum","venue":"Current Medical Research and Opinion","topic":"Fibromyalgia and Chronic Fatigue Syndrome Research","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"Pfizer","keywords":"Medicine; Pregabalin; Fibromyalgia; Placebo; Double blind; Anesthesia; Randomized controlled trial; Placebo-controlled study; Physical therapy; Internal medicine; Alternative medicine","score_opus":0.07000949703835077,"score_gpt":0.4312884633059609,"score_spread":0.36127896626761014,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2138234348","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7857287,0.051207162,0.0001776241,0.006802001,0.01227629,0.13936093,0.00028408924,0.000107901564,0.00405531],"genre_scores_gemma":[0.8884647,0.045270175,0.000027995171,0.000013804137,0.0015854555,0.028742846,0.004148002,0.00019570351,0.031551313],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.98745733,0.002334238,0.0015345206,0.0011479568,0.006216591,0.0013093348],"domain_scores_gemma":[0.99182045,0.0037108604,0.0005082862,0.001392839,0.0011823424,0.0013852267],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.005955304,0.00073930755,0.004244568,0.0011930335,0.0006103631,0.00021765938,0.0008249929,0.00059968076,0.00047168627],"category_scores_gemma":[0.0043716305,0.00036991687,0.0005176153,0.0007328344,0.0016351452,0.00012446541,0.0001827547,0.003025576,0.000025784548],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.862323,0.021955386,0.0006372282,0.0021215903,0.0011707777,0.000114674905,0.0021457986,7.842922e-7,4.4759437e-7,0.000025806388,0.101554275,0.007950233],"study_design_scores_gemma":[0.9378697,0.032702114,0.0005262809,0.009340657,0.00040521513,0.000011248962,0.000805179,0.0008713121,0.0000020748157,0.000019441502,0.01713466,0.00031206865],"about_ca_topic_score_codex":0.0010173646,"about_ca_topic_score_gemma":0.0001493225,"teacher_disagreement_score":0.11061809,"about_ca_system_score_codex":0.0005535397,"about_ca_system_score_gemma":0.0054438533,"threshold_uncertainty_score":0.9998753},"labels":[],"label_agreement":null},{"id":"W2139218479","doi":"10.1185/03007995.2010.507492","title":"Clinical development of onercept, a tumor necrosis factor binding protein, in psoriasis","year":2010,"lang":"en","type":"review","venue":"Current Medical Research and Opinion","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research","funders":"","keywords":"Medicine; Psoriasis; Discontinuation; Tumor necrosis factor alpha; Clinical trial; Psoriatic arthritis; Systemic inflammatory response syndrome; Sepsis; Internal medicine; Arthritis; Etiology; Placebo; Dermatology; Pathology","score_opus":0.2546228500833358,"score_gpt":0.4820121677577306,"score_spread":0.2273893176743948,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2139218479","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.04686648,0.949159,0.000004614287,0.000020116051,0.0024889275,0.0012720156,0.00012064754,0.000021843962,0.00004634599],"genre_scores_gemma":[0.00039878636,0.99773085,0.00009894324,0.0000017472914,0.00024021172,0.00068392884,0.0005833268,0.000032249245,0.00022998327],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9948184,0.0015149731,0.0015468949,0.0007632189,0.00042219574,0.00093433884],"domain_scores_gemma":[0.9974447,0.0014212594,0.0003185721,0.00036930025,0.00013752353,0.00030863847],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0041403254,0.00040809132,0.0018730799,0.0007106018,0.00020866824,0.000023356168,0.0005783762,0.0011912682,0.00093607994],"category_scores_gemma":[0.0027911905,0.0002857714,0.00027472124,0.00055203645,0.00072657096,0.000055571036,0.00045633616,0.002783285,0.0003335215],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008082923,0.0006618799,0.00028734407,0.0048743295,0.00013710027,0.000005925891,0.00020978549,1.2055454e-10,0.000037485446,0.00005248377,0.0002761423,0.9933767],"study_design_scores_gemma":[0.0013099521,0.0002955133,0.000332927,0.017831406,0.000028748358,0.0000122281535,0.00003920063,1.4743405e-7,0.000105122366,0.000024813402,0.9797651,0.00025484402],"about_ca_topic_score_codex":0.000017176815,"about_ca_topic_score_gemma":0.000036155026,"teacher_disagreement_score":0.99312186,"about_ca_system_score_codex":0.00016271256,"about_ca_system_score_gemma":0.0023990204,"threshold_uncertainty_score":0.9999772},"labels":[],"label_agreement":null},{"id":"W2139848588","doi":"10.1185/030079904125004484","title":"Relationship between LDL-C and non-HDL-C levels and clinical outcome in the GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) study","year":2004,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Heart Research Centre","funders":"American Heart Association","keywords":"Atorvastatin; Medicine; Quartile; Internal medicine; Coronary heart disease; National Cholesterol Education Program; Cholesterol; Guideline; Cardiology; Metabolic syndrome; Confidence interval","score_opus":0.4358632798930135,"score_gpt":0.5607694194324756,"score_spread":0.12490613953946211,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2139848588","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9818338,0.008845159,0.00010167279,0.0067549814,0.0001256183,0.0022976745,0.000014317994,0.000009393437,0.000017374005],"genre_scores_gemma":[0.9976768,0.0015288694,0.00004777734,0.00011309348,0.00047522318,0.00009541762,0.00004814582,0.000011088807,0.000003615275],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99509263,0.0012182469,0.0005255906,0.00048149654,0.0022915152,0.00039052224],"domain_scores_gemma":[0.9972011,0.0013338779,0.00004564331,0.00030847618,0.00015880975,0.00095212145],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01825543,0.00013702449,0.00037125134,0.00015785865,0.00028392702,0.00005383144,0.000077943834,0.00012055554,0.000013866464],"category_scores_gemma":[0.0059809336,0.000090352434,0.000045611992,0.0002591115,0.0004838527,0.000105295796,0.00016104025,0.0011360216,0.0000044608987],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012385934,0.0002831021,0.8300807,0.00024839074,0.0000151396,0.00002314456,0.00047638227,7.5393686e-8,1.5169124e-7,0.00011959773,0.00007172589,0.16855773],"study_design_scores_gemma":[0.0068523567,0.0012789677,0.98801774,0.00039398577,0.00005873695,0.00003472221,0.0007534293,0.00016611359,1.6032989e-7,0.0018099705,0.00054807117,0.000085737505],"about_ca_topic_score_codex":0.00026851043,"about_ca_topic_score_gemma":0.00009419437,"teacher_disagreement_score":0.16847199,"about_ca_system_score_codex":0.0000656294,"about_ca_system_score_gemma":0.00061049894,"threshold_uncertainty_score":0.7160168},"labels":[],"label_agreement":null},{"id":"W2140719894","doi":"10.1185/030079905x56565","title":"Rivastigmine and donepezil treatment in moderate to moderately-severe Alzheimer's disease over a 2-year period","year":2005,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Cholinesterase and Neurodegenerative Diseases","field":"Medicine","cited_by":230,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Novartis Pharma; Novartis","keywords":"Rivastigmine; Donepezil; Tolerability; Medicine; Adverse effect; Discontinuation; Cholinesterase; Internal medicine; Dementia; Population; Randomized controlled trial; Disease","score_opus":0.14255179854658334,"score_gpt":0.45086080174606846,"score_spread":0.3083090031994851,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2140719894","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97140807,0.018387053,0.000042839543,0.009253505,0.000095347445,0.00068216183,0.00005154479,0.000019040754,0.00006042548],"genre_scores_gemma":[0.98783135,0.01073438,0.000039489234,0.00032254512,0.0007043977,0.00014609411,0.000122064346,0.000017885168,0.000081794555],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99783766,0.00013853249,0.00024210392,0.0005166452,0.0008153622,0.0004496883],"domain_scores_gemma":[0.9975959,0.0001368023,0.00001593482,0.00020518815,0.00010980537,0.0019363615],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027389632,0.00019071254,0.0002873162,0.00024294102,0.000129041,0.00006717882,0.00006258181,0.000061056395,0.00019621386],"category_scores_gemma":[0.00050045445,0.00013951407,0.000043718042,0.00022357776,0.00016769947,0.00012229123,0.00012604703,0.00030954086,0.000026272775],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0175627,0.005209558,0.07553997,0.000438013,0.00012479028,0.00054074096,0.0020254066,0.00006977791,0.00044763912,0.0009699221,0.010393871,0.8866776],"study_design_scores_gemma":[0.040683255,0.0054804804,0.66548485,0.0045918045,0.00017300765,0.00017322834,0.00046567013,0.11545672,0.0025718051,0.0008781577,0.16273093,0.001310069],"about_ca_topic_score_codex":0.000026788543,"about_ca_topic_score_gemma":0.00004532679,"teacher_disagreement_score":0.8853676,"about_ca_system_score_codex":0.00006920335,"about_ca_system_score_gemma":0.00040757644,"threshold_uncertainty_score":0.56892186},"labels":[],"label_agreement":null},{"id":"W2143632543","doi":"10.1185/030079906x104614","title":"Improving the global management of the neurogenic bladder patient: part II.Future treatment strategies","year":2006,"lang":"en","type":"review","venue":"Current Medical Research and Opinion","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"Allergan; Ipsen","keywords":"Medicine; Overactive bladder; Urinary incontinence; Reimbursement; Intensive care medicine; Dosing; Population; Disease; Urinary system; Urinary bladder; Urology; Internal medicine; Health care; Alternative medicine; Pathology","score_opus":0.13997246888930823,"score_gpt":0.4645990195552691,"score_spread":0.3246265506659609,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2143632543","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00023947848,0.9934424,0.000004356381,0.000989771,0.00097615016,0.0026713004,0.00013039872,0.000017369242,0.0015287399],"genre_scores_gemma":[0.0002251284,0.99789906,0.00000580777,0.000009835014,0.0010129422,0.00032075177,0.0002568035,0.00002556321,0.00024411407],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9944604,0.0007662115,0.00064862584,0.0005776465,0.0027404628,0.0008066652],"domain_scores_gemma":[0.99815947,0.00028262625,0.00015138763,0.000756871,0.0001878729,0.00046179953],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001041435,0.00037193828,0.00079415797,0.00010836904,0.0005167899,0.000080672486,0.0005186899,0.0002549191,0.00014917173],"category_scores_gemma":[0.00009840723,0.0001590775,0.00041124274,0.00081827777,0.0008045903,0.000057041863,0.0009970175,0.0013477489,0.000013426495],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005580581,0.00052784337,0.000024298717,0.011602265,0.0003027334,0.00004031246,0.000047689584,4.053301e-8,3.1558397e-8,0.0013949915,0.004946668,0.98105735],"study_design_scores_gemma":[0.00062752614,0.001591193,0.00010394518,0.007544817,0.00023986712,0.00009973407,0.0002209732,0.000017495906,0.0000011775842,0.00021063165,0.9892225,0.00012008337],"about_ca_topic_score_codex":0.00008519948,"about_ca_topic_score_gemma":0.000012763294,"teacher_disagreement_score":0.9842759,"about_ca_system_score_codex":0.0002466859,"about_ca_system_score_gemma":0.0018515346,"threshold_uncertainty_score":0.6486992},"labels":[],"label_agreement":null},{"id":"W2144528397","doi":"10.1185/03007995.2014.975786","title":"The current landscape of treatment options for venous thromboembolism: a focus on novel oral anticoagulants","year":2014,"lang":"en","type":"review","venue":"Current Medical Research and Opinion","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Edoxaban; Dabigatran; Apixaban; Rivaroxaban; Intensive care medicine; Direct thrombin inhibitor; Clinical trial; Pulmonary embolism; Pharmacodynamics; Adverse effect; Warfarin; Pharmacokinetics; Pharmacology; Internal medicine; Atrial fibrillation","score_opus":0.2514164696356102,"score_gpt":0.5098408109641079,"score_spread":0.25842434132849773,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2144528397","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00004312094,0.992712,0.000370559,0.00078123,0.0017653765,0.0038719627,0.00017512731,0.00002659616,0.0002539812],"genre_scores_gemma":[0.00041310798,0.9965095,0.000028630393,0.000010871236,0.0012974757,0.0011368487,0.0005171449,0.000051970874,0.00003444109],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99589103,0.00029378675,0.0008386842,0.0006555169,0.001452503,0.0008684473],"domain_scores_gemma":[0.9959952,0.0021103758,0.00024781877,0.00065884896,0.00028627506,0.00070147665],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002250142,0.00043580774,0.0027436067,0.00038860057,0.00045014927,0.00007313266,0.0003884428,0.00023948278,0.000034917804],"category_scores_gemma":[0.0013129084,0.00023262126,0.0004984393,0.00035397144,0.00047619874,0.000027991386,0.00024013229,0.0008838809,0.000034502318],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000059008198,0.0031715992,0.0000055044034,0.013649684,0.00034134614,0.0000016700983,0.00004433449,9.899508e-8,1.12882134e-7,0.011383944,0.012390227,0.9589525],"study_design_scores_gemma":[0.0015848083,0.0050464566,0.00015540968,0.028627101,0.0004858341,0.000011948276,0.000018051527,0.00015097822,0.0000010793009,0.00048182262,0.96324897,0.00018751674],"about_ca_topic_score_codex":0.000038705,"about_ca_topic_score_gemma":0.000019175686,"teacher_disagreement_score":0.958765,"about_ca_system_score_codex":0.00022065527,"about_ca_system_score_gemma":0.0012699333,"threshold_uncertainty_score":0.9486019},"labels":[],"label_agreement":null},{"id":"W2145546237","doi":"10.1185/030079906x132631","title":"Economic implications of growth hormone use in patients with short bowel syndrome","year":2006,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Clinical Nutrition and Gastroenterology","field":"Nursing","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Short bowel syndrome; Parenteral nutrition; Somatropin; Malabsorption; Pediatrics; Growth hormone deficiency; Surgery; Growth hormone; Intensive care medicine; Internal medicine; Hormone","score_opus":0.06444060966351599,"score_gpt":0.39155649114533275,"score_spread":0.32711588148181675,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2145546237","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99007744,0.0002181556,0.000055185767,0.009146509,0.00018329207,0.0002504705,0.00004303873,0.000009254619,0.000016650953],"genre_scores_gemma":[0.99926394,0.00031063534,0.000032369375,0.00008535967,0.00006778992,0.000022425149,0.0002091678,0.0000069508096,0.0000013646529],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986239,0.00013013682,0.0003354723,0.0002345079,0.00036455962,0.00031141436],"domain_scores_gemma":[0.9991201,0.00039761906,0.000030151234,0.0001260612,0.00010369986,0.0002223799],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045602972,0.00006909263,0.00017151039,0.00018782126,0.000048880975,0.000017130349,0.00012112919,0.00007817031,0.000024288864],"category_scores_gemma":[0.00034167903,0.000056022935,0.000024547973,0.000118703945,0.00040764664,0.00009750742,0.00006730245,0.00038758828,0.000005017449],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005917217,0.0008729897,0.97893184,0.000038707036,0.0000032690366,8.9126013e-7,0.0000060650436,2.9501626e-7,0.0000070769293,0.00024479392,0.013745117,0.0055572363],"study_design_scores_gemma":[0.0019676848,0.0013170629,0.99325603,0.00014307577,0.0000015170808,0.0000028316076,0.0000036254785,0.000040818348,0.000008789429,0.001114798,0.0021015557,0.000042209867],"about_ca_topic_score_codex":0.0001732962,"about_ca_topic_score_gemma":0.00025113192,"teacher_disagreement_score":0.014324194,"about_ca_system_score_codex":0.00005680599,"about_ca_system_score_gemma":0.000017989834,"threshold_uncertainty_score":0.22845489},"labels":[],"label_agreement":null},{"id":"W2146473798","doi":"10.1185/030079907x210444","title":"The Barthel Index and modified Rankin Scale as prognostic tools for long-term outcomes after stroke: a qualitative review of the literature","year":2007,"lang":"en","type":"review","venue":"Current Medical Research and Opinion","topic":"Stroke Rehabilitation and Recovery","field":"Medicine","cited_by":113,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"AstraZeneca","keywords":"Medicine; Modified Rankin Scale; Barthel index; Stroke (engine); Term (time); Scale (ratio); Physical therapy; Index (typography); Physical medicine and rehabilitation; Intensive care medicine; Internal medicine; Activities of daily living; Ischemic stroke","score_opus":0.20580107981137316,"score_gpt":0.5485744398505992,"score_spread":0.342773360039226,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2146473798","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0006107718,0.9909567,0.00007893857,0.0019906533,0.000703951,0.005423922,0.00014515415,0.000008239969,0.0000816742],"genre_scores_gemma":[0.0003912488,0.99766517,0.00001457888,0.000106819214,0.00030947317,0.00089130347,0.00017581439,0.000023187205,0.0004224013],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9953467,0.0011083705,0.0008534728,0.00042716874,0.0017942388,0.0004700205],"domain_scores_gemma":[0.9834055,0.014929784,0.00020493058,0.00041362314,0.0005966505,0.00044955008],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0056091957,0.00029025914,0.0012588814,0.00020567667,0.0001891422,0.000089610825,0.0002664453,0.00035476786,0.00004021022],"category_scores_gemma":[0.024734361,0.00012023689,0.0005420569,0.00043981106,0.0010513534,0.0000749626,0.00020779796,0.0014873975,0.000004148135],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001622571,0.00010740694,0.0012923887,0.16897161,0.000094850744,0.0000019710837,0.00034622932,4.9583054e-10,2.1737517e-8,0.0001990996,0.0006870385,0.8281371],"study_design_scores_gemma":[0.0010659226,0.00041228582,0.0075906496,0.40311655,0.00013777554,0.00003307759,0.000115107316,0.0000026915309,2.450388e-7,0.00020104133,0.58719814,0.00012654767],"about_ca_topic_score_codex":0.0000019946283,"about_ca_topic_score_gemma":0.000004039545,"teacher_disagreement_score":0.82801056,"about_ca_system_score_codex":0.0000639697,"about_ca_system_score_gemma":0.0009196321,"threshold_uncertainty_score":0.9834807},"labels":[],"label_agreement":null},{"id":"W2146626244","doi":"10.1185/030079906x158066","title":"Meta-analysis of cannabis based treatments for neuropathic and multiple sclerosis-related pain","year":2006,"lang":"en","type":"review","venue":"Current Medical Research and Opinion","topic":"Cannabis and Cannabinoid Research","field":"Medicine","cited_by":215,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mount Sinai Hospital; PharmIdeas (Canada)","funders":"Bayer Canada; Bayer HealthCare","keywords":"Medicine; Neuropathic pain; Multiple sclerosis; Cannabis; Meta-analysis; Cannabidiol; Psychiatry; Internal medicine; Anesthesia","score_opus":0.4307523687674539,"score_gpt":0.48561267720592605,"score_spread":0.05486030843847217,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2146626244","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000054133492,0.99429137,0.00017725179,0.0019736392,0.00013657768,0.0026768467,0.0006440169,0.00001991907,0.000026253621],"genre_scores_gemma":[0.00017686526,0.9950984,0.00002220303,0.000026793343,0.00014114217,0.00089587155,0.0023895365,0.000056168377,0.0011930056],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99271035,0.001924356,0.0011105152,0.0009412649,0.0024937605,0.00081976084],"domain_scores_gemma":[0.9960821,0.0012812979,0.00023875613,0.0005586177,0.0006695977,0.0011696176],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.009062513,0.0004484444,0.0038389184,0.001726266,0.00020930692,0.000058560134,0.00025725158,0.0005142405,0.0002864191],"category_scores_gemma":[0.0057290476,0.00028412137,0.0018574632,0.0019897441,0.00082329777,0.00003869125,0.00019342196,0.0012808117,0.0000028315785],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009079986,0.00066969,0.00008236884,0.02111426,0.0226478,0.00001159803,0.00001653546,3.704848e-7,9.185996e-7,0.00004381267,0.026363833,0.928958],"study_design_scores_gemma":[0.0014229864,0.001161879,0.00024635822,0.003119698,0.070375085,0.00000589023,0.000007757699,0.0041550566,0.0000019411825,0.000021847083,0.9192761,0.00020539656],"about_ca_topic_score_codex":0.00033931574,"about_ca_topic_score_gemma":0.000052959596,"teacher_disagreement_score":0.9287526,"about_ca_system_score_codex":0.00014385713,"about_ca_system_score_gemma":0.0017254023,"threshold_uncertainty_score":0.9999611},"labels":[],"label_agreement":null},{"id":"W2147759467","doi":"10.1185/030079906x132541","title":"Relationship between hemoglobin level and quality of life in anemic patients with chronic kidney disease receiving epoetin alfa","year":2006,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Erythropoietin and Anemia Treatment","field":"Medicine","cited_by":80,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Montréal; Group for Research in Decision Analysis","funders":"","keywords":"Medicine; Epoetin alfa; Kidney disease; Hemoglobin; Anemia; Internal medicine; Erythropoietin; Quality of life (healthcare); Intensive care medicine; Gastroenterology","score_opus":0.16099891755677606,"score_gpt":0.4227268406957679,"score_spread":0.26172792313899185,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2147759467","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9896013,0.005680731,0.000041133873,0.004003393,0.00005970203,0.0004441938,0.00006224234,0.000011370226,0.00009592484],"genre_scores_gemma":[0.9978793,0.0010951466,0.00006436266,0.000018805194,0.00022528248,0.000022459171,0.00062923797,0.000010089221,0.00005530479],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975868,0.00020801567,0.00041220113,0.00031169964,0.001139299,0.00034197557],"domain_scores_gemma":[0.9978135,0.00081495347,0.00007041353,0.00017199457,0.00012930487,0.000999802],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011809752,0.00011826145,0.0002914441,0.00015896547,0.00009262726,0.00001246014,0.00006238913,0.00009126167,0.000062646664],"category_scores_gemma":[0.004367949,0.00008482167,0.000025526937,0.00026845167,0.00048219488,0.000054654676,0.00008601871,0.0005305564,0.000003878483],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029772217,0.00043939133,0.983696,0.0011233214,0.000005686476,0.0000028849304,0.000039335253,1.016961e-7,0.000004764787,0.0003406246,0.0017661939,0.012284004],"study_design_scores_gemma":[0.00537314,0.00042749726,0.99025154,0.002147819,0.0000075149724,5.885385e-7,0.000023821407,0.000024544725,0.000014811562,0.0003547174,0.0012928236,0.00008118273],"about_ca_topic_score_codex":0.0004636873,"about_ca_topic_score_gemma":0.00006645895,"teacher_disagreement_score":0.012202821,"about_ca_system_score_codex":0.00014423675,"about_ca_system_score_gemma":0.00082164037,"threshold_uncertainty_score":0.52291584},"labels":[],"label_agreement":null},{"id":"W2147817551","doi":"10.1185/030079904125004358","title":"Association between mean intraocular pressure, disease stability and cost of treating glaucoma in Canada","year":2004,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Glaucoma and retinal disorders","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; Brock University; PharmIdeas (Canada)","funders":"","keywords":"Medicine; Intraocular pressure; Glaucoma; Ophthalmology; Christian ministry; Spearman's rank correlation coefficient","score_opus":0.04839776097522691,"score_gpt":0.36496399491088904,"score_spread":0.31656623393566213,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2147817551","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9895041,0.006646752,0.000038801347,0.0031656898,0.000080302074,0.0004461311,0.000027050835,0.0000046614923,0.00008652023],"genre_scores_gemma":[0.9971369,0.0026555888,0.0000092533,0.0000118184,0.00008209473,0.00001551403,0.000077300174,0.000005150634,0.0000063823295],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977835,0.0001673794,0.00025859245,0.00021345692,0.0012592998,0.0003177785],"domain_scores_gemma":[0.99864805,0.00038862607,0.000043100237,0.000107482,0.00013554504,0.00067717285],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011374077,0.00007777205,0.00022800539,0.00007994433,0.00005861499,0.000008427168,0.00005885055,0.000061658444,0.00004637766],"category_scores_gemma":[0.0029952792,0.000060713362,0.000020753008,0.00019633363,0.00015211831,0.000039448816,0.000068429465,0.00047188383,4.828303e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011314495,0.0001260955,0.96385133,0.00065062376,0.000021513359,0.000008218337,0.00011133394,6.958315e-8,0.000016805838,0.00012455219,0.00015976232,0.034816567],"study_design_scores_gemma":[0.001863111,0.00016122893,0.9925701,0.00083859736,0.000019423518,9.1493257e-7,0.00020203264,0.0002003501,0.00014079665,0.000596113,0.0033535867,0.00005373222],"about_ca_topic_score_codex":0.25111932,"about_ca_topic_score_gemma":0.16382207,"teacher_disagreement_score":0.08729724,"about_ca_system_score_codex":0.00029784034,"about_ca_system_score_gemma":0.0016861601,"threshold_uncertainty_score":0.851436},"labels":[],"label_agreement":null},{"id":"W2147866356","doi":"10.1185/030079904125003197","title":"Quality assessment of meta-analyses of RCTs of pharmacotherapy in major depressive disorder","year":2004,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Meta-analysis and systematic reviews","field":"Decision Sciences","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Checklist; Meta-analysis; Kappa; MEDLINE; Randomized controlled trial; Internal medicine; Population; Major depressive disorder; Cochrane Library; Pharmacotherapy; Physical therapy; Psychology","score_opus":0.9331273537804017,"score_gpt":0.7443359877222335,"score_spread":0.18879136605816815,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2147866356","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88650817,0.0736853,0.034636494,0.0024154035,0.0003182663,0.0012961682,0.00007649397,0.0000019168228,0.0010617621],"genre_scores_gemma":[0.9950587,0.0042472677,0.0005454293,0.000011278104,0.00003081257,0.00004367336,0.00000947262,0.0000041315125,0.00004921106],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.96575147,0.012313788,0.007103917,0.0006376602,0.013895801,0.00029738058],"domain_scores_gemma":[0.9868838,0.007794065,0.0021996545,0.0011795698,0.0016273084,0.0003155721],"candidate_categories":["metaresearch","insufficient_payload"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.12373022,0.00015738608,0.0032859088,0.0006283871,0.00004382608,0.000044167093,0.0010607978,0.00007399472,0.0057704467],"category_scores_gemma":[0.040830404,0.00006813322,0.000974873,0.0015615755,0.00043603205,0.00011902165,0.00019839844,0.00034998116,0.000010554643],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025436323,0.0061954637,0.35175708,0.004136249,0.0069035133,0.000007965362,0.0018776165,0.00040716428,0.01099476,0.045543462,0.009728014,0.56219435],"study_design_scores_gemma":[0.017439183,0.0019245876,0.64772624,0.0023823034,0.0020856636,0.000007909246,0.0035240373,0.013234342,0.030226288,0.21059315,0.069905244,0.00095108215],"about_ca_topic_score_codex":0.00027805232,"about_ca_topic_score_gemma":0.00006860681,"teacher_disagreement_score":0.5612433,"about_ca_system_score_codex":0.000022495955,"about_ca_system_score_gemma":0.00041084533,"threshold_uncertainty_score":0.9951384},"labels":[],"label_agreement":null},{"id":"W2148461943","doi":"10.1185/030079904x2114","title":"Efficacy and safety of transdermal fentanyl and sustained-release oral morphine in patients with cancer and chronic non-cancer pain","year":2004,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Pain Management and Opioid Use","field":"Medicine","cited_by":109,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"Cilag","keywords":"Medicine; Fentanyl; Adverse effect; Cancer pain; Somnolence; Morphine; Constipation; Transdermal; Chronic pain; Internal medicine; Randomized controlled trial; Cancer; Anesthesia; Incidence (geometry); Physical therapy; Pharmacology","score_opus":0.03037748228040237,"score_gpt":0.37276218749624807,"score_spread":0.3423847052158457,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2148461943","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9805359,0.0145020485,0.00021209128,0.0037586598,0.00006421147,0.0008882515,0.000014890079,0.000007633583,0.000016316044],"genre_scores_gemma":[0.95500344,0.04465623,0.000025244155,0.00006203558,0.00012587142,0.000041776435,0.000054068307,0.0000116475585,0.000019662775],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981373,0.000093847135,0.00023762905,0.0003256914,0.00079266937,0.00041285894],"domain_scores_gemma":[0.9990675,0.00017609335,0.000034463734,0.00010807418,0.00010201525,0.000511868],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010773398,0.00014193027,0.0002943149,0.0002034189,0.00008287087,0.000017371141,0.000059936356,0.00007682574,0.00006457294],"category_scores_gemma":[0.0003162183,0.00010020083,0.0000138330715,0.00026578608,0.0005806249,0.00008799871,0.0000959816,0.00045326445,3.0395776e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029747165,0.0005242863,0.6269228,0.0019314548,0.00004241824,0.000016891334,0.0003584175,0.0000033410893,0.00002406979,0.00016330603,0.00038714524,0.36665118],"study_design_scores_gemma":[0.024775054,0.0016110117,0.96590286,0.0030456053,0.000019883688,5.678828e-7,0.000109577064,0.0012561091,0.000027097556,0.00008102273,0.0030496214,0.00012158411],"about_ca_topic_score_codex":0.00027355837,"about_ca_topic_score_gemma":0.00019212019,"teacher_disagreement_score":0.36652958,"about_ca_system_score_codex":0.00011002213,"about_ca_system_score_gemma":0.00031859227,"threshold_uncertainty_score":0.40860713},"labels":[],"label_agreement":null},{"id":"W2150556712","doi":"10.1185/030079906x104786","title":"Glimepiride versus pioglitazone combination therapy in subjects with type 2 diabetes inadequately controlled on metformin monotherapy: results of a randomized clinical trial","year":2006,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":79,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sanofi (Canada)","funders":"National Institute of Diabetes and Digestive and Kidney Diseases","keywords":"Glimepiride; Pioglitazone; Medicine; Metformin; Type 2 diabetes; Rosiglitazone; Hypoglycemia; Internal medicine; Diabetes mellitus; Randomized controlled trial; Clinical endpoint; Urology; Endocrinology","score_opus":0.1340628565789854,"score_gpt":0.4469974842120171,"score_spread":0.3129346276330317,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2150556712","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9866168,0.0055558165,0.000016573476,0.0016471293,0.0006834366,0.004034543,0.0000035436847,0.00002229435,0.0014198432],"genre_scores_gemma":[0.98242617,0.01650951,0.000039785366,0.000032388547,0.00032147215,0.00031229327,0.00020601833,0.000015744412,0.00013659433],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9957876,0.0010483862,0.0009140378,0.00036733717,0.00145561,0.00042698928],"domain_scores_gemma":[0.9929871,0.0060927253,0.00018036392,0.00023135818,0.00027080104,0.00023767547],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010221426,0.00017648842,0.0011973615,0.00044856453,0.000049345414,0.00002461601,0.000108029024,0.00013450618,0.000031266976],"category_scores_gemma":[0.0058485987,0.00010338757,0.00014036208,0.00046115267,0.00051156443,0.000066663,0.000038029364,0.00045394053,0.000006843212],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.81657785,0.003364052,0.0009082096,0.000058964033,0.0002142732,0.000008634271,0.000039464674,3.6210383e-7,0.000009324618,0.002359101,0.0008345419,0.17562525],"study_design_scores_gemma":[0.9650999,0.02571044,0.0022942242,0.00063565344,0.00003848541,1.695541e-7,0.000024910829,0.0010025355,0.00032583333,0.0010487672,0.0037230065,0.00009607787],"about_ca_topic_score_codex":0.000102378435,"about_ca_topic_score_gemma":0.00003106735,"teacher_disagreement_score":0.17552917,"about_ca_system_score_codex":0.000074329495,"about_ca_system_score_gemma":0.00026604428,"threshold_uncertainty_score":0.70017415},"labels":[],"label_agreement":null},{"id":"W2150557505","doi":"10.1185/030079906x100032","title":"Does the treatment of gastroesophageal reflux disease (GERD) meet patients’ needs? A survey‐based study","year":2006,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Gastroesophageal reflux and treatments","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"AstraZeneca","keywords":"GERD; Medicine; Medical prescription; Asymptomatic; Disease; Reflux; Telephone interview; Internal medicine; Medical record; Physical therapy; Family medicine; Pediatrics; Nursing","score_opus":0.0778253260323295,"score_gpt":0.41520244817145957,"score_spread":0.33737712213913007,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2150557505","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961099,0.0012747138,0.000024106463,0.00040160798,0.00042182909,0.0015436491,0.00013367119,0.00002246482,0.000068029774],"genre_scores_gemma":[0.99818593,0.0003934641,0.000012963088,0.000015391968,0.00035879534,0.00017826162,0.00064660097,0.000019132485,0.00018947036],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9957874,0.000623259,0.00043511722,0.0003902897,0.002168979,0.0005949526],"domain_scores_gemma":[0.9975482,0.00068705314,0.00007699987,0.0004530748,0.00037968231,0.0008549847],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010210958,0.00023198973,0.00039322797,0.0002555059,0.00022775261,0.00003487703,0.00016363367,0.000061976505,0.00013497967],"category_scores_gemma":[0.00073039025,0.00009877868,0.0001107762,0.00045413256,0.00041009803,0.000051034236,0.000071780305,0.0002541751,0.000014020818],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008706057,0.013171985,0.9499018,0.00009778967,0.00005505886,0.000103011815,0.00009929861,3.5382752e-7,0.0000012364293,0.00004045596,0.0009792242,0.034679156],"study_design_scores_gemma":[0.0074035143,0.007059211,0.9834174,0.00012465134,0.00004381177,8.9192247e-7,0.000044671964,0.00011262543,0.00005048486,0.00011484077,0.0015809564,0.000046958845],"about_ca_topic_score_codex":0.00019270496,"about_ca_topic_score_gemma":0.000041599244,"teacher_disagreement_score":0.0346322,"about_ca_system_score_codex":0.00013380744,"about_ca_system_score_gemma":0.00044062996,"threshold_uncertainty_score":0.40280774},"labels":[],"label_agreement":null},{"id":"W2150762958","doi":"10.1185/030079906x96245","title":"Estimation of symptom-free days in generalized anxiety disorder","year":2006,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes","field":"Psychology","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's Health Research Institute","funders":"","keywords":"Medicine; Placebo; Anxiety; Population; Generalized anxiety disorder; Venlafaxine; Internal medicine; Quartile; Major depressive disorder; Randomized controlled trial; Physical therapy; Psychiatry; Mood; Confidence interval; Antidepressant","score_opus":0.07676903180071445,"score_gpt":0.4581342199479335,"score_spread":0.3813651881472191,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2150762958","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8765521,0.09704332,0.013388306,0.0016118739,0.0024339296,0.0009592789,0.00008359566,0.00006972653,0.00785789],"genre_scores_gemma":[0.93092895,0.06785103,0.00017132418,0.000014674588,0.000410499,0.00016900091,0.0002404311,0.000018575582,0.0001955402],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9969752,0.00038074606,0.00041826058,0.0004899713,0.0012245731,0.00051123777],"domain_scores_gemma":[0.99846715,0.00061933044,0.000087219676,0.00033936434,0.00024200759,0.00024493178],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013815939,0.0001539857,0.00024623724,0.00059250847,0.00010160097,0.000026640124,0.0003349806,0.00019059294,0.00084628456],"category_scores_gemma":[0.0025617846,0.00012521143,0.00004569106,0.001152341,0.0004331953,0.00012102039,0.00020600115,0.00050077535,0.000045454453],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015949507,0.0012734203,0.17677347,0.00013532999,0.000014084569,0.000001948231,0.00021187558,0.00000283225,0.000010444985,0.0070787226,0.023809975,0.7905284],"study_design_scores_gemma":[0.010804514,0.00064750365,0.7129923,0.0008825729,0.000012610158,0.000013458156,0.00038795243,0.004107105,0.00020876818,0.04719153,0.2223695,0.00038217637],"about_ca_topic_score_codex":0.00060278596,"about_ca_topic_score_gemma":0.00006395057,"teacher_disagreement_score":0.79014623,"about_ca_system_score_codex":0.00005026209,"about_ca_system_score_gemma":0.000118296826,"threshold_uncertainty_score":0.9266223},"labels":[],"label_agreement":null},{"id":"W2153070704","doi":"10.1185/03007995.2014.918029","title":"Diagnosis, comorbidities, and management of restless legs syndrome","year":2014,"lang":"en","type":"review","venue":"Current Medical Research and Opinion","topic":"Restless Legs Syndrome Research","field":"Medicine","cited_by":83,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Medicine; Restless legs syndrome; Comorbidity; Anxiety; Depression (economics); Disease; Psychiatry; Differential diagnosis; Pediatrics; Physical therapy; Insomnia; Internal medicine; Pathology","score_opus":0.3307372617754096,"score_gpt":0.5471310927163142,"score_spread":0.21639383094090464,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2153070704","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00027245615,0.99585205,0.000020139392,0.0004950765,0.00047357893,0.0020972241,0.00005072246,0.000028044302,0.00071069563],"genre_scores_gemma":[0.00023978399,0.9979009,0.00004363261,0.0000053391227,0.0002995971,0.00071171386,0.0003967498,0.00006811303,0.00033416788],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9921813,0.0008857236,0.0009829327,0.0008753431,0.004105785,0.000968932],"domain_scores_gemma":[0.9952983,0.001853805,0.00017748689,0.0007828404,0.00026914902,0.0016183893],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0044830223,0.00042520766,0.0024148629,0.000917103,0.00016167718,0.000071652175,0.0005368402,0.00053091435,0.00033704183],"category_scores_gemma":[0.001108747,0.00030755342,0.00021968003,0.0007624354,0.0016477966,0.000071210954,0.0012256631,0.0024492447,0.00007933446],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000021654056,0.00025866897,0.00013847368,0.22791637,0.00016011059,0.00028022614,0.000010542418,1.99444e-9,1.48759165e-8,0.002296447,0.008098026,0.76081944],"study_design_scores_gemma":[0.0007531722,0.000629765,0.00066542084,0.17666776,0.00010167412,0.00069533265,0.00002049457,0.000009426732,3.2825207e-7,0.00014026307,0.82012707,0.00018925741],"about_ca_topic_score_codex":0.000056112807,"about_ca_topic_score_gemma":0.0000028441166,"teacher_disagreement_score":0.81202906,"about_ca_system_score_codex":0.00017034984,"about_ca_system_score_gemma":0.00084839866,"threshold_uncertainty_score":0.99993765},"labels":[],"label_agreement":null},{"id":"W2153769961","doi":"10.1185/030079904125003250","title":"Generic replacement of clozapine: a simple decision model from a Canadian perspective","year":2004,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Novartis (Canada); Royal Ottawa Mental Health Centre","funders":"","keywords":"Clozapine; Medicine; Schizophrenia (object-oriented programming); Incidence (geometry); Psychiatry","score_opus":0.22165207092856176,"score_gpt":0.4459791323805348,"score_spread":0.22432706145197306,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2153769961","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.85761356,0.07678151,0.023883203,0.023905987,0.001418115,0.0009148972,0.0018004237,0.000029592567,0.01365268],"genre_scores_gemma":[0.97491896,0.024178626,0.00022987588,0.0003212509,0.00025414376,0.000022780696,0.000053931504,0.000011682647,0.000008720675],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.99852663,0.000018829438,0.00043508946,0.00040221095,0.00015803093,0.00045919247],"domain_scores_gemma":[0.99847,0.00014694146,0.0000705749,0.00022648196,0.00008754831,0.0009984624],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010754191,0.00009968031,0.00026506177,0.00034054485,0.00011942425,0.000036042722,0.00024811426,0.000105543695,0.00051841664],"category_scores_gemma":[0.0010873391,0.00010198279,0.000055799086,0.0002232321,0.00020244998,0.00008466082,0.00011615833,0.0003960107,0.00011982686],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021462841,0.0003277721,0.0025065788,0.000049336933,0.000050675615,0.0000033732567,0.00096012006,0.0003875583,0.000014612632,0.93375677,0.012442282,0.04928627],"study_design_scores_gemma":[0.0017833441,0.00018197397,0.0015311101,0.00008783296,0.000001206109,0.0000011249847,0.00008048607,0.062044784,0.000062029656,0.7712854,0.16279528,0.00014541432],"about_ca_topic_score_codex":0.055329096,"about_ca_topic_score_gemma":0.0052524083,"teacher_disagreement_score":0.16247138,"about_ca_system_score_codex":0.0004711633,"about_ca_system_score_gemma":0.00060279586,"threshold_uncertainty_score":0.95096153},"labels":[],"label_agreement":null},{"id":"W2155011514","doi":"10.1185/030079905x43712","title":"Revealing the multidimensional framework of the Minnesota nicotine withdrawal scale","year":2005,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Smoking Behavior and Cessation","field":"Medicine","cited_by":75,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pfizer (Canada)","funders":"Pfizer","keywords":"Nicotine withdrawal; Craving; Irritability; Clinical psychology; Confirmatory factor analysis; Varenicline; Exploratory factor analysis; Mood; Anxiety; Psychiatry; Anger; Construct validity; Anhedonia; Medicine; Psychology; Smoking cessation; Psychometrics; Nicotine; Addiction; Structural equation modeling; Schizophrenia (object-oriented programming)","score_opus":0.0761572998217576,"score_gpt":0.4341971350825373,"score_spread":0.3580398352607797,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2155011514","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9775743,0.0023233893,0.000213197,0.018874792,0.0005973965,0.00029803297,0.0000041041094,0.0000104281535,0.00010439808],"genre_scores_gemma":[0.9972953,0.0014924925,0.00011712835,0.00009495225,0.0008849523,0.000016115428,0.000017871254,0.000007484749,0.00007368213],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9973201,0.00015847119,0.0002273953,0.0001839273,0.0018566116,0.00025349986],"domain_scores_gemma":[0.99871624,0.0005303037,0.000043970285,0.00028262933,0.00021128339,0.00021557815],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017375301,0.00007316912,0.00013073825,0.00005252377,0.00022684332,0.000010485788,0.00015174694,0.00011386297,0.00021238094],"category_scores_gemma":[0.0017614,0.0000353089,0.00005079691,0.00029442023,0.00055087864,0.00003940346,0.00015568461,0.0009875374,0.00000427049],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033009,0.0009646874,0.45172188,0.00027391248,0.00003096004,0.000001504927,0.001178,0.0000028538439,0.0011427953,0.005057735,0.016632969,0.52266264],"study_design_scores_gemma":[0.0022880198,0.00045327278,0.8186908,0.004940855,0.000040321807,0.000065619075,0.00042710983,0.0022126995,0.008128788,0.0007725289,0.16183221,0.00014780612],"about_ca_topic_score_codex":0.000032391345,"about_ca_topic_score_gemma":0.000005974269,"teacher_disagreement_score":0.5225148,"about_ca_system_score_codex":0.00003667683,"about_ca_system_score_gemma":0.0002157785,"threshold_uncertainty_score":0.42904136},"labels":[],"label_agreement":null},{"id":"W2155850242","doi":"10.1185/03007990903069249","title":"Probiotic dietary supplementation in patients with stage 3 and 4 chronic kidney disease: a 6-month pilot scale trial in Canada","year":2009,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Gut microbiota and health","field":"Biochemistry, Genetics and Molecular Biology","cited_by":132,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; The Scarborough Hospital","funders":"Temple University","keywords":"Medicine; Internal medicine; Creatinine; Uric acid; Placebo; Kidney disease; Blood urea nitrogen; Gastroenterology; Probiotic; Clinical trial; Crossover study; Renal function; Randomized controlled trial","score_opus":0.03312535570918103,"score_gpt":0.3632865502161355,"score_spread":0.33016119450695447,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2155850242","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958711,0.0019096658,0.000005123876,0.0012490193,0.000114882045,0.00076375104,0.00007280799,0.0000014012148,0.000012209478],"genre_scores_gemma":[0.9958289,0.0026865012,0.0000073802958,0.000086670174,0.000118867836,0.000021050424,0.0012314433,0.0000046476493,0.000014498279],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99867386,0.0001227022,0.00017559882,0.0002815449,0.00038553908,0.00036076314],"domain_scores_gemma":[0.99931,0.000016485828,0.000023040497,0.00010121031,0.000039529237,0.00050970924],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034701824,0.00008360834,0.000106928885,0.000066349494,0.000054869703,0.000014507849,0.00007432317,0.00003597424,0.000027212804],"category_scores_gemma":[0.00013800098,0.0000661785,0.000006856699,0.00010662346,0.00007929056,0.0000065101462,0.000054589353,0.00023618904,4.1946808e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.046106767,0.0023675817,0.7966631,0.0010634805,0.000015095345,0.00001455497,0.0001179714,0.0000028515938,0.0025037522,0.000049915798,0.01789138,0.13320352],"study_design_scores_gemma":[0.033432823,0.0057831528,0.9499019,0.0004125854,0.0000016163679,3.0780905e-7,0.00003186614,0.00012276472,0.00010056605,0.000023025814,0.010063937,0.00012549058],"about_ca_topic_score_codex":0.020727303,"about_ca_topic_score_gemma":0.26624903,"teacher_disagreement_score":0.24552172,"about_ca_system_score_codex":0.00015364849,"about_ca_system_score_gemma":0.0028379397,"threshold_uncertainty_score":0.98579377},"labels":[],"label_agreement":null},{"id":"W2155860297","doi":"10.1185/030079904x10142","title":"Migraine treatment strategies: the global Migraine And Zolmitriptan Evaluation (MAZE) survey – phase IV*","year":2004,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Migraine and Headache Studies","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Joseph’s Healthcare Hamilton","funders":"AstraZeneca","keywords":"Triptans; Medicine; Migraine; Pharmacy; Migraine treatment; Zolmitriptan; Rizatriptan; Family medicine; Sumatriptan; Psychiatry; Internal medicine","score_opus":0.3178509980921958,"score_gpt":0.5624532324101766,"score_spread":0.24460223431798084,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2155860297","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.87880963,0.089621745,0.00030607215,0.027954329,0.0001948568,0.0017836754,0.000105874824,0.000042205877,0.0011816135],"genre_scores_gemma":[0.95989656,0.03867286,0.000026075957,0.000091454545,0.00066877156,0.00011995175,0.00039373647,0.000009770421,0.000120829165],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9964081,0.0004237037,0.00032598153,0.0004257399,0.0018669112,0.000549564],"domain_scores_gemma":[0.9980229,0.0005006919,0.00004398295,0.00027064997,0.00047390987,0.00068787177],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004084241,0.00020534411,0.0003421131,0.00010341386,0.00033072644,0.000070628026,0.00010858817,0.00011131144,0.00015362298],"category_scores_gemma":[0.0036199836,0.00011541664,0.000074620606,0.00048021693,0.000772045,0.00008239556,0.000110026485,0.0004435146,0.000014417654],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022443589,0.0040926207,0.028981796,0.0006078875,0.00039383574,0.000053429136,0.0044596572,0.0000010980372,0.00009505418,0.010170456,0.048515413,0.90038437],"study_design_scores_gemma":[0.04142715,0.013703777,0.34208745,0.0016911331,0.00017116392,0.00019892165,0.0053881044,0.0027301046,0.00007794135,0.015607735,0.5764629,0.00045359466],"about_ca_topic_score_codex":0.0019009964,"about_ca_topic_score_gemma":0.0035224042,"teacher_disagreement_score":0.8999308,"about_ca_system_score_codex":0.00028740172,"about_ca_system_score_gemma":0.0013338276,"threshold_uncertainty_score":0.47065538},"labels":[],"label_agreement":null},{"id":"W2156774389","doi":"10.1185/030079904125003610","title":"Comparison of hospitalization rates in patients with community-acquired pneumonia treated with telithromycin for 5 or 7 days or clarithromycin for 10 days","year":2004,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Pneumonia and Respiratory Infections","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Zoo","funders":"","keywords":"Telithromycin; Medicine; Clarithromycin; Clinical endpoint; Internal medicine; Population; Community-acquired pneumonia; Pneumonia; Respiratory tract infections; Antibacterial agent; Randomized controlled trial; Antibiotics; Helicobacter pylori; Respiratory system","score_opus":0.14107474568794162,"score_gpt":0.4651035068709187,"score_spread":0.3240287611829771,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2156774389","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99355745,0.00023708331,0.0027276257,0.00082813913,0.000099932484,0.0024145322,0.00007956488,0.000030190165,0.000025480605],"genre_scores_gemma":[0.99807036,0.0002968824,0.0001719286,0.00003191299,0.00008026759,0.00034228578,0.0009435273,0.0000280996,0.000034743683],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978814,0.00019180054,0.0004407205,0.00027177154,0.0007756595,0.00043864665],"domain_scores_gemma":[0.99791986,0.00065221085,0.000104848776,0.0002550131,0.00069310673,0.0003749689],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006975544,0.00018203689,0.00052176655,0.0003030764,0.00034452777,0.000026460284,0.00013177117,0.00017594898,0.000044594068],"category_scores_gemma":[0.0010913848,0.00010028467,0.0000368691,0.00064905774,0.00055190193,0.00012115223,0.000052890817,0.00044822288,0.0000014432179],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014382109,0.009081226,0.9398488,0.0030916804,0.00013240655,0.0000046740556,0.0011157554,0.000030121728,0.00080938154,0.0004865848,0.00079509465,0.030222194],"study_design_scores_gemma":[0.03643993,0.05926079,0.878692,0.007273033,0.00006769292,0.000010822746,0.0013185507,0.0009875551,0.0027675394,0.0002617987,0.01257947,0.00034082436],"about_ca_topic_score_codex":0.00009883257,"about_ca_topic_score_gemma":0.0003293512,"teacher_disagreement_score":0.06115678,"about_ca_system_score_codex":0.00012903911,"about_ca_system_score_gemma":0.0007228225,"threshold_uncertainty_score":0.408949},"labels":[],"label_agreement":null},{"id":"W2157403060","doi":"10.1185/03007990802563706","title":"Economic evaluation of sorafenib in the treatment of hepatocellular carcinoma in Canada","year":2008,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; Ottawa Regional Cancer Foundation; Bayer (Canada)","funders":"","keywords":"Sorafenib; Medicine; Hepatocellular carcinoma; Internal medicine; Placebo; Christian ministry; Oncology; Economic evaluation; Pathology; Alternative medicine","score_opus":0.3126463337726336,"score_gpt":0.4002029687421255,"score_spread":0.0875566349694919,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2157403060","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98009443,0.018097382,9.96003e-7,0.00064585486,0.00011388383,0.0008649974,0.000009020785,0.0000012552102,0.00017216521],"genre_scores_gemma":[0.98795795,0.011756256,0.0000038725916,0.0000047384897,0.00007399286,0.00011417477,0.00008047278,0.0000050522253,0.0000034833279],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974368,0.00042424706,0.0003589221,0.00019315229,0.0013274521,0.00025939138],"domain_scores_gemma":[0.9991449,0.00033732093,0.00004376763,0.00019234701,0.00011219139,0.00016944532],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016116253,0.00009170467,0.0002841645,0.00019696816,0.000035836256,0.0000022727377,0.000089021836,0.00005545941,0.00013716775],"category_scores_gemma":[0.00019403147,0.00005896133,0.000043989236,0.00021929166,0.00017812157,0.000026895139,0.000018038727,0.00017636141,0.0000022711622],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000116284806,0.0005022801,0.9354333,0.00008741044,0.0000099458175,0.00005492535,0.0007020611,5.966944e-7,0.000013489889,0.000055017095,0.00018708974,0.06283758],"study_design_scores_gemma":[0.006047559,0.001480567,0.9381771,0.00029516543,0.000022033668,0.000030950043,0.00046571434,0.047253072,0.0020356304,0.00014064064,0.0039753527,0.000076198034],"about_ca_topic_score_codex":0.35530528,"about_ca_topic_score_gemma":0.16402918,"teacher_disagreement_score":0.19127612,"about_ca_system_score_codex":0.00067856105,"about_ca_system_score_gemma":0.00447432,"threshold_uncertainty_score":0.85122514},"labels":[],"label_agreement":null},{"id":"W2158832244","doi":"10.1185/030079903125002108","title":"Switching treatment-resistant patients with schizophrenia or schizoaffective disorder to olanzapine: a one-year open-label study with five-year follow-up","year":2003,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"Memorial University of Newfoundland; Eli Lilly and Company","keywords":"Medicine; Olanzapine; Schizoaffective disorder; Schizophrenia (object-oriented programming); Open label; Psychiatry; Atypical antipsychotic; Open label study; Pediatrics; Internal medicine; Psychosis; Antipsychotic; Clinical trial; Adverse effect","score_opus":0.08683636340195997,"score_gpt":0.41204852826089233,"score_spread":0.32521216485893234,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2158832244","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9907301,0.0009442782,0.0001451889,0.0007916736,0.00019603242,0.0067554475,0.00005044495,0.000058710186,0.0003281186],"genre_scores_gemma":[0.9954867,0.00085747003,0.0016399411,0.000031349882,0.00017521925,0.0011228414,0.00015241289,0.00007833375,0.0004557845],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9931501,0.0006812422,0.0003918845,0.0011576784,0.0033931686,0.0012259268],"domain_scores_gemma":[0.9954732,0.0006251316,0.00007302503,0.00069122366,0.0006670197,0.0024703962],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0012465249,0.00047212883,0.0007670954,0.00052323437,0.00066243776,0.00028214662,0.0003912675,0.000125814,0.00035132768],"category_scores_gemma":[0.0024049622,0.00025554973,0.00004867249,0.001247375,0.00025210556,0.0002564746,0.00035820785,0.0009717435,0.000119052245],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.43450332,0.035105284,0.2937702,0.00023679451,0.0012168171,0.00020093123,0.0010650103,3.649294e-7,0.000016426831,0.0026532195,0.0010565687,0.23017506],"study_design_scores_gemma":[0.380484,0.17607744,0.42665297,0.0037388613,0.00020232626,0.00002696583,0.0027531998,0.000054610024,0.00011128239,0.00043390944,0.008648231,0.0008161946],"about_ca_topic_score_codex":0.00055642246,"about_ca_topic_score_gemma":0.0026853164,"teacher_disagreement_score":0.22935887,"about_ca_system_score_codex":0.00041550977,"about_ca_system_score_gemma":0.0023436495,"threshold_uncertainty_score":0.9999897},"labels":[],"label_agreement":null},{"id":"W2160686867","doi":"10.1185/03007990802537122","title":"Effects of tolterodine extended release on patient perception of bladder condition and overactive bladder symptoms","year":2008,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; University of Toronto","funders":"","keywords":"Tolterodine; Medicine; Overactive bladder; Urology; Urinary bladder","score_opus":0.04857267151701749,"score_gpt":0.4073395634564596,"score_spread":0.3587668919394421,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2160686867","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943786,0.003627488,0.000062811465,0.00050809025,0.00015139733,0.0008063171,0.000022155573,0.00001182604,0.00043129333],"genre_scores_gemma":[0.97379553,0.02577127,0.000015424475,0.000028212999,0.0001522626,0.000047249796,0.00012554135,0.000012678571,0.000051801595],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9968042,0.00032633755,0.00031398138,0.00034752645,0.0018397878,0.00036817262],"domain_scores_gemma":[0.99785715,0.0009024174,0.00006449901,0.00016723285,0.00039387416,0.00061484304],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005543224,0.00013678904,0.00031825335,0.0003287323,0.00012978794,0.00000707278,0.000062275976,0.00012575426,0.00039290922],"category_scores_gemma":[0.0013661373,0.0001025493,0.00005252732,0.00023996765,0.00086147006,0.0001043966,0.00011888124,0.00071600033,0.000013321572],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011394847,0.00786809,0.013226421,0.0055221817,0.00033583783,0.00029457218,0.003951005,7.691389e-7,0.023320695,0.00089085475,0.016574666,0.9166201],"study_design_scores_gemma":[0.011646106,0.034492724,0.9122691,0.004070839,0.000052586074,0.000317233,0.0005914196,0.0016605367,0.026843293,0.0010209737,0.006716223,0.00031893994],"about_ca_topic_score_codex":0.000039692073,"about_ca_topic_score_gemma":5.895585e-7,"teacher_disagreement_score":0.91630113,"about_ca_system_score_codex":0.000050070652,"about_ca_system_score_gemma":0.00026209015,"threshold_uncertainty_score":0.43020803},"labels":[],"label_agreement":null},{"id":"W2161354785","doi":"10.1185/03007995.2015.1107534","title":"Burden of symptomatic uterine fibroids in Canadian women: a cohort study","year":2015,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Uterine Myomas and Treatments","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Western University; Université Laval","funders":"","keywords":"Medicine; Quality of life (healthcare); Cohort; Cohort study; Physical therapy; Internal medicine; Pediatrics","score_opus":0.09225413330101942,"score_gpt":0.4494602623844802,"score_spread":0.35720612908346083,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2161354785","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966609,0.00081717735,0.0000019564357,0.0010455888,0.00019664137,0.00075001665,0.000007205029,0.000008055369,0.00051246246],"genre_scores_gemma":[0.9989907,0.0005467513,0.00001251004,0.000009295406,0.00015271944,0.00012000698,0.000036806578,0.000007986597,0.00012318829],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997761,0.00012030417,0.0002543069,0.00021663765,0.0011409345,0.0005067793],"domain_scores_gemma":[0.997718,0.00007678965,0.000019864805,0.00020104116,0.00013800035,0.0018463205],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016958385,0.00008941174,0.00029212487,0.00035781824,0.000030103804,0.000012351786,0.000096051124,0.00005366676,0.00020362796],"category_scores_gemma":[0.00092495675,0.00006563896,0.000016050186,0.00031824998,0.00013227103,0.00004019938,0.00011604089,0.00028064684,0.00001845731],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014188582,0.00072863215,0.9581711,0.00027457825,0.000046793255,0.0001447945,0.0015738753,1.1490875e-7,0.000004029576,0.00007768582,0.0009472407,0.037889246],"study_design_scores_gemma":[0.0076799416,0.0064668274,0.9370272,0.0009976075,0.0000074777254,0.000053004107,0.0016187697,0.0015929268,0.000011561787,0.000321303,0.044106476,0.000116909076],"about_ca_topic_score_codex":0.049506612,"about_ca_topic_score_gemma":0.0053980537,"teacher_disagreement_score":0.04410856,"about_ca_system_score_codex":0.0003130036,"about_ca_system_score_gemma":0.0010868618,"threshold_uncertainty_score":0.9568228},"labels":[],"label_agreement":null},{"id":"W2165140611","doi":"10.1185/030079906x162674","title":"Randomized study of tramadol/acetaminophen versus placebo in painful diabetic peripheral neuropathy","year":2006,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Pain Mechanisms and Treatments","field":"Medicine","cited_by":109,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"McGill University","keywords":"Medicine; Tramadol; Acetaminophen; Peripheral neuropathy; Placebo; Randomized controlled trial; Peripheral; Diabetic neuropathy; Anesthesia; Internal medicine; Diabetes mellitus; Analgesic","score_opus":0.09226693513633698,"score_gpt":0.4176050997037606,"score_spread":0.3253381645674236,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2165140611","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939584,0.0030751284,0.000079829835,0.00035754844,0.00044775766,0.0016605117,0.0000025215315,0.00001567923,0.00040262553],"genre_scores_gemma":[0.9984119,0.00108123,0.000025105142,0.000008438089,0.00019820993,0.00016436493,0.000036213118,0.000012682289,0.000061886036],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9963409,0.0010434792,0.00042340628,0.00032584008,0.0014292072,0.0004372107],"domain_scores_gemma":[0.9980618,0.0012507775,0.000047823574,0.00019794433,0.000102309335,0.00033938052],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003296041,0.00014140642,0.0005770508,0.00023085321,0.00006622358,0.000016633054,0.0001041383,0.000085220614,0.0001266802],"category_scores_gemma":[0.0021889638,0.00009949099,0.00006617985,0.00029156797,0.0002822508,0.00003990489,0.00008516776,0.00053696136,0.0000063100492],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.46806467,0.028942583,0.12979822,0.00144362,0.00029328724,0.00066421187,0.0030965013,0.000006846918,0.00039654277,0.0037132762,0.0017359164,0.36184433],"study_design_scores_gemma":[0.9247309,0.006336272,0.058723465,0.0008547559,0.000050494054,0.000008076551,0.00091110455,0.0057446957,0.00012493208,0.001159268,0.0011761319,0.00017988712],"about_ca_topic_score_codex":0.00026969903,"about_ca_topic_score_gemma":0.00004757554,"teacher_disagreement_score":0.45666626,"about_ca_system_score_codex":0.00006597284,"about_ca_system_score_gemma":0.00016829322,"threshold_uncertainty_score":0.4057125},"labels":[],"label_agreement":null},{"id":"W2167248921","doi":"10.1185/030079906x167381","title":"Effect of inhaled insulin on patient-reported outcomes and treatment preference in patients with type 1 diabetes","year":2007,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Inhalation and Respiratory Drug Delivery","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Pfizer; Eli Lilly and Company","keywords":"Medicine; Insulin; Diabetes mellitus; Crossover study; Insulin glargine; Context (archaeology); Type 2 diabetes; Insulin pen; Internal medicine; Type 1 diabetes; Endocrinology; Pediatrics; Placebo","score_opus":0.06424815007399848,"score_gpt":0.39263409689443585,"score_spread":0.32838594682043737,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2167248921","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981933,0.00082073297,0.0000013920575,0.00006930128,0.00014257662,0.000620518,0.0000023212788,0.000007920315,0.00014194236],"genre_scores_gemma":[0.99933654,0.00053397135,0.0000041559847,0.000021008786,0.000029803003,0.000011668895,0.000046409055,0.0000060515895,0.000010414362],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982613,0.00015123413,0.00026205467,0.00020286265,0.00087615487,0.00024644166],"domain_scores_gemma":[0.99873704,0.00060549047,0.00004993009,0.00012038453,0.00017770557,0.00030945305],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009111173,0.00010384752,0.0002569577,0.00026386973,0.00003993759,0.0000057525485,0.000029809697,0.000082450315,0.00003444688],"category_scores_gemma":[0.0012440236,0.00005544108,0.00001666295,0.00023480316,0.00020077288,0.000030624098,0.000034883033,0.0002711497,0.000003587515],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014317787,0.00044954114,0.6316917,0.00011486023,0.00001621115,0.000009374764,0.00007330294,5.8442314e-8,0.00000910672,0.000008634992,0.0000278614,0.36616758],"study_design_scores_gemma":[0.008436572,0.016896527,0.9703548,0.00096179027,0.000008261068,0.0000010976349,0.000016864333,0.00005681466,0.0020037587,0.000003876072,0.001191492,0.00006815907],"about_ca_topic_score_codex":0.000009312735,"about_ca_topic_score_gemma":0.000006272919,"teacher_disagreement_score":0.36609942,"about_ca_system_score_codex":0.0000546044,"about_ca_system_score_gemma":0.00011318324,"threshold_uncertainty_score":0.22608216},"labels":[],"label_agreement":null},{"id":"W2167525817","doi":"10.1185/03007995.2014.982246","title":"Contemporary management of uterine fibroids: focus on emerging medical treatments","year":2014,"lang":"en","type":"review","venue":"Current Medical Research and Opinion","topic":"Uterine Myomas and Treatments","field":"Medicine","cited_by":121,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary; Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Ulipristal acetate; Hysterectomy; Uterine artery embolization; Uterine fibroids; Leiomyoma; Endometrial ablation; Cochrane Library; Systematic review; Watchful waiting; Review article; Intensive care medicine; General surgery; MEDLINE; Surgery; Randomized controlled trial; Population; Internal medicine; Family planning; Pathology; Cancer","score_opus":0.22801679799897245,"score_gpt":0.5297126304550334,"score_spread":0.3016958324560609,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2167525817","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007828857,0.99210554,0.000043491913,0.00081322965,0.00069673173,0.0014474471,0.000057807156,0.00003523686,0.0047222343],"genre_scores_gemma":[0.00077958236,0.9968051,0.00004183896,0.000014957635,0.0006133919,0.00026409904,0.00071204925,0.00005305219,0.00071596756],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99376565,0.0003876075,0.0009560309,0.00073970295,0.0035349089,0.000616118],"domain_scores_gemma":[0.99718785,0.00048012758,0.00019095038,0.0005868986,0.00010921812,0.0014449531],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0014025614,0.00046583082,0.0019444382,0.0005022608,0.00010536329,0.000022103115,0.0003374647,0.00038821818,0.0007818965],"category_scores_gemma":[0.00035069842,0.00029202353,0.0003428467,0.00039081156,0.00037488816,0.000039475624,0.0005795264,0.0010717545,0.00011147338],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012637702,0.0010387087,0.000053450884,0.049091186,0.0006494726,0.00042755925,0.000010665211,1.0609006e-9,1.9361467e-8,0.0007468218,0.0074653383,0.9403904],"study_design_scores_gemma":[0.002726534,0.0022335616,0.000084376836,0.10994905,0.0001133998,0.000087633096,0.000008010303,0.00001953434,0.0000011398572,0.00009726973,0.88451904,0.0001604304],"about_ca_topic_score_codex":0.000034309676,"about_ca_topic_score_gemma":6.4096633e-7,"teacher_disagreement_score":0.94022995,"about_ca_system_score_codex":0.0001502899,"about_ca_system_score_gemma":0.00063835614,"threshold_uncertainty_score":0.9999532},"labels":[],"label_agreement":null},{"id":"W2169369869","doi":"10.1185/030079907x199655","title":"Comment on: The relative dosing of epoetin alfa and darbepoetin alfa in chronic kidney disease","year":2007,"lang":"en","type":"letter","venue":"Current Medical Research and Opinion","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Montréal; PharmIdeas (Canada)","funders":"Amgen","keywords":"Medicine; Darbepoetin alfa; Epoetin alfa; Dosing; Kidney disease; Internal medicine; Erythropoietin","score_opus":0.23062913471945348,"score_gpt":0.4338414552437033,"score_spread":0.20321232052424984,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2169369869","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0008913585,0.030495452,0.00008260579,0.96133393,0.00064981624,0.0005818908,0.00050519337,0.0000063598122,0.0054533794],"genre_scores_gemma":[0.057556853,0.18827091,0.00002818054,0.74560946,0.0070024934,0.00021549307,0.0009606748,0.00011193087,0.00024401951],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9972542,0.00022184172,0.0008510957,0.000603934,0.00030660295,0.00076231884],"domain_scores_gemma":[0.9966323,0.0019854023,0.0002386313,0.00035572704,0.0000423999,0.0007455338],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0044953055,0.00024256944,0.0005320308,0.00052206044,0.00015163266,0.000076690136,0.00040795017,0.00037286786,0.0005635479],"category_scores_gemma":[0.002911774,0.00020036969,0.00009219454,0.000263845,0.00092048995,0.00007496187,0.00032073385,0.0037789769,0.0000822356],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007227092,0.00009961322,0.0009841688,0.0005504913,0.000032137024,0.000016237935,0.00011189822,3.2787784e-7,2.712374e-7,0.09344596,0.8926325,0.012054144],"study_design_scores_gemma":[0.0007818649,0.00017539132,0.0006649739,0.0010711254,0.0000025927677,0.0000012130757,0.0000064021615,0.0018849067,0.0000054309876,0.04570972,0.94950956,0.00018680983],"about_ca_topic_score_codex":0.00014676755,"about_ca_topic_score_gemma":0.0000062280265,"teacher_disagreement_score":0.2157245,"about_ca_system_score_codex":0.0003636546,"about_ca_system_score_gemma":0.00038856454,"threshold_uncertainty_score":0.99851936},"labels":[],"label_agreement":null},{"id":"W2180653297","doi":"10.1185/03007995.2015.1119677","title":"Understanding adherence to medications in type 2 diabetes care and clinical trials to overcome barriers: a narrative review","year":2015,"lang":"en","type":"review","venue":"Current Medical Research and Opinion","topic":"Medication Adherence and Compliance","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Winnipeg Regional Health Authority; Health Sciences Centre; University of Manitoba","funders":"","keywords":"Medicine; Polypharmacy; Glycemic; MEDLINE; Type 2 diabetes; Psychological intervention; Clinical trial; Pharmacy; Family medicine; Health care; Medication adherence; PsycINFO; Patient education; Intensive care medicine; Diabetes mellitus; Nursing; Internal medicine","score_opus":0.8216353992386789,"score_gpt":0.674231368889912,"score_spread":0.14740403034876692,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2180653297","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000026858852,0.9907074,0.00007582882,0.003878933,0.0009168274,0.0039479653,0.000041748295,0.000021054339,0.00038341235],"genre_scores_gemma":[0.000059511953,0.9976979,0.000065842716,0.0005164636,0.0006187118,0.00065794337,0.0002801253,0.000021716694,0.00008181836],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9918903,0.0027520058,0.0017444559,0.0008624471,0.0021595503,0.0005912122],"domain_scores_gemma":[0.9900569,0.003741194,0.00027272367,0.0005691412,0.00067516917,0.0046848822],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.018551035,0.00031437486,0.0027481131,0.00050976354,0.00013602128,0.00004595075,0.0004014743,0.00038893236,0.00090535195],"category_scores_gemma":[0.07875376,0.00021795368,0.00015885638,0.0016761208,0.0004574739,0.000069687594,0.00037412392,0.0019827324,0.0006286069],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000029542898,0.00005937341,0.00025528704,0.027783012,0.000047222147,0.000005089685,0.0004421593,1.6582167e-9,2.7557418e-8,0.00018504259,0.12269415,0.84849906],"study_design_scores_gemma":[0.00052000995,0.0013392867,0.000041356812,0.24018647,0.000090506655,0.0000061687288,0.0008670691,0.00000671183,2.9922777e-8,0.00017490447,0.7566148,0.0001527099],"about_ca_topic_score_codex":0.000009943709,"about_ca_topic_score_gemma":0.000013241497,"teacher_disagreement_score":0.84834635,"about_ca_system_score_codex":0.00043909272,"about_ca_system_score_gemma":0.005448523,"threshold_uncertainty_score":0.9912969},"labels":[],"label_agreement":null},{"id":"W2181767505","doi":"10.1185/030079904x3285","title":"Risk factors for osteoporosis","year":2004,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Bone health and osteoporosis research","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Osteoporosis Canada","funders":"","keywords":"Medicine; Osteoporosis; Intensive care medicine; Internal medicine","score_opus":0.14192424243388757,"score_gpt":0.48032555789161774,"score_spread":0.33840131545773017,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2181767505","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9723317,0.012292891,0.00086777477,0.011078744,0.00091239763,0.0019706748,0.00008044072,0.000070313974,0.00039506485],"genre_scores_gemma":[0.95977706,0.038146228,0.00032821367,0.00011876752,0.0009312089,0.0002338326,0.00030103727,0.00003192768,0.00013173178],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9961326,0.00012203375,0.00033303027,0.00043678546,0.0020178936,0.0009576389],"domain_scores_gemma":[0.99603355,0.0010110792,0.000041226183,0.00026191148,0.00044165616,0.0022105528],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.002574233,0.00014074756,0.00030423814,0.00028317593,0.00045375983,0.000041161595,0.00014894735,0.00020951682,0.00020539512],"category_scores_gemma":[0.009252013,0.00009978043,0.0000911695,0.00038718284,0.00048594846,0.00007682001,0.00013523841,0.0012311587,0.00004884612],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016292228,0.0017122397,0.086429946,0.002400022,0.00005233669,0.000013706669,0.0011431902,5.8146384e-7,0.00017142842,0.004501783,0.025467481,0.8764781],"study_design_scores_gemma":[0.018289704,0.010400298,0.23214598,0.0024776773,0.000028491933,0.00004937482,0.0016897297,0.00047407753,0.00258864,0.013201846,0.7182242,0.0004299375],"about_ca_topic_score_codex":0.00032498818,"about_ca_topic_score_gemma":0.00003624878,"teacher_disagreement_score":0.87604815,"about_ca_system_score_codex":0.0001541638,"about_ca_system_score_gemma":0.0012976152,"threshold_uncertainty_score":0.9990935},"labels":[],"label_agreement":null},{"id":"W2192762816","doi":"10.1185/03007995.2015.1112772","title":"Efficacy and safety of low-dose SoluMatrix meloxicam in the treatment of osteoarthritis pain: a 12-week, phase 3 study","year":2015,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Meloxicam; Osteoarthritis; WOMAC; Acetaminophen; Placebo; Discontinuation; Adverse effect; Randomized controlled trial; Internal medicine; Anesthesia; Physical therapy","score_opus":0.1321570508707899,"score_gpt":0.4473242269642781,"score_spread":0.3151671760934882,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2192762816","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98465055,0.012681399,0.000015214889,0.0005643995,0.00022221176,0.0017763171,0.000008995661,0.000006737684,0.00007415046],"genre_scores_gemma":[0.9908356,0.008725351,0.0000063724024,0.00001129495,0.000285751,0.00008639812,0.000032571144,0.000008163932,0.000008493286],"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99663985,0.0009339849,0.00042387767,0.00024043155,0.001424399,0.00033746628],"domain_scores_gemma":[0.9976633,0.0012979647,0.000057569297,0.00025059335,0.00014930956,0.00058125675],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005642373,0.00012625243,0.00042159803,0.00018785823,0.00006231375,0.000010256631,0.000103830665,0.00008667097,0.000028227685],"category_scores_gemma":[0.00276054,0.00007471696,0.000040830415,0.00024897567,0.00044333903,0.000038641094,0.000056970806,0.00032073923,0.0000029483838],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005334838,0.012153955,0.022599427,0.00060142553,0.00003227266,0.00010962378,0.0086878175,9.43201e-8,0.00006772773,0.00008346468,0.0012033317,0.949126],"study_design_scores_gemma":[0.3144739,0.32342613,0.20268497,0.008611698,0.00011704549,0.00012643333,0.015950015,0.0026924051,0.001437981,0.00042623884,0.12946226,0.0005909279],"about_ca_topic_score_codex":0.00006587142,"about_ca_topic_score_gemma":0.000040437444,"teacher_disagreement_score":0.9485351,"about_ca_system_score_codex":0.00005153127,"about_ca_system_score_gemma":0.00038184895,"threshold_uncertainty_score":0.33048236},"labels":[],"label_agreement":null},{"id":"W2201330237","doi":"10.1185/03007995.2015.1123145","title":"A review of aripiprazole long-acting injection","year":2015,"lang":"en","type":"review","venue":"Current Medical Research and Opinion","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Robarts Clinical Trials; University of Alberta","funders":"New Mexico State University; Bristol-Myers Squibb","keywords":"Aripiprazole; Medicine; Tolerability; Antipsychotic; Schizophrenia (object-oriented programming); Placebo; Atypical antipsychotic; Psychiatry; Adverse effect; Pharmacology; Alternative medicine","score_opus":0.36827171712688916,"score_gpt":0.5696753129102482,"score_spread":0.20140359578335904,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2201330237","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000029021157,0.99661267,0.000026462692,0.00038093518,0.0005087711,0.0018005392,0.000025485642,0.000025461704,0.000616749],"genre_scores_gemma":[0.000004197686,0.99798334,0.00004897921,0.000017963004,0.0008418984,0.0002605819,0.0007543659,0.000032673477,0.000055991062],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9942054,0.00066448795,0.00087072764,0.00053435744,0.003092605,0.00063240156],"domain_scores_gemma":[0.99615854,0.0007085619,0.00021377283,0.00047153386,0.0007733284,0.001674289],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0054545673,0.00029818152,0.0017824741,0.00060153904,0.00009917143,0.000024329422,0.0002322607,0.0003138162,0.00037057605],"category_scores_gemma":[0.008658092,0.00019146012,0.0002964782,0.0010551193,0.00039421776,0.000065113156,0.00035840803,0.0021975935,0.00011795915],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015759723,0.00026140705,0.000013712587,0.2511669,0.00008213302,0.00002671224,0.000006764917,4.7698995e-10,6.6790715e-9,0.00008464235,0.012899157,0.73530096],"study_design_scores_gemma":[0.00064432324,0.0008028668,0.000008307543,0.35088494,0.00008645712,0.00019590641,0.000005999393,0.0000045070283,2.8618265e-7,0.000064372536,0.6472209,0.00008109868],"about_ca_topic_score_codex":0.00004866324,"about_ca_topic_score_gemma":0.000008372401,"teacher_disagreement_score":0.7352199,"about_ca_system_score_codex":0.00031755303,"about_ca_system_score_gemma":0.0054968316,"threshold_uncertainty_score":0.9996924},"labels":[],"label_agreement":null},{"id":"W2234278652","doi":"10.1185/03007995.2016.1140030","title":"Treatment patterns, overall survival, healthcare resource use and costs in elderly Medicare beneficiaries with chronic myeloid leukemia using second-generation tyrosine kinase inhibitors as second-line therapy","year":2016,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Nilotinib; Medicine; Dasatinib; Hazard ratio; Internal medicine; Myeloid leukemia; Imatinib; Medicare Advantage; Medicare Part D; Emergency medicine; Health care; Medical prescription; Confidence interval; Pharmacology; Prescription drug","score_opus":0.11388979774079895,"score_gpt":0.3880523490510253,"score_spread":0.2741625513102264,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2234278652","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9633861,0.030416213,0.000038653427,0.0044797026,0.00030551045,0.0011964379,0.00012422715,0.000039533174,0.000013631476],"genre_scores_gemma":[0.94962424,0.04829278,0.000027776432,0.000094861454,0.0010993702,0.000113009715,0.0005707132,0.000050884108,0.00012636752],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9955936,0.00047491302,0.00054923125,0.0008556472,0.0016536406,0.00087296806],"domain_scores_gemma":[0.9973548,0.00072217366,0.00011478272,0.00044095883,0.00026193354,0.001105357],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008528278,0.00039583474,0.0005855384,0.00036350606,0.00026092984,0.00009957548,0.00011786619,0.0003087725,0.00047833714],"category_scores_gemma":[0.0005562542,0.00023573345,0.00005332437,0.00028325303,0.00041905823,0.00029044182,0.00012773093,0.0006610479,0.0000063896337],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019515168,0.000504595,0.11727227,0.0005502699,0.000119165095,0.00024948703,0.00055177335,0.0000012464377,0.003392319,0.00024734088,0.00075037,0.8744096],"study_design_scores_gemma":[0.1683556,0.07375668,0.349882,0.04308194,0.0001325314,0.001191066,0.0012873006,0.006733107,0.041039377,0.0002843175,0.31180713,0.0024489346],"about_ca_topic_score_codex":0.0028488645,"about_ca_topic_score_gemma":0.0116227055,"teacher_disagreement_score":0.8719607,"about_ca_system_score_codex":0.0050597587,"about_ca_system_score_gemma":0.003620271,"threshold_uncertainty_score":0.9987596},"labels":[],"label_agreement":null},{"id":"W2320257141","doi":"10.1185/03007995.2013.852525","title":"Risk factors associated with myocardial infarction in venous thromboembolism patients","year":2013,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Medicine; Venous thromboembolism; Myocardial infarction; Population; Internal medicine; Intensive care medicine; Risk factor; Risk assessment; Cardiology; Thrombosis","score_opus":0.06071674484127297,"score_gpt":0.3625028343006414,"score_spread":0.3017860894593684,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2320257141","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99609053,0.0007568894,0.00001708862,0.0006984587,0.00055965077,0.001148324,0.000009518637,0.00003557546,0.000683949],"genre_scores_gemma":[0.99177045,0.0075242976,0.0000049152154,0.00006217866,0.00021973783,0.00014162045,0.00024500903,0.000019223322,0.000012560695],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99676126,0.00025340638,0.00028246394,0.00036835135,0.0017127637,0.00062173454],"domain_scores_gemma":[0.9984954,0.00032637978,0.00006636927,0.0001925743,0.0003095877,0.00060968066],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00092612696,0.00016040729,0.00047092343,0.00031796252,0.00017560604,0.000055226064,0.000111626585,0.00015312909,0.0003561402],"category_scores_gemma":[0.0021812262,0.00011050885,0.00005557522,0.0004374168,0.00027233348,0.00015402846,0.0001480681,0.0009186544,0.00004922527],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000057697674,0.004456199,0.8135393,0.0001362441,0.00018868092,0.0000041921003,0.0007840154,0.0000012631534,0.0000045322786,0.00030708002,0.015801786,0.164719],"study_design_scores_gemma":[0.0023692707,0.0016639523,0.9876119,0.00071795366,0.00002257648,4.651126e-7,0.00017483866,0.00020053641,0.000008013016,0.00049816346,0.006616698,0.000115637326],"about_ca_topic_score_codex":0.001046783,"about_ca_topic_score_gemma":0.00007130717,"teacher_disagreement_score":0.17407258,"about_ca_system_score_codex":0.00017630881,"about_ca_system_score_gemma":0.00017523636,"threshold_uncertainty_score":0.45064202},"labels":[],"label_agreement":null},{"id":"W2348253579","doi":"10.1080/03007995.2016.1190325","title":"Risk factors associated with treatment discontinuation and down-titration in type 2 diabetes patients treated with sulfonylureas","year":2016,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Diabetes Management and Research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Discontinuation; Medicine; Hypoglycemia; Sulfonylurea; Hazard ratio; Internal medicine; Diabetes mellitus; Type 2 diabetes; Retrospective cohort study; Insulin; Endocrinology; Confidence interval","score_opus":0.06569403585936662,"score_gpt":0.366007461864272,"score_spread":0.3003134260049054,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2348253579","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976849,0.00062486745,0.000009691935,0.0006635513,0.000052416668,0.00074555055,0.000014506477,0.0000206244,0.00018391354],"genre_scores_gemma":[0.9955225,0.0037290629,0.0000032230535,0.0000037214668,0.000056798446,0.000046692745,0.00038446533,0.000012485161,0.00024105643],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99773103,0.0002340865,0.00016921428,0.00032570053,0.0010918151,0.0004481726],"domain_scores_gemma":[0.9986929,0.00049508904,0.00004872696,0.00012371063,0.00025418363,0.00038534048],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007394985,0.00013999183,0.00022830807,0.00028629255,0.00010551903,0.000043664728,0.000051652678,0.00008559944,0.000069990216],"category_scores_gemma":[0.0014252249,0.00006111943,0.000015165766,0.00042795707,0.00034198185,0.00015175849,0.000045978966,0.0002074554,0.0000041798758],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026700736,0.00062441087,0.75391877,0.000025368716,0.00005132133,0.0000017730749,0.00006217706,3.2566675e-8,0.000016067659,0.000036565973,0.00019251936,0.244804],"study_design_scores_gemma":[0.0061133034,0.006045383,0.98408616,0.001331622,0.000019979963,6.4706825e-8,0.000036462083,0.000224182,0.00017661702,0.000052329164,0.0018192374,0.0000946931],"about_ca_topic_score_codex":0.000052978052,"about_ca_topic_score_gemma":0.00018362224,"teacher_disagreement_score":0.2447093,"about_ca_system_score_codex":0.00015052069,"about_ca_system_score_gemma":0.00012803997,"threshold_uncertainty_score":0.2492378},"labels":[],"label_agreement":null},{"id":"W2498107952","doi":"10.1080/03007995.2016.1220934","title":"Association between time to progression and subsequent survival inceritinib-treated patients with advanced ALK-positive non-small-cell lung cancer","year":2016,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Ceritinib; Hazard ratio; Internal medicine; Proportional hazards model; Confidence interval; Lung cancer; Anaplastic lymphoma kinase; Oncology; Gastroenterology; Surgery","score_opus":0.027203361286943395,"score_gpt":0.4169194016918633,"score_spread":0.3897160404049199,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2498107952","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99073964,0.0017044593,0.00013895573,0.004825648,0.00014396299,0.0016463794,0.00018450934,0.000027778744,0.0005886491],"genre_scores_gemma":[0.99431497,0.00351946,0.00009561984,0.00003902023,0.00033967415,0.00039183747,0.00045847613,0.000026113134,0.0008148543],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976846,0.00011853788,0.00019767525,0.0003867635,0.0011678307,0.00044457908],"domain_scores_gemma":[0.99811655,0.0003807922,0.00006662478,0.000114324066,0.0005382591,0.0007834257],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043883183,0.00014487011,0.0002529594,0.00012553617,0.00017487255,0.000029522686,0.000060521015,0.000102891696,0.00018730182],"category_scores_gemma":[0.0003251039,0.00008091237,0.0000209172,0.00023890565,0.00010337435,0.00010287496,0.00009765794,0.00023398243,0.000019857694],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034200767,0.00026609702,0.64905894,0.00012634996,0.00009700782,0.0000034647692,0.00015287404,3.6424375e-8,0.00013145673,0.000005101174,0.0015228757,0.34829378],"study_design_scores_gemma":[0.009341068,0.002277558,0.96976185,0.0050171507,0.000105326224,6.5690915e-7,0.000027301396,0.000038526534,0.0010557172,0.000014653616,0.012187272,0.00017290097],"about_ca_topic_score_codex":0.00006217027,"about_ca_topic_score_gemma":0.000016694443,"teacher_disagreement_score":0.34812087,"about_ca_system_score_codex":0.0005127004,"about_ca_system_score_gemma":0.0003909134,"threshold_uncertainty_score":0.32995105},"labels":[],"label_agreement":null},{"id":"W2545262119","doi":"10.1080/03007995.2016.1255185","title":"A meta-analysis of the efficacy of venlafaxine extended release 75–225 mg/day for the treatment of major depressive disorder","year":2016,"lang":"en","type":"review","venue":"Current Medical Research and Opinion","topic":"Treatment of Major Depression","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pfizer (Canada)","funders":"","keywords":"Medicine; Venlafaxine; Tolerability; Major depressive disorder; Placebo; Internal medicine; Adverse effect; Hamilton Rating Scale for Depression; Antidepressant","score_opus":0.30237590550256815,"score_gpt":0.5163051105067888,"score_spread":0.2139292050042207,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2545262119","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00014574973,0.99389464,0.00024724068,0.000950621,0.00027300607,0.0038390853,0.0006188322,0.000007768242,0.000023085977],"genre_scores_gemma":[0.0016793454,0.99645346,0.000021604066,0.000003248244,0.00020834342,0.0009365233,0.0003045709,0.000034310615,0.00035859595],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9945247,0.000959804,0.0011332426,0.00059868675,0.0023354269,0.00044812614],"domain_scores_gemma":[0.98719865,0.009950354,0.0006954843,0.0012936748,0.0004643009,0.00039752643],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015573265,0.0004034095,0.003535565,0.0005114997,0.00014631117,0.000009018557,0.00052993716,0.0002953834,0.0004753738],"category_scores_gemma":[0.0042037102,0.00013713565,0.0031098411,0.0009332812,0.0009548511,0.000030174808,0.00023676158,0.00041284863,0.0000033135077],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000349528,0.0025809966,0.00007364251,0.006601592,0.052789014,0.0000026707148,0.00008239177,1.5913992e-7,0.000002454343,0.00014728206,0.00062918355,0.9367411],"study_design_scores_gemma":[0.0049597477,0.0017758018,0.0011824864,0.009531348,0.16770083,0.000005186728,0.000017544113,0.00006713036,0.000065670894,0.00008350922,0.81446964,0.00014109936],"about_ca_topic_score_codex":0.0000621242,"about_ca_topic_score_gemma":0.00001201484,"teacher_disagreement_score":0.93659997,"about_ca_system_score_codex":0.00011231552,"about_ca_system_score_gemma":0.0007646916,"threshold_uncertainty_score":0.55922294},"labels":[],"label_agreement":null},{"id":"W2547724305","doi":"10.1080/03007995.2016.1257977","title":"Systematic literature review of the health economic implications of early detection by screening populations at risk for type 2 diabetes","year":2016,"lang":"en","type":"review","venue":"Current Medical Research and Opinion","topic":"Diabetes, Cardiovascular Risks, and Lipoproteins","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Type 2 diabetes; Cost effectiveness; Psychological intervention; MEDLINE; Diabetes mellitus; Scopus; Cost–benefit analysis; Intensive care medicine; Risk analysis (engineering); Psychiatry","score_opus":0.14747198322079405,"score_gpt":0.47129848790238665,"score_spread":0.3238265046815926,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2547724305","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000047619706,0.99331516,0.00034476802,0.00041335955,0.0004942808,0.0047293385,0.0006350233,0.000010094741,0.000010363962],"genre_scores_gemma":[0.00009390405,0.9983321,0.00002932638,0.000013810109,0.00034719508,0.000607431,0.00051049795,0.00002767066,0.000038052356],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9966045,0.0009555316,0.0010136596,0.00034369572,0.0007329726,0.0003496242],"domain_scores_gemma":[0.9971849,0.0008164894,0.00062158616,0.0006613331,0.00036507708,0.00035066597],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0043058307,0.00019467494,0.0017833257,0.00019224934,0.0002206566,0.000015919331,0.00024670095,0.00021238752,0.000023125976],"category_scores_gemma":[0.0043963147,0.00010375621,0.0006607695,0.00040583077,0.00021924995,0.00004615133,0.00015026286,0.0005844396,0.0000063584403],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000004601403,0.000020507117,0.000034431137,0.4208202,0.00011229852,1.5067805e-8,0.000006914221,2.222596e-9,7.4801044e-8,0.00003248959,0.002068996,0.57689947],"study_design_scores_gemma":[0.00021763962,0.00028226213,0.0002443661,0.5986312,0.00019758347,0.00000422042,0.0000013679604,0.000005435128,0.0000016539075,0.00005516143,0.40029958,0.000059526694],"about_ca_topic_score_codex":0.000076274686,"about_ca_topic_score_gemma":0.000028453258,"teacher_disagreement_score":0.5768399,"about_ca_system_score_codex":0.00019039687,"about_ca_system_score_gemma":0.000546567,"threshold_uncertainty_score":0.5263117},"labels":[],"label_agreement":null},{"id":"W2590491310","doi":"10.1080/03007995.2017.1300142","title":"The content validation of the Self-Reported Misuse, Abuse and Diversion of Prescription Opioids (SR-MAD) instrument for use in patients with acute or chronic pain","year":2017,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Opioid Use Disorder Treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Chronic pain; Content validity; Medical prescription; Opioid; Psychiatry; Cognition; Cognitive interview; Clinical psychology; Physical therapy; Psychometrics; Internal medicine","score_opus":0.12024160526015626,"score_gpt":0.3891779392027667,"score_spread":0.26893633394261046,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2590491310","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99604934,0.00067689334,0.00006379617,0.00091015187,0.00023171685,0.0020349298,0.000024156881,0.0000051932016,0.0000038316853],"genre_scores_gemma":[0.9876247,0.012029905,0.00006365457,0.000006159702,0.000034811783,0.00009845298,0.000103848004,0.000008239514,0.000030246172],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99803406,0.00017971013,0.00029912664,0.00021934169,0.001029248,0.00023851488],"domain_scores_gemma":[0.9985564,0.00035094033,0.00018517619,0.0003916944,0.00035614753,0.00015966411],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012153864,0.00009936893,0.00018896321,0.00007129773,0.00030731672,0.00004024744,0.00015539005,0.00006987204,0.0000057085795],"category_scores_gemma":[0.001576295,0.000045599092,0.00003265857,0.00008254995,0.00040977658,0.00013328834,0.00015019927,0.00020896799,1.8429155e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031743862,0.0011282824,0.88574094,0.00072012516,0.00018935848,0.0000018090187,0.0006289597,1.7366956e-7,0.000075154356,0.000100224024,0.0004983626,0.10774223],"study_design_scores_gemma":[0.010832842,0.0036177554,0.9776411,0.0022102147,0.000067646666,0.0000013358165,0.00019681841,0.0009569673,0.0011591243,0.000050655475,0.0032014435,0.00006406314],"about_ca_topic_score_codex":0.0001510353,"about_ca_topic_score_gemma":0.00007970865,"teacher_disagreement_score":0.10767816,"about_ca_system_score_codex":0.0001292252,"about_ca_system_score_gemma":0.00040647291,"threshold_uncertainty_score":0.23636629},"labels":[],"label_agreement":null},{"id":"W2679991926","doi":"10.1080/03007995.2017.1345730","title":"Network meta-analysis of liraglutide versus dipeptidyl peptidase-4 inhibitors for the treatment of type 2 diabetes in Japanese patients","year":2017,"lang":"en","type":"review","venue":"Current Medical Research and Opinion","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Liraglutide; Dipeptidyl peptidase-4; Type 2 diabetes; Dipeptidyl peptidase-4 inhibitor; Saxagliptin; Sitagliptin; Internal medicine; Diabetes mellitus; Dipeptidyl peptidase; Pharmacology; Glucagon-like peptide-1; Meta-analysis; Endocrinology; Enzyme; Biochemistry","score_opus":0.4695309847121052,"score_gpt":0.513261358917863,"score_spread":0.04373037420575776,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2679991926","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0007148478,0.9952501,7.341523e-7,0.00012612472,0.0007518936,0.0029358917,0.000104278915,0.000006038016,0.00011009483],"genre_scores_gemma":[0.0012832124,0.99597496,0.000013417204,0.000003391339,0.0003264314,0.0007732127,0.001417044,0.000024252424,0.00018406485],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99649227,0.00029891988,0.00084113807,0.00047526887,0.0012986624,0.0005937242],"domain_scores_gemma":[0.99478316,0.0034717505,0.0003862526,0.00073055545,0.0003085103,0.0003197407],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017147749,0.00034946552,0.003400159,0.0006327666,0.00012396692,0.000026074978,0.00031964108,0.00020884362,0.000115792616],"category_scores_gemma":[0.0015378655,0.00017393191,0.0014025589,0.00084618555,0.0004674548,0.000042670108,0.00017619111,0.00029908196,0.000004875734],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018956295,0.001498792,0.0010019139,0.006716226,0.048433397,0.000001409864,0.00007599434,6.0113547e-7,7.937258e-9,0.00005332356,0.0024802806,0.9395485],"study_design_scores_gemma":[0.0020758535,0.0038581933,0.00042152053,0.003072236,0.086559184,3.6936942e-8,0.00001912524,0.00014305783,4.395573e-7,0.000019312929,0.90370864,0.0001223754],"about_ca_topic_score_codex":0.00006449267,"about_ca_topic_score_gemma":0.00005746383,"teacher_disagreement_score":0.9394261,"about_ca_system_score_codex":0.0001577879,"about_ca_system_score_gemma":0.00028821162,"threshold_uncertainty_score":0.70927376},"labels":[],"label_agreement":null},{"id":"W2754295200","doi":"10.1080/03007995.2017.1380617","title":"Moving toward consensus on diagnosis and management of severe asthma in adults","year":2017,"lang":"en","type":"review","venue":"Current Medical Research and Opinion","topic":"Asthma and respiratory diseases","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Novartis Pharma; Novartis","keywords":"Medicine; Asthma; Asthma management; Intensive care medicine; MEDLINE; Personalized medicine; Alternative medicine; Family medicine; Bioinformatics; Immunology; Pathology","score_opus":0.2616818952326109,"score_gpt":0.5082629594126179,"score_spread":0.24658106418000703,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2754295200","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0008970207,0.9966208,7.654923e-7,0.00033347125,0.0003022779,0.0012434849,0.000049146198,0.0000090794865,0.0005439957],"genre_scores_gemma":[0.00086946815,0.9984768,0.000010698116,0.0000101994465,0.0002743531,0.00020984402,0.00008346736,0.000020072996,0.000045066445],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9969117,0.0002941642,0.0005073316,0.0005125968,0.0013562712,0.00041790894],"domain_scores_gemma":[0.9979537,0.00066393154,0.00014277069,0.00035698243,0.000099630226,0.00078299694],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011073465,0.00024272809,0.0010745913,0.0004078719,0.00010157382,0.000025017784,0.00019913501,0.00026402724,0.0000811199],"category_scores_gemma":[0.0014495875,0.00016295127,0.00013337121,0.00016384608,0.000610777,0.000022443222,0.00037386816,0.0009617829,0.000014386447],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013268531,0.00031209437,0.0005823044,0.111721225,0.00003933425,0.00020835748,0.000024833584,6.070045e-9,2.1807416e-9,0.00016464808,0.002443606,0.8843709],"study_design_scores_gemma":[0.0009906867,0.0005466706,0.0024024402,0.25102535,0.000026199361,0.000021268655,0.000052873802,0.0000070789038,9.854123e-8,0.000021203412,0.74480087,0.00010526281],"about_ca_topic_score_codex":0.000018364339,"about_ca_topic_score_gemma":0.000003831135,"teacher_disagreement_score":0.88426566,"about_ca_system_score_codex":0.0000698394,"about_ca_system_score_gemma":0.0005069935,"threshold_uncertainty_score":0.664496},"labels":[],"label_agreement":null},{"id":"W2755128776","doi":"10.1080/03007995.2017.1380618","title":"Evaluation of the quality of care of elderly patients with chronic and breakthrough pain treated with opioids: SAND study","year":2017,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Pain Management and Opioid Use","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Observational study; Quality of life (healthcare); Visual analogue scale; Physical therapy; Brief Pain Inventory; Patient satisfaction; Population; Chronic pain; Internal medicine; Surgery","score_opus":0.13078294745031657,"score_gpt":0.47060407354021966,"score_spread":0.3398211260899031,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2755128776","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953843,0.0026623528,0.000028500563,0.00020026541,0.000044646353,0.0014840623,0.000010231828,0.0000030463364,0.00018261277],"genre_scores_gemma":[0.99916315,0.0007052384,0.000007633453,0.0000022839215,0.000046336707,0.000029583272,0.000030515335,0.000005756568,0.000009523506],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99563986,0.0007996372,0.00026551148,0.00020920209,0.0029129882,0.00017279598],"domain_scores_gemma":[0.9979148,0.0002589771,0.00018887584,0.00044365224,0.001061623,0.00013210645],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0056470847,0.00008907669,0.0002809857,0.00007255787,0.00015167182,0.00001340659,0.00016792883,0.00004719167,0.000029101444],"category_scores_gemma":[0.0027555062,0.000045523026,0.000022357368,0.00012206374,0.0007624835,0.00006483777,0.00013664993,0.00021954783,1.3731243e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00050412316,0.0005009584,0.7745376,0.0009453039,0.0000640489,2.4477373e-7,0.0006555992,1.76309e-7,0.000009771076,0.000031173393,0.00008990908,0.22266105],"study_design_scores_gemma":[0.008312909,0.0058913496,0.9824664,0.001830423,0.000072224015,7.2825635e-8,0.0007631757,0.00026436866,0.00012071088,0.0000441149,0.00018663483,0.000047620557],"about_ca_topic_score_codex":0.00040927337,"about_ca_topic_score_gemma":0.00024686,"teacher_disagreement_score":0.22261344,"about_ca_system_score_codex":0.00005061972,"about_ca_system_score_gemma":0.00040059714,"threshold_uncertainty_score":0.32987973},"labels":[],"label_agreement":null},{"id":"W2767963750","doi":"10.1080/03007995.2017.1401529","title":"Real-world cardiovascular disease burden in patients with atherosclerotic cardiovascular disease: a comprehensive systematic literature review","year":2017,"lang":"en","type":"review","venue":"Current Medical Research and Opinion","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Mace; Stroke (engine); Internal medicine; Myocardial infarction; Incidence (geometry); Observational study; Adverse effect; Mortality rate; Percutaneous coronary intervention","score_opus":0.136619001560884,"score_gpt":0.42454012431765503,"score_spread":0.28792112275677106,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767963750","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00002630465,0.983539,0.000016094069,0.000168218,0.00053343293,0.015472709,0.00013912919,0.000047993002,0.000057121495],"genre_scores_gemma":[0.00005553806,0.99399465,0.000010746789,0.000025447694,0.0014453924,0.0024132824,0.0018361983,0.00013337337,0.00008534155],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.983327,0.003369867,0.0013358056,0.0016932341,0.009050941,0.0012231575],"domain_scores_gemma":[0.98999804,0.00034901858,0.00029062337,0.0047469563,0.0010716178,0.0035437504],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.006743578,0.00088998163,0.0071790717,0.00079912075,0.00038074335,0.0002031663,0.0007574703,0.00035911493,0.000033105833],"category_scores_gemma":[0.0034067251,0.0005426997,0.0032786145,0.0012284052,0.0005659826,0.00017193059,0.0005389364,0.0030822314,0.000053023825],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000067555535,0.00016605938,0.000096920114,0.56176966,0.002257054,0.00035303447,0.000013102229,2.889631e-7,2.1339219e-10,0.000024723331,0.00028019553,0.4349714],"study_design_scores_gemma":[0.0013538742,0.00012806432,0.0014499692,0.5098684,0.0026271432,0.000016210375,0.0000024947828,0.000008759255,1.1462108e-9,0.000006078461,0.4842695,0.00026956006],"about_ca_topic_score_codex":0.00016878,"about_ca_topic_score_gemma":0.0000046183145,"teacher_disagreement_score":0.4839893,"about_ca_system_score_codex":0.0005651341,"about_ca_system_score_gemma":0.0030397435,"threshold_uncertainty_score":0.99970245},"labels":[],"label_agreement":null},{"id":"W2769813465","doi":"10.1080/03007995.2017.1410471","title":"Efficacy and safety of aripiprazole lauroxil once-monthly versus aripiprazole once-monthly long-acting injectable formulations in patients with acute symptoms of schizophrenia: an indirect comparison of two double-blind placebo-controlled studies","year":2017,"lang":"en","type":"review","venue":"Current Medical Research and Opinion","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Aripiprazole; Akathisia; Medicine; Tolerability; Positive and Negative Syndrome Scale; Placebo; Adverse effect; Internal medicine; Antipsychotic; Schizophrenia (object-oriented programming); Randomized controlled trial; Psychiatry; Psychosis","score_opus":0.2557213761562765,"score_gpt":0.5200668732555312,"score_spread":0.26434549709925476,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2769813465","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.20176733,0.79205537,0.000008002349,0.000055565004,0.0003377312,0.0053475057,0.00018486408,0.000018196071,0.0002254494],"genre_scores_gemma":[0.2782996,0.7197474,0.00019054944,6.494272e-7,0.00018048812,0.00035866312,0.0011646176,0.000046434692,0.000011556262],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99276197,0.000624929,0.001943931,0.000834669,0.0029409342,0.0008935511],"domain_scores_gemma":[0.9935278,0.0026242202,0.0011760469,0.0008175542,0.0009062701,0.00094807456],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0027909903,0.00058674434,0.0043635527,0.0011617271,0.00035918696,0.000059286587,0.00048321774,0.00038040645,0.000025013122],"category_scores_gemma":[0.003082847,0.00038741346,0.00024490608,0.0007305419,0.0012548093,0.00032499176,0.00051266066,0.0019733065,0.000002316259],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.29354486,0.0022537352,0.0060692434,0.0057987124,0.0019525407,0.000017006498,0.00031031648,0.0000037868078,2.1876701e-7,0.00017887198,0.00002512661,0.68984556],"study_design_scores_gemma":[0.8178886,0.030434398,0.02033226,0.10828527,0.0027163832,0.000012991014,0.0003676531,0.0010651678,0.00005826304,0.00014716572,0.017728139,0.000963702],"about_ca_topic_score_codex":0.00021013267,"about_ca_topic_score_gemma":0.0008205422,"teacher_disagreement_score":0.6888819,"about_ca_system_score_codex":0.00032799688,"about_ca_system_score_gemma":0.0028834096,"threshold_uncertainty_score":0.9998578},"labels":[],"label_agreement":null},{"id":"W2775608437","doi":"10.1080/03007995.2017.1416347","title":"Relationship between patient copayments in Medicare Part D and vaccination claim status for herpes zoster and tetanus-diphtheria-acellular pertussis","year":2017,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Herpesvirus Infections and Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Medicine; Diphtheria; Copayment; Vaccination; Logistic regression; Tetanus; Confounding; Pertussis vaccine; Pediatrics; Immunization; Internal medicine; Health care; Immunology; Health insurance; Law; Antigen","score_opus":0.22308274570242578,"score_gpt":0.48135763649130087,"score_spread":0.2582748907888751,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2775608437","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9880936,0.006836461,0.00008990049,0.0033240812,0.0003286306,0.00095375115,0.000057590736,0.000013190326,0.00030276252],"genre_scores_gemma":[0.9942202,0.005049776,0.000053677686,0.000021041877,0.00022026367,0.00016530353,0.00018907776,0.000013464293,0.00006719173],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99812794,0.00015382284,0.000287847,0.000351464,0.00067948713,0.0003994356],"domain_scores_gemma":[0.9981858,0.0007285256,0.00006973884,0.00023159773,0.00013179456,0.0006525474],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00102282,0.00012850377,0.00024999614,0.00017038042,0.0005589118,0.00009378412,0.000059204267,0.00016209138,0.000097565404],"category_scores_gemma":[0.0035309843,0.000095508476,0.00002770575,0.000076509736,0.00024212032,0.00015190156,0.00013748066,0.00034277717,0.0000048831043],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000073923555,0.00014107737,0.48175672,0.00016966165,0.000016467066,0.0000045432203,0.00020744327,4.6896846e-9,8.4261853e-7,0.00012859325,0.00054253003,0.5169582],"study_design_scores_gemma":[0.0037637572,0.0007190338,0.7851092,0.00065939385,0.000020594889,0.000005712413,0.000157768,0.00016942743,0.00003336508,0.0010775224,0.2081949,0.00008928038],"about_ca_topic_score_codex":0.00010045066,"about_ca_topic_score_gemma":0.000049441,"teacher_disagreement_score":0.5168689,"about_ca_system_score_codex":0.00010425172,"about_ca_system_score_gemma":0.00017267911,"threshold_uncertainty_score":0.42987543},"labels":[],"label_agreement":null},{"id":"W2778234808","doi":"10.1080/03007995.2017.1421146","title":"Real-world effectiveness, adherence and persistence among patients with type 2 diabetes mellitus initiating dulaglutide treatment","year":2017,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Eli Lilly (Canada)","funders":"","keywords":"Medicine; Dulaglutide; Persistence (discontinuity); Internal medicine; Diabetes mellitus; Type 2 Diabetes Mellitus; Type 2 diabetes; Physical therapy; Exenatide; Endocrinology","score_opus":0.09947148768741258,"score_gpt":0.39894085193484075,"score_spread":0.29946936424742815,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2778234808","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99358535,0.0029595473,0.0000036400959,0.00021302918,0.00025906874,0.00082817033,0.000005448784,0.000024028903,0.0021217137],"genre_scores_gemma":[0.9867982,0.012703267,0.00004747179,0.000008117138,0.0001225708,0.000096162374,0.00010055184,0.000013101134,0.00011053037],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979756,0.00013056627,0.00015162979,0.00041617735,0.0008488377,0.00047721318],"domain_scores_gemma":[0.9984245,0.0003986685,0.000071503375,0.0003350789,0.00021109176,0.00055916706],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006714763,0.00016997692,0.00029827125,0.00013546867,0.0004978398,0.00012227694,0.00012225888,0.000052979398,0.00005011695],"category_scores_gemma":[0.000801801,0.00010852442,0.000029639139,0.00011838955,0.0007263644,0.00018387838,0.00020746417,0.00023473403,0.0000106573425],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015441157,0.00034060772,0.72202384,0.00033255396,0.0000749376,0.000008472353,0.000057716505,2.5007092e-8,0.0000038788057,0.00018240897,0.000096698015,0.27672446],"study_design_scores_gemma":[0.0033423917,0.003726336,0.9863745,0.0025219063,0.000045070094,2.568558e-7,0.000034620647,0.00019605715,0.00013474519,0.00014008474,0.0033726254,0.000111429654],"about_ca_topic_score_codex":0.00018840028,"about_ca_topic_score_gemma":0.000093687515,"teacher_disagreement_score":0.27661303,"about_ca_system_score_codex":0.00012316112,"about_ca_system_score_gemma":0.00013051639,"threshold_uncertainty_score":0.44254974},"labels":[],"label_agreement":null},{"id":"W2809106259","doi":"10.1080/03007995.2018.1490255","title":"A palliative care perspective on deprescribing cholinesterase inhibitors in Alzheimer’s disease","year":2018,"lang":"en","type":"editorial","venue":"Current Medical Research and Opinion","topic":"Dementia and Cognitive Impairment Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Trillium Health Centre; Baycrest Hospital","funders":"","keywords":"Medicine; Deprescribing; Palliative care; Dementia; Quality of life (healthcare); Intensive care medicine; Disease; Perspective (graphical); Cholinesterase; End-of-life care; Polypharmacy; Psychiatry; Nursing; Internal medicine","score_opus":0.10565739365181995,"score_gpt":0.49304631603627236,"score_spread":0.38738892238445244,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2809106259","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.05279681,0.14124438,0.000043288146,0.005210173,0.7880423,0.0073376573,0.00070960255,0.00014458131,0.004471193],"genre_scores_gemma":[0.19601625,0.03690859,0.000009800127,0.00007603285,0.76287293,0.0007546423,0.0031225854,0.00010102834,0.00013811617],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9895329,0.00067795574,0.00051851245,0.0011470418,0.0069403388,0.0011832382],"domain_scores_gemma":[0.99269664,0.0018271145,0.00008949191,0.0004442337,0.0026753284,0.0022671837],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.001964945,0.00044050298,0.00062090205,0.0011082126,0.00025858276,0.00014342817,0.00034212967,0.00060820155,0.00037510437],"category_scores_gemma":[0.012905756,0.0003490534,0.00015699261,0.0006698913,0.0009963814,0.00011853734,0.0005483963,0.0046429094,0.00014177297],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0041758227,0.0014862895,0.027557202,0.001152494,0.0001293622,0.00040269204,0.0018457501,5.391564e-8,0.0000016164495,0.00010585,0.8630251,0.10011772],"study_design_scores_gemma":[0.008123866,0.0043177158,0.02892545,0.02248907,0.00009338972,0.0000016570112,0.0037567413,0.0001760595,0.000053230226,0.00043249835,0.9311066,0.0005236835],"about_ca_topic_score_codex":0.00035764748,"about_ca_topic_score_gemma":0.00013626875,"teacher_disagreement_score":0.14321944,"about_ca_system_score_codex":0.00079776463,"about_ca_system_score_gemma":0.0038568366,"threshold_uncertainty_score":0.99989617},"labels":[],"label_agreement":null},{"id":"W2885386026","doi":"10.1080/03007995.2018.1512477","title":"Short-term rehospitalizations in young adults with schizophrenia treated with once-monthly paliperidone palmitate or oral atypical antipsychotics: a retrospective analysis","year":2018,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"Janssen Scientific Affairs","keywords":"Medicine; Odds ratio; Schizophrenia (object-oriented programming); Confidence interval; Paliperidone Palmitate; Paliperidone; Young adult; Internal medicine; Pediatrics; Antipsychotic; Psychiatry","score_opus":0.05571376054149504,"score_gpt":0.4005687660881389,"score_spread":0.3448550055466439,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2885386026","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99616325,0.00088087266,0.00030952613,0.001093243,0.00009527977,0.0011531819,0.000058364145,0.000060138795,0.00018611779],"genre_scores_gemma":[0.994856,0.003298346,0.0006278663,0.000009652062,0.00036119262,0.00019566872,0.0005531327,0.000032422617,0.00006569168],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9949647,0.0002842021,0.0004207901,0.00090471125,0.0024559463,0.0009696066],"domain_scores_gemma":[0.99697125,0.00022317027,0.000050255672,0.0005052255,0.00084305805,0.0014070193],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00078631553,0.00030892956,0.0006654475,0.0009022951,0.00029510612,0.000102549624,0.0002067061,0.0001722129,0.0003454044],"category_scores_gemma":[0.00085805974,0.00017431605,0.00008223064,0.003396978,0.0014843377,0.00016029345,0.00011272944,0.0009660199,0.000026595686],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.13864943,0.0013081355,0.8295903,0.00010081834,0.00053160853,0.00038912668,0.0003340694,3.7382713e-7,0.000004305702,0.00039497376,0.00028516244,0.028411686],"study_design_scores_gemma":[0.012481659,0.010528479,0.9712554,0.0017936662,0.00012827029,0.000058151316,0.00021457022,0.0030101864,0.00004985576,0.00011251344,0.00015375213,0.00021349902],"about_ca_topic_score_codex":0.0001580089,"about_ca_topic_score_gemma":0.008754106,"teacher_disagreement_score":0.1416651,"about_ca_system_score_codex":0.00026850245,"about_ca_system_score_gemma":0.00073476305,"threshold_uncertainty_score":0.7108402},"labels":[],"label_agreement":null},{"id":"W2912647253","doi":"10.1080/03007995.2019.1576479","title":"The role of sodium glucose cotransporter-2 (SGLT-2) inhibitors in heart failure and chronic kidney disease in type 2 diabetes","year":2019,"lang":"en","type":"review","venue":"Current Medical Research and Opinion","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Heart Research Centre; University of Toronto; St. Michael's Hospital; University of Manitoba","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Type 2 diabetes; Diabetes mellitus; Heart failure; Kidney disease; Canagliflozin; Cotransporter; Disease; Internal medicine; Sodium; Empagliflozin; Endocrinology","score_opus":0.05041699803246688,"score_gpt":0.391567039502338,"score_spread":0.34115004146987116,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2912647253","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.002438032,0.9940983,1.15801804e-7,0.0012360679,0.00043052807,0.0017135448,0.000024872335,0.000008687173,0.000049870538],"genre_scores_gemma":[0.0039664414,0.99501055,0.0000029132968,0.000013497152,0.00026363521,0.0001533919,0.00051835005,0.000023178534,0.000048015438],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99716413,0.0002547906,0.00052721275,0.0004370044,0.0010019297,0.00061494554],"domain_scores_gemma":[0.9982055,0.0005045291,0.00007467646,0.00032879057,0.00006938014,0.0008171437],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013841324,0.0002500635,0.0009413192,0.00039507874,0.000054061995,0.000032828564,0.00017619271,0.00018238813,0.00005091418],"category_scores_gemma":[0.00075505127,0.00014893239,0.00011399303,0.00049368804,0.00042822817,0.00005665697,0.00020698264,0.0009176929,0.000020246673],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000054330965,0.0003261996,0.01346254,0.02724094,0.000052351028,0.00000789745,0.000021307505,7.8078255e-9,7.250625e-7,0.00020189711,0.0038162097,0.95481557],"study_design_scores_gemma":[0.0011151654,0.00051812956,0.0010984248,0.047329634,0.00007736266,4.302859e-7,0.000018202738,0.00004942029,0.000004445401,0.00013887035,0.949537,0.00011293903],"about_ca_topic_score_codex":0.000021528693,"about_ca_topic_score_gemma":0.000033848748,"teacher_disagreement_score":0.9547027,"about_ca_system_score_codex":0.00015761961,"about_ca_system_score_gemma":0.001349543,"threshold_uncertainty_score":0.60732865},"labels":[],"label_agreement":null},{"id":"W2913275054","doi":"10.1080/03007995.2019.1580094","title":"Treatment sequence network meta-analysis in Crohn’s disease: a methodological case study","year":2019,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Ustekinumab; Vedolizumab; Placebo; Internal medicine; Adalimumab; Crohn's disease; Randomization; Randomized controlled trial; Population; Meta-analysis; Infliximab; Clinical trial; Disease; Pathology","score_opus":0.41407654584083364,"score_gpt":0.5200536044546522,"score_spread":0.10597705861381856,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2913275054","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9887897,0.009694875,0.00017589997,0.00021083241,0.00014735518,0.00090393226,0.000026003374,0.0000076750075,0.000043738433],"genre_scores_gemma":[0.9976448,0.0015293453,0.00006264556,0.000027676322,0.00022100714,0.00027905652,0.000116563555,0.000008802727,0.00011011826],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9959008,0.0019176365,0.00029199934,0.0006554462,0.0007378355,0.0004962881],"domain_scores_gemma":[0.99834627,0.00028310058,0.00003935097,0.00047415495,0.000106296015,0.0007508231],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028400153,0.0001702891,0.00043277987,0.00013444587,0.000099986966,0.000038580914,0.00019210274,0.000106781175,0.0004337006],"category_scores_gemma":[0.0010072783,0.00011408965,0.0002770129,0.00037694132,0.00018741054,0.000005890634,0.0002732828,0.00027111513,0.000021771797],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002503286,0.0037623285,0.9079287,0.0002210701,0.018652039,0.028417032,0.00033545034,0.00038433698,0.00009039083,0.0006279998,0.0012573573,0.03581999],"study_design_scores_gemma":[0.0055428795,0.0030412592,0.94644505,0.000044912533,0.009069365,0.0002084761,0.0011516135,0.006751299,0.00003082652,0.00090041023,0.025958123,0.0008557985],"about_ca_topic_score_codex":0.00010167498,"about_ca_topic_score_gemma":0.00027252056,"teacher_disagreement_score":0.038516317,"about_ca_system_score_codex":0.00004464646,"about_ca_system_score_gemma":0.00032511234,"threshold_uncertainty_score":0.47487172},"labels":[],"label_agreement":null},{"id":"W2940284440","doi":"10.1080/03007995.2019.1608101","title":"Ghostwriting in biomedicine: a review of the published literature","year":2019,"lang":"en","type":"review","venue":"Current Medical Research and Opinion","topic":"Pharmaceutical industry and healthcare","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Medical Association","keywords":"Medicine; Relevance (law); Consistency (knowledge bases); Publishing; Computer science; Law; Political science","score_opus":0.8005847108475234,"score_gpt":0.72599677644244,"score_spread":0.07458793440508338,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2940284440","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000007270889,0.9854417,4.7366012e-7,0.007953067,0.0033302063,0.0020498994,0.00016196563,0.000013196686,0.001042259],"genre_scores_gemma":[0.000023108327,0.9972804,0.0000014486519,0.00088383345,0.0011153932,0.00017865212,0.0003213322,0.000022386463,0.00017344061],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99127597,0.0045646867,0.0012635349,0.00059909216,0.0013857575,0.0009109701],"domain_scores_gemma":[0.9944085,0.0034782006,0.00029112797,0.0004376496,0.00037772735,0.0010067802],"candidate_categories":["metaresearch","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.011727182,0.00033649555,0.0015304424,0.00040015427,0.00017753568,0.00003213098,0.0010708594,0.001587596,0.001613614],"category_scores_gemma":[0.010239745,0.00019314875,0.000262841,0.002275896,0.00091994606,0.00011200887,0.00078490283,0.015013685,0.000046926296],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000014408235,0.00014749325,0.00007614764,0.3109133,0.000024507219,0.000009648,0.000034295987,3.1840892e-9,1.7661026e-7,0.0006831431,0.032223836,0.65587306],"study_design_scores_gemma":[0.00036443907,0.000061601015,0.000011222615,0.34747285,0.000046772093,0.00002927856,0.000009164689,0.000018615177,9.095138e-7,0.00010218216,0.6517792,0.000103804174],"about_ca_topic_score_codex":0.0000104569,"about_ca_topic_score_gemma":0.0000024732458,"teacher_disagreement_score":0.6557692,"about_ca_system_score_codex":0.00014783168,"about_ca_system_score_gemma":0.002104649,"threshold_uncertainty_score":0.99970853},"labels":[],"label_agreement":null},{"id":"W2960566636","doi":"10.1080/03007995.2019.1636017","title":"Bipolar depression: the clinical characteristics and unmet needs of a complex disorder","year":2019,"lang":"en","type":"review","venue":"Current Medical Research and Opinion","topic":"Bipolar Disorder and Treatment","field":"Medicine","cited_by":207,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Bipolar disorder; Medicine; Psychiatry; Depression (economics); Mania; Hypomania; Anxiety; Comorbidity; Prevalence of mental disorders; Psychosocial; Substance abuse; Mood","score_opus":0.3659037293290053,"score_gpt":0.5502939973862744,"score_spread":0.1843902680572691,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2960566636","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00008437283,0.9973007,0.000044395976,0.0005004356,0.00056132255,0.001284028,0.000101105405,0.000011155065,0.0001125291],"genre_scores_gemma":[0.00048728113,0.99811906,0.000012141132,0.000015577525,0.00052592583,0.00006556984,0.00067229074,0.000028718006,0.00007345846],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99640125,0.0007322226,0.00081830367,0.00036416357,0.0012660259,0.0004180282],"domain_scores_gemma":[0.9966251,0.0018687886,0.00017595298,0.0005178608,0.00016291512,0.0006493469],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022023877,0.00027674416,0.0015582003,0.00025266595,0.00014595714,0.000030496905,0.0002496088,0.00041543753,0.00021366139],"category_scores_gemma":[0.0015128588,0.00013865923,0.0002505648,0.00040851405,0.0010163529,0.000027737378,0.00052285317,0.0018608083,0.000035095945],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000046586196,0.00052468636,0.019005312,0.017535884,0.00015531945,0.0000018462707,0.000045704393,1.95129e-10,2.3368006e-8,0.00024554916,0.0014168223,0.96102226],"study_design_scores_gemma":[0.0009951114,0.0006010451,0.014264241,0.014831774,0.0002616932,0.0000604017,0.000037893442,0.000025213589,3.3859163e-8,0.00003923674,0.9687681,0.00011521378],"about_ca_topic_score_codex":0.000023891691,"about_ca_topic_score_gemma":0.000004528129,"teacher_disagreement_score":0.9673513,"about_ca_system_score_codex":0.000026783788,"about_ca_system_score_gemma":0.00080106483,"threshold_uncertainty_score":0.80843896},"labels":[],"label_agreement":null},{"id":"W2963273115","doi":"10.1080/03007995.2019.1645999","title":"Incidence of select chronic comorbidities among a population-based cohort of HIV-positive individuals receiving highly active antiretroviral therapy","year":2019,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"HIV-related health complications and treatments","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Provincial Health Services Authority; Simon Fraser University; AIDS Vancouver; University of British Columbia","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Incidence (geometry); COPD; Internal medicine; Population; Asthma; Kidney disease; Comorbidity; Cohort; Diabetes mellitus; Endocrinology","score_opus":0.04721944358949187,"score_gpt":0.41253330750242706,"score_spread":0.3653138639129352,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2963273115","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99492294,0.0031282702,0.00007851556,0.0004386497,0.000109047025,0.0010671461,0.000060829865,0.000014246902,0.00018035083],"genre_scores_gemma":[0.99467915,0.004561412,0.000041672905,0.000012009561,0.00007602038,0.000056410074,0.00053629174,0.000010902791,0.000026101447],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99753964,0.00024531942,0.00038307137,0.0002758947,0.0012342136,0.00032184506],"domain_scores_gemma":[0.99806273,0.00087044504,0.00015069921,0.0002241976,0.00040584555,0.000286072],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008619959,0.000112284564,0.0003751858,0.0002932205,0.000114962975,0.0000087527615,0.000115495845,0.00012640661,0.00018922162],"category_scores_gemma":[0.0005073037,0.000087387976,0.00005001074,0.0004372988,0.00030569377,0.00009546654,0.000051754683,0.0005429813,0.000013159086],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016799102,0.00032641526,0.95348424,0.00034163787,0.000058727903,0.0000011406054,0.00021811134,0.0000010717753,0.00009593882,0.00028142516,0.00020000982,0.04482328],"study_design_scores_gemma":[0.0019152993,0.0023265888,0.98944587,0.0030343072,0.000009836218,0.0000024334886,0.0000597705,0.0016973373,0.0011243703,0.000122059304,0.00019802338,0.00006410855],"about_ca_topic_score_codex":0.00081879663,"about_ca_topic_score_gemma":0.0000116054025,"teacher_disagreement_score":0.044759173,"about_ca_system_score_codex":0.00020067314,"about_ca_system_score_gemma":0.00094724394,"threshold_uncertainty_score":0.35635784},"labels":[],"label_agreement":null},{"id":"W2963470829","doi":"10.1080/03007995.2019.1646001","title":"Evolving the management of acute perioperative pain towards opioid free protocols: a narrative review","year":2019,"lang":"en","type":"review","venue":"Current Medical Research and Opinion","topic":"Anesthesia and Pain Management","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Mallinckrodt Pharmaceuticals; Edwards Lifesciences; Mayo Clinic","keywords":"Medicine; Opioid; Perioperative; Intensive care medicine; Medical prescription; Health care; Chronic pain; Patient satisfaction; Narrative review; Anesthesia; Physical therapy; Nursing","score_opus":0.22411527359088387,"score_gpt":0.5262681989910906,"score_spread":0.30215292540020666,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2963470829","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[2.9218728e-7,0.9543033,0.00017497102,0.0031216654,0.000118929194,0.04087605,0.000011174606,0.000017719147,0.0013758545],"genre_scores_gemma":[6.6367966e-7,0.9811042,0.00011365199,0.00028479588,0.0002966047,0.016951133,0.00023059038,0.00003331368,0.0009850344],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9927869,0.002260331,0.00088485423,0.0006449337,0.002846276,0.00057674287],"domain_scores_gemma":[0.99717414,0.000723476,0.00025049437,0.0010065264,0.00040188566,0.0004434604],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011414784,0.0004077315,0.0018537918,0.00020389089,0.00021703792,0.00005118528,0.00086112856,0.00021837771,0.00061162806],"category_scores_gemma":[0.00110753,0.00020918618,0.00038311543,0.0006988326,0.00059877126,0.00006324454,0.0007072887,0.0016271423,0.000048930164],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000025343483,0.00013091302,0.0000057169877,0.28192136,0.00045001303,0.000029919685,0.00027114808,1.5731515e-9,7.2591093e-9,0.0010337586,0.04383232,0.6722995],"study_design_scores_gemma":[0.0003983013,0.00064987206,0.000021939442,0.3490422,0.00033039504,0.000016952414,0.00022737915,0.000029300249,5.899119e-8,0.000048185437,0.64911586,0.00011954459],"about_ca_topic_score_codex":0.000009145818,"about_ca_topic_score_gemma":6.003296e-7,"teacher_disagreement_score":0.67217994,"about_ca_system_score_codex":0.00016216814,"about_ca_system_score_gemma":0.0011622126,"threshold_uncertainty_score":0.8530365},"labels":[],"label_agreement":null},{"id":"W2965680320","doi":"10.1080/03007995.2019.1652053","title":"Healthcare resource use and cost associated with timing of pharmacological treatment for major depressive disorder in the United States: a real-world study","year":2019,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Treatment of Major Depression","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pfizer (Canada); University of Toronto; McGill University; University Health Network","funders":"","keywords":"Major depressive disorder; Medicine; Propensity score matching; Reuptake inhibitor; Serotonin reuptake inhibitor; Internal medicine; Antidepressant; Pediatrics; Psychiatry; Mood; Anxiety","score_opus":0.22911013328252444,"score_gpt":0.4943244858213626,"score_spread":0.2652143525388382,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2965680320","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9906621,0.001351002,0.000013177092,0.003219492,0.00004426576,0.004622587,0.00004639353,0.000015714615,0.000025298088],"genre_scores_gemma":[0.9949054,0.0037945746,0.000014000514,0.00006019494,0.00004460164,0.0004937538,0.0005817338,0.0000143373645,0.00009139352],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99718326,0.0007035361,0.00027350502,0.00037266305,0.0010586433,0.0004083702],"domain_scores_gemma":[0.9958532,0.0033571334,0.00007966909,0.0001889163,0.0001964094,0.00032470172],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001164929,0.00015204665,0.00034580808,0.0002913701,0.00013042822,0.000028988741,0.00010195732,0.000077150384,0.00003402388],"category_scores_gemma":[0.0009224621,0.00007550961,0.000027422404,0.00047464485,0.00021921373,0.000058121663,0.00008967479,0.00043745316,8.394624e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036516925,0.0043745153,0.94939476,0.0002016274,0.0001440304,0.000039256138,0.0021478098,0.000002910036,0.000013950694,0.000045136992,0.0011184438,0.038865846],"study_design_scores_gemma":[0.03711275,0.016261699,0.9200511,0.0027207248,0.00012106352,0.000008566479,0.0045087133,0.0043205325,0.000056725745,0.000059019938,0.014629158,0.00014995818],"about_ca_topic_score_codex":0.0012260147,"about_ca_topic_score_gemma":0.00078468106,"teacher_disagreement_score":0.038715888,"about_ca_system_score_codex":0.00014455827,"about_ca_system_score_gemma":0.00016249859,"threshold_uncertainty_score":0.30791926},"labels":[],"label_agreement":null},{"id":"W2966313356","doi":"10.1080/03007995.2019.1653068","title":"Safety and efficacy of fulranumab in osteoarthritis of the hip and knee: results from four early terminated phase III randomized studies","year":2019,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Osteoarthritis Treatment and Mechanisms","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Osteoarthritis; WOMAC; Placebo; Adverse effect; Randomized controlled trial; Physical therapy; Joint pain; Internal medicine","score_opus":0.06471807264002945,"score_gpt":0.4008501879959862,"score_spread":0.3361321153559568,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2966313356","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9658748,0.031179266,0.0000028690467,0.0007298991,0.00034441066,0.0016767457,0.000073885916,0.0000068679947,0.00011128368],"genre_scores_gemma":[0.979189,0.020530395,0.000018475992,0.000007723655,0.00007323659,0.000026617654,0.000060913993,0.000008077272,0.00008558653],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99756974,0.00041929344,0.000578466,0.00031964405,0.0008397455,0.0002731267],"domain_scores_gemma":[0.9970208,0.002236304,0.0001071072,0.00022091912,0.00016690686,0.00024796103],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019482804,0.00013317855,0.0007952749,0.00015246906,0.0000658729,0.00001000032,0.00007417749,0.0001149294,0.000032058713],"category_scores_gemma":[0.003542654,0.00008083083,0.00006134199,0.00020198432,0.00086053123,0.00006030399,0.00020097588,0.0004120361,0.0000017569635],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.13978048,0.0004735105,0.0019191237,0.00031929422,0.00006091466,0.000021598054,0.002512463,2.0432974e-8,0.0014126142,0.00031324849,0.00005415511,0.8531326],"study_design_scores_gemma":[0.96742827,0.0064330874,0.01052016,0.00875136,0.00005346999,0.000021376401,0.0006846706,0.0001530154,0.0036098002,0.0010143106,0.0012000435,0.0001304379],"about_ca_topic_score_codex":0.00010044246,"about_ca_topic_score_gemma":0.00002407421,"teacher_disagreement_score":0.85300213,"about_ca_system_score_codex":0.000022499094,"about_ca_system_score_gemma":0.00013173319,"threshold_uncertainty_score":0.42411438},"labels":[],"label_agreement":null},{"id":"W3004219983","doi":"10.1080/03007995.2020.1722945","title":"Comparative persistence of anti-tumor necrosis factor therapy in ankylosing spondylitis patients: a multicenter international study","year":2020,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University; McGill University Health Centre","funders":"","keywords":"Medicine; Persistence (discontinuity); Ankylosing spondylitis; Discontinuation; Proportional hazards model; Demography; Socioeconomic status; Etanercept; Internal medicine; Cohort study; Tumor necrosis factor alpha; Population; Environmental health","score_opus":0.23588589998103776,"score_gpt":0.4569416212889799,"score_spread":0.22105572130794215,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3004219983","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957054,0.0018585509,0.0000059522736,0.0011820786,0.00026592988,0.00077010517,0.00011581016,0.000007391191,0.000088777946],"genre_scores_gemma":[0.99528855,0.0043888176,0.00001714281,0.000063614025,0.0000993955,0.000036335055,0.00009795848,0.0000057179977,0.0000024842268],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979548,0.00012884517,0.00027889118,0.0002952576,0.0010893447,0.00025288956],"domain_scores_gemma":[0.9990801,0.00018165875,0.000044467703,0.0000820653,0.00029072436,0.0003209345],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020932883,0.00010497451,0.0003262731,0.00012923099,0.00006795351,0.000018105016,0.00010347263,0.00002964507,0.0003687007],"category_scores_gemma":[0.00068284216,0.00007819021,0.00004451863,0.00026026685,0.00023200977,0.00007732836,0.00014098668,0.00032635292,0.000006347768],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012578339,0.0032303112,0.9437366,0.00007039347,0.000077590965,0.000030938307,0.0062747905,3.419992e-8,0.00006061229,0.000012421745,0.00023610314,0.04501236],"study_design_scores_gemma":[0.012831201,0.0045817974,0.97079784,0.00071887375,0.000004242621,0.0000017088859,0.0030995929,0.00042888775,0.00016841824,0.000005881799,0.007286546,0.00007502718],"about_ca_topic_score_codex":0.000089095105,"about_ca_topic_score_gemma":0.000016923135,"teacher_disagreement_score":0.04493733,"about_ca_system_score_codex":0.000055721535,"about_ca_system_score_gemma":0.0000774598,"threshold_uncertainty_score":0.40370145},"labels":[],"label_agreement":null},{"id":"W3005412604","doi":"10.1080/03007995.2020.1725742","title":"The impact of clinical heterogeneity on conducting network meta-analyses in transthyretin amyloidosis with polyneuropathy","year":2020,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Amyloidosis: Diagnosis, Treatment, Outcomes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Medicine; Clinical trial; Meta-analysis; Transthyretin; Population; Adverse effect; Polyneuropathy; Internal medicine; Quality of life (healthcare); Disease; Intensive care medicine","score_opus":0.5737111034907555,"score_gpt":0.5725074252408492,"score_spread":0.0012036782499063037,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3005412604","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97953147,0.017284641,0.000058004778,0.0026588757,0.000099756064,0.0002981721,0.000020483652,0.0000056705026,0.000042939137],"genre_scores_gemma":[0.981523,0.017853042,0.000025740883,0.00010327088,0.00037869468,0.00005380106,0.000044090957,0.00001546283,0.0000029426635],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9965656,0.0011742925,0.00054254365,0.00049835886,0.0007535692,0.0004656406],"domain_scores_gemma":[0.9979948,0.0009939738,0.0001239137,0.00028108407,0.000109807916,0.00049643865],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020401028,0.00018821351,0.0005125087,0.00003979615,0.00013627383,0.000029451614,0.00030233213,0.00012938361,0.00003496515],"category_scores_gemma":[0.0033847457,0.00009406125,0.00031658853,0.00029488347,0.000559619,0.0000052891646,0.0001459606,0.0005714071,0.0000035707014],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038301141,0.0013476622,0.8666204,0.0001284668,0.0036174397,0.000028739918,0.00017722139,0.00023661512,0.003565446,0.00012367005,0.009626614,0.1106976],"study_design_scores_gemma":[0.013884229,0.042112064,0.82858163,0.0006775767,0.00090831163,0.000032408137,0.0007406345,0.0023417792,0.07678375,0.00018568116,0.032502115,0.0012498315],"about_ca_topic_score_codex":0.000062653075,"about_ca_topic_score_gemma":0.000045471486,"teacher_disagreement_score":0.10944776,"about_ca_system_score_codex":0.000013541029,"about_ca_system_score_gemma":0.00025716503,"threshold_uncertainty_score":0.40521014},"labels":[],"label_agreement":null},{"id":"W3006625121","doi":"10.1080/03007995.2020.1729708","title":"Varenicline: mode of action, efficacy, safety and accumulated experience salient for clinical populations","year":2020,"lang":"en","type":"review","venue":"Current Medical Research and Opinion","topic":"Smoking Behavior and Cessation","field":"Medicine","cited_by":61,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Varenicline; Medicine; Smoking cessation; Nicotine replacement therapy; Adverse effect; Clinical trial; Pharmacology; Intensive care medicine; Internal medicine","score_opus":0.6961278574739443,"score_gpt":0.6769596484335964,"score_spread":0.019168209040347994,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3006625121","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0015506698,0.99319625,0.001593962,0.00045119022,0.0012546853,0.0018027419,0.000103654034,0.00003388468,0.000012982557],"genre_scores_gemma":[0.003605247,0.9940851,0.000055611636,0.000010531785,0.0006940428,0.00011236288,0.0014011438,0.000024090148,0.000011895504],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99656576,0.0003232002,0.0010836875,0.00054204965,0.00118311,0.00030221322],"domain_scores_gemma":[0.99708784,0.001351395,0.00020466895,0.00026225386,0.0003327256,0.00076113944],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013487589,0.0002008516,0.0011238797,0.00019807898,0.00015726381,0.000023435086,0.00014985843,0.00044487725,0.00007565924],"category_scores_gemma":[0.0061774035,0.00014766223,0.00021645747,0.00041038275,0.00042551884,0.000052729378,0.00016917873,0.0011264236,0.0000017248424],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020414127,0.0003156331,0.0012943516,0.006319461,0.00003039692,0.0000016309061,0.000094403586,3.727015e-8,1.8499543e-7,0.00042504093,0.0014696819,0.98984504],"study_design_scores_gemma":[0.001538966,0.00062461005,0.004050638,0.013681095,0.00017420959,0.000016040596,0.00005199143,0.00043043165,0.000001249488,0.00007287922,0.979225,0.00013290625],"about_ca_topic_score_codex":0.000016696917,"about_ca_topic_score_gemma":0.0000016127725,"teacher_disagreement_score":0.9897121,"about_ca_system_score_codex":0.00007736923,"about_ca_system_score_gemma":0.00077916763,"threshold_uncertainty_score":0.7395375},"labels":[],"label_agreement":null},{"id":"W3010977327","doi":"10.1080/03007995.2020.1744120","title":"Use of dienogest in endometriosis: a narrative literature review and expert commentary","year":2020,"lang":"en","type":"review","venue":"Current Medical Research and Opinion","topic":"Endometriosis Research and Treatment","field":"Medicine","cited_by":113,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mount Sinai Hospital","funders":"Bayer","keywords":"Dienogest; Endometriosis; Medicine; Context (archaeology); Narrative review; Quality of life (healthcare); Pelvic pain; General surgery; Intensive care medicine; Gynecology; Surgery; Nursing","score_opus":0.28400794027305504,"score_gpt":0.5318228009939459,"score_spread":0.24781486072089082,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3010977327","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000008980875,0.98909277,0.0000015365113,0.007363302,0.00011368565,0.0032410068,0.00014309253,0.000011341817,0.000024262474],"genre_scores_gemma":[0.000018984814,0.9978176,0.000053665917,0.00031243838,0.00024392943,0.00064483087,0.00086277415,0.00003037687,0.000015445677],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99451584,0.0012279993,0.00088093017,0.0007019396,0.0020449436,0.0006283437],"domain_scores_gemma":[0.989498,0.008136996,0.00014319287,0.0003546343,0.00030253638,0.0015645946],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0017338103,0.00039564134,0.0027150642,0.0013560702,0.000086688895,0.000058985166,0.00021610431,0.00029151354,0.00012604387],"category_scores_gemma":[0.034164388,0.00024573703,0.00023785108,0.0031111457,0.00055021455,0.00013998606,0.00055390527,0.0025696587,0.0000069795296],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008081253,0.0005861212,0.000055227825,0.11937641,0.00018176957,0.000235536,0.0002639505,1.6324032e-10,1.2273331e-7,0.00003049738,0.022929614,0.85625994],"study_design_scores_gemma":[0.0009935554,0.0011833833,0.00001720698,0.29025155,0.000069572496,0.00009963416,0.00003496204,0.0000016568977,8.718672e-7,0.0000072497273,0.7072332,0.00010720084],"about_ca_topic_score_codex":0.00005074559,"about_ca_topic_score_gemma":0.000009080369,"teacher_disagreement_score":0.8561527,"about_ca_system_score_codex":0.00022983852,"about_ca_system_score_gemma":0.0006674127,"threshold_uncertainty_score":0.99999946},"labels":[],"label_agreement":null},{"id":"W3013459387","doi":"10.1080/03007995.2020.1747999","title":"Matching-adjusted indirect treatment comparison of siponimod and other disease modifying treatments in secondary progressive multiple sclerosis","year":2020,"lang":"en","type":"review","venue":"Current Medical Research and Opinion","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Medicine; Natalizumab; Internal medicine; Placebo; Multiple sclerosis; Clinical trial; Oncology; Disease; Pathology; Immunology; Alternative medicine","score_opus":0.5232521119595535,"score_gpt":0.527572708074761,"score_spread":0.00432059611520752,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3013459387","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.006416738,0.98891956,0.0000063582584,0.00027232486,0.00014280723,0.0037580437,0.00038628338,0.000032847336,0.000065061584],"genre_scores_gemma":[0.0155263245,0.9825664,0.000061868544,0.000007540882,0.00026942455,0.0010859077,0.00040571182,0.000060834973,0.000015950993],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99414814,0.00095864874,0.0009779298,0.00096905604,0.0021112198,0.00083500135],"domain_scores_gemma":[0.9955175,0.0019521681,0.00024557003,0.00037095783,0.0001612693,0.0017525428],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00089453865,0.0005466047,0.0027403815,0.0007441959,0.00020162186,0.00005511733,0.00023354554,0.00029781414,0.00012127004],"category_scores_gemma":[0.002573548,0.000361716,0.00025546426,0.0006981798,0.00086444104,0.00007539713,0.00058582646,0.0015563931,0.000013426137],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048112412,0.0016501393,0.008908345,0.029033462,0.0004056685,0.00004881386,0.0008496247,4.3132978e-8,0.0000018776041,0.000013172273,0.00019289812,0.95841485],"study_design_scores_gemma":[0.012165446,0.0035352306,0.0325029,0.1907097,0.00046393505,0.000014411481,0.0005675815,0.0012367954,0.000020414505,0.00006161984,0.75811005,0.00061190175],"about_ca_topic_score_codex":0.0002547973,"about_ca_topic_score_gemma":0.00006560348,"teacher_disagreement_score":0.95780295,"about_ca_system_score_codex":0.00052216917,"about_ca_system_score_gemma":0.0016124969,"threshold_uncertainty_score":0.9998835},"labels":[],"label_agreement":null},{"id":"W3014083971","doi":"10.1080/03007995.2020.1747998","title":"The importance of considering differences in study and patient characteristics before undertaking indirect treatment comparisons: a case study of siponimod for secondary progressive multiple sclerosis","year":2020,"lang":"en","type":"review","venue":"Current Medical Research and Opinion","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Medicine; Ocrelizumab; Interferon beta-1a; Clinical trial; Multiple sclerosis; Physical therapy; Internal medicine; Oncology; Immunology; Interferon beta","score_opus":0.4790940381106173,"score_gpt":0.4984205220973128,"score_spread":0.01932648398669551,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3014083971","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.35658437,0.63591105,0.000001638811,0.00007118257,0.00009233664,0.007221389,0.00011012262,0.000006646565,0.0000012673112],"genre_scores_gemma":[0.438642,0.5597963,0.000013146776,9.221882e-7,0.000055304863,0.0014490966,0.00002717747,0.000015666366,4.2971558e-7],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9952063,0.0008503328,0.0013082345,0.00064733584,0.0014366591,0.0005511687],"domain_scores_gemma":[0.99250597,0.005877945,0.0004955157,0.0003238003,0.00034055128,0.00045619934],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013541195,0.00036496323,0.0023780933,0.0003146262,0.00035214968,0.000050639817,0.00018363172,0.0001321121,0.000006790369],"category_scores_gemma":[0.0071488996,0.00020247007,0.00012766497,0.00042288352,0.0007872977,0.000039230814,0.0005787394,0.0009895547,1.7690226e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002412622,0.0028234376,0.12073915,0.01000339,0.00047043967,0.00018494602,0.0050662085,3.7625214e-9,2.0359842e-7,0.0000022349275,0.000030671865,0.86043805],"study_design_scores_gemma":[0.03747072,0.11608002,0.3023328,0.20420638,0.0012913498,0.0005360659,0.1986841,0.0033678685,0.000010185206,0.000038472866,0.13472639,0.0012556657],"about_ca_topic_score_codex":0.00021049877,"about_ca_topic_score_gemma":0.0013869271,"teacher_disagreement_score":0.8591824,"about_ca_system_score_codex":0.00019613875,"about_ca_system_score_gemma":0.0010173352,"threshold_uncertainty_score":0.8558417},"labels":[],"label_agreement":null},{"id":"W3040176507","doi":"10.1080/03007995.2020.1790349","title":"Sensory descriptors which identify neuropathic pain mechanisms in low back pain: a systematic review","year":2020,"lang":"en","type":"review","venue":"Current Medical Research and Opinion","topic":"Pain Mechanisms and Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Physiotherapy Association","funders":"","keywords":"Medicine; Dysesthesia; Neuropathic pain; Allodynia; Low back pain; Nociception; Systematic review; Physical therapy; Neuralgia; Quantitative sensory testing; Hyperalgesia; Physical medicine and rehabilitation; Anesthesia; Sensory system; MEDLINE; Neuroscience; Alternative medicine; Internal medicine; Psychology; Pathology","score_opus":0.19622458296503553,"score_gpt":0.4610019090772578,"score_spread":0.26477732611222227,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3040176507","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[3.6292755e-7,0.9893122,0.0023139499,0.0010262816,0.0007166075,0.006511369,0.000027421438,0.0000482611,0.00004357649],"genre_scores_gemma":[0.000016096334,0.9975023,0.00006507981,0.0004584158,0.0003283136,0.00096267305,0.00047551648,0.00008972277,0.000101844584],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.97586244,0.016848989,0.0017425071,0.0011649444,0.0033472972,0.0010337904],"domain_scores_gemma":[0.993053,0.0037044468,0.00032304245,0.00073379383,0.00034564288,0.0018400499],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.037255958,0.0006592242,0.004129345,0.0005679991,0.00013892664,0.000084936415,0.00048349568,0.00056850445,0.00031135586],"category_scores_gemma":[0.055993125,0.00044404232,0.00041810152,0.0015939623,0.00015000273,0.00007678801,0.00037549093,0.003264128,0.0005635758],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000009232256,0.0002386996,0.0000021563824,0.64867204,0.00007323,0.0003546512,0.000018135832,1.5157977e-9,1.8293925e-7,0.00018446655,0.0016574672,0.34878972],"study_design_scores_gemma":[0.00055905513,0.00064996997,0.0000010963589,0.82571787,0.00022974848,0.00013179555,0.000025931582,0.00042083728,2.7370632e-7,0.00028845068,0.17172055,0.0002544287],"about_ca_topic_score_codex":0.0000151900385,"about_ca_topic_score_gemma":0.000007500228,"teacher_disagreement_score":0.3485353,"about_ca_system_score_codex":0.00036288108,"about_ca_system_score_gemma":0.0016555731,"threshold_uncertainty_score":0.99980116},"labels":[],"label_agreement":null},{"id":"W3048971314","doi":"10.1080/03007995.2020.1810008","title":"Reply: RE: De Meo D, Zucchi B, Castagna V, et al. Validity and reliability of the Unified Classification System applied to periprosthetic femur fractures: a comparison with the Vancouver system. Curr Med Res Opin. 2020. DOI:10.1080/03007995.2020.1776232","year":2020,"lang":"en","type":"letter","venue":"Current Medical Research and Opinion","topic":"Orthopaedic implants and arthroplasty","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Periprosthetic; Medicine; Reliability (semiconductor); Femur; Validity; Femur fracture; Arthroplasty; Surgery; Clinical psychology; Psychometrics","score_opus":0.07802097610167356,"score_gpt":0.38237448191454787,"score_spread":0.3043535058128743,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3048971314","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.024348833,0.002974526,0.00065609335,0.96159667,0.0021741204,0.0059647304,0.0003942242,0.00015624346,0.0017345743],"genre_scores_gemma":[0.92834336,0.0032948712,0.00011402718,0.06334678,0.0031212035,0.00063022826,0.0006824418,0.00012284734,0.00034422718],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99107337,0.0019046203,0.0009929686,0.001151808,0.0039822953,0.000894924],"domain_scores_gemma":[0.995049,0.0018230709,0.00046492997,0.0012525484,0.00052756286,0.0008828744],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.004409958,0.00052889244,0.0011548375,0.00013185089,0.00062609813,0.00012973412,0.0005747387,0.00049087184,0.00012720466],"category_scores_gemma":[0.0025670263,0.00026852213,0.00014927557,0.0006470911,0.0013896545,0.00006813523,0.00055995764,0.0051362365,0.000017274684],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001287928,0.0001429687,0.0013820876,0.0059605795,0.00005662498,0.000081167644,0.0009057603,0.0000013491458,0.000018731624,0.00018069541,0.98382044,0.0061616623],"study_design_scores_gemma":[0.0017893977,0.0009659343,0.0042345133,0.005973339,0.0000960975,0.000176156,0.0032385888,0.0008048325,0.000038315426,0.000021250336,0.9823787,0.00028287357],"about_ca_topic_score_codex":0.00018341986,"about_ca_topic_score_gemma":0.00007509542,"teacher_disagreement_score":0.90399456,"about_ca_system_score_codex":0.0003344109,"about_ca_system_score_gemma":0.0017474649,"threshold_uncertainty_score":0.9999767},"labels":[],"label_agreement":null},{"id":"W3049727595","doi":"10.1080/03007995.2020.1810007","title":"RE: De Meo D, Zucchi B, Castagna V, et al. Validity and reliability of the Unified Classification System applied to periprosthetic femur fractures: a comparison with the Vancouver system. Curr Med Res Opin. 2020. DOI:10.1080/03007995.2020.1776232","year":2020,"lang":"en","type":"letter","venue":"Current Medical Research and Opinion","topic":"Orthopaedic implants and arthroplasty","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Periprosthetic; Medicine; Reliability (semiconductor); Femur; Validity; Surgery; Arthroplasty; Clinical psychology; Psychometrics","score_opus":0.07768337343092892,"score_gpt":0.3837157413883578,"score_spread":0.3060323679574289,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3049727595","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.030163981,0.0032607298,0.00082345394,0.95445263,0.0023522875,0.0063733654,0.00045056682,0.00015438037,0.001968606],"genre_scores_gemma":[0.9606564,0.0025785146,0.0000840527,0.032838978,0.002482981,0.00048703802,0.0005423829,0.00009439718,0.00023526537],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99152684,0.0017812188,0.000907457,0.0010338774,0.003879067,0.0008715161],"domain_scores_gemma":[0.9953968,0.0017811728,0.0004093032,0.0010595553,0.00049033563,0.0008628426],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.003836738,0.0005118538,0.0011014711,0.00012637112,0.0005979879,0.00012440313,0.00055904384,0.000524282,0.00012972164],"category_scores_gemma":[0.0020258815,0.00025776096,0.00014105848,0.00061081623,0.0013507134,0.00006435574,0.00052707,0.0049838196,0.000018095749],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011588238,0.00014528708,0.0014957462,0.006115626,0.000054667627,0.000071715,0.00092629605,0.0000014700912,0.00001762963,0.00018498751,0.9831124,0.006715358],"study_design_scores_gemma":[0.0018516653,0.0009495569,0.0046752254,0.0058638663,0.00009536715,0.00012892243,0.0040449263,0.0009059265,0.00003651709,0.000019875619,0.9811456,0.00028252986],"about_ca_topic_score_codex":0.00013711554,"about_ca_topic_score_gemma":0.0001089429,"teacher_disagreement_score":0.9304924,"about_ca_system_score_codex":0.00031143625,"about_ca_system_score_gemma":0.0016454144,"threshold_uncertainty_score":0.9999875},"labels":[],"label_agreement":null},{"id":"W3080405503","doi":"10.1080/03007995.2020.1815683","title":"Systematic literature review of humanistic and economic burdens of chronic rhinosinusitis with nasal polyposis","year":2020,"lang":"en","type":"review","venue":"Current Medical Research and Opinion","topic":"Sinusitis and nasal conditions","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Medicine; Chronic rhinosinusitis; Medical prescription; Quality of life (healthcare); Nasal polyps; Systematic review; Randomized controlled trial; MEDLINE; Internal medicine; Sinusitis; Health care; Endoscopic sinus surgery; Evidence-based medicine; Physical therapy; Surgery; Alternative medicine; Pathology","score_opus":0.08357800714526753,"score_gpt":0.44992370853035946,"score_spread":0.3663457013850919,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3080405503","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000021050802,0.9973201,0.000011812092,0.0002485612,0.00019749018,0.0018248875,0.00028105295,0.000010592899,0.000084457926],"genre_scores_gemma":[0.00019158494,0.99843234,0.000011110718,0.00001876609,0.0005340519,0.000120248355,0.0006392755,0.000028896371,0.000023702474],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9969176,0.0004164485,0.00094289833,0.0004251444,0.000997186,0.0003007019],"domain_scores_gemma":[0.9976331,0.0008556965,0.0003174873,0.0003145688,0.00025484944,0.00062426954],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009790217,0.00027429033,0.0025176234,0.0003136602,0.00008118435,0.000029179311,0.00017818224,0.00022761578,0.00022796463],"category_scores_gemma":[0.0011503603,0.00017358742,0.00019727995,0.0004035324,0.0005513496,0.000045036628,0.00016611844,0.0010847731,0.000011909072],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000014331457,0.000066569366,0.000006009722,0.8663192,0.00015457168,0.00005659422,0.000028879716,6.3764305e-10,2.0138161e-7,0.0008198296,0.002906037,0.12962782],"study_design_scores_gemma":[0.00041706266,0.0012645784,0.000026088977,0.82406914,0.00043072554,0.0005617417,0.000006621047,0.000013378475,4.6574428e-7,0.00000726579,0.17309177,0.00011113924],"about_ca_topic_score_codex":0.0000117796735,"about_ca_topic_score_gemma":0.000005331808,"teacher_disagreement_score":0.17018573,"about_ca_system_score_codex":0.0001614112,"about_ca_system_score_gemma":0.0017340233,"threshold_uncertainty_score":0.70786893},"labels":[],"label_agreement":null},{"id":"W3080596765","doi":"10.1080/03007995.2020.1815682","title":"Systematic literature review of the epidemiology and clinical burden of chronic rhinosinusitis with nasal polyposis","year":2020,"lang":"en","type":"review","venue":"Current Medical Research and Opinion","topic":"Sinusitis and nasal conditions","field":"Medicine","cited_by":128,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"AstraZeneca","keywords":"Medicine; Chronic rhinosinusitis; Epidemiology; Nasal polyps; Intensive care medicine; Dermatology; Clinical epidemiology; Systematic review; Sinusitis; MEDLINE; Internal medicine; Surgery","score_opus":0.187408076042334,"score_gpt":0.5285382074559681,"score_spread":0.34113013141363413,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3080596765","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000021410186,0.9953774,0.0000146716475,0.0018213808,0.00037025774,0.0022130597,0.00013037199,0.000007806877,0.000043592005],"genre_scores_gemma":[0.000070650894,0.99856913,0.000017886747,0.00008774069,0.00088179647,0.00009545321,0.00023467324,0.000021288306,0.000021354103],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9936079,0.002805194,0.0016506814,0.00046894685,0.0011139624,0.00035332268],"domain_scores_gemma":[0.9929475,0.0049495124,0.0005463915,0.00046670221,0.00040561584,0.0006842425],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.004629826,0.00025661354,0.003475527,0.0001675035,0.00009033842,0.000009716738,0.00029860213,0.00041245957,0.000082303835],"category_scores_gemma":[0.015489555,0.000120930315,0.0004190467,0.00083086453,0.0012796428,0.00003265672,0.0003339298,0.0021798692,0.000004511437],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000015488795,0.0000671538,0.00007820382,0.68329376,0.00016834613,0.00001779473,0.000015684476,3.8031878e-10,3.229385e-8,0.00043520157,0.003759184,0.31214917],"study_design_scores_gemma":[0.00039805574,0.0011122382,0.00019295022,0.77850914,0.00047324944,0.00047520257,0.0000055009577,0.000015025159,8.664891e-8,0.000012867441,0.21872929,0.00007640102],"about_ca_topic_score_codex":0.00001295489,"about_ca_topic_score_gemma":0.0000024849846,"teacher_disagreement_score":0.31207278,"about_ca_system_score_codex":0.00007316583,"about_ca_system_score_gemma":0.0018086433,"threshold_uncertainty_score":0.9928034},"labels":[],"label_agreement":null},{"id":"W3092419127","doi":"10.1080/03007995.2020.1835851","title":"Healthcare resource utilization and costs associated with first-line ibrutinib compared to chemoimmunotherapy treatment among Medicare beneficiaries with chronic lymphocytic leukemia","year":2020,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Ibrutinib; Medicine; Chemoimmunotherapy; Medicare Advantage; Chronic lymphocytic leukemia; Internal medicine; Ofatumumab; Pharmacy; Health care; Oncology; Leukemia; Family medicine","score_opus":0.13488527936780695,"score_gpt":0.4044661884187354,"score_spread":0.26958090905092846,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3092419127","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9566903,0.025049843,0.00037072992,0.015065719,0.00007751142,0.0024228927,0.000050006565,0.00015136415,0.000121632824],"genre_scores_gemma":[0.9772183,0.020906715,0.000030847197,0.00033163323,0.00045304358,0.00021484698,0.000738888,0.000061325176,0.000044402284],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9943916,0.0002829578,0.0004611709,0.0008674791,0.0029515713,0.0010452186],"domain_scores_gemma":[0.99535775,0.0011695984,0.00009587454,0.00039474203,0.0005236506,0.0024584024],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009219978,0.00035836035,0.0007012341,0.00022951176,0.000464125,0.00010642028,0.0002395018,0.00025647675,0.00012774505],"category_scores_gemma":[0.0023629465,0.00023844777,0.000043297023,0.0010958781,0.00096894824,0.00009776471,0.000221017,0.0007291889,0.0000117007085],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.026104739,0.0008646254,0.04202009,0.0055633867,0.0010375127,0.00071104115,0.012707654,0.000325753,0.000071832794,0.00083779555,0.009979692,0.89977586],"study_design_scores_gemma":[0.17489369,0.053565662,0.058328476,0.03626173,0.00017313627,0.0003773935,0.0031886143,0.4494333,0.0016807382,0.00007319697,0.2205638,0.0014602662],"about_ca_topic_score_codex":0.0021490846,"about_ca_topic_score_gemma":0.003903412,"teacher_disagreement_score":0.8983156,"about_ca_system_score_codex":0.033712834,"about_ca_system_score_gemma":0.028169343,"threshold_uncertainty_score":0.97734004},"labels":[],"label_agreement":null},{"id":"W3095779395","doi":"10.1080/03007995.2020.1846172","title":"Cost–utility analysis of second-line therapy with rituximab compared to tumour necrosis factor inhibitors in rheumatoid arthritis","year":2020,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal; Montreal Clinical Research Institute; Alberta Bone and Joint Health Institute; University of Calgary","funders":"","keywords":"Medicine; Rituximab; Rheumatoid arthritis; Second-line therapy; Antirheumatic Agents; Tumor necrosis factor alpha; Necrosis; Oncology; Internal medicine; Tumor necrosis factor α; Immunology; Chemotherapy; Lymphoma","score_opus":0.13620362382076182,"score_gpt":0.40953698873218386,"score_spread":0.273333364911422,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3095779395","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9634187,0.029163606,0.00025694064,0.0057776514,0.000077237564,0.0010562734,0.00014768018,0.000031095715,0.00007080357],"genre_scores_gemma":[0.8745567,0.12494898,0.000052693125,0.00010573981,0.000070480215,0.0000882779,0.00015737924,0.000015815187,0.000003899463],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9955854,0.00033660876,0.00061711704,0.00055697066,0.0021981741,0.0007057508],"domain_scores_gemma":[0.9969475,0.00047111383,0.00006318142,0.00025988053,0.00042868042,0.0018296378],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0011581212,0.00020553241,0.00094295933,0.0007087747,0.00011270145,0.00005789445,0.00022909195,0.00010485322,0.0017682558],"category_scores_gemma":[0.0015594179,0.00015254701,0.00011819742,0.0023110409,0.00060424296,0.0001233354,0.00016614069,0.0009535838,0.000020502916],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0062426357,0.0020552992,0.21034302,0.0003142212,0.00045739982,0.000051408562,0.0034189655,0.0000022352094,0.0016614847,0.00011009563,0.003812587,0.7715306],"study_design_scores_gemma":[0.037708055,0.009602757,0.743855,0.006517709,0.000008884901,0.000029216744,0.0019059365,0.01291642,0.011570967,0.0002436004,0.17495655,0.0006848959],"about_ca_topic_score_codex":0.00022422863,"about_ca_topic_score_gemma":0.00059096207,"teacher_disagreement_score":0.7708458,"about_ca_system_score_codex":0.000049665756,"about_ca_system_score_gemma":0.00052028295,"threshold_uncertainty_score":0.99914426},"labels":[],"label_agreement":null},{"id":"W3112727151","doi":"10.1080/03007995.2020.1860358","title":"The Rapid Mood Screener (RMS): a novel and pragmatic screener for bipolar I disorder","year":2020,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Bipolar Disorder and Treatment","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Bipolar disorder; Major depressive disorder; Mood; Medicine; Observational study; Psychiatry; Bipolar II disorder; Clinical psychology; Depression (economics); Bipolar I disorder; Medical diagnosis; Psychology; Internal medicine; Mania","score_opus":0.10576058156983975,"score_gpt":0.4115225177313636,"score_spread":0.30576193616152386,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112727151","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.01792087,0.77013177,0.022933733,0.18384553,0.00046761392,0.003852866,0.00015863834,0.00009737553,0.0005915826],"genre_scores_gemma":[0.7487779,0.24590297,0.000991221,0.00072275556,0.0019081904,0.0007814332,0.0006218109,0.000088220004,0.00020545033],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99777406,0.00009645224,0.00024181031,0.00036450574,0.0010197005,0.0005034445],"domain_scores_gemma":[0.99795806,0.00069555,0.00003040449,0.00019242564,0.00015864197,0.0009649425],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009998155,0.00015110867,0.00023533283,0.000064311236,0.00043713956,0.00006518426,0.0001312028,0.00010604032,0.000080941085],"category_scores_gemma":[0.0020577936,0.00008446501,0.000062991465,0.00023310624,0.0004782822,0.000059388454,0.00018619501,0.0005228696,0.000010771446],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004680134,0.00048552983,0.009091461,0.00056393497,0.000099173034,0.0000019726283,0.00021610875,5.825753e-8,0.000050627215,0.0042413143,0.0049736565,0.97980815],"study_design_scores_gemma":[0.0061460985,0.001942062,0.018980209,0.0003510263,0.000034879056,0.000033197073,0.00026618695,0.0065434556,0.00004200065,0.0004446564,0.9650905,0.0001257194],"about_ca_topic_score_codex":0.000036824324,"about_ca_topic_score_gemma":0.000048244725,"teacher_disagreement_score":0.97968245,"about_ca_system_score_codex":0.000018043833,"about_ca_system_score_gemma":0.00022973526,"threshold_uncertainty_score":0.3444383},"labels":[],"label_agreement":null},{"id":"W3119218090","doi":"10.1080/03007995.2021.1874324","title":"Effect of low-fat dairy products fortified with 1500IU nano encapsulated vitamin D<sub>3</sub> on cardiometabolic indicators in adults with abdominal obesity: a total blinded randomized controlled trial","year":2021,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Vitamin D Research Studies","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"National Institute for Medical Research Development","keywords":"Medicine; Vitamin D and neurology; Triglyceride; Randomized controlled trial; Glycemic; Obesity; Vitamin; Anthropometry; Internal medicine; Insulin; Gastroenterology; Endocrinology; Cholesterol","score_opus":0.021419472774957517,"score_gpt":0.35398708343574603,"score_spread":0.3325676106607885,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3119218090","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98299,0.0055877944,0.000023265902,0.0008151794,0.00044834046,0.009971181,0.000012134343,0.000031376334,0.00012072288],"genre_scores_gemma":[0.9908299,0.0066450806,0.000015521226,0.000009774033,0.0005809718,0.0017230064,0.00012420637,0.00003641306,0.000035164067],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.98866755,0.003326769,0.00097452605,0.0009721294,0.0049789357,0.0010801144],"domain_scores_gemma":[0.9928218,0.0045762253,0.00022687436,0.0005569614,0.0009069117,0.00091122265],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0100325765,0.00043402708,0.0032507572,0.0018305295,0.00018241764,0.00004584275,0.00020685914,0.00026649592,0.000027213046],"category_scores_gemma":[0.0329388,0.00023576154,0.0002531073,0.0031050185,0.0017948991,0.00010651671,0.00027906906,0.0017068107,0.0000074687323],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9264357,0.0019544053,0.0012869892,0.0029705798,0.0006758152,0.00037715898,0.0004473646,9.702276e-7,0.0029189312,0.000058739734,0.00020522185,0.06266812],"study_design_scores_gemma":[0.90482974,0.010879742,0.0037427684,0.007977513,0.00013661715,0.000060468577,0.00018585556,0.00033050537,0.07158385,0.000012729655,0.000037919486,0.00022228832],"about_ca_topic_score_codex":0.000023313647,"about_ca_topic_score_gemma":0.000020649393,"teacher_disagreement_score":0.06866492,"about_ca_system_score_codex":0.00014607758,"about_ca_system_score_gemma":0.0017940188,"threshold_uncertainty_score":0.97520715},"labels":[],"label_agreement":null},{"id":"W3161818128","doi":"10.1080/03007995.2021.1929896","title":"Development of a visual, patient-reported tool for assessing the multi-dimensional burden of endometriosis","year":2021,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Endometriosis Research and Treatment","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mount Sinai Hospital","funders":"","keywords":"Medicine; Endometriosis; Delphi method; Quality of life (healthcare); Psychosocial; Pelvic pain; Delphi; Patient-reported outcome; Physical therapy; Family medicine; Gynecology; Nursing; Psychiatry; Surgery","score_opus":0.18695679087554523,"score_gpt":0.5031652555898702,"score_spread":0.316208464714325,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3161818128","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9799214,0.016135294,0.0014047767,0.0011789438,0.00022116164,0.0010666056,0.000014151867,0.0000093035005,0.000048378486],"genre_scores_gemma":[0.9884511,0.0041483613,0.006822251,0.000014315464,0.00011821491,0.0002124054,0.00017788717,0.000013541394,0.000041872747],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99579555,0.00021553595,0.0006375302,0.0003094985,0.0026043642,0.00043754614],"domain_scores_gemma":[0.9916814,0.00618087,0.00011816712,0.00022096065,0.0013580403,0.00044054526],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0023064932,0.000115559145,0.00037508435,0.0003849476,0.00020060287,0.00002535211,0.00009652911,0.00008418299,0.00015046689],"category_scores_gemma":[0.044600107,0.00006931513,0.00010976023,0.00096450903,0.00032701116,0.000055447366,0.0002648235,0.00038409914,0.0000024015158],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033041867,0.0025470317,0.005898544,0.0009977857,0.00031592362,0.000030713567,0.0004378398,3.7003156e-7,0.009123307,0.00010973803,0.00086182967,0.9793465],"study_design_scores_gemma":[0.034805883,0.0052118185,0.054954574,0.009783527,0.00013892527,0.0002297175,0.0033751016,0.008360511,0.42312875,0.0002720358,0.459232,0.00050714595],"about_ca_topic_score_codex":0.000017515436,"about_ca_topic_score_gemma":0.0000030899068,"teacher_disagreement_score":0.97883934,"about_ca_system_score_codex":0.00008828796,"about_ca_system_score_gemma":0.0021706345,"threshold_uncertainty_score":0.96344763},"labels":[],"label_agreement":null},{"id":"W3178434074","doi":"10.1080/03007995.2021.1953456","title":"Matching-adjusted indirect comparison of efficacy outcomes for ciltacabtagene autoleucel in CARTITUDE-1 versus idecabtagene vicleucel in KarMMa for the treatment of patients with relapsed or refractory multiple myeloma","year":2021,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Medicine; Internal medicine; Confidence interval; Hazard ratio; Multiple myeloma; Gastroenterology; Refractory (planetary science); Progression-free survival; Odds ratio; Oncology; Overall survival","score_opus":0.2050472340995364,"score_gpt":0.46977746952371724,"score_spread":0.26473023542418084,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3178434074","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9917193,0.0042024646,0.00016325341,0.00050282764,0.00027891863,0.0029498853,0.00015950477,0.0000114238255,0.000012389224],"genre_scores_gemma":[0.99539787,0.0028757611,0.0004329055,0.0000060016005,0.00006511723,0.00055859546,0.0005824478,0.000026101872,0.000055219385],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.996559,0.00024309993,0.00066581875,0.00045960827,0.0014359915,0.0006364497],"domain_scores_gemma":[0.9922118,0.006357835,0.00013023854,0.00037995662,0.0004992413,0.00042090006],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007912538,0.0002209476,0.0008094054,0.00033109402,0.00012092298,0.000016141814,0.00016779918,0.00014883124,0.000051500938],"category_scores_gemma":[0.0036465041,0.0001223709,0.000120232864,0.00054836366,0.00028430004,0.0000622359,0.000084615756,0.0003462015,0.0000013823719],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.031196259,0.010077615,0.60848796,0.0008177844,0.00029562478,0.00002654265,0.001526386,0.00001096164,0.00021221506,0.000032104806,0.00011956068,0.347197],"study_design_scores_gemma":[0.069179155,0.009169256,0.9081406,0.00081449153,0.00004291833,9.3996226e-7,0.00063576736,0.003191961,0.0041971006,0.000019473462,0.0044860924,0.00012223813],"about_ca_topic_score_codex":0.00028621365,"about_ca_topic_score_gemma":0.001845181,"teacher_disagreement_score":0.34707475,"about_ca_system_score_codex":0.00029616748,"about_ca_system_score_gemma":0.00091966096,"threshold_uncertainty_score":0.49901405},"labels":[],"label_agreement":null},{"id":"W3185110408","doi":"10.1080/03007995.2021.1957807","title":"Cognitive function improvement after fecal microbiota transplantation in Alzheimer’s dementia patient: a case report","year":2021,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Clostridium difficile and Clostridium perfringens research","field":"Medicine","cited_by":153,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Research Foundation of Korea","keywords":"Medicine; Dementia; Fecal bacteriotherapy; Cognition; Transplantation; Intensive care medicine; Gerontology; Psychiatry; Internal medicine; Disease; Clostridium difficile; Antibiotics","score_opus":0.08422120638097003,"score_gpt":0.40744986422545176,"score_spread":0.32322865784448174,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3185110408","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.965165,0.031986512,0.00013669698,0.0012478867,0.0004625222,0.0006835148,0.000049499915,0.00001698519,0.00025134228],"genre_scores_gemma":[0.98959756,0.009085381,0.000013782305,0.00006889246,0.00028994275,0.00017389079,0.0007345295,0.000016241014,0.000019755176],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99665636,0.00021402136,0.00048945635,0.0005967739,0.0014308075,0.00061258255],"domain_scores_gemma":[0.9983091,0.0002691887,0.000040359813,0.00019929791,0.000540618,0.0006414414],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010163526,0.0001580695,0.0002439033,0.00028215355,0.00013579964,0.00005459088,0.000045647994,0.00017125129,0.00080875447],"category_scores_gemma":[0.00085530046,0.00013892278,0.000072477946,0.0005504417,0.00022957046,0.00008085263,0.00014273958,0.0010213328,0.00003349014],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034052199,0.0020551959,0.00516248,0.00073170767,0.00035941278,0.09812154,0.0005100137,9.944116e-8,0.0058692745,0.000045526886,0.0014189733,0.8823206],"study_design_scores_gemma":[0.05902579,0.021863023,0.100327365,0.02137538,0.002247955,0.21965252,0.011517145,0.002822567,0.4190508,0.0006358063,0.13896957,0.0025120585],"about_ca_topic_score_codex":0.00016365855,"about_ca_topic_score_gemma":0.00021930985,"teacher_disagreement_score":0.8798085,"about_ca_system_score_codex":0.00008053694,"about_ca_system_score_gemma":0.00081549963,"threshold_uncertainty_score":0.8855294},"labels":[],"label_agreement":null},{"id":"W3185400263","doi":"10.1080/03007995.2021.1954894","title":"Prevalence, incidence and economic burden of schizophrenia among Medicaid beneficiaries","year":2021,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"Janssen Scientific Affairs","keywords":"Medicine; Medicaid; Schizophrenia (object-oriented programming); Incidence (geometry); Cohort; Demography; Indirect costs; Health care; Psychiatry; Environmental health; Internal medicine","score_opus":0.05604061656589541,"score_gpt":0.39635568613872985,"score_spread":0.3403150695728344,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3185400263","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9454257,0.05005401,0.000024876948,0.0036731823,0.00023994377,0.00032739204,0.000026595293,0.000018472821,0.00020982962],"genre_scores_gemma":[0.91463345,0.08444086,0.00023204356,0.000008176318,0.00048790517,0.00004484861,0.000059727834,0.0000115910525,0.00008140733],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9968198,0.00020408678,0.00036251615,0.00048686308,0.0016195318,0.00050723425],"domain_scores_gemma":[0.99729484,0.00078271684,0.00005159034,0.00031714368,0.00030251115,0.0012511738],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013634663,0.0001463162,0.00036287407,0.0002318684,0.00016305984,0.000047759797,0.0001515227,0.00014559455,0.0007266013],"category_scores_gemma":[0.0033935073,0.00011295088,0.0000543251,0.00023607047,0.0011294603,0.00012490472,0.0004511033,0.00075007556,0.000024246367],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004161826,0.0005592198,0.21373871,0.0029070603,0.00019095058,0.00028818546,0.00043741948,7.4326306e-7,0.00019483118,0.01973804,0.0026394397,0.7551436],"study_design_scores_gemma":[0.01474145,0.0030955058,0.9322169,0.0095796725,0.000082334634,0.00047452975,0.00079953304,0.00637784,0.004893873,0.015825834,0.011472628,0.00043989054],"about_ca_topic_score_codex":0.00022950656,"about_ca_topic_score_gemma":0.00018586486,"teacher_disagreement_score":0.7547037,"about_ca_system_score_codex":0.000078926874,"about_ca_system_score_gemma":0.0019486853,"threshold_uncertainty_score":0.79557747},"labels":[],"label_agreement":null},{"id":"W3191713770","doi":"10.1080/03007995.2021.1968362","title":"Indirect comparisons of siponimod with fingolimod and ofatumumab in multiple sclerosis: assessing the feasibility of propensity score matching analyses","year":2021,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"Novartis","keywords":"Medicine; Fingolimod; Propensity score matching; Matching (statistics); Multiple sclerosis; Ofatumumab; Physical therapy; Internal medicine; Psychiatry","score_opus":0.631404866743863,"score_gpt":0.5189867310299335,"score_spread":0.11241813571392945,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3191713770","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98839915,0.009475219,0.00019453175,0.0011675505,0.000043285232,0.00062113605,0.000013800367,0.000008635342,0.00007671171],"genre_scores_gemma":[0.9923963,0.007230508,0.00024363979,0.000008698332,0.000052534546,0.00003132428,0.0000244446,0.000009383311,0.0000031473105],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9960301,0.00076301367,0.00043743107,0.0004221553,0.0019057785,0.00044153127],"domain_scores_gemma":[0.99664325,0.0019100807,0.00010036737,0.0003454396,0.0006671385,0.00033371605],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0031840205,0.00013791233,0.00062913715,0.0002138486,0.00023198687,0.000045813962,0.00014861411,0.0000797677,0.000023193274],"category_scores_gemma":[0.0085186,0.00007940785,0.000049933053,0.00079026574,0.0014914214,0.000115627714,0.00055616756,0.001052286,3.8970194e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003988064,0.000857213,0.9455684,0.001509499,0.00007324338,0.000009416689,0.00078539393,0.0000029267671,0.009525012,0.000025659758,0.00014627629,0.041098148],"study_design_scores_gemma":[0.002483945,0.00036322983,0.98235226,0.005665597,0.000013543452,0.000009941392,0.0013166415,0.00204858,0.005567208,0.000051317336,0.000056972527,0.00007075056],"about_ca_topic_score_codex":0.00052696286,"about_ca_topic_score_gemma":0.00061538356,"teacher_disagreement_score":0.041027397,"about_ca_system_score_codex":0.000073049225,"about_ca_system_score_gemma":0.000823948,"threshold_uncertainty_score":0.99983305},"labels":[],"label_agreement":null},{"id":"W3199623651","doi":"10.1080/03007995.2021.1981278","title":"Treatment patterns and sequencing in patients with rheumatic diseases: a retrospective claims data analysis","year":2021,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Statistics Canada","funders":"Pfizer","keywords":"Medicine; Psoriatic arthritis; Biosimilar; Ankylosing spondylitis; Rheumatoid arthritis; Internal medicine; Etanercept; Retrospective cohort study; Arthritis","score_opus":0.07643300516365084,"score_gpt":0.4015707805054439,"score_spread":0.3251377753417931,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3199623651","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98522526,0.013123295,0.0001895393,0.00079544313,0.00005027072,0.00040838204,0.00015866123,0.000013398743,0.000035764384],"genre_scores_gemma":[0.89334005,0.10516313,0.000037410227,0.000009808662,0.000043959262,0.00003777653,0.0013455803,0.000009386597,0.000012903744],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969112,0.00026129227,0.00023629073,0.0005703649,0.0015530301,0.00046777155],"domain_scores_gemma":[0.9981438,0.00028202447,0.000027806027,0.0004893364,0.0002491971,0.0008078159],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00051547517,0.00013076985,0.0004119091,0.000336458,0.00013374643,0.00008315574,0.0001173438,0.000054796506,0.00024047849],"category_scores_gemma":[0.0011470584,0.00008659657,0.000031730502,0.00073396997,0.00030696567,0.00016096173,0.00027099054,0.00041746342,0.0000039669135],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024726236,0.00043505247,0.8438037,0.00014321564,0.00023450398,0.000068813555,0.00028051902,1.0318393e-7,7.3920677e-7,0.0001363454,0.000069085814,0.15458064],"study_design_scores_gemma":[0.0052759503,0.001266387,0.987333,0.0014154738,0.00001779157,0.000011177387,0.000436713,0.0029499454,0.0000056549516,0.0003229039,0.00087014085,0.000094885996],"about_ca_topic_score_codex":0.00032075853,"about_ca_topic_score_gemma":0.0005822695,"teacher_disagreement_score":0.15448575,"about_ca_system_score_codex":0.0002826195,"about_ca_system_score_gemma":0.0007988162,"threshold_uncertainty_score":0.35313058},"labels":[],"label_agreement":null},{"id":"W4206114597","doi":"10.1080/03007995.2022.2031144","title":"The use of progestin subdermal implants in the management of endometriosis-related pain symptoms and quality of life: a systematic review","year":2022,"lang":"en","type":"review","venue":"Current Medical Research and Opinion","topic":"Endometriosis Research and Treatment","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Pelvic pain; Endometriosis; Medroxyprogesterone acetate; Progestin; Implant; Randomized controlled trial; Observational study; Quality of life (healthcare); Visual analogue scale; Gynecology; Surgery; Obstetrics; Internal medicine; Estrogen","score_opus":0.4168927478318649,"score_gpt":0.5228385278024101,"score_spread":0.10594577997054522,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4206114597","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00026566183,0.9909758,0.0000037190252,0.00029504177,0.00006472565,0.008286692,0.00007682885,0.000004774241,0.000026747184],"genre_scores_gemma":[0.0011146534,0.9970759,0.00000923405,0.000012115086,0.000017035301,0.001549425,0.00018976348,0.000015890473,0.000015957918],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9838431,0.008558223,0.0022670012,0.00039987252,0.0043759597,0.00055587507],"domain_scores_gemma":[0.94566375,0.052218422,0.0007084092,0.00068755395,0.00022912017,0.0004927554],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.030486131,0.0002633314,0.002616745,0.0006847404,0.0001242711,0.000024546303,0.00047773775,0.00013013446,0.000060648323],"category_scores_gemma":[0.07336376,0.000118841206,0.0002981983,0.002577448,0.00065818493,0.000040098825,0.000525723,0.0012898251,0.0000014491468],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005453655,0.00042963715,0.0001460904,0.54076433,0.00039396837,0.0000141072405,0.00002254284,2.3079734e-9,2.7260047e-8,0.0003278493,0.00018137252,0.45766556],"study_design_scores_gemma":[0.0019214487,0.0013569517,0.0003047762,0.76975775,0.00046098375,0.00005596991,0.00012836131,0.000016069067,4.7239155e-7,0.000019521025,0.2258655,0.00011216956],"about_ca_topic_score_codex":0.00007782299,"about_ca_topic_score_gemma":0.000005837052,"teacher_disagreement_score":0.4575534,"about_ca_system_score_codex":0.00011545007,"about_ca_system_score_gemma":0.0006510933,"threshold_uncertainty_score":0.99831855},"labels":[],"label_agreement":null},{"id":"W4210946737","doi":"10.1080/03007995.2022.2037846","title":"Impact of switching to infliximab biosimilars on treatment patterns among US veterans receiving innovator infliximab","year":2022,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Medicine; Biosimilar; Infliximab; Innovator; Population; Rheumatoid arthritis; Discontinuation; Internal medicine; Disease","score_opus":0.11043825545334685,"score_gpt":0.4623763787597316,"score_spread":0.35193812330638474,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4210946737","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955767,0.0015077795,0.00019856096,0.0011813467,0.0008458235,0.000427198,0.00015745703,0.000022880355,0.000082274004],"genre_scores_gemma":[0.9984111,0.0011386796,0.000031835956,0.00011063963,0.00009120187,0.00008970253,0.00006957282,0.000015525091,0.00004174112],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99707675,0.000878536,0.00044513145,0.00047510234,0.00043817257,0.00068632653],"domain_scores_gemma":[0.9984053,0.0008244031,0.00007815916,0.00030647352,0.00012455524,0.00026113848],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001982319,0.00021788439,0.00041781345,0.00046065412,0.00033621062,0.000026385595,0.0003424335,0.00017124526,0.0014469858],"category_scores_gemma":[0.0011174232,0.00014791526,0.00014499355,0.0006089618,0.00025624209,0.00005215726,0.0004781264,0.0011498678,0.000012292147],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014856772,0.0019021236,0.2799816,0.00010551048,0.00029464057,0.000015950127,0.0011626934,0.000005523933,0.011636067,0.00026268503,0.0040337103,0.6991138],"study_design_scores_gemma":[0.0064634965,0.023347836,0.8426701,0.0010213482,0.000029560975,0.000045345692,0.00045403317,0.00032137055,0.010266488,0.00031072996,0.11449978,0.0005699442],"about_ca_topic_score_codex":0.00034827398,"about_ca_topic_score_gemma":0.000022607648,"teacher_disagreement_score":0.69854385,"about_ca_system_score_codex":0.00030362015,"about_ca_system_score_gemma":0.0002625327,"threshold_uncertainty_score":0.9994658},"labels":[],"label_agreement":null},{"id":"W4220717164","doi":"10.1080/03007995.2022.2049162","title":"Development and evaluation of a predictive algorithm for unsatisfactory response among patients with pulmonary arterial hypertension using health insurance claims data","year":2022,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Pulmonary Hypertension Research and Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"Janssen Scientific Affairs","keywords":"Medicine; Algorithm; Internal medicine; Comorbidity; Framingham Risk Score; Emergency medicine; Pediatrics; Disease","score_opus":0.241932831906,"score_gpt":0.4448016409292165,"score_spread":0.20286880902321647,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220717164","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99323523,0.003253128,0.00032653334,0.0003738757,0.00022630283,0.0020676563,0.00050419546,0.000010382788,0.0000026855832],"genre_scores_gemma":[0.9955776,0.00070686906,0.00136032,0.00002674571,0.000080291975,0.0002121827,0.0020136265,0.00001768082,0.0000046806576],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9942199,0.00086920144,0.00033633134,0.0005320097,0.0036137647,0.00042878184],"domain_scores_gemma":[0.9977727,0.00046009762,0.0000980367,0.00031812894,0.0006950421,0.0006560117],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005135415,0.00013414258,0.0003203193,0.00027788666,0.00053971703,0.000012825845,0.00013953217,0.000053798394,0.000040552244],"category_scores_gemma":[0.00084186014,0.0000983733,0.000017741017,0.00026592353,0.00035967425,0.00015569625,0.00049511844,0.00043416367,3.3317394e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009415173,0.0018011641,0.10540783,0.00022267904,0.000087265595,0.00003525996,0.00015553641,0.0000011529905,0.000090119196,0.0000019745705,0.00056273094,0.88221914],"study_design_scores_gemma":[0.007441553,0.002989663,0.87155116,0.00068919826,0.000016400167,0.000054756223,0.00026200607,0.11347398,0.000021888061,0.000042930184,0.003361833,0.000094659445],"about_ca_topic_score_codex":0.00006016237,"about_ca_topic_score_gemma":0.0000048109728,"teacher_disagreement_score":0.8821245,"about_ca_system_score_codex":0.0002638469,"about_ca_system_score_gemma":0.0025202911,"threshold_uncertainty_score":0.4470888},"labels":[],"label_agreement":null},{"id":"W4230143059","doi":"10.1185/030079900542902","title":"Dose Response and Safety of Cizolirtine Citrate (E-4018) in Patients with Pain Following Extraction of Third Molars","year":2000,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Dental Radiography and Imaging","field":"Dentistry","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Molar; Dentistry; Anesthesia","score_opus":0.029024237747711804,"score_gpt":0.37399881758493514,"score_spread":0.34497457983722335,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4230143059","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99716026,0.002069775,0.00007699987,0.000092853894,0.00015853561,0.00023409263,0.000014633205,0.000007679862,0.00018517344],"genre_scores_gemma":[0.99863136,0.0012284464,0.000032741063,0.0000070637225,0.000028778284,0.000007419034,0.00003060074,0.000007718979,0.000025870584],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997288,0.0006784707,0.0003622537,0.00023886075,0.00114121,0.0002911937],"domain_scores_gemma":[0.9988181,0.0006763191,0.000056780616,0.000137107,0.00007553406,0.00023614266],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0041864906,0.000093793016,0.00020515788,0.00029723663,0.00007332467,0.000021169257,0.00010889359,0.0000740184,0.00014095368],"category_scores_gemma":[0.0010747889,0.0000748373,0.000044401597,0.0005202643,0.00029541677,0.00021435042,0.000046148547,0.00047725838,0.0000025886798],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008367462,0.00048845,0.60904646,0.00020726502,0.00002321917,0.000021138767,0.00020988892,5.621777e-7,0.00024085563,0.000043185686,0.00027097797,0.38108057],"study_design_scores_gemma":[0.003377401,0.00061589316,0.9917687,0.0012327518,0.0000037558673,0.000004755939,0.00011834522,0.00034730756,0.00019891142,0.00018267723,0.0020674253,0.000082028615],"about_ca_topic_score_codex":0.000055373348,"about_ca_topic_score_gemma":0.000017226477,"teacher_disagreement_score":0.38272232,"about_ca_system_score_codex":0.000025362451,"about_ca_system_score_gemma":0.00008358663,"threshold_uncertainty_score":0.30517763},"labels":[],"label_agreement":null},{"id":"W4234826894","doi":"10.1185/03007995.2014.928275","title":"Once daily controlled-release pregabalin in the treatment of patients with fibromyalgia: a phase III, double-blind, randomized withdrawal, placebo-controlled study","year":2014,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Fibromyalgia and Chronic Fatigue Syndrome Research","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"Pfizer","keywords":"Pregabalin; Medicine; Placebo; Tolerability; Discontinuation; Clinical endpoint; Randomized controlled trial; Adverse effect; Fibromyalgia; Anesthesia; Clinical trial; Internal medicine","score_opus":0.053608015568913085,"score_gpt":0.4062697412229176,"score_spread":0.3526617256540045,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4234826894","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97735345,0.0046926728,0.00017600601,0.0011905391,0.000121560326,0.016237747,0.0000073231326,0.000019102703,0.0002015737],"genre_scores_gemma":[0.99435943,0.0025340982,0.000017344844,0.000004206919,0.00009611219,0.0026866144,0.00016020682,0.000023598566,0.00011840931],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9914671,0.0022916198,0.0009793779,0.00060816965,0.0038204908,0.0008332451],"domain_scores_gemma":[0.99348795,0.004507208,0.00018728875,0.0006015456,0.0004987031,0.0007172764],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0066497945,0.00033926216,0.0019758777,0.00046655626,0.0002102061,0.000069462614,0.00033871393,0.00015579985,0.00024254591],"category_scores_gemma":[0.0020535272,0.00015889917,0.000219195,0.00062759756,0.001080495,0.000102702055,0.00007289958,0.00084247236,0.0000103125785],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.96184206,0.017985633,0.0039415825,0.0010085884,0.00040305074,0.000029120481,0.00192578,0.0000015071192,0.0000049225996,0.0002358143,0.0004505734,0.012171357],"study_design_scores_gemma":[0.9666039,0.024334399,0.0012626722,0.0019096712,0.00011991366,0.0000069488965,0.0006675015,0.0043630977,0.000017783495,0.00005616471,0.00051159185,0.0001463837],"about_ca_topic_score_codex":0.00024932748,"about_ca_topic_score_gemma":0.000017608596,"teacher_disagreement_score":0.017005933,"about_ca_system_score_codex":0.00017302296,"about_ca_system_score_gemma":0.0009934775,"threshold_uncertainty_score":0.647972},"labels":[],"label_agreement":null},{"id":"W4239583063","doi":"10.1185/030079907x253762","title":"Clopidogrel versus aspirin in patients with atherothrombosis: CAPRIE-based calculation of cost-effectiveness for Germany","year":2008,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Clopidogrel; Aspirin; Myocardial infarction; Internal medicine; Stroke (engine); Cardiology; Framingham Risk Score; Emergency medicine; Disease","score_opus":0.14654931667180354,"score_gpt":0.4303641704455804,"score_spread":0.28381485377377685,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4239583063","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99261963,0.0029552502,0.0026376704,0.0000633468,0.00013601144,0.0015195503,0.000013008027,0.000016520593,0.00003900839],"genre_scores_gemma":[0.9982209,0.0012777701,0.00003528414,0.000008344624,0.000083008745,0.000176461,0.0001766088,0.000018292303,0.0000033270437],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99823266,0.00016683408,0.0001540685,0.0002148078,0.0009845174,0.00024711914],"domain_scores_gemma":[0.99906975,0.00029588107,0.000030403817,0.00014900656,0.00020343621,0.00025149825],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006850873,0.00008883079,0.00026051042,0.00015890844,0.000064273554,0.0000033882468,0.000056059704,0.00008540284,0.00001862117],"category_scores_gemma":[0.00031667587,0.00006522619,0.000074290394,0.00022678047,0.00035406472,0.00003867087,0.00001986572,0.00019275492,0.0000013777529],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018150253,0.0018634252,0.77562207,0.0014040348,0.00017927548,0.000010625655,0.00010560126,0.000008868191,0.000021336704,0.00026966826,0.0005027533,0.20186208],"study_design_scores_gemma":[0.028265376,0.0023639959,0.9562991,0.0016442867,0.00001453602,0.0000013653618,0.000014438152,0.00055859063,0.00027006964,0.000017386172,0.010453936,0.00009688206],"about_ca_topic_score_codex":0.000030047413,"about_ca_topic_score_gemma":0.0000048241895,"teacher_disagreement_score":0.2017652,"about_ca_system_score_codex":0.000048535123,"about_ca_system_score_gemma":0.0002841539,"threshold_uncertainty_score":0.26598468},"labels":[],"label_agreement":null},{"id":"W4249688750","doi":"10.1185/03007991003715657","title":"Comment on: Are intranasal corticosteroids all equally consistent in managing ocular symptoms of seasonal allergic rhinitis?","year":2010,"lang":"en","type":"letter","venue":"Current Medical Research and Opinion","topic":"Allergic Rhinitis and Sensitization","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Nasal administration; Dermatology; Allergy; Anesthesia; Pharmacology; Immunology","score_opus":0.08842048054114557,"score_gpt":0.38155415570002754,"score_spread":0.293133675158882,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4249688750","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.022729043,0.0049390085,0.00021491025,0.96834296,0.0017552136,0.0011467548,0.00006827557,0.000032458156,0.0007713864],"genre_scores_gemma":[0.32473475,0.063961335,0.00012329519,0.59403265,0.007930123,0.00020414025,0.00862125,0.00019683216,0.0001956165],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.993325,0.00053991546,0.00084736897,0.00068119715,0.0037728704,0.0008336638],"domain_scores_gemma":[0.9973619,0.00089940004,0.00021308941,0.00044305733,0.00044384316,0.0006387042],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0016096252,0.00035365927,0.00086627743,0.00054097513,0.0000986179,0.000058812966,0.00026496217,0.0011727781,0.00037418088],"category_scores_gemma":[0.0009928629,0.00029450798,0.00014526215,0.00023673658,0.00074280635,0.000053125576,0.0002441214,0.0080576595,0.000020064315],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005653325,0.00080709875,0.0023215294,0.0028715983,0.00023233762,0.0024382533,0.00032760476,9.98602e-7,0.000012899387,0.00129619,0.8830311,0.1060951],"study_design_scores_gemma":[0.004256912,0.0017275019,0.004071787,0.011572118,0.000031802818,0.00017058736,0.000099918456,0.0031640157,0.000016547945,0.0006496096,0.97389925,0.0003399472],"about_ca_topic_score_codex":0.00005256852,"about_ca_topic_score_gemma":0.000030603103,"teacher_disagreement_score":0.37431028,"about_ca_system_score_codex":0.00016707112,"about_ca_system_score_gemma":0.00050865696,"threshold_uncertainty_score":0.9999507},"labels":[],"label_agreement":null},{"id":"W4280563518","doi":"10.1080/03007995.2022.2076474","title":"Oral, intranasal, and intravenous abuse potential of serdexmethylphenidate, a novel prodrug of d-methylphenidate","year":2022,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Forensic Toxicology and Drug Analysis","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Altasciences (Canada); Systems, Applications & Products in Data Processing (Canada); University of Toronto","funders":"","keywords":"Medicine; Placebo; Crossover study; Methylphenidate; Pharmacology; Anesthesia; Internal medicine; Psychiatry","score_opus":0.15587980583202146,"score_gpt":0.4960759154135574,"score_spread":0.3401961095815359,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4280563518","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9863283,0.009013992,0.00058722147,0.002036085,0.0011905234,0.00046668266,0.00021167826,0.000024279925,0.00014122303],"genre_scores_gemma":[0.987391,0.011949529,0.00014724398,0.000103784965,0.00015582536,0.000063990694,0.00010672511,0.000014932296,0.00006696987],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9961931,0.0012087108,0.0005811902,0.00044189583,0.0010028741,0.00057223544],"domain_scores_gemma":[0.9979761,0.0008426319,0.00016498168,0.00021674723,0.00024846807,0.00055106403],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0054290774,0.0001755197,0.00048731174,0.0004102684,0.00047157044,0.000010523389,0.00038925483,0.00023706138,0.0018397688],"category_scores_gemma":[0.0006837931,0.00015658447,0.00008043817,0.00066571066,0.0020599926,0.000081551945,0.0005294419,0.002193495,0.0000037526906],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0057623717,0.0078003258,0.008000171,0.0018098865,0.0011003852,0.00008536188,0.0067520286,0.00031363734,0.05361892,0.016233206,0.022015883,0.8765078],"study_design_scores_gemma":[0.024603907,0.01041091,0.014103166,0.0004782325,0.00066175585,0.0004575047,0.006736605,0.059867322,0.054258656,0.016031953,0.8108922,0.0014977674],"about_ca_topic_score_codex":0.000089631525,"about_ca_topic_score_gemma":0.000024451803,"teacher_disagreement_score":0.8750101,"about_ca_system_score_codex":0.000037380876,"about_ca_system_score_gemma":0.00036737398,"threshold_uncertainty_score":0.9990727},"labels":[],"label_agreement":null},{"id":"W4281383295","doi":"10.1080/03007995.2022.2081455","title":"Risk factors and pooled incidence of intestinal stoma complications: systematic review and Meta-analysis","year":2022,"lang":"en","type":"review","venue":"Current Medical Research and Opinion","topic":"Stoma care and complications","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Incidence (geometry); Meta-analysis; Observational study; Systematic review; Risk factor; Overweight; Epidemiology; MEDLINE; Surgery; Internal medicine; Obesity","score_opus":0.42147780713320093,"score_gpt":0.5376191069850134,"score_spread":0.11614129985181243,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281383295","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000013445872,0.996574,0.00019690667,0.00045068443,0.000027372967,0.0025158098,0.00015633457,0.0000176342,0.000047814083],"genre_scores_gemma":[0.00014092878,0.9980113,0.000045764413,0.00003932433,0.000023789038,0.0012366258,0.0004628193,0.000014868744,0.000024570494],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9953852,0.0012293798,0.0010434953,0.00057324127,0.0015085206,0.00026015186],"domain_scores_gemma":[0.9933314,0.0045260955,0.0004664531,0.0006933871,0.00036071273,0.0006219866],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0028134517,0.00027991022,0.004152744,0.0006272584,0.00023528525,0.000028412625,0.00030685542,0.00011263545,0.0005068408],"category_scores_gemma":[0.009996867,0.00016744075,0.0005990445,0.0015230349,0.000486973,0.00004146846,0.0004936761,0.0012327066,0.0000051552424],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000036569504,0.00016071065,0.00012281029,0.8882781,0.017396556,0.0000028772351,0.00004603344,3.698968e-9,1.7249207e-8,0.0006064237,0.0006783652,0.09270442],"study_design_scores_gemma":[0.00020862963,0.00053413183,0.00058953254,0.11792821,0.5984388,0.00026449337,0.00011344688,0.00005276943,1.0007451e-7,0.00022043403,0.28136173,0.00028773662],"about_ca_topic_score_codex":0.00009264356,"about_ca_topic_score_gemma":0.000007770603,"teacher_disagreement_score":0.7703499,"about_ca_system_score_codex":0.00006847353,"about_ca_system_score_gemma":0.00048126164,"threshold_uncertainty_score":0.99834234},"labels":[],"label_agreement":null},{"id":"W4283836524","doi":"10.1080/03007995.2022.2096351","title":"Rapid improvement in severe long COVID following perispinal etanercept","year":2022,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Long-Term Effects of COVID-19","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Etanercept; Neuroinflammation; Stroke (engine); Trail Making Test; Internal medicine; Physical therapy; Physical medicine and rehabilitation; Tumor necrosis factor alpha; Inflammation","score_opus":0.0729468863621934,"score_gpt":0.4428301901702262,"score_spread":0.3698833038080328,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283836524","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9609974,0.01652365,0.00026778644,0.01804096,0.001773967,0.0018233738,0.000014075406,0.000065774686,0.0004930279],"genre_scores_gemma":[0.99534714,0.0027656273,0.000044702727,0.0007070393,0.00048103125,0.00033552968,0.00017361715,0.000023148948,0.00012218261],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9946005,0.0004866137,0.00035767816,0.0005368659,0.003253699,0.0007646539],"domain_scores_gemma":[0.9974916,0.00086898805,0.000040045477,0.00031037987,0.00006538273,0.0012236164],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.004502053,0.00016462275,0.0003390729,0.00043002062,0.00038465287,0.000042666754,0.00028193928,0.000089910485,0.0022806006],"category_scores_gemma":[0.0042570005,0.00014139045,0.000100970516,0.0005236257,0.00022172832,0.00010142695,0.0007731844,0.0018795388,0.000022511009],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016005614,0.0010043385,0.079126336,0.0018608951,0.000050735336,0.0010261175,0.0008624693,0.0000034397813,0.00032216322,0.00026452856,0.012086076,0.90179235],"study_design_scores_gemma":[0.026037969,0.017198097,0.18626195,0.0036109146,0.000043033728,0.00052196387,0.0020691743,0.0073140226,0.00015104294,0.0010897628,0.75484675,0.00085530226],"about_ca_topic_score_codex":0.00009431085,"about_ca_topic_score_gemma":0.000017689768,"teacher_disagreement_score":0.900937,"about_ca_system_score_codex":0.0005945849,"about_ca_system_score_gemma":0.001366289,"threshold_uncertainty_score":0.9986315},"labels":[],"label_agreement":null},{"id":"W4292202432","doi":"10.1080/03007995.2022.2113689","title":"Efficacy and safety of tanezumab, NSAIDs, and placebo in patients with moderate to severe hip or knee osteoarthritis and a history of depression, anxiety, or insomnia: post-hoc analysis of phase 3 trials","year":2022,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Fibromyalgia and Chronic Fatigue Syndrome Research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; WOMAC; Insomnia; Placebo; Anxiety; Osteoarthritis; Depression (economics); Internal medicine; Physical therapy; Post-hoc analysis; Psychiatry; Alternative medicine","score_opus":0.06947531499666458,"score_gpt":0.3925690875726348,"score_spread":0.3230937725759702,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4292202432","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98069555,0.017272808,0.000015711565,0.00028391177,0.000060447295,0.0014006554,0.0002472417,0.000004737439,0.000018952704],"genre_scores_gemma":[0.9918882,0.0076544825,0.00007062854,0.000005337507,0.000013268444,0.000080195816,0.00020492836,0.000014015053,0.000068934],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99581563,0.0008040796,0.0006963718,0.00044334095,0.0018735976,0.00036697532],"domain_scores_gemma":[0.9972253,0.0013905427,0.000137067,0.00024246055,0.00036409145,0.00064054306],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030470467,0.00015332777,0.000981125,0.00088783825,0.00008804552,0.000009835849,0.00011041417,0.00009901391,0.000641204],"category_scores_gemma":[0.0035521605,0.00010010542,0.000043673714,0.0009049487,0.00058550836,0.000086076645,0.00042966704,0.0005979243,2.7530123e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.2755618,0.0026089377,0.055329107,0.006083362,0.00048419382,0.000042887834,0.0029994107,0.000007853327,0.0004683014,0.000035467736,0.002150713,0.654228],"study_design_scores_gemma":[0.36477378,0.17090766,0.41633227,0.01666306,0.00078794925,0.00020434851,0.003305439,0.0067038196,0.00039559044,0.000083748266,0.018947909,0.00089442375],"about_ca_topic_score_codex":0.00011597737,"about_ca_topic_score_gemma":0.0000281422,"teacher_disagreement_score":0.65333354,"about_ca_system_score_codex":0.0001839759,"about_ca_system_score_gemma":0.0012934047,"threshold_uncertainty_score":0.7020734},"labels":[],"label_agreement":null},{"id":"W4307092490","doi":"10.1080/03007995.2022.2139052","title":"Updated results from a matching-adjusted indirect comparison of efficacy outcomes for ciltacabtagene autoleucel in CARTITUDE-1 versus idecabtagene vicleucel in KarMMa for the treatment of patients with relapsed or refractory multiple myeloma","year":2022,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Medicine; Internal medicine; Confidence interval; Hazard ratio; Odds ratio; Gastroenterology; Oncology","score_opus":0.18304367590100745,"score_gpt":0.4477553956450189,"score_spread":0.2647117197440115,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4307092490","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99165624,0.0018550801,0.000058293663,0.00058857084,0.0003122557,0.004273504,0.001231142,0.000016406932,0.000008509775],"genre_scores_gemma":[0.9945164,0.00089643925,0.00027878457,0.0000067683563,0.000055882192,0.0010231817,0.0031547153,0.000029261,0.000038616545],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9956946,0.0003895918,0.0008558386,0.0005517186,0.0018636297,0.0006446659],"domain_scores_gemma":[0.9912316,0.00743786,0.00021201762,0.00043788232,0.00028616583,0.00039446005],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011968303,0.00023779745,0.00081763795,0.0004609436,0.00022542193,0.000014051389,0.00026901314,0.00010972445,0.00007789764],"category_scores_gemma":[0.003258067,0.00013750499,0.00011155646,0.00063764857,0.0002599413,0.00005917312,0.00015689415,0.000496209,0.0000010276417],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.19800723,0.015264408,0.48216674,0.00030428177,0.00049661903,0.000027392258,0.003840631,0.000080858255,0.00019496906,0.000014097557,0.00058980583,0.29901296],"study_design_scores_gemma":[0.119675756,0.015395923,0.8441696,0.00033799096,0.000047105692,4.51263e-7,0.00091334985,0.0099848425,0.0009929177,0.00001740929,0.008325906,0.000138751],"about_ca_topic_score_codex":0.00159808,"about_ca_topic_score_gemma":0.0017208124,"teacher_disagreement_score":0.36200285,"about_ca_system_score_codex":0.00048045174,"about_ca_system_score_gemma":0.0007163063,"threshold_uncertainty_score":0.5607291},"labels":[],"label_agreement":null},{"id":"W4320032979","doi":"10.1080/03007995.2023.2177401","title":"A Latin American consensus meeting on the essentials of mixed pain","year":2023,"lang":"en","type":"review","venue":"Current Medical Research and Opinion","topic":"Pain Management and Opioid Use","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Latin Americans; Population; MEDLINE; Alternative medicine; Consensus conference; Neuropathic pain; Family medicine; Law; Political science; Pathology","score_opus":0.343799713959595,"score_gpt":0.5194971402766067,"score_spread":0.17569742631701163,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4320032979","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00030878506,0.99429107,0.000020012498,0.0028915242,0.00048230917,0.0015392753,0.000021219656,0.000045384135,0.00040043963],"genre_scores_gemma":[0.00009981667,0.9984801,0.00001572116,0.000038412363,0.000705224,0.00014459396,0.00017385656,0.000036950405,0.00030536723],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9938473,0.0022621376,0.0007046603,0.00043851935,0.0021922213,0.00055513286],"domain_scores_gemma":[0.98563176,0.013038243,0.00026553293,0.000447218,0.00016179548,0.0004554325],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.013107561,0.00024736754,0.001239158,0.00046977523,0.00015161872,0.000030894476,0.00031920255,0.00015086598,0.00009889206],"category_scores_gemma":[0.030033335,0.00013660213,0.0002357187,0.0010801723,0.0010515947,0.0000067386727,0.00034492998,0.0014054906,0.00008972132],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000032032003,0.00011589198,0.000104302955,0.023458866,0.00011510795,0.000019232066,0.000031755993,9.552557e-9,1.7717633e-7,0.0013043492,0.05555341,0.91926485],"study_design_scores_gemma":[0.0002782896,0.00041372157,0.00017971617,0.07697439,0.000069124624,6.558037e-7,0.00015979075,0.00015027059,8.304806e-7,0.0001636357,0.92149925,0.00011032702],"about_ca_topic_score_codex":0.0000675006,"about_ca_topic_score_gemma":0.000009611746,"teacher_disagreement_score":0.9191545,"about_ca_system_score_codex":0.000052287545,"about_ca_system_score_gemma":0.0005719195,"threshold_uncertainty_score":0.9781371},"labels":[],"label_agreement":null},{"id":"W4320493944","doi":"10.1080/03007995.2023.2177413","title":"Total healthcare cost savings through improved bipolar I disorder identification using the Rapid Mood Screener in patients diagnosed with major depressive disorder","year":2023,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Bipolar Disorder and Treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Major depressive disorder; Medical diagnosis; Mood; Bipolar disorder; Cohort; Health care; Health plan; Psychiatry; Internal medicine","score_opus":0.06807593206071481,"score_gpt":0.40398455834636776,"score_spread":0.33590862628565293,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4320493944","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9505707,0.03946183,0.0006410483,0.006281927,0.00033261423,0.0025665062,0.00007117018,0.000054332413,0.000019881947],"genre_scores_gemma":[0.9847969,0.01382044,0.000022827133,0.000038332335,0.00013999594,0.00033844612,0.00078767876,0.000032217504,0.000023205303],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967701,0.00028393144,0.00035043005,0.0005111338,0.0014088973,0.0006755001],"domain_scores_gemma":[0.99859625,0.0003216773,0.000072164046,0.00035574136,0.00028197045,0.00037221643],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007368619,0.00019619438,0.00026620665,0.00021113615,0.00042974376,0.00006188567,0.00015789867,0.00014162598,0.000066451066],"category_scores_gemma":[0.0007200229,0.00011677175,0.000051618295,0.00096550555,0.0003932607,0.00017220044,0.00020538383,0.0008009912,0.000016263222],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003025316,0.0008198644,0.6711784,0.00025061893,0.000043330023,0.000003713281,0.0007300542,0.0000011692092,0.000017650413,0.00009089278,0.00019458073,0.32636717],"study_design_scores_gemma":[0.007761774,0.00081009325,0.97854877,0.0006975604,0.00002392292,0.0000058585542,0.0008241805,0.002822919,0.000038697406,0.00012524605,0.008193737,0.00014723086],"about_ca_topic_score_codex":0.0019969544,"about_ca_topic_score_gemma":0.0011626983,"teacher_disagreement_score":0.32621995,"about_ca_system_score_codex":0.00010809999,"about_ca_system_score_gemma":0.00030802545,"threshold_uncertainty_score":0.47618136},"labels":[],"label_agreement":null},{"id":"W4379376267","doi":"10.1080/03007995.2023.2219155","title":"Safety and efficacy of aripiprazole 2-month ready-to-use 960 mg: secondary analysis of outcomes in adult patients with bipolar I disorder in a randomized, open-label, parallel-arm, pivotal study","year":2023,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Bipolar Disorder and Treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Brain and Cognition Discovery Foundation; University of Toronto","funders":"National Eye Institute; H. Lundbeck A/S; Otsuka Pharmaceutical","keywords":"Medicine; Aripiprazole; Tolerability; Clinical Global Impression; Adverse effect; Young Mania Rating Scale; Bipolar disorder; Bipolar I disorder; Randomized controlled trial; Clinical endpoint; Visual analogue scale; Internal medicine; Mania; Schizophrenia (object-oriented programming); Mood; Psychiatry; Anesthesia; Placebo","score_opus":0.056950610330233215,"score_gpt":0.4097856326431164,"score_spread":0.3528350223128832,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379376267","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99297696,0.0032542187,0.000027537597,0.0005872656,0.000058974707,0.0029501,0.00009680668,0.00001004018,0.000038068414],"genre_scores_gemma":[0.9909953,0.008233195,0.000041935855,0.000013001624,0.0000085201245,0.00015536466,0.00051307114,0.000014605396,0.000025045645],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9964821,0.00054445,0.00076254166,0.00047046947,0.001315881,0.00042460143],"domain_scores_gemma":[0.99747896,0.0014305193,0.000094337986,0.0003124106,0.00023535146,0.0004484261],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002244074,0.00019150837,0.0013046719,0.0012083161,0.00006491905,0.000025695845,0.0001801483,0.00009027497,0.00005681765],"category_scores_gemma":[0.002745142,0.00012161324,0.000055816694,0.0019989198,0.0003417054,0.00012509486,0.000396259,0.0005438351,0.0000030109343],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03860426,0.0094826305,0.8610123,0.0001518275,0.000607867,0.000008021395,0.0011159955,0.0000026296298,8.386596e-7,0.0000985783,0.00002610741,0.08888898],"study_design_scores_gemma":[0.20134932,0.0022646033,0.7940864,0.00035388806,0.00013262135,3.276642e-7,0.00037131566,0.00079982117,9.794298e-7,0.000017752764,0.0005352078,0.00008776749],"about_ca_topic_score_codex":0.0033405414,"about_ca_topic_score_gemma":0.005773874,"teacher_disagreement_score":0.16274506,"about_ca_system_score_codex":0.00004485981,"about_ca_system_score_gemma":0.00023831964,"threshold_uncertainty_score":0.5049921},"labels":[],"label_agreement":null},{"id":"W4382918906","doi":"10.1080/03007995.2023.2222583","title":"A systematic literature review of the economic and healthcare resource burden of cytomegalovirus","year":2023,"lang":"en","type":"review","venue":"Current Medical Research and Opinion","topic":"Cytomegalovirus and herpesvirus research","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Moderna","keywords":"Medicine; Population; Psychological intervention; Asymptomatic; Cytomegalovirus; MEDLINE; Health care; Indirect costs; Economic impact analysis; Economic cost; Systematic review; Latin Americans; Meta-analysis; Pediatrics; Environmental health; Demography; Family medicine; Gerontology; Economic growth; Surgery; Human immunodeficiency virus (HIV); Pathology; Psychiatry; Political science","score_opus":0.15570494742637214,"score_gpt":0.4847372610479011,"score_spread":0.32903231362152896,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4382918906","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000133107305,0.9938769,4.4357492e-7,0.0016105159,0.0002534982,0.0038448474,0.00024711582,0.000015544021,0.00013785627],"genre_scores_gemma":[0.000013486646,0.99865025,0.0000027146316,0.000032037977,0.0005585293,0.00025853553,0.0001607749,0.000050940806,0.00027269768],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99345446,0.0014760633,0.0015864075,0.00058051036,0.0023097708,0.00059280795],"domain_scores_gemma":[0.99541336,0.00209336,0.00042970607,0.00085826765,0.0003721433,0.0008331673],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00675962,0.00032928292,0.0030569094,0.0006420269,0.00014191472,0.000043506316,0.00057029974,0.0004663072,0.00007759315],"category_scores_gemma":[0.0055154706,0.00017852534,0.00044489384,0.0012106412,0.00082176575,0.00004452844,0.0009136268,0.0025863985,0.000040444815],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000022851069,0.000025768592,0.0000033633203,0.69147533,0.00010061526,0.000009723136,0.000076931094,2.397613e-9,8.479441e-8,0.00041443456,0.0052651516,0.30260578],"study_design_scores_gemma":[0.0001943117,0.00015463805,0.0000036312163,0.5290753,0.00007453377,0.00008040275,0.000020691192,0.000013909094,2.8545927e-7,0.000029746172,0.47028685,0.00006570847],"about_ca_topic_score_codex":0.00012708257,"about_ca_topic_score_gemma":0.000013829101,"teacher_disagreement_score":0.4650217,"about_ca_system_score_codex":0.0002580119,"about_ca_system_score_gemma":0.002924635,"threshold_uncertainty_score":0.9997147},"labels":[],"label_agreement":null},{"id":"W4386083867","doi":"10.1080/03007995.2023.2247968","title":"Enhancement and external validation of algorithms using diagnosis codes to identify invasive <i>Escherichia coli</i> disease","year":2023,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Data-Driven Disease Surveillance","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Algorithm; Medicine; Diagnosis code; Bacteremia; Predictive value; Sepsis; Disease; Internal medicine; Computer science","score_opus":0.15565135152360093,"score_gpt":0.48168646841257445,"score_spread":0.3260351168889735,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386083867","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99202716,0.0039163665,0.0015577319,0.0012431534,0.00037340328,0.00065765297,0.00017984054,0.000029932771,0.000014761911],"genre_scores_gemma":[0.9712028,0.027363652,0.00028464093,0.00009355385,0.0003692412,0.00017494634,0.0004688468,0.000017286273,0.000025055731],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99708045,0.00020889116,0.0003020927,0.00037818137,0.0016550558,0.00037533217],"domain_scores_gemma":[0.9975752,0.00053993816,0.000051615236,0.00021905903,0.00028390563,0.0013302795],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014110993,0.00011239706,0.0002528483,0.00023994545,0.000109981156,0.00004062948,0.00012365273,0.00004688831,0.0001589194],"category_scores_gemma":[0.0040714536,0.00009748101,0.000036672092,0.0005773075,0.0003083368,0.00010211655,0.0003685903,0.00025124892,0.000037570037],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016599309,0.0015693943,0.5203164,0.0058147586,0.00014436191,0.00019952864,0.000749964,0.0000075414364,0.02821744,0.00035774105,0.032921247,0.40804166],"study_design_scores_gemma":[0.0037442276,0.0010972795,0.92795014,0.010260966,0.000060814353,0.000006408317,0.00029388972,0.0064779073,0.024700113,0.0012718238,0.023764031,0.0003724118],"about_ca_topic_score_codex":0.000048642763,"about_ca_topic_score_gemma":0.0000041587537,"teacher_disagreement_score":0.40766925,"about_ca_system_score_codex":0.00005665786,"about_ca_system_score_gemma":0.00042943002,"threshold_uncertainty_score":0.48742044},"labels":[],"label_agreement":null},{"id":"W4388500252","doi":"10.1080/03007995.2023.2281503","title":"The performance of bibliometric analyses in the health sciences","year":2023,"lang":"en","type":"review","venue":"Current Medical Research and Opinion","topic":"scientometrics and bibliometrics research","field":"Decision Sciences","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Université de Montréal; Centre Hospitalier Universitaire de Sherbrooke; Université de Sherbrooke","funders":"","keywords":"Scopus; China; Bibliometrics; Medicine; Pace; Biomedical sciences; Citation impact; Citation; MEDLINE; Library science; Political science; Computer science; Geography; Pathology","score_opus":0.9614202202530888,"score_gpt":0.7944987910901559,"score_spread":0.16692142916293295,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388500252","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00042600732,0.9960479,0.00001360152,0.0014957145,0.00093706313,0.00080844737,0.00002743235,0.0000071716013,0.00023664396],"genre_scores_gemma":[0.00056311843,0.9989734,0.0000060680104,0.0000114961995,0.00023956703,0.00009157463,0.0000125111455,0.000010021546,0.000092231254],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.93852663,0.0056914124,0.0025110338,0.0012094672,0.050202157,0.0018593115],"domain_scores_gemma":[0.87541765,0.11973229,0.0006969555,0.0011559356,0.0020680737,0.00092906354],"candidate_categories":["metaresearch","bibliometrics","sts","scholarly_communication","open_science"],"consensus_categories":["metaresearch","bibliometrics","sts"],"category_scores_codex":[0.2665892,0.00022925039,0.0011848857,0.3953161,0.0013588828,0.002367867,0.00866867,0.00020591245,0.00006378887],"category_scores_gemma":[0.20539846,0.00008430016,0.000266305,0.84207547,0.0029964538,0.00025117796,0.0021534723,0.002231029,0.00016753373],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000037846098,0.0000838129,0.00043033788,0.0015773978,0.000007848251,0.0000015793083,0.000031368632,1.2821505e-7,7.329291e-9,0.00059057894,0.021217044,0.9760561],"study_design_scores_gemma":[0.00011135361,0.0007408076,0.0020592937,0.0042634164,0.0000026322527,0.00000699869,0.0002456717,0.00090169895,1.1141382e-7,0.00090233074,0.99067336,0.00009230223],"about_ca_topic_score_codex":0.00016549791,"about_ca_topic_score_gemma":0.000034381203,"teacher_disagreement_score":0.97596383,"about_ca_system_score_codex":0.00012087805,"about_ca_system_score_gemma":0.004341407,"threshold_uncertainty_score":0.99994123},"labels":[],"label_agreement":null},{"id":"W4389763594","doi":"10.1080/03007995.2023.2295411","title":"The use of large language models in medicine: proceeding with caution","year":2023,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Artificial Intelligence in Healthcare and Education","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University of British Columbia Hospital; Carleton University; University of Toronto","funders":"","keywords":"Medicine; Transparency (behavior); Consistency (knowledge bases); Liability; Internet privacy; Computer security; Artificial intelligence; Law","score_opus":0.6244928489176927,"score_gpt":0.5985246997722155,"score_spread":0.025968149145477293,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389763594","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97575086,0.0033216833,0.0005428175,0.019278346,0.00040926767,0.0005439263,0.0000027994795,0.000025340873,0.00012494803],"genre_scores_gemma":[0.98775226,0.011677838,0.000011343293,0.000028588669,0.00034427055,0.000047794903,0.000052973224,0.0000059648564,0.000078971025],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9982591,0.00007474425,0.00024698052,0.00014810509,0.00093255256,0.00033849062],"domain_scores_gemma":[0.9984968,0.0008796471,0.000029500714,0.00010651812,0.0002524715,0.0002351121],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023149378,0.000050873605,0.00011923333,0.00021446969,0.00013810942,0.0000113730575,0.000061668645,0.00005598686,0.00002615848],"category_scores_gemma":[0.002780492,0.000027609578,0.00001011347,0.00076696783,0.00031414392,0.000094247924,0.00004387796,0.00045425678,0.000007369773],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000532892,0.0002568787,0.06174699,0.00095390534,0.000013247722,0.000013297312,0.012686935,0.000007898949,0.00013183644,0.017849028,0.024641044,0.88116604],"study_design_scores_gemma":[0.002432825,0.0062755262,0.11409969,0.028180758,0.000031081814,0.00007201078,0.11482944,0.45827875,0.0030846917,0.035957403,0.23622322,0.00053461164],"about_ca_topic_score_codex":0.0005564079,"about_ca_topic_score_gemma":0.00016086879,"teacher_disagreement_score":0.88063145,"about_ca_system_score_codex":0.000038497066,"about_ca_system_score_gemma":0.00034729874,"threshold_uncertainty_score":0.33287096},"labels":[],"label_agreement":null},{"id":"W4389937130","doi":"10.1080/03007995.2023.2286102","title":"Chatbots, generative AI, and scholarly manuscripts: WAME recommendations on chatbots and generative artificial intelligence in relation to scholarly publications","year":2023,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Artificial Intelligence in Healthcare and Education","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; University of Toronto; Public Health Ontario","funders":"","keywords":"Medicine; Generative grammar; Relation (database); Artificial intelligence; Cognitive science; Computer science; Data mining; Psychology","score_opus":0.544422434547207,"score_gpt":0.5616866559129249,"score_spread":0.017264221365717924,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389937130","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5654368,0.0025701434,0.00692852,0.42206207,0.0011735302,0.00151927,0.000029386225,0.00007964111,0.00020067801],"genre_scores_gemma":[0.96229786,0.031504646,0.00088839926,0.0019679416,0.0015255166,0.0006743477,0.0007124432,0.000033147015,0.00039569652],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99697864,0.0003890445,0.0005249811,0.00062598416,0.00096231274,0.0005190297],"domain_scores_gemma":[0.9973555,0.0006833277,0.000054570548,0.00024057968,0.0007210693,0.0009449076],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.00325643,0.0001591055,0.00022790639,0.0011720075,0.00057874003,0.00048681648,0.00011838955,0.00021548169,0.00010515498],"category_scores_gemma":[0.008840432,0.00014246882,0.000022030477,0.001588494,0.0002820172,0.0010201568,0.00015666678,0.001531334,0.00014644327],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012307614,0.00023711305,0.0077510295,0.0000786323,0.00001017597,0.0000033005224,0.0049271556,0.0000025436188,0.0002799597,0.038537797,0.008948497,0.93910074],"study_design_scores_gemma":[0.00074189226,0.0071902666,0.42084613,0.006813496,0.000033977038,0.000073186384,0.021135699,0.064691424,0.007692989,0.18648738,0.28306854,0.0012250129],"about_ca_topic_score_codex":0.00018794346,"about_ca_topic_score_gemma":0.0002427925,"teacher_disagreement_score":0.9378757,"about_ca_system_score_codex":0.00019250649,"about_ca_system_score_gemma":0.0005046546,"threshold_uncertainty_score":0.9995085},"labels":[],"label_agreement":null},{"id":"W4392197973","doi":"10.1080/03007995.2024.2322048","title":"Prevalence of comorbidities with the potential to increase the risk of nonadherence to topical ocular hypotensive medication in patients with open-angle glaucoma","year":2024,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Glaucoma and retinal disorders","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Heidelberg Engineering; Santen; AbbVie Canada; Alimera Sciences; Pfizer","keywords":"Medicine; Glaucoma; Open angle glaucoma; Medication adherence; Ocular hypertension; Comorbidity; Glaucoma medication; Ophthalmology; Internal medicine; Intensive care medicine","score_opus":0.028271684341487562,"score_gpt":0.35465903525410997,"score_spread":0.3263873509126224,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392197973","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98637044,0.0019976678,0.00042292764,0.009724923,0.00011149324,0.0012397998,0.000022648257,0.0000048429306,0.00010523193],"genre_scores_gemma":[0.99843824,0.0012131006,0.000061254934,0.000078528494,0.00006453708,0.000075202865,0.000019817131,0.000006801946,0.00004253333],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975212,0.0002772456,0.00020475296,0.00024214195,0.0015246731,0.00022995443],"domain_scores_gemma":[0.99864185,0.00043667713,0.000034080073,0.00024062392,0.00034213992,0.0003046349],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001055828,0.00008957936,0.0001819075,0.00011057015,0.00008554844,0.00002426651,0.0003360239,0.000048612128,0.00008327921],"category_scores_gemma":[0.0011274192,0.000038005317,0.000023283172,0.00041826718,0.0006122608,0.00004971575,0.0002662775,0.0005023155,0.000007010255],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032102421,0.0006929756,0.89698845,0.0014941896,0.000073681535,0.00002633087,0.0014493398,8.5016535e-7,0.000048390786,0.001189259,0.010980437,0.08384586],"study_design_scores_gemma":[0.0010449628,0.0028830061,0.98872644,0.0025981574,0.000027090506,0.0000063167795,0.0005790148,0.00029177684,0.000069208094,0.00016599408,0.0035534839,0.00005455892],"about_ca_topic_score_codex":0.0005804043,"about_ca_topic_score_gemma":0.00008925317,"teacher_disagreement_score":0.09173799,"about_ca_system_score_codex":0.000023455492,"about_ca_system_score_gemma":0.0003564719,"threshold_uncertainty_score":0.22559002},"labels":[],"label_agreement":null},{"id":"W4394576831","doi":"10.1080/03007995.2024.2326585","title":"Real-world clinical outcomes and healthcare costs in patients with Crohn’s disease treated with vedolizumab versus ustekinumab in the United States","year":2024,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Vedolizumab; Ustekinumab; Medicine; Crohn's disease; Health care; Disease; Internal medicine; Intensive care medicine; Adalimumab","score_opus":0.0629340616122963,"score_gpt":0.43190965535171183,"score_spread":0.3689755937394155,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394576831","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997137,0.0010202775,0.0000029029948,0.0010567956,0.0001369454,0.00054820045,0.00006036269,0.0000093789995,0.000028152643],"genre_scores_gemma":[0.9939813,0.0045554973,0.0000032367736,0.000058238013,0.00009117247,0.000073308875,0.0012086728,0.000014823458,0.000013720456],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976541,0.0005975771,0.000249454,0.00041226807,0.0007016136,0.00038498873],"domain_scores_gemma":[0.9987967,0.00031126084,0.000022919869,0.00023041437,0.00012144135,0.00051729113],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009103841,0.00013955976,0.00014205361,0.00020925926,0.00007505418,0.00006891373,0.00015325079,0.000068731264,0.000008614546],"category_scores_gemma":[0.0005481575,0.00007840068,0.000023053668,0.00035932273,0.0004451113,0.000009751015,0.00011234797,0.00051869225,0.0000022910274],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0076527717,0.0002620844,0.9731307,0.0002257719,0.0000229796,0.00025246834,0.0000730439,0.0000010256122,9.407458e-8,0.00027068227,0.0007687548,0.017339638],"study_design_scores_gemma":[0.0042800517,0.0006254641,0.98905325,0.0005442526,0.000005575212,4.929726e-7,0.000107607244,0.000334461,5.768445e-7,0.000029223285,0.004916306,0.00010275044],"about_ca_topic_score_codex":0.00042724746,"about_ca_topic_score_gemma":0.0022729842,"teacher_disagreement_score":0.017236888,"about_ca_system_score_codex":0.00006131802,"about_ca_system_score_gemma":0.0004889176,"threshold_uncertainty_score":0.31970868},"labels":[],"label_agreement":null},{"id":"W4394680555","doi":"10.1080/03007995.2024.2340720","title":"Understanding preferences for receiving health communications and information about clinical trials: a cross-sectional study among US adults","year":2024,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Health Literacy and Information Accessibility","field":"Health Professions","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"AbbVie Canada","keywords":"Medicine; Cross-sectional study; Clinical trial; Family medicine; Environmental health; Internal medicine; Pathology","score_opus":0.8072724322065451,"score_gpt":0.7220520273630743,"score_spread":0.08522040484347082,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394680555","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8921481,0.014238391,0.065117925,0.00672173,0.008663105,0.011354658,0.0004329376,0.00027158431,0.0010515781],"genre_scores_gemma":[0.9721436,0.025467232,0.00018294726,0.0002668099,0.0006994578,0.0007846757,0.0004335329,0.000007503959,0.000014264936],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.989949,0.0047119805,0.0033843254,0.00031963855,0.0010581054,0.0005769698],"domain_scores_gemma":[0.9786671,0.019146038,0.0004211309,0.00034197682,0.00056062586,0.00086316856],"candidate_categories":["metaresearch","sts","research_integrity"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.09018023,0.0001192958,0.00038821567,0.0003361504,0.0023353088,0.00032518437,0.00029727403,0.00025395057,0.00015680584],"category_scores_gemma":[0.02891735,0.0000857112,0.000059598686,0.00038189083,0.00052840845,0.0022154,0.0003822493,0.002317632,0.000024961053],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023694204,0.00012760342,0.7382431,0.0029266628,0.000015224142,4.460433e-8,0.0049071442,4.779981e-8,8.807386e-9,0.0052020163,0.005220531,0.24312069],"study_design_scores_gemma":[0.001735338,0.00069342955,0.80205226,0.0030181976,0.000002256237,5.7351184e-7,0.003781403,0.034925677,2.193356e-8,0.0031286492,0.15057844,0.00008378406],"about_ca_topic_score_codex":0.00033662035,"about_ca_topic_score_gemma":0.0003002737,"teacher_disagreement_score":0.2430369,"about_ca_system_score_codex":0.00030634267,"about_ca_system_score_gemma":0.002081435,"threshold_uncertainty_score":0.9999841},"labels":[],"label_agreement":null},{"id":"W4399123297","doi":"10.1080/03007995.2024.2360128","title":"A prospective cohort study of chronic postsurgical pain after ambulatory surgeries","year":2024,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Anesthesia and Pain Management","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Impact; McMaster University; St. Joseph’s Healthcare Hamilton","funders":"","keywords":"Medicine; Ambulatory; Prospective cohort study; Chronic pain; Cohort; Anesthesia; Surgery; Physical therapy; Internal medicine","score_opus":0.046364448613669784,"score_gpt":0.40627871379956104,"score_spread":0.35991426518589126,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399123297","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9663003,0.029740877,0.00014698852,0.001625354,0.00025191027,0.0015902052,0.0000011884814,0.000050839728,0.00029234553],"genre_scores_gemma":[0.9949497,0.0041010194,0.00000284642,0.000035801724,0.00042952423,0.00025777932,0.000018006347,0.0000125891165,0.0001927457],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99691164,0.0004758065,0.00025927892,0.00036352314,0.0016634823,0.00032628822],"domain_scores_gemma":[0.99859333,0.00069723243,0.000015062921,0.00018946952,0.00012709624,0.0003778129],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0055821235,0.000107618755,0.00027444147,0.0002212092,0.000060163584,0.000029872437,0.000073394775,0.00007483707,0.0005991883],"category_scores_gemma":[0.0006650561,0.00007397409,0.000053183623,0.00034107352,0.00039031953,0.00004687574,0.00009681751,0.000586908,0.000025904112],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039774977,0.0010965682,0.89490455,0.0015725314,0.00010498687,0.00031131995,0.0005967429,5.33649e-8,0.0000029007922,0.0011922668,0.00746526,0.09235506],"study_design_scores_gemma":[0.0007277115,0.0031754123,0.83364356,0.0017433439,0.000020118627,0.000016811284,0.0004356105,0.0013031755,0.0000058476,0.00025386893,0.1585897,0.000084810956],"about_ca_topic_score_codex":0.000034626566,"about_ca_topic_score_gemma":0.000010584855,"teacher_disagreement_score":0.15112445,"about_ca_system_score_codex":0.000103295926,"about_ca_system_score_gemma":0.0003760256,"threshold_uncertainty_score":0.6560692},"labels":[],"label_agreement":null},{"id":"W4399327477","doi":"10.1080/03007995.2024.2363945","title":"Medical cannabis and its efficacy/effectiveness on the management of osteoarthritis pain and function","year":2024,"lang":"en","type":"review","venue":"Current Medical Research and Opinion","topic":"Cannabis and Cannabinoid Research","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"National Institute on Disability, Independent Living, and Rehabilitation Research; Northwestern University","keywords":"Medicine; Osteoarthritis; Cannabis; Medical prescription; Medical cannabis; Physical therapy; Opioid; Pain management; Alternative medicine; Psychiatry; Internal medicine; Pharmacology","score_opus":0.10707905605491527,"score_gpt":0.45743100656459956,"score_spread":0.35035195050968426,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399327477","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0006444864,0.9893843,0.000012345385,0.0065553025,0.00060501153,0.002479696,0.000041012056,0.00002226797,0.00025557153],"genre_scores_gemma":[0.0006923783,0.9973416,7.670238e-7,0.000032548982,0.00054006604,0.0006708881,0.0001104883,0.00004332601,0.0005679763],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99281895,0.0015764205,0.0005455709,0.0007788926,0.003657826,0.00062234915],"domain_scores_gemma":[0.9973639,0.000783273,0.00006612494,0.00033803002,0.0002343515,0.0012142896],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.011297466,0.0003468353,0.0010692164,0.0004653953,0.00020949307,0.00008065389,0.00023814291,0.00045056987,0.0002901969],"category_scores_gemma":[0.0026130343,0.00019009663,0.0001776073,0.0007230291,0.0009086985,0.00003263708,0.00069840037,0.0026288866,0.000024792727],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016014779,0.00020217709,0.000003819188,0.092945844,0.00016654114,0.00008929109,0.00002620357,1.9797037e-9,1.5654327e-7,0.004612074,0.03026079,0.871533],"study_design_scores_gemma":[0.0008975624,0.0026425608,0.00021253077,0.12165144,0.00015771673,0.0000943629,0.000056393863,0.000059949765,0.0000010914292,0.00015176997,0.8739373,0.00013729197],"about_ca_topic_score_codex":0.000021896141,"about_ca_topic_score_gemma":0.0000059776144,"teacher_disagreement_score":0.87139565,"about_ca_system_score_codex":0.00011431382,"about_ca_system_score_gemma":0.000961482,"threshold_uncertainty_score":0.9996721},"labels":[],"label_agreement":null},{"id":"W4399458977","doi":"10.1080/03007995.2024.2366443","title":"Update on efficacy of the approved remdesivir regimen for treatment of COVID-19: a systematic review with meta-analysis and trial sequential analysis of randomized controlled trials","year":2024,"lang":"en","type":"review","venue":"Current Medical Research and Opinion","topic":"COVID-19 Clinical Research Studies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; George & Fay Yee Centre for Healthcare Innovation","funders":"","keywords":"Medicine; Meta-analysis; Regimen; Randomized controlled trial; Coronavirus disease 2019 (COVID-19); 2019-20 coronavirus outbreak; Intensive care medicine; Internal medicine; Virology; Disease","score_opus":0.5002402108300233,"score_gpt":0.6203149645727072,"score_spread":0.12007475374268384,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399458977","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000004559042,0.9471375,0.0007299621,0.00414237,0.00012026133,0.04739906,0.00044833784,0.00001019963,0.0000077996],"genre_scores_gemma":[0.00016223294,0.98883826,0.000022118906,0.000053395983,0.00015781105,0.010223695,0.00034538793,0.000028124849,0.00016894969],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.96786296,0.018934948,0.006845729,0.0010480249,0.0048008496,0.00050750177],"domain_scores_gemma":[0.5899412,0.3979746,0.0060420823,0.0024277722,0.0018780243,0.001736294],"candidate_categories":["metaresearch","metaepi_broad"],"consensus_categories":["metaresearch","metaepi_broad"],"category_scores_codex":[0.080280975,0.0006426754,0.058335684,0.0022024477,0.00011847739,0.0000374249,0.00046780356,0.00031643923,0.0001444252],"category_scores_gemma":[0.5928722,0.00021644564,0.01935349,0.003998319,0.0019711421,0.000023042116,0.0003006296,0.0006312236,0.0000010575843],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.14271036,0.00064679113,1.9700475e-7,0.47585556,0.37287182,0.0000027647582,0.000034388504,4.2743744e-7,5.9295328e-8,0.0002296714,0.00020246903,0.007445494],"study_design_scores_gemma":[0.2115487,0.0022299027,1.2549503e-7,0.0983748,0.6699536,5.887343e-7,0.000007864969,0.0003715339,5.961592e-7,0.00005697363,0.017349143,0.00010617347],"about_ca_topic_score_codex":0.000082236795,"about_ca_topic_score_gemma":0.000017984474,"teacher_disagreement_score":0.51259124,"about_ca_system_score_codex":0.00027514962,"about_ca_system_score_gemma":0.004710572,"threshold_uncertainty_score":0.9904674},"labels":[],"label_agreement":null},{"id":"W4399531955","doi":"10.1080/03007995.2024.2360647","title":"Association between fatigue and depressive symptoms in persons with post-COVID-19 condition: a post hoc analysis","year":2024,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Long-Term Effects of COVID-19","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; University of Toronto; University of Ottawa; University Health Network; Brain and Cognition Discovery Foundation","funders":"Brain and Cognition Discovery Foundation","keywords":"Medicine; Coronavirus disease 2019 (COVID-19); Depressive symptoms; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); 2019-20 coronavirus outbreak; Post-hoc analysis; Depression (economics); Association (psychology); Psychiatry; Internal medicine; Disease; Anxiety; Virology; Outbreak","score_opus":0.055173774999207524,"score_gpt":0.44765564981482914,"score_spread":0.39248187481562163,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399531955","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9196717,0.014927269,0.0011695541,0.062676966,0.00018875298,0.0009829516,0.00018919056,0.00008491958,0.00010870093],"genre_scores_gemma":[0.9951725,0.0025219696,0.000018456205,0.00039224312,0.0005047588,0.00010915498,0.0011767956,0.000017490376,0.00008665201],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99622095,0.00042013873,0.00027266378,0.0005751504,0.0019894822,0.0005216168],"domain_scores_gemma":[0.9933831,0.004606649,0.00005376503,0.0002012211,0.00026018778,0.0014950545],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0019880855,0.00017359461,0.000419118,0.0010578332,0.0001748269,0.00015190843,0.00012362351,0.00022740614,0.00024711288],"category_scores_gemma":[0.009130601,0.00012580762,0.0000782707,0.0012373464,0.00035049958,0.00020502701,0.00013464771,0.0010816596,0.000012955867],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005124913,0.0001754799,0.93834805,0.0028855377,0.0010813402,0.00033546612,0.0016260457,0.0000016788167,0.000041114894,0.0005486697,0.0054951548,0.04894895],"study_design_scores_gemma":[0.006971693,0.004808621,0.9452653,0.0050782403,0.00079370115,0.00006719913,0.00048987684,0.0035963939,0.00004922296,0.00059495575,0.031866252,0.00041853008],"about_ca_topic_score_codex":0.00032796207,"about_ca_topic_score_gemma":0.00022972259,"teacher_disagreement_score":0.07550078,"about_ca_system_score_codex":0.00053842214,"about_ca_system_score_gemma":0.0014544438,"threshold_uncertainty_score":0.9992159},"labels":[],"label_agreement":null},{"id":"W4400238199","doi":"10.1080/03007995.2024.2374510","title":"Relationship between anhedonia and psychosocial functioning in post-COVID-19 condition: a <i>post-hoc</i> analysis","year":2024,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Long-Term Effects of COVID-19","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University of Ottawa; Brain and Cognition Discovery Foundation","funders":"","keywords":"Anhedonia; Medicine; Psychosocial; Pleasure; Coronavirus disease 2019 (COVID-19); Post-hoc analysis; 2019-20 coronavirus outbreak; Post hoc; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Clinical psychology; Psychiatry; Internal medicine; Psychotherapist; Psychology; Schizophrenia (object-oriented programming); Virology; Disease","score_opus":0.10443084912476105,"score_gpt":0.4860879345447012,"score_spread":0.38165708541994015,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400238199","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.87994355,0.025048578,0.0022909965,0.09032082,0.00084817794,0.000994538,0.00008888048,0.00015509008,0.00030935823],"genre_scores_gemma":[0.9950746,0.0017695851,0.00005301325,0.0006091034,0.0013170053,0.00009198256,0.0009845346,0.000019440547,0.00008069755],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.996296,0.0004970643,0.00041373025,0.000638717,0.0016370175,0.0005174766],"domain_scores_gemma":[0.9914035,0.006497987,0.00003898653,0.00023387755,0.00020024489,0.0016253724],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0035535141,0.00017616907,0.0003900304,0.0013554284,0.00033328816,0.00017366515,0.000123923,0.00027105928,0.00037427153],"category_scores_gemma":[0.014362858,0.00014878396,0.00011304528,0.0019108334,0.00056139065,0.00024001767,0.00014305086,0.0015159482,0.00005410103],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007730032,0.00016745066,0.9208082,0.0030694632,0.00022651374,0.00019941297,0.0012671897,0.0000010700202,0.00002231756,0.0047601974,0.012087991,0.056617215],"study_design_scores_gemma":[0.0034601004,0.0017612055,0.91103226,0.0014876,0.00021113896,0.000052855652,0.00028877784,0.0009989408,0.000004693942,0.005224286,0.075231336,0.00024679845],"about_ca_topic_score_codex":0.0001923907,"about_ca_topic_score_gemma":0.00015084434,"teacher_disagreement_score":0.11513107,"about_ca_system_score_codex":0.0002978705,"about_ca_system_score_gemma":0.0016154506,"threshold_uncertainty_score":0.9939396},"labels":[],"label_agreement":null},{"id":"W4400587954","doi":"10.1080/03007995.2024.2380006","title":"Use of telerehabilitation platforms for delivering patient education among patients with asthma: a scoping review","year":2024,"lang":"en","type":"review","venue":"Current Medical Research and Opinion","topic":"Asthma and respiratory diseases","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Telerehabilitation; Asthma; Telemedicine; Physical therapy; Quality of life (healthcare); Telehealth; Intensive care medicine; Physical medicine and rehabilitation; Medical emergency; Health care; Nursing; Internal medicine","score_opus":0.15963977368541205,"score_gpt":0.48733094734846666,"score_spread":0.3276911736630546,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400587954","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0024833553,0.9907067,0.000050843784,0.000029530307,0.00045932052,0.0061773295,0.00006722476,0.000018657982,0.0000070695837],"genre_scores_gemma":[0.00009383601,0.9976791,0.00008337439,0.000017350705,0.00023136717,0.0010388818,0.0008097672,0.000039029594,0.000007250363],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9968495,0.00011023551,0.0007734571,0.00048617253,0.0014393355,0.00034131313],"domain_scores_gemma":[0.99747115,0.00068861665,0.00020745918,0.00026147076,0.0007554203,0.0006158633],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00065186946,0.00026163488,0.0010498777,0.00038403762,0.0000946627,0.000032392487,0.000098306315,0.00018311245,0.00003806479],"category_scores_gemma":[0.0032744654,0.00014742011,0.00022999402,0.0004559321,0.0003379978,0.0001582495,0.00012974931,0.00062207197,0.000007143618],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003529759,0.00027381376,0.00018912138,0.3670553,0.000025626468,6.433834e-7,0.000017557171,1.004323e-8,5.1380975e-9,0.000020178753,0.001350182,0.6310322],"study_design_scores_gemma":[0.00016671672,0.0011121709,0.00026062183,0.62165576,0.00013120458,0.0000022493407,0.0000111788195,0.000007922109,1.2838679e-7,0.000010907126,0.376542,0.00009914044],"about_ca_topic_score_codex":0.000009058623,"about_ca_topic_score_gemma":0.0000037629243,"teacher_disagreement_score":0.6309331,"about_ca_system_score_codex":0.00013400169,"about_ca_system_score_gemma":0.0032474168,"threshold_uncertainty_score":0.6011618},"labels":[],"label_agreement":null},{"id":"W4400813247","doi":"10.1080/03007995.2024.2378172","title":"Why fexofenadine is considered as a truly non-sedating antihistamine with no brain penetration: a systematic review","year":2024,"lang":"en","type":"review","venue":"Current Medical Research and Opinion","topic":"Allergic Rhinitis and Sensitization","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"Sanofi-Aventis Deutschland; Sanofi","keywords":"Fexofenadine; Medicine; Antihistamine; Sedation; Sedative; Histamine H1 receptor; Cetirizine; Pharmacology; Histamine H1 Antagonists; Terfenadine; Psychomotor learning; Histamine; Anesthesia; Cognition; Internal medicine; Receptor; Antagonist; Psychiatry","score_opus":0.14287436446427945,"score_gpt":0.47640026400199953,"score_spread":0.33352589953772005,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400813247","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000021184856,0.9873512,0.00015982572,0.0060754362,0.000494923,0.0045209667,0.00003814889,0.00004794908,0.0013094421],"genre_scores_gemma":[0.000009463905,0.99459064,0.00004582662,0.0014088542,0.0008735615,0.00032845495,0.0015922436,0.00006977522,0.0010811962],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9938449,0.0006508325,0.0013334646,0.00082339154,0.0027686255,0.00057877885],"domain_scores_gemma":[0.99621177,0.0011933453,0.00029095937,0.00053741893,0.00081204984,0.00095447403],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0030314587,0.00048824245,0.002824696,0.0004244977,0.00020218016,0.00015645938,0.00019804282,0.0003444864,0.00074995897],"category_scores_gemma":[0.0078875255,0.00028362952,0.0002454059,0.0009696571,0.00035704556,0.00009177717,0.00015915201,0.0017766593,0.0004491081],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000018737697,0.00007395491,4.2050266e-7,0.73639333,0.00016038484,0.00023343685,0.000058511327,9.334912e-10,1.0279479e-7,0.00022113541,0.18215786,0.08068214],"study_design_scores_gemma":[0.0003686268,0.0005440819,2.890917e-7,0.52416337,0.00037719042,0.00082337303,0.000016982309,0.0001663366,8.817638e-8,0.000019568393,0.47337127,0.00014884259],"about_ca_topic_score_codex":0.000038782015,"about_ca_topic_score_gemma":0.000012813393,"teacher_disagreement_score":0.2912134,"about_ca_system_score_codex":0.0001698353,"about_ca_system_score_gemma":0.0023737922,"threshold_uncertainty_score":0.9999616},"labels":[],"label_agreement":null},{"id":"W4401371156","doi":"10.1080/03007995.2024.2388839","title":"Comparison of real-world healthcare resource utilization among advanced therapy-naïve and advanced therapy-experienced patients with ulcerative colitis initiated on ustekinumab or vedolizumab","year":2024,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Vedolizumab; Medicine; Ustekinumab; Ulcerative colitis; Health care; Physical therapy; Internal medicine; Disease; Infliximab","score_opus":0.11734899045336464,"score_gpt":0.46125905180242377,"score_spread":0.3439100613490591,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401371156","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948717,0.0035474796,0.000049024256,0.00012675635,0.00021099915,0.0009082601,0.000060978073,0.000022186254,0.00020262218],"genre_scores_gemma":[0.9886601,0.010296972,0.0000154183,0.000034285516,0.00012139173,0.00014414493,0.0006648959,0.000025561234,0.00003721146],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.997523,0.00044183916,0.00031182525,0.00050928793,0.0008468548,0.00036715544],"domain_scores_gemma":[0.99880326,0.0001485104,0.00007335101,0.00022705099,0.00035288362,0.000394918],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003659836,0.00018440715,0.00022094703,0.00015534418,0.0001821293,0.000046546193,0.00013920553,0.0001239395,0.00004418841],"category_scores_gemma":[0.0003595499,0.00012853247,0.000028626799,0.000310215,0.0005720753,0.00002235819,0.000090241025,0.00035550917,0.0000011200754],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.028845971,0.0007486015,0.072406866,0.000664239,0.00008178615,0.00002722969,0.0025820127,0.000012833286,0.00028069704,0.00096815685,0.0013449368,0.8920367],"study_design_scores_gemma":[0.008592848,0.008888784,0.91980255,0.0029296386,0.000005115754,0.0000018640441,0.0015923996,0.0016211149,0.007791163,0.00011708887,0.048219617,0.00043780095],"about_ca_topic_score_codex":0.000021405875,"about_ca_topic_score_gemma":0.0002016127,"teacher_disagreement_score":0.8915989,"about_ca_system_score_codex":0.000048710077,"about_ca_system_score_gemma":0.00043184328,"threshold_uncertainty_score":0.52414024},"labels":[],"label_agreement":null},{"id":"W4401520882","doi":"10.1080/03007995.2024.2391112","title":"Comparative efficacy of ciltacabtagene autoleucel versus idecabtagene vicleucel in the treatment of patients with relapsed or refractory multiple myeloma previously treated with 2–4 prior lines of therapy: a matching-adjusted indirect comparison","year":2024,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Thermo Fisher Scientific (Canada)","funders":"","keywords":"Medicine; Refractory (planetary science); Internal medicine; Multiple myeloma; Oncology; Surgery","score_opus":0.17942306898730398,"score_gpt":0.4459208483556996,"score_spread":0.26649777936839564,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401520882","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98428655,0.012563553,0.000026508242,0.00013690928,0.00008593297,0.0027415836,0.00008441922,0.000026493251,0.000048063994],"genre_scores_gemma":[0.9907763,0.008327022,0.00014726212,0.0000025481534,0.00006626513,0.0001897406,0.00043502255,0.000026009848,0.000029801009],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99553156,0.00059578544,0.0006701515,0.00048106324,0.002198841,0.0005225886],"domain_scores_gemma":[0.99549216,0.0031042828,0.00016469463,0.00040293537,0.00044131247,0.00039461875],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00076104316,0.00029499398,0.0009522032,0.00050455955,0.00009189051,0.00002384731,0.00021960524,0.00013314097,0.000074868876],"category_scores_gemma":[0.00049947546,0.00013429199,0.00008998289,0.0011166744,0.0006675346,0.000090260306,0.00005069581,0.0005061351,0.0000032676949],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.11390783,0.019563675,0.3019154,0.0017163426,0.0011795688,0.000136247,0.0125085255,0.000007647376,0.00066743005,0.00002043216,0.0002137778,0.5481631],"study_design_scores_gemma":[0.051250536,0.04669496,0.88195825,0.0042510647,0.00008973317,0.0000063183684,0.00095631724,0.0030089354,0.0085664075,0.000005279396,0.0030309018,0.00018127574],"about_ca_topic_score_codex":0.00038947826,"about_ca_topic_score_gemma":0.0003070976,"teacher_disagreement_score":0.58004284,"about_ca_system_score_codex":0.00017864315,"about_ca_system_score_gemma":0.00089838007,"threshold_uncertainty_score":0.54762685},"labels":[],"label_agreement":null},{"id":"W4402169337","doi":"10.1080/03007995.2024.2391553","title":"Matching-adjusted indirect comparison of talquetamab vs selinexor-dexamethasone and vs belantamab mafodotin in patients with relapsed/refractory multiple myeloma","year":2024,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Dexamethasone; Multiple myeloma; Internal medicine; Propensity score matching; Refractory (planetary science); Oncology","score_opus":0.07985771078524738,"score_gpt":0.405961925221136,"score_spread":0.3261042144358886,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402169337","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98218155,0.015641522,0.00008215671,0.00056500774,0.00023593192,0.0010879086,0.00008056494,0.000051215546,0.0000741579],"genre_scores_gemma":[0.99484867,0.004133097,0.00020545475,0.000011956962,0.0001408394,0.00009462433,0.000473613,0.000038061287,0.00005369565],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99518687,0.0004211935,0.00055075577,0.00064785493,0.0024475716,0.00074578193],"domain_scores_gemma":[0.9969019,0.001521684,0.00006365729,0.00028328897,0.00026008635,0.00096937997],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014762593,0.0002636975,0.00069465867,0.0007730198,0.00010683063,0.000059058333,0.00014513599,0.00022636657,0.00017791653],"category_scores_gemma":[0.001609611,0.00018032263,0.000054407534,0.00075108686,0.0005749772,0.00016560407,0.00025027437,0.0016982855,0.00002477957],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0066435398,0.0016922947,0.72424567,0.0017606836,0.000110118155,0.000107915715,0.00066860707,2.6480848e-7,0.000034273027,0.0000506608,0.0005178478,0.26416814],"study_design_scores_gemma":[0.011540626,0.0044151875,0.9698623,0.005350013,0.000025300513,0.000016731807,0.00021020275,0.003640547,0.00029504017,0.000091316084,0.0043691825,0.00018356639],"about_ca_topic_score_codex":0.00029842023,"about_ca_topic_score_gemma":0.00017163585,"teacher_disagreement_score":0.2639846,"about_ca_system_score_codex":0.00015605753,"about_ca_system_score_gemma":0.0004887955,"threshold_uncertainty_score":0.73783},"labels":[],"label_agreement":null},{"id":"W4402274480","doi":"10.1080/03007995.2024.2401632","title":"A systematic review and meta-analysis evaluating the association of high sensitivity troponin levels with outcomes in patients with stable coronary artery disease","year":2024,"lang":"en","type":"review","venue":"Current Medical Research and Opinion","topic":"Acute Myocardial Infarction Research","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Coronary artery disease; Meta-analysis; Internal medicine; Cardiology; Troponin; Myocardial infarction","score_opus":0.23309387247825514,"score_gpt":0.4991350349256298,"score_spread":0.26604116244737464,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402274480","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001586067,0.9906467,0.000025259616,0.003303704,0.00004544484,0.0054280944,0.00037366187,0.000010941154,0.0000075600965],"genre_scores_gemma":[0.0012862341,0.99711597,0.000014669183,0.000103376275,0.00003546136,0.0007777494,0.00042004808,0.000028111064,0.00021839082],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.98915243,0.0041269865,0.0009595546,0.00057884795,0.0047195586,0.00046262052],"domain_scores_gemma":[0.99418634,0.003590759,0.00036284284,0.000532923,0.0007905639,0.00053654873],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.012381855,0.0003322063,0.0048432564,0.0005960522,0.00010776968,0.00006247159,0.00013781189,0.00014626674,0.00009517168],"category_scores_gemma":[0.007064911,0.00013572087,0.0004905439,0.0016226772,0.00031490964,0.00008577961,0.00026368196,0.0016277565,0.000009049706],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013551644,0.0003223817,0.002727458,0.91253865,0.07116585,0.000038537248,0.000031818196,2.3356924e-7,4.0031813e-9,0.000047141075,0.0007680457,0.012224388],"study_design_scores_gemma":[0.0015553432,0.0016736892,0.015566087,0.26925683,0.70386857,0.00002517191,0.000039499922,0.00026871025,2.554907e-8,0.000037718786,0.007333116,0.00037524302],"about_ca_topic_score_codex":0.00006292323,"about_ca_topic_score_gemma":0.000016357715,"teacher_disagreement_score":0.64328176,"about_ca_system_score_codex":0.00035855,"about_ca_system_score_gemma":0.0012349469,"threshold_uncertainty_score":0.84578687},"labels":[],"label_agreement":null},{"id":"W4403042441","doi":"10.1080/03007995.2024.2408464","title":"Letter to Editor regarding: “Between human and AI: methodological issues on reliability, effectiveness and accuracy to avoid misinterpretation” by Semeraro et al.","year":2024,"lang":"en","type":"letter","venue":"Current Medical Research and Opinion","topic":"Artificial Intelligence in Healthcare and Education","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Reliability (semiconductor); Medical physics","score_opus":0.4292428938627757,"score_gpt":0.6237447560590911,"score_spread":0.19450186219631538,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403042441","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.020892544,0.0044832337,0.0007100488,0.96770656,0.0045480337,0.0015015877,0.00004958852,0.00004844256,0.000059932736],"genre_scores_gemma":[0.03458505,0.0098930895,0.00026431654,0.87624997,0.07596044,0.00072203,0.0016364779,0.0001091241,0.0005795084],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9939927,0.0020193895,0.00054673915,0.0011234166,0.0016965949,0.0006212002],"domain_scores_gemma":[0.9889633,0.009206252,0.000050109156,0.00035163778,0.00043423357,0.0009944738],"candidate_categories":["metaresearch","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.006451558,0.00030370845,0.00063574844,0.00043135282,0.00024913833,0.00020579623,0.00018286226,0.0006596298,0.000083751496],"category_scores_gemma":[0.020480432,0.00022294532,0.00006520524,0.00029955714,0.000385562,0.00011381293,0.00032736827,0.004886128,0.00007012495],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016843996,0.000058914447,0.00082953315,0.0021013704,0.000024845838,0.00001694303,0.0005441606,4.0738062e-8,0.00006945482,0.00003833027,0.8969931,0.099154845],"study_design_scores_gemma":[0.000093430855,0.0020084041,0.00074737874,0.0061657643,0.000018305147,0.000008075199,0.000047000933,0.000022483442,0.00057141983,0.0024318267,0.98768556,0.00020033609],"about_ca_topic_score_codex":0.00026646364,"about_ca_topic_score_gemma":0.0000045398738,"teacher_disagreement_score":0.098954506,"about_ca_system_score_codex":0.0001692495,"about_ca_system_score_gemma":0.00025051145,"threshold_uncertainty_score":0.99740964},"labels":[],"label_agreement":null},{"id":"W4403072264","doi":"10.1080/03007995.2024.2393863","title":"Getting Help During Active Pain Crises in Sickle Cell Disease: Patient and Caregiver Perspectives in Canada","year":2024,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Pfizer (Canada); Occupational and Environmental Medical Association of Canada","funders":"Pfizer Canada","keywords":"Medicine; Disease; Intensive care medicine; Physical therapy; Internal medicine","score_opus":0.03115207663068522,"score_gpt":0.3448050922203728,"score_spread":0.3136530155896876,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403072264","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.87957615,0.11501342,0.000006391509,0.0046897847,0.00020192521,0.00030049164,0.000010248998,0.000010849372,0.00019071733],"genre_scores_gemma":[0.96986026,0.02994452,0.0000022025342,0.000027417691,0.00009045832,0.000026677628,0.000016583877,0.000009808884,0.000022049606],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9980633,0.00020874012,0.0001753478,0.00034677502,0.0007858989,0.00041992136],"domain_scores_gemma":[0.9988756,0.0003908591,0.000011456667,0.000080423924,0.000056632878,0.00058499386],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005524599,0.000100870726,0.00015920891,0.00022388215,0.000078649486,0.000024695002,0.00004496126,0.00006040647,0.000071596914],"category_scores_gemma":[0.0011153785,0.00007697916,0.000019910933,0.00031244694,0.0001700815,0.00006190587,0.000109585446,0.00092148903,0.0000015991774],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007821017,0.0006154571,0.081832305,0.0063952496,0.000035327557,0.0019253768,0.023693275,0.000008428625,0.00013795403,0.00026625989,0.007393545,0.87691474],"study_design_scores_gemma":[0.008258135,0.0013504372,0.5198849,0.032719355,0.000031283547,0.000053312462,0.3202813,0.037583154,0.00059309584,0.00102973,0.077306844,0.0009084955],"about_ca_topic_score_codex":0.07246503,"about_ca_topic_score_gemma":0.036047958,"teacher_disagreement_score":0.87600625,"about_ca_system_score_codex":0.00046674933,"about_ca_system_score_gemma":0.0017459049,"threshold_uncertainty_score":0.98154163},"labels":[],"label_agreement":null},{"id":"W4403231995","doi":"10.1080/03007995.2024.2409837","title":"Patient-reported outcomes in patients with relapsed or refractory follicular lymphoma treated with zanubrutinib plus obinutuzumab versus obinutuzumab monotherapy: results from the ROSEWOOD trial","year":2024,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"BeiGene","keywords":"Medicine; Obinutuzumab; Internal medicine; Refractory (planetary science); Oncology; Follicular lymphoma; Lymphoma; Rituximab","score_opus":0.07134928530396044,"score_gpt":0.3822081702828955,"score_spread":0.31085888497893505,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403231995","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99087644,0.0033505568,0.000015861377,0.00083699333,0.0010266033,0.0034016396,0.00012774837,0.00012809117,0.00023606583],"genre_scores_gemma":[0.9951338,0.0024894753,0.000032457665,0.000050995473,0.00048721308,0.0003436404,0.0011653652,0.000086422704,0.00021058883],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99096894,0.00063948607,0.000973214,0.0012152032,0.005053926,0.0011492405],"domain_scores_gemma":[0.99271643,0.0047297264,0.00014229868,0.00104047,0.00043889016,0.00093216123],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017491013,0.0004479583,0.00078050693,0.00040136135,0.00025520052,0.00019815551,0.00038548882,0.00037014915,0.00018927218],"category_scores_gemma":[0.0053218007,0.00021268621,0.0001203076,0.0013875341,0.00085695274,0.0002159601,0.00024859997,0.0014622897,0.0000374856],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.80577755,0.0011013828,0.003013753,0.00023449506,0.0008144033,0.0013306431,0.0017261298,0.0000060997104,0.0000042846605,0.0000727053,0.004856939,0.18106164],"study_design_scores_gemma":[0.8793908,0.028009696,0.019081611,0.0049532186,0.00010495212,0.000039615024,0.000578112,0.011053147,0.000076759185,0.00005529165,0.056158017,0.0004987791],"about_ca_topic_score_codex":0.0037500714,"about_ca_topic_score_gemma":0.0003520619,"teacher_disagreement_score":0.18056285,"about_ca_system_score_codex":0.019271081,"about_ca_system_score_gemma":0.035166405,"threshold_uncertainty_score":0.9844938},"labels":[],"label_agreement":null},{"id":"W4404144841","doi":"10.1080/03007995.2024.2418993","title":"Dapagliflozin or saxagliptin in pediatric type 2 diabetes: a plain language summary","year":2024,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Barrie Urology Group","funders":"","keywords":"Medicine; Dapagliflozin; Saxagliptin; Type 2 diabetes; Diabetes mellitus; Internal medicine; Pediatrics; Endocrinology; Sitagliptin","score_opus":0.07953331488767264,"score_gpt":0.43195344674160274,"score_spread":0.3524201318539301,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404144841","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.80390275,0.18172123,0.000015518171,0.005679936,0.0021620907,0.0011032344,0.000014648365,0.00016360833,0.0052369814],"genre_scores_gemma":[0.8726191,0.119936384,0.000081890306,0.00019067094,0.0025375104,0.00019031111,0.00041823433,0.000049775754,0.003976125],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99734086,0.00013005584,0.00023733874,0.00039254772,0.001313068,0.0005861053],"domain_scores_gemma":[0.9986317,0.00059875334,0.000012060818,0.00018432278,0.00006810215,0.0005050554],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002052571,0.0001359073,0.00023444825,0.00060098927,0.00004884089,0.000067844776,0.00011849068,0.00010133867,0.00062098156],"category_scores_gemma":[0.0018385617,0.000089358466,0.000039306353,0.0009804902,0.00012139148,0.0000872688,0.00020636927,0.00066485425,0.00019895047],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028162744,0.0007142373,0.035317134,0.0034892228,0.00005637144,0.00046371584,0.0005423533,7.4021195e-8,0.000025312986,0.0009871268,0.19821143,0.7599114],"study_design_scores_gemma":[0.0037355898,0.0030212426,0.031127222,0.0056353696,0.000065239095,0.000007733889,0.00049816445,0.004081391,0.00008675575,0.00052630773,0.9508985,0.00031646073],"about_ca_topic_score_codex":0.000017507791,"about_ca_topic_score_gemma":0.000036136586,"teacher_disagreement_score":0.7595949,"about_ca_system_score_codex":0.00013689014,"about_ca_system_score_gemma":0.00047003198,"threshold_uncertainty_score":0.6799312},"labels":[],"label_agreement":null},{"id":"W4406034549","doi":"10.1080/03007995.2024.2440059","title":"Effects of brexpiprazole on patient life engagement in schizophrenia: <i>post hoc</i> analysis of Positive and Negative Syndrome Scale data","year":2025,"lang":"en","type":"review","venue":"Current Medical Research and Opinion","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University of Calgary","funders":"H. Lundbeck A/S","keywords":"Medicine; Positive and Negative Syndrome Scale; Post-hoc analysis; Schizophrenia (object-oriented programming); Post hoc; Psychiatry; Negative symptom; Scale (ratio); Clinical psychology; Internal medicine; Psychosis","score_opus":0.0960438075940058,"score_gpt":0.4539796613723036,"score_spread":0.35793585377829784,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406034549","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.015087436,0.98057574,0.000009689634,0.00029732648,0.00017010352,0.0028590702,0.00093338446,0.000009187707,0.000058075744],"genre_scores_gemma":[0.009917975,0.9872361,0.000085742606,0.000016838552,0.00006164985,0.0002623202,0.002389908,0.000019821999,0.000009652137],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9932176,0.0015544561,0.00095484406,0.0010037518,0.0026560407,0.0006133168],"domain_scores_gemma":[0.9900786,0.00741801,0.00023189213,0.00081728544,0.00035877273,0.0010954044],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002137825,0.00040461213,0.0026352429,0.0025642395,0.00010889548,0.0000280894,0.00045468708,0.00030257084,0.00005875685],"category_scores_gemma":[0.0074161645,0.00027907963,0.00025816282,0.0025890314,0.0006983549,0.000082081664,0.0014332777,0.0018591988,0.0000059693784],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003469988,0.0017697758,0.00010061348,0.03938741,0.0017214271,0.00013512926,0.00011925673,6.883809e-8,4.7004627e-7,0.00020225106,0.00040613543,0.9526875],"study_design_scores_gemma":[0.035958216,0.037396047,0.039808586,0.7543227,0.009841452,0.00009303387,0.00052443723,0.00089411857,0.00015616378,0.00039251675,0.11925669,0.001356025],"about_ca_topic_score_codex":0.00019241332,"about_ca_topic_score_gemma":0.00009678845,"teacher_disagreement_score":0.95133144,"about_ca_system_score_codex":0.00018959101,"about_ca_system_score_gemma":0.0028757162,"threshold_uncertainty_score":0.99996614},"labels":[],"label_agreement":null},{"id":"W4406919465","doi":"10.1080/03007995.2025.2458538","title":"Perioperative and periprocedural management of GLP-1 receptor-based agonists and SGLT2 inhibitors: narrative review and the STOP-GAP and STOP DKA-2 algorithms","year":2025,"lang":"en","type":"review","venue":"Current Medical Research and Opinion","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Bruyère; Queensway-Carleton Hospital; St. Joseph’s Healthcare Hamilton; St. Michael's Hospital; Western University; LMC Diabetes & Endocrinology (Canada); Queen's University; Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"Novo Nordisk Canada; Eli Lilly Canada","keywords":"Medicine; Narrative review; Perioperative; Glucagon-like peptide 1 receptor; Intensive care medicine; Receptor; Agonist; Internal medicine; Anesthesia","score_opus":0.09666611352847027,"score_gpt":0.4688349465877436,"score_spread":0.37216883305927334,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406919465","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00016250557,0.99066156,0.000013225246,0.00403478,0.00023334821,0.0043821028,0.000043252763,0.00001564639,0.00045359257],"genre_scores_gemma":[0.00009025436,0.9977578,0.00011904566,0.00012583348,0.00015460032,0.0007160876,0.00029825544,0.000020008463,0.0007181245],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9965284,0.0006153452,0.00061829714,0.0007711454,0.0010168408,0.00044997712],"domain_scores_gemma":[0.9981189,0.00069060386,0.00015890329,0.00028499938,0.00020963118,0.00053696154],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0022415528,0.00045283374,0.0017666597,0.00025565445,0.0003273471,0.00010602764,0.00014289566,0.00018120962,0.00006683416],"category_scores_gemma":[0.0006421602,0.00025446797,0.000110103436,0.0003941989,0.002017159,0.00008754739,0.0006455443,0.00079131545,0.0000017392679],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008339663,0.0001355375,0.000022247223,0.15905079,0.00031922726,0.000008676926,0.00048306008,1.4133467e-9,6.2871294e-8,0.0012845612,0.0041456404,0.8344668],"study_design_scores_gemma":[0.0037664785,0.00083225063,0.00006683209,0.17303975,0.0008037212,0.000012024243,0.0008854342,0.000035329835,9.93584e-7,0.000051023402,0.8202867,0.0002194808],"about_ca_topic_score_codex":0.000017260012,"about_ca_topic_score_gemma":0.00000269346,"teacher_disagreement_score":0.8342473,"about_ca_system_score_codex":0.0000880186,"about_ca_system_score_gemma":0.00038604884,"threshold_uncertainty_score":0.99999076},"labels":[],"label_agreement":null},{"id":"W4406962517","doi":"10.1080/03007995.2025.2459784","title":"US general population food allergy treatment preferences: a discrete choice experiment","year":2025,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Economic and Environmental Valuation","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Coastal Health","funders":"","keywords":"Medicine; Food allergy; Population; Allergy; Environmental health; Immunology","score_opus":0.3011725331382148,"score_gpt":0.4000065059508784,"score_spread":0.0988339728126636,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406962517","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9751838,0.01804586,0.00080831896,0.0009679319,0.0008358706,0.00033416756,0.000035511646,0.000015938827,0.0037726364],"genre_scores_gemma":[0.983865,0.014935998,0.00005187125,0.00003787794,0.00023845307,0.00015865247,0.00023175523,0.0000069585276,0.00047339714],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99873966,0.000051575968,0.00037324542,0.00040537803,0.00012897092,0.0003011911],"domain_scores_gemma":[0.9994481,0.00009673834,0.00006264169,0.00017472009,0.000011282015,0.000206489],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005791564,0.00011083396,0.00020578079,0.00017431645,0.00016875334,0.000057601603,0.00013021259,0.00009296075,0.00055248337],"category_scores_gemma":[0.00017324572,0.00010227518,0.00004588861,0.000110959765,0.00010721337,0.0001267088,0.00011312946,0.00016106627,0.00008603601],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005046318,0.00052776985,0.58308357,0.000083961175,0.00011043936,4.024319e-7,0.0003158899,0.000024012183,0.0000065179656,0.21011873,0.0023194242,0.2033588],"study_design_scores_gemma":[0.0014692615,0.0006957585,0.64529663,0.00012636476,0.0000013989621,4.983186e-7,0.00006199916,0.006162341,0.00006473188,0.028759878,0.3171951,0.00016604732],"about_ca_topic_score_codex":0.00082408456,"about_ca_topic_score_gemma":0.00012618325,"teacher_disagreement_score":0.31487566,"about_ca_system_score_codex":0.00032931933,"about_ca_system_score_gemma":0.000041036335,"threshold_uncertainty_score":0.6049305},"labels":[],"label_agreement":null},{"id":"W4409033671","doi":"10.1080/03007995.2025.2476743","title":"Expert advice on helping people with obstructive sleep apnea and excessive daytime sleepiness: a plain language summary","year":2025,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Child Nutrition and Feeding Issues","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Heart, Lung, and Blood Institute; National Institute on Aging; Jazz Pharmaceuticals","keywords":"Medicine; Obstructive sleep apnea; Advice (programming); Excessive daytime sleepiness; Sleep (system call); Daytime; Plain language; Sleep apnea; Physical therapy; Psychiatry; Sleep disorder; Anesthesia; Insomnia; Linguistics","score_opus":0.033556498537416025,"score_gpt":0.39812654675971754,"score_spread":0.3645700482223015,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409033671","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.83085924,0.11088345,0.0012523994,0.042225163,0.001428051,0.0019912794,0.000054956276,0.00029409194,0.011011384],"genre_scores_gemma":[0.98446184,0.013064882,0.00014344764,0.00067400804,0.0009493233,0.00012038622,0.00023917497,0.000021446878,0.0003255095],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99804926,0.00010894792,0.00018325153,0.00040995993,0.00088685966,0.00036171707],"domain_scores_gemma":[0.9986353,0.0005112095,0.000029815872,0.00016925824,0.00017161995,0.00048278042],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004996099,0.00014677158,0.00029071822,0.00032831094,0.00021522296,0.000046923094,0.000098579985,0.00011445143,0.00010467644],"category_scores_gemma":[0.0012921268,0.00010525731,0.000027059496,0.0004422077,0.0003411693,0.0000825496,0.00014789485,0.0007220581,0.000007667374],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0053974222,0.0014542344,0.023893995,0.0030173291,0.00016326309,0.0001758335,0.010295205,2.5568787e-7,0.0005627745,0.004972922,0.049330454,0.90073633],"study_design_scores_gemma":[0.03927649,0.0077115316,0.3079677,0.058052093,0.00009847018,0.00036404253,0.034747705,0.013956302,0.0038606513,0.0022578943,0.53036445,0.001342659],"about_ca_topic_score_codex":0.000078421435,"about_ca_topic_score_gemma":0.000020197089,"teacher_disagreement_score":0.8993937,"about_ca_system_score_codex":0.00005762443,"about_ca_system_score_gemma":0.00012426719,"threshold_uncertainty_score":0.42922685},"labels":[],"label_agreement":null},{"id":"W4409117945","doi":"10.1080/03007995.2025.2488948","title":"Response to “Frontiers in bibliometric analysis: the overrepresentation of bibliometric analyses in grey publisher journals”","year":2025,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"scientometrics and bibliometrics research","field":"Decision Sciences","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Université de Montréal; Centre Hospitalier Universitaire de Sherbrooke; Université de Sherbrooke","funders":"","keywords":"Medicine; Bibliometrics; Grey literature; Library science; MEDLINE; Computer science","score_opus":0.7187109624252355,"score_gpt":0.6964715231902021,"score_spread":0.022239439235033354,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409117945","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9012479,0.072656296,0.010742339,0.012184943,0.0017130851,0.0006814641,0.000016898437,0.000008294115,0.00074874755],"genre_scores_gemma":[0.9791311,0.02030003,0.00012211535,0.00007394885,0.000057454326,0.000050962604,0.0000071255845,0.000006048538,0.0002512197],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9634696,0.0044735535,0.002045636,0.0012057532,0.027502347,0.0013031098],"domain_scores_gemma":[0.94667333,0.041962866,0.00036355297,0.0014363538,0.007966549,0.0015973322],"candidate_categories":["metaresearch","bibliometrics","scholarly_communication"],"consensus_categories":["metaresearch","bibliometrics"],"category_scores_codex":[0.14779484,0.0001732923,0.00070584717,0.97614175,0.00022499148,0.0028013638,0.003361363,0.00020539071,0.0003499509],"category_scores_gemma":[0.46284467,0.000103288185,0.00020699674,0.9932336,0.0005523335,0.000996425,0.0016634244,0.0013397634,0.000017686903],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040199797,0.00025912185,0.5454539,0.0000146282955,0.00004187666,0.0000053842336,0.00006647569,0.000043818753,0.000042064505,0.000060130886,0.049977258,0.40363336],"study_design_scores_gemma":[0.00083840336,0.00019278491,0.9642307,0.00012709289,0.000009343567,8.2256685e-7,0.0008681316,0.00834281,0.0000520014,0.005376117,0.019867968,0.00009383],"about_ca_topic_score_codex":0.0007648334,"about_ca_topic_score_gemma":0.0001471547,"teacher_disagreement_score":0.4187768,"about_ca_system_score_codex":0.00023357008,"about_ca_system_score_gemma":0.00113987,"threshold_uncertainty_score":0.9982338},"labels":[],"label_agreement":null},{"id":"W4409209288","doi":"10.1080/03007995.2025.2488951","title":"Letter to the editor: author response for “why fexofenadine is considered as a truly non-sedating antihistamine with no brain penetration: a systematic review”","year":2025,"lang":"en","type":"letter","venue":"Current Medical Research and Opinion","topic":"Allergic Rhinitis and Sensitization","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"","keywords":"Medicine; Fexofenadine; Antihistamine; Terfenadine; Pharmacology","score_opus":0.07809174928061956,"score_gpt":0.4191702298417136,"score_spread":0.341078480561094,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409209288","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00005939383,0.00799267,0.0032786797,0.97862774,0.0027838955,0.006893852,0.00011491287,0.0000311824,0.00021769955],"genre_scores_gemma":[0.0002060583,0.005217128,0.00023687117,0.9422992,0.03752757,0.0012875281,0.0021206653,0.000067624846,0.011037341],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99353904,0.0011631636,0.0009100304,0.0007551546,0.0029338868,0.00069875637],"domain_scores_gemma":[0.9911504,0.005839835,0.00022724582,0.0007060344,0.0015898101,0.00048667472],"candidate_categories":["metaresearch","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.006127672,0.00037175888,0.0010947682,0.00037495955,0.00042745628,0.00015134,0.0002956435,0.0005196569,0.0002476087],"category_scores_gemma":[0.03058973,0.00021558942,0.00013747455,0.00054021494,0.00029696577,0.000069252295,0.00013932343,0.0023988213,0.000071674534],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007926618,0.00004386895,0.0000026848816,0.11860412,0.00008722467,0.00010891109,0.00021091527,2.672407e-8,0.000008454894,0.000020956162,0.8795436,0.0005765793],"study_design_scores_gemma":[0.0012708249,0.0014284683,0.000013792604,0.18973765,0.00008467397,0.000100529374,0.000034509307,0.0006675727,0.0000075702014,0.000022566792,0.80644953,0.00018231373],"about_ca_topic_score_codex":0.00003422045,"about_ca_topic_score_gemma":0.000014568751,"teacher_disagreement_score":0.07309407,"about_ca_system_score_codex":0.00016086912,"about_ca_system_score_gemma":0.0016675687,"threshold_uncertainty_score":0.99990267},"labels":[],"label_agreement":null},{"id":"W4409643669","doi":"10.1080/03007995.2025.2495171","title":"Association of OFF period characteristics with patient communication behaviors in Parkinson’s disease","year":2025,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Medicine; Parkinson's disease; Association (psychology); Disease; Period (music); Internal medicine; Gerontology","score_opus":0.03760859820761235,"score_gpt":0.385980931094842,"score_spread":0.34837233288722963,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409643669","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99048114,0.0061117704,0.000025771857,0.0025625022,0.00013270702,0.00048272582,0.000050598563,0.000010538791,0.00014226188],"genre_scores_gemma":[0.9875598,0.011866396,0.000031455227,0.000027053646,0.000022336772,0.000110502464,0.0003186074,0.0000058107257,0.00005806025],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981607,0.000178779,0.00024809162,0.00020403843,0.00096976105,0.00023859736],"domain_scores_gemma":[0.9989573,0.00014391773,0.00007021976,0.00022131523,0.00022614682,0.00038114618],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00059086905,0.00008646203,0.00020688708,0.00022086185,0.00008018855,0.000015995483,0.00007836566,0.00007107743,0.000077112265],"category_scores_gemma":[0.0008594577,0.00006571991,0.000028847579,0.0002847373,0.000113587106,0.000044962413,0.000094931835,0.00034624932,0.0000029360162],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006983433,0.0014744742,0.67895836,0.00025855703,0.00002918443,0.000018799485,0.0001446963,3.5105867e-8,0.000009221436,0.00044579455,0.0006602747,0.3173023],"study_design_scores_gemma":[0.0021507218,0.00040015602,0.90886444,0.0021202173,0.000032906424,9.857863e-7,0.000111030124,0.00039247985,0.00004958818,0.00022018608,0.08560154,0.000055769764],"about_ca_topic_score_codex":0.000037732872,"about_ca_topic_score_gemma":0.000024018706,"teacher_disagreement_score":0.3172465,"about_ca_system_score_codex":0.0002172083,"about_ca_system_score_gemma":0.00052000984,"threshold_uncertainty_score":0.26799804},"labels":[],"label_agreement":null},{"id":"W4410395778","doi":"10.1080/03007995.2025.2503976","title":"Functional improvement as a treatment goal in major depressive disorder: a narrative review of the evidence for vortioxetine","year":2025,"lang":"en","type":"review","venue":"Current Medical Research and Opinion","topic":"Treatment of Major Depression","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Grey Nuns Community Hospital","funders":"H. Lundbeck A/S","keywords":"Vortioxetine; Medicine; Narrative review; Major depressive disorder; Psychotherapist; Psychiatry; Clinical psychology; Intensive care medicine; Mood","score_opus":0.19688177402998905,"score_gpt":0.5313244995851152,"score_spread":0.3344427255551261,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410395778","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000052240237,0.98760575,0.000039863775,0.0033770464,0.00062819757,0.008150838,0.00007363949,0.000010761986,0.00006163208],"genre_scores_gemma":[0.000031610536,0.993724,0.000018380533,0.000046279354,0.00028512327,0.0047819973,0.00039533942,0.000018563116,0.0006987438],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99541205,0.00058157666,0.00093913416,0.00072442164,0.0018834912,0.0004593062],"domain_scores_gemma":[0.995261,0.003160778,0.00029938022,0.0005348257,0.0003810848,0.00036290716],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0014922679,0.0003702497,0.0015189913,0.0002963529,0.000171238,0.000014359518,0.00027452977,0.00024985493,0.00022825615],"category_scores_gemma":[0.012455738,0.0001864496,0.00047787017,0.0006258252,0.0003462304,0.000056659843,0.0003881515,0.000788522,0.0000066388325],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024848894,0.00079050165,0.0001507338,0.18349826,0.00011180129,0.0000046386663,0.00003908323,9.567331e-9,4.952263e-7,0.00007673089,0.0055482807,0.809531],"study_design_scores_gemma":[0.0021462273,0.0013293708,0.00018154172,0.49601766,0.00024033918,0.000012054977,0.000019778196,0.000005156582,0.000006484357,0.00008917319,0.49986842,0.000083787745],"about_ca_topic_score_codex":0.00007776676,"about_ca_topic_score_gemma":0.00003157942,"teacher_disagreement_score":0.80944717,"about_ca_system_score_codex":0.0005060967,"about_ca_system_score_gemma":0.0040354077,"threshold_uncertainty_score":0.9958628},"labels":[],"label_agreement":null},{"id":"W4410601738","doi":"10.1080/03007995.2025.2506808","title":"Patient-reported real-world experience of risankizumab on-body device (OBD) for the treatment of Crohn’s disease in the UK (COMMODUS)","year":2025,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"AbbVie Canada","keywords":"Medicine; Crohn's disease; Disease; Internal medicine; Gastroenterology","score_opus":0.06658225976352167,"score_gpt":0.4296402699105698,"score_spread":0.36305801014704814,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410601738","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950514,0.0030902654,0.000079448626,0.0004379533,0.00022033307,0.00088501425,0.00003984334,0.0000020517027,0.00019369746],"genre_scores_gemma":[0.99402255,0.005299062,0.000004264136,0.000038820657,0.00008627911,0.00042419598,0.00008533977,0.0000045356783,0.000034952565],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99848896,0.00021185477,0.00029532876,0.00024531112,0.0005223468,0.00023622543],"domain_scores_gemma":[0.99882156,0.00038712105,0.00006219876,0.0004371931,0.00014230669,0.00014962208],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005349618,0.00009525405,0.000115163784,0.000082327555,0.00010859818,0.000011758364,0.0002463607,0.000048107286,0.00001956091],"category_scores_gemma":[0.0010553469,0.000052844116,0.00006950508,0.00017548929,0.00041476617,0.0000026354169,0.0000782032,0.000108059365,4.212005e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02078646,0.0070152953,0.4305186,0.0015322273,0.0003060973,0.00015071237,0.0037254116,0.00004494869,0.0014518113,0.015344541,0.02014608,0.4989778],"study_design_scores_gemma":[0.0022246947,0.0008685604,0.9225971,0.00042448475,0.000018892299,4.4034627e-7,0.000535571,0.0010496323,0.0028466047,0.000497535,0.068827935,0.000108513115],"about_ca_topic_score_codex":0.00012697921,"about_ca_topic_score_gemma":0.00014757607,"teacher_disagreement_score":0.4988693,"about_ca_system_score_codex":0.000034733774,"about_ca_system_score_gemma":0.0004949787,"threshold_uncertainty_score":0.21549205},"labels":[],"label_agreement":null},{"id":"W4411429725","doi":"10.1080/03007995.2025.2515280","title":"Real-world clinical outcomes of patients with moderate-to-severe rheumatoid arthritis initiating upadacitinib in the United Kingdom: final analysis from a prospective observational cohort study (ENDEAVOUR)","year":2025,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Medicine; Rheumatoid arthritis; Observational study; Internal medicine; Quality of life (healthcare); Clinical trial; Cohort; Physical therapy; Clinical endpoint; Outpatient clinic; Rheumatology; Cohort study","score_opus":0.16487967930514588,"score_gpt":0.46151269522096755,"score_spread":0.2966330159158217,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411429725","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954622,0.0004934176,0.00020470792,0.0012975435,0.00010593836,0.0020813714,0.0000924445,0.000017983582,0.00024442212],"genre_scores_gemma":[0.9905574,0.008111919,0.000113863156,0.00009814464,0.00004949142,0.00031768167,0.00072469615,0.00001120522,0.000015638932],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9939246,0.0011003807,0.0009162087,0.000570568,0.002970128,0.0005180912],"domain_scores_gemma":[0.99470973,0.003458033,0.00011191095,0.00038045534,0.00093996903,0.00039992362],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0040885666,0.00019568582,0.0008144134,0.0011953559,0.00026427224,0.00008691902,0.00029971276,0.000088474604,0.0001987336],"category_scores_gemma":[0.005697741,0.00012304944,0.0001070694,0.0032773577,0.0004928827,0.00012391491,0.00021594691,0.0012622001,0.000004475077],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021410324,0.0022958722,0.97676975,0.00003239368,0.00073170254,0.000015525493,0.0005704004,0.000003868818,1.775455e-7,0.0017273141,0.00039798496,0.015313953],"study_design_scores_gemma":[0.008222949,0.0010780237,0.9861732,0.001220791,0.000012813917,5.829407e-7,0.00060228305,0.00096047745,0.0000017224013,0.0008279343,0.0007913146,0.00010787788],"about_ca_topic_score_codex":0.0028579761,"about_ca_topic_score_gemma":0.0025360603,"teacher_disagreement_score":0.015206075,"about_ca_system_score_codex":0.00008287405,"about_ca_system_score_gemma":0.00077394774,"threshold_uncertainty_score":0.682114},"labels":[],"label_agreement":null},{"id":"W4412156752","doi":"10.1080/03007995.2025.2529991","title":"Why wastewater-based epidemiology must tackle noncommunicable diseases","year":2025,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"SARS-CoV-2 detection and testing","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Medicine; Scope (computer science); Global health; Health care; Epidemiological transition; Epidemiology; Developing country; Healthcare system; Disease; Disease burden; Environmental health; Economic growth; Risk analysis (engineering); Public health; Computer science; Pathology; Economics","score_opus":0.22785099741348938,"score_gpt":0.50564488386113,"score_spread":0.2777938864476407,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412156752","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8143004,0.07426897,0.0060524866,0.0877037,0.0044549713,0.0017042438,0.000035109566,0.0004749028,0.011005189],"genre_scores_gemma":[0.9885762,0.0029140268,0.00037980956,0.0068585766,0.0007316073,0.00015297238,0.00015276684,0.000023277957,0.00021080172],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99761707,0.000573354,0.0003502319,0.00033696243,0.00056899374,0.0005533766],"domain_scores_gemma":[0.99558926,0.0033239112,0.00003692131,0.00039014663,0.00020778395,0.00045198112],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.002072413,0.00012120749,0.00034733987,0.0003386656,0.00027645638,0.000021078446,0.00019495508,0.00014673274,0.00020769134],"category_scores_gemma":[0.018459255,0.00009040259,0.000071621354,0.0004999613,0.00059248594,0.000046039895,0.0002553886,0.0009950881,0.00003542382],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010946543,0.001980232,0.1167957,0.0025146762,0.000089089415,0.000052947995,0.000078496094,0.0000013216263,0.0031319459,0.0030754437,0.27077407,0.6004114],"study_design_scores_gemma":[0.0031932895,0.0007299268,0.006067061,0.002887457,0.000016754382,0.00001731257,0.00010394026,0.013899224,0.0056952517,0.0020396363,0.96521986,0.00013029439],"about_ca_topic_score_codex":0.00014788844,"about_ca_topic_score_gemma":0.000015711828,"teacher_disagreement_score":0.6944458,"about_ca_system_score_codex":0.00007598802,"about_ca_system_score_gemma":0.00051852426,"threshold_uncertainty_score":0.9898087},"labels":[],"label_agreement":null},{"id":"W4412178851","doi":"10.1080/03007995.2025.2530736","title":"Impact of moderate-to-severe ulcerative colitis and Crohn’s disease on sexual activity: United States and European patient perspectives from the communicating needs and features of IBD experiences (CONFIDE) survey","year":2025,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Eli Lilly and Company","keywords":"Medicine; Ulcerative colitis; Crohn's disease; Inflammatory bowel disease; Disease; Family medicine; Dermatology; Internal medicine","score_opus":0.04442576170667768,"score_gpt":0.387553048967778,"score_spread":0.3431272872611003,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412178851","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953171,0.003800862,0.000017412774,0.00020866745,0.000026936112,0.00026754322,0.00031347448,0.0000024200729,0.00004559377],"genre_scores_gemma":[0.9956953,0.004024063,0.0000041855205,0.000027908945,0.00002625067,0.000018994533,0.00019106978,0.000005536074,0.0000066743983],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99797475,0.0012170637,0.00013309481,0.00023254928,0.00027525093,0.00016727975],"domain_scores_gemma":[0.99872243,0.00050821475,0.000044447144,0.00020265738,0.00021689168,0.0003053808],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006505767,0.00010589413,0.00012679219,0.00008204249,0.00018406479,0.000050851566,0.0001262516,0.0000355697,0.0000058828127],"category_scores_gemma":[0.0018693133,0.000070655624,0.000016330614,0.000121164085,0.00082508475,0.00000820226,0.00041264977,0.00020950745,7.4828854e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0405838,0.0015929128,0.50835574,0.000766816,0.00065869454,0.000047643753,0.10861832,0.0000455325,0.005473129,0.0014151098,0.008585599,0.32385674],"study_design_scores_gemma":[0.00054325,0.0004707439,0.9862707,0.0002300591,0.000003820033,4.973317e-7,0.011514123,0.000365367,0.0003515092,0.000056883062,0.000121422585,0.000071620685],"about_ca_topic_score_codex":0.00077222055,"about_ca_topic_score_gemma":0.0002487775,"teacher_disagreement_score":0.477915,"about_ca_system_score_codex":0.000012364395,"about_ca_system_score_gemma":0.00018720275,"threshold_uncertainty_score":0.30400592},"labels":[],"label_agreement":null},{"id":"W4412522050","doi":"10.1080/03007995.2025.2536607","title":"Diagnostic accuracy of cardiovascular and imaging biomarkers to identify index patients with familial hypercholesterolaemia","year":2025,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Medicine; Internal medicine; Cohort; Intima-media thickness; Population; Cardiology; Carotid arteries","score_opus":0.03401270397466517,"score_gpt":0.40080789210865436,"score_spread":0.3667951881339892,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412522050","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96685773,0.02773785,0.0023251122,0.0013068565,0.00036661787,0.0012616109,0.00001078361,0.000015267538,0.000118184966],"genre_scores_gemma":[0.9900993,0.009458486,0.000038051585,0.000101634505,0.00017443483,0.000073043855,0.0000391664,0.000011307292,0.000004550369],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99664694,0.00022583624,0.0002713971,0.00041148512,0.0020397396,0.00040459033],"domain_scores_gemma":[0.9979438,0.0005225253,0.000024632802,0.0004140573,0.00041179406,0.0006831989],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021949613,0.00012741816,0.00040582626,0.0003484365,0.00012307304,0.000034524353,0.00011917753,0.000080780395,0.000010429286],"category_scores_gemma":[0.006009766,0.000090873786,0.000101228565,0.000506135,0.00033595867,0.0000885132,0.0002673196,0.00049955765,0.0000026202306],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002811878,0.00014732577,0.2958635,0.0010857659,0.00024903202,0.000010735658,0.00006264046,3.1818738e-7,0.000008949259,0.00003691409,0.0009710206,0.7012826],"study_design_scores_gemma":[0.0042125774,0.0003273723,0.9421557,0.0033275527,0.000058568203,0.000008747251,0.00010658907,0.00008919868,0.000050585637,0.00006853878,0.049504686,0.00008988576],"about_ca_topic_score_codex":0.00041405985,"about_ca_topic_score_gemma":0.0000074894383,"teacher_disagreement_score":0.70119274,"about_ca_system_score_codex":0.000066302935,"about_ca_system_score_gemma":0.00046426317,"threshold_uncertainty_score":0.71946853},"labels":[],"label_agreement":null},{"id":"W4412636315","doi":"10.1080/03007995.2025.2537898","title":"Development and validation of patient-reported outcome measures for platysma prominence","year":2025,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Facial Rejuvenation and Surgery Techniques","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"AbbVie Canada; Allergan","keywords":"Medicine; Outcome (game theory); Patient-reported outcome; Physical medicine and rehabilitation; Quality of life (healthcare)","score_opus":0.22141489727314584,"score_gpt":0.48248296953270764,"score_spread":0.2610680722595618,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412636315","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.985241,0.0017476617,0.0048142583,0.0061164577,0.00038341671,0.0011759312,0.000004333528,0.00004173599,0.00047522184],"genre_scores_gemma":[0.99740535,0.0010791911,0.0010723283,0.00009561822,0.000020566684,0.00015018627,0.000071824186,0.0000047283584,0.00010018773],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984736,0.000043523938,0.00037999786,0.00017349242,0.00076739845,0.00016203028],"domain_scores_gemma":[0.9989947,0.0002941182,0.00004585446,0.00008221465,0.00039551777,0.00018761061],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001523003,0.0000611541,0.00017884673,0.00024287816,0.000082030616,0.000011379635,0.000039010516,0.000102582235,0.00001516297],"category_scores_gemma":[0.006174698,0.000046096382,0.00002212595,0.00018759063,0.00015269601,0.00003680796,0.000059409773,0.00023244855,3.9182845e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025135884,0.00018887271,0.051814955,0.00052659155,0.00001989352,0.0000014704715,0.00020990352,1.21027135e-8,0.00045260583,0.0034371389,0.004242646,0.9388546],"study_design_scores_gemma":[0.0014113253,0.00037069636,0.02349078,0.0016677738,0.0000069633256,0.000005610811,0.00014978962,0.00033300978,0.057385683,0.0014805674,0.91360646,0.00009134934],"about_ca_topic_score_codex":0.0000046633027,"about_ca_topic_score_gemma":0.000001592507,"teacher_disagreement_score":0.9387632,"about_ca_system_score_codex":0.000033586228,"about_ca_system_score_gemma":0.0004446747,"threshold_uncertainty_score":0.73921365},"labels":[],"label_agreement":null},{"id":"W4413100043","doi":"10.1080/03007995.2025.2544596","title":"Patient preferences for food allergy treatments in the United States: a discrete choice experiment","year":2025,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Food Allergy and Anaphylaxis Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Coastal Health","funders":"Genentech; National Institutes of Health; Food Allergy Research and Education","keywords":"Medicine; Confidence interval; Odds ratio; Food allergy; Allergy; Logistic regression; Relative risk; Anaphylaxis; Odds; Demography; Internal medicine; Pediatrics; Immunology","score_opus":0.14009381977495514,"score_gpt":0.47220170540025347,"score_spread":0.33210788562529836,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413100043","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9553231,0.02283411,0.0002631517,0.017639942,0.00040281017,0.0022372918,0.000047576945,0.000024562936,0.001227466],"genre_scores_gemma":[0.97761726,0.020429594,0.000019309897,0.00022064889,0.00013109524,0.0008878647,0.0005570618,0.000007661627,0.00012952261],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99732214,0.00030603673,0.0002564101,0.00032971296,0.0012546236,0.00053108105],"domain_scores_gemma":[0.9981907,0.001092273,0.000020844172,0.0002141626,0.00017749278,0.00030452726],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008973181,0.00012420883,0.0001890066,0.00040879453,0.00020439275,0.000049020666,0.00020601408,0.00008994351,0.00007329967],"category_scores_gemma":[0.001373802,0.00006946908,0.000051316812,0.00069291965,0.00030569464,0.00004221896,0.0001431,0.0005534193,0.0000034297284],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002741079,0.0045266813,0.005447566,0.0012764209,0.0004473175,0.000018335722,0.004894531,0.000003913579,0.00004823739,0.011775976,0.05047632,0.9183436],"study_design_scores_gemma":[0.0039255507,0.0075586266,0.014464913,0.001677434,0.0000018356061,0.0000020077364,0.003086428,0.0021272027,0.00024128628,0.0026339116,0.9641817,0.000099102675],"about_ca_topic_score_codex":0.00019613154,"about_ca_topic_score_gemma":0.00020744631,"teacher_disagreement_score":0.91824454,"about_ca_system_score_codex":0.000074590265,"about_ca_system_score_gemma":0.00034513252,"threshold_uncertainty_score":0.28328672},"labels":[],"label_agreement":null},{"id":"W4414011969","doi":"10.1080/03007995.2025.2552277","title":"Real world treatment patterns and unmet needs of migraine preventive treatments in Japan: JMDC claims analysis","year":2025,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Migraine and Headache Studies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Amgen Astellas Biopharma; Eli Lilly Japan; Pfizer Japan; Eisai; Otsuka Pharmaceutical; Daiichi Sankyo Company; AbbVie Canada; Lundbeckfonden","keywords":"Medicine; Migraine; Alternative medicine; Migraine treatment; Intensive care medicine; Family medicine; Traditional medicine; Internal medicine; Pathology","score_opus":0.09211711857671473,"score_gpt":0.4799770714778839,"score_spread":0.38785995290116915,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414011969","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9881234,0.0065528364,0.000038776147,0.0032687092,0.000041110976,0.00055004616,0.00003462981,0.0000095323385,0.0013809211],"genre_scores_gemma":[0.93024063,0.06606265,0.000021148742,0.000017626371,0.00008812707,0.00008462534,0.00016463803,0.000005099249,0.0033154648],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982145,0.00017417838,0.00036049233,0.000268238,0.00061881606,0.0003638134],"domain_scores_gemma":[0.99887675,0.0004716078,0.00003908489,0.00018952874,0.000113079645,0.00030994907],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00069117284,0.00014933984,0.00057991216,0.0014539717,0.00007932822,0.000010171046,0.00006201481,0.000075991615,0.000119462224],"category_scores_gemma":[0.0002962105,0.000102077094,0.00011622939,0.0016593918,0.00029337636,0.000031881922,0.00016382501,0.0002948896,0.0000014062833],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030718866,0.0010435013,0.8670384,0.00040393425,0.0008316227,0.0000075630355,0.0016316973,5.9979314e-8,0.0000135200025,0.00080798724,0.0027484105,0.12516607],"study_design_scores_gemma":[0.0036199174,0.0014244121,0.9823811,0.0012577289,0.0002732791,0.0000012038748,0.0016519314,0.0002690482,0.00012030614,0.00051463436,0.0084075285,0.00007889856],"about_ca_topic_score_codex":0.0025531317,"about_ca_topic_score_gemma":0.0038469536,"teacher_disagreement_score":0.12508717,"about_ca_system_score_codex":0.00013488508,"about_ca_system_score_gemma":0.00022154891,"threshold_uncertainty_score":0.4162583},"labels":[],"label_agreement":null},{"id":"W4414036237","doi":"10.1080/03007995.2025.2558140","title":"Patient-reported efficacy of adjunctive brexpiprazole in major depressive disorder in a phase 4, open-label, interventional study","year":2025,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Treatment of Major Depression","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Global Affairs Canada; University of Toronto; University of Calgary; Translational Research in Oncology; University of Alberta","funders":"","keywords":"Medicine; Major depressive disorder; Open label; Adjunctive treatment; Psychiatry; Internal medicine; Clinical trial; Mood","score_opus":0.12058437022977776,"score_gpt":0.5085594885769612,"score_spread":0.38797511834718346,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414036237","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9887334,0.0071800333,0.00007401572,0.0008227192,0.0003130933,0.002540679,0.00001308401,0.000010707359,0.00031228672],"genre_scores_gemma":[0.9988129,0.0005517337,0.000024040764,0.000012014029,0.000031339205,0.00034129457,0.00015362771,0.000009287196,0.000063727166],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9967512,0.00042471534,0.00068771455,0.00050548255,0.001273048,0.0003578664],"domain_scores_gemma":[0.998469,0.0006383657,0.000101973696,0.00028902516,0.0002229183,0.00027869656],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011314534,0.00014714756,0.00043275545,0.00067415345,0.00006689176,0.000024288558,0.0002161782,0.000105121806,0.00019848013],"category_scores_gemma":[0.003995086,0.00011168282,0.0000354294,0.0007845108,0.00023921407,0.00013573036,0.00076206104,0.0007561667,0.000003482574],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0060342704,0.07344914,0.38448137,0.00030183015,0.00010990712,0.0001548726,0.0005479759,4.061704e-7,0.00011627449,0.00016211659,0.001628448,0.5330134],"study_design_scores_gemma":[0.16644011,0.010137873,0.80631983,0.010557326,0.00003916065,0.000011166126,0.0011882763,0.0008321843,0.00047754296,0.0008004147,0.003032845,0.00016326591],"about_ca_topic_score_codex":0.0003879799,"about_ca_topic_score_gemma":0.0001864652,"teacher_disagreement_score":0.5328501,"about_ca_system_score_codex":0.00012314293,"about_ca_system_score_gemma":0.0005133396,"threshold_uncertainty_score":0.47827798},"labels":[],"label_agreement":null},{"id":"W4414159968","doi":"10.1080/03007995.2025.2556012","title":"Enhanced guidance on artificial intelligence for medical publication and communication professionals","year":2025,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Artificial Intelligence in Healthcare and Education","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"WiLAN (Canada)","funders":"","keywords":"Transparency (behavior); Action (physics); Position paper; Value (mathematics); Work (physics); Field (mathematics); Health care; Applications of artificial intelligence","score_opus":0.42752275509540927,"score_gpt":0.6220029593459846,"score_spread":0.19448020425057533,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414159968","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.1755914,0.032414645,0.1095993,0.66986763,0.003809302,0.0051445016,0.000020059406,0.00014616182,0.0034070138],"genre_scores_gemma":[0.98389703,0.013069514,0.00028208274,0.001147729,0.00056041667,0.00058910705,0.0002060867,0.000009024295,0.00023901377],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9973738,0.00023845988,0.00056498934,0.00036841386,0.0011047105,0.00034963377],"domain_scores_gemma":[0.9955114,0.0026101507,0.00006084107,0.00030494021,0.0009700226,0.0005426566],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0043230685,0.00009942148,0.00019066202,0.00028054934,0.0004220466,0.000052816344,0.00019253703,0.00023959993,0.00020150766],"category_scores_gemma":[0.024110546,0.000079344696,0.000029191322,0.00043992515,0.0005021882,0.00009047317,0.00012406478,0.0007619236,0.000024026043],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002893423,0.0004073689,0.0002910032,0.00040711105,0.0000063674443,1.7933205e-7,0.00026338088,4.443024e-8,0.000032892884,0.1348173,0.010945679,0.85253936],"study_design_scores_gemma":[0.0007259358,0.0037536132,0.012877604,0.028374529,0.00003396603,0.000021303435,0.005712201,0.045114927,0.061133552,0.50619864,0.33542415,0.0006296051],"about_ca_topic_score_codex":0.000044276592,"about_ca_topic_score_gemma":0.000030937295,"teacher_disagreement_score":0.85190976,"about_ca_system_score_codex":0.00008753729,"about_ca_system_score_gemma":0.0012403479,"threshold_uncertainty_score":0.98410976},"labels":[],"label_agreement":null},{"id":"W4414251322","doi":"10.1080/03007995.2025.2559871","title":"High-dose influenza vaccine for elderly: a closer look into the real-world data","year":2025,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Influenza Virus Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Global Affairs Canada","funders":"","keywords":"Vaccination; Influenza vaccine; Observational study; Vaccine efficacy; Age groups; Public health; Seasonal influenza; Live attenuated influenza vaccine","score_opus":0.2952574141746262,"score_gpt":0.5582042879172429,"score_spread":0.26294687374261666,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414251322","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.49980167,0.1856007,0.002139322,0.2847357,0.00535639,0.01516724,0.0004222607,0.00042787232,0.006348837],"genre_scores_gemma":[0.52396894,0.4330915,0.0026097244,0.009799406,0.012802295,0.004431028,0.0028928996,0.00023695169,0.010167267],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9954782,0.00032302845,0.00050857896,0.00071082445,0.0020456428,0.0009337022],"domain_scores_gemma":[0.994133,0.0031427878,0.000055392917,0.0012629426,0.00078241964,0.0006234821],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.00581793,0.00021162754,0.00047256323,0.00053333025,0.0006846119,0.000096274685,0.0008887711,0.00010841828,0.00012014072],"category_scores_gemma":[0.015425116,0.00012506502,0.000064051164,0.0011156049,0.00094101665,0.00015485098,0.0020721492,0.0014898637,0.000046102716],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024651014,0.00034038594,0.011475487,0.0011929286,0.00017472965,0.000008347018,0.000252148,1.3471193e-7,0.000043782507,0.014444921,0.27985376,0.6897483],"study_design_scores_gemma":[0.0050737066,0.0008542006,0.02724975,0.0013778995,0.000027002561,0.000001368651,0.00022481091,0.0009108518,0.000120930374,0.005714006,0.95832705,0.000118424716],"about_ca_topic_score_codex":0.0011187326,"about_ca_topic_score_gemma":0.0010641415,"teacher_disagreement_score":0.68962985,"about_ca_system_score_codex":0.00015876243,"about_ca_system_score_gemma":0.0013194311,"threshold_uncertainty_score":0.99286836},"labels":[],"label_agreement":null},{"id":"W4415029843","doi":"10.1080/03007995.2025.2573652","title":"Unlocking insights from mother-infant linked data in pharmacoepidemiology: opportunities, challenges, and future directions","year":2025,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Pregnancy and Medication Impact","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Institute for Clinical Evaluative Sciences; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Linkage (software); Linked data; SAFER; Identification (biology); Data quality; Health care; Record linkage","score_opus":0.40354280813984633,"score_gpt":0.5143832288103051,"score_spread":0.11084042067045874,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415029843","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.027984982,0.8786405,0.00023022453,0.08746989,0.0017546902,0.00057731377,0.000058355687,0.00005869745,0.0032253987],"genre_scores_gemma":[0.14195958,0.8558201,0.00003898353,0.00041158017,0.0010881975,0.000045015975,0.0005397156,0.0000075633866,0.00008923366],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99782556,0.00045609783,0.0003390188,0.0004687017,0.00056269154,0.00034791697],"domain_scores_gemma":[0.99751234,0.0012440049,0.000040761166,0.00044578259,0.00008356832,0.0006735476],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018168576,0.00012128959,0.00031274234,0.00037364627,0.00012994192,0.000012668793,0.00022337204,0.00020732182,0.00011529275],"category_scores_gemma":[0.0034699298,0.0000906134,0.000018430801,0.00023543905,0.0003872973,0.00012816257,0.00034520618,0.0011869186,0.0000031657748],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012150183,0.00021211762,0.002067129,0.0003044653,0.000040816947,0.000019484678,0.0006255433,5.4384457e-9,0.00002018455,0.0045974245,0.0072669857,0.98472434],"study_design_scores_gemma":[0.0018590306,0.00009372466,0.06353586,0.003555075,0.000012584102,0.000009226886,0.000590081,0.0016416655,0.000009027371,0.0030881844,0.9255319,0.00007363842],"about_ca_topic_score_codex":0.00014596105,"about_ca_topic_score_gemma":0.00007366755,"teacher_disagreement_score":0.98465073,"about_ca_system_score_codex":0.000055376873,"about_ca_system_score_gemma":0.0007599705,"threshold_uncertainty_score":0.5156637},"labels":[],"label_agreement":null},{"id":"W4415267400","doi":"10.1080/03007995.2025.2573654","title":"Closing the loop in colorectal cancer screening: real-world adherence to follow-up colonoscopy after positive mt-sDNA vs FIT/FOBT, stratified by payer type","year":2025,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Colorectal Cancer Screening and Detection","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Colonoscopy; Colorectal cancer; Closing (real estate); Loop (graph theory); Cancer; MEDLINE","score_opus":0.09587312390493323,"score_gpt":0.45968778223763185,"score_spread":0.3638146583326986,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415267400","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98073024,0.0075422516,0.0005760742,0.0072633345,0.0016506556,0.0011636938,0.000033868033,0.00004139313,0.0009985145],"genre_scores_gemma":[0.9946457,0.0033078631,0.000033062708,0.00028825935,0.00030104653,0.00035963624,0.0000459558,0.00001301266,0.0010054479],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99731785,0.000283565,0.00032243205,0.0004969693,0.0010166881,0.00056247134],"domain_scores_gemma":[0.9982448,0.00077952124,0.000039445247,0.00017297396,0.00029867864,0.00046453087],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011764695,0.00017129809,0.00030477266,0.0003043555,0.00022023727,0.00008111203,0.00017194495,0.00014467939,0.00020166603],"category_scores_gemma":[0.0012299118,0.0001225701,0.0000512377,0.0014305193,0.00028934528,0.00007578157,0.00019600395,0.001160625,0.000011114032],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.11259576,0.00042540327,0.1018007,0.00038703706,0.00011585825,0.000037717215,0.0012098078,0.000003036041,0.002166124,0.0003426763,0.07064757,0.7102683],"study_design_scores_gemma":[0.013076829,0.03161428,0.78120387,0.01882672,0.00010112368,0.000016174461,0.0012635269,0.015475737,0.026451603,0.0005850517,0.110488765,0.0008963234],"about_ca_topic_score_codex":0.0029070657,"about_ca_topic_score_gemma":0.0053258142,"teacher_disagreement_score":0.709372,"about_ca_system_score_codex":0.00026508438,"about_ca_system_score_gemma":0.0007913028,"threshold_uncertainty_score":0.5042403},"labels":[],"label_agreement":null},{"id":"W4415522922","doi":"10.1080/03007995.2025.2580036","title":"Profiles and diagnostic patterns of colorectal cancers among 602 patients attending a tertiary care center in Saudi Arabia for suspected colic disease","year":2025,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Colorectal Cancer Screening and Detection","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre","funders":"","keywords":"Tertiary care; Disease; Center (category theory); Colorectal cancer; Cancer; Tertiary level","score_opus":0.02996666037109281,"score_gpt":0.3779224111454222,"score_spread":0.3479557507743294,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415522922","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939205,0.0038066688,0.000098219534,0.00036554286,0.00041856876,0.0012380588,0.000111305046,0.000015799089,0.000025323643],"genre_scores_gemma":[0.9970748,0.0021365767,0.00000671472,0.000017286764,0.00009749454,0.00037803772,0.0002715997,0.000007895107,0.000009629676],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985162,0.000096286334,0.00023562176,0.0003085663,0.00052078883,0.00032256357],"domain_scores_gemma":[0.9985893,0.0006840192,0.000037236223,0.00008797425,0.00022889754,0.0003726121],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028069795,0.00010096454,0.0002119857,0.0003072702,0.00009249916,0.000016801956,0.000059201753,0.00007487859,0.000016651173],"category_scores_gemma":[0.0034215366,0.000084657615,0.000037813454,0.00025952028,0.00021556488,0.00004982161,0.000113505324,0.00034891316,2.1815863e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020749313,0.00014087421,0.92237794,0.0018075646,0.00001354108,0.0000041657363,0.00024805556,2.2908559e-7,0.000009750108,0.000018624309,0.0006233855,0.072680905],"study_design_scores_gemma":[0.0034290724,0.0010567749,0.9880511,0.005058515,0.000011441459,7.0011066e-7,0.00024044557,0.0011712839,0.00020209553,0.00004755034,0.00066327245,0.000067743356],"about_ca_topic_score_codex":0.000434875,"about_ca_topic_score_gemma":0.00056908396,"teacher_disagreement_score":0.072613165,"about_ca_system_score_codex":0.00024287202,"about_ca_system_score_gemma":0.00035460098,"threshold_uncertainty_score":0.40961462},"labels":[],"label_agreement":null},{"id":"W4415952402","doi":"10.1080/03007995.2025.2583758","title":"Impact of increased patient out-of-pocket costs on oral anticoagulant discontinuation among Medicare beneficiaries with atrial fibrillation treated with apixaban","year":2025,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Apixaban; Discontinuation; Oral anticoagulant; Atrial fibrillation; Formulary; Rivaroxaban; Warfarin; Stroke (engine)","score_opus":0.09397982059196973,"score_gpt":0.4422105197232904,"score_spread":0.34823069913132065,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415952402","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99683565,0.00083688437,0.00028549606,0.00064493634,0.00017495913,0.0009788314,0.000024460473,0.00002140875,0.0001973686],"genre_scores_gemma":[0.9984029,0.0007465565,0.000030635794,0.0000048195284,0.00029125446,0.0000026946689,0.0004929299,0.000009937544,0.000018264143],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99724936,0.0002178417,0.00042381528,0.00027393008,0.0015642233,0.0002708191],"domain_scores_gemma":[0.9982863,0.00066420063,0.0001608313,0.00020147444,0.00042176645,0.00026539768],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007342731,0.00015970094,0.0004699333,0.00043207902,0.00009746207,0.000024356255,0.000067737645,0.00010717372,0.00007828677],"category_scores_gemma":[0.0016389902,0.00009097925,0.00010792611,0.00052638503,0.00037833265,0.00009321242,0.00006815371,0.00024288883,0.0000012435391],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005208307,0.0000480467,0.8220662,0.00018243527,0.00019547141,0.0000035874564,0.00014117811,0.000016796017,0.000031539323,0.000632827,0.00032011393,0.17115353],"study_design_scores_gemma":[0.0059165703,0.006220841,0.9792462,0.0036232146,0.00009550527,0.0000010996149,0.0002273551,0.0030398148,0.00042131453,0.00005894762,0.0010315904,0.00011752619],"about_ca_topic_score_codex":0.00044151652,"about_ca_topic_score_gemma":0.00011135973,"teacher_disagreement_score":0.171036,"about_ca_system_score_codex":0.000106289976,"about_ca_system_score_gemma":0.00042059208,"threshold_uncertainty_score":0.3710026},"labels":[],"label_agreement":null},{"id":"W4416466577","doi":"10.1080/03007995.2025.2585558","title":"Understanding patient, caregiver, and prescriber preferences for an antipsychotic regimen administered once every 2 months for schizophrenia or bipolar I disorder: a qualitative interview study in North America","year":2025,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto","funders":"H. Lundbeck A/S; Otsuka Pharmaceutical","keywords":"Schizophrenia (object-oriented programming); Qualitative research; Antipsychotic; Regimen; Schizophrenia research; Bipolar disorder; Young adult","score_opus":0.37491160157817793,"score_gpt":0.5063250928710146,"score_spread":0.13141349129283664,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416466577","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9533719,0.034310296,0.002988893,0.0020273717,0.00030453663,0.0067782663,0.00016274766,0.000031192652,0.000024783905],"genre_scores_gemma":[0.98442733,0.013440535,0.00040562393,0.000030059624,0.00007475366,0.0013158531,0.00023547088,0.000017309883,0.000053067906],"study_design_codex":"design_other","study_design_gemma":"qualitative","domain_scores_codex":[0.99651605,0.0007872809,0.0004390611,0.00071740255,0.00090525625,0.000634939],"domain_scores_gemma":[0.9966619,0.0020834452,0.00006828033,0.0002921086,0.00023855086,0.0006557392],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013162654,0.00022352877,0.00050225947,0.0004857944,0.00028256373,0.000092383874,0.00019308069,0.000087824454,0.000019381536],"category_scores_gemma":[0.002405111,0.0001525453,0.00005965172,0.0006314358,0.00044720102,0.00018437806,0.00018854594,0.00049796735,0.0000010012473],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.053631503,0.0038507555,0.03655101,0.0021963227,0.00027916697,0.000019879079,0.015734477,1.8934996e-7,0.0000027262083,0.00066927244,0.0023110886,0.8847536],"study_design_scores_gemma":[0.14378864,0.16910508,0.23205966,0.022069603,0.00036531663,0.000033067372,0.30954263,0.011399738,0.000061522864,0.029532101,0.08048907,0.0015535905],"about_ca_topic_score_codex":0.00020113199,"about_ca_topic_score_gemma":0.004818634,"teacher_disagreement_score":0.8832,"about_ca_system_score_codex":0.00019570385,"about_ca_system_score_gemma":0.0009888608,"threshold_uncertainty_score":0.62206167},"labels":[],"label_agreement":null},{"id":"W7127186683","doi":"10.1080/03007995.2026.2615874","title":"Community HERO treatment survey: US subanalysis of a global survey on the experiences of people with HIV","year":2025,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"HIV/AIDS Research and Interventions","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"York University","funders":"Gilead Sciences","keywords":"HERO; Human immunodeficiency virus (HIV); Alternative medicine; Health care; Qualitative research; Antiretroviral therapy","score_opus":0.16322829696107724,"score_gpt":0.4889261639739713,"score_spread":0.32569786701289405,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7127186683","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99486375,0.0021783633,0.0002942301,0.0012712767,0.000043232285,0.00036850412,0.00015089397,0.0000055454284,0.00082420494],"genre_scores_gemma":[0.9963596,0.002861212,0.000005049758,0.000008952411,0.00002055547,0.00008416483,0.00024359173,0.0000033175804,0.00041354742],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9951808,0.0026316054,0.00031328495,0.00017901552,0.0013723751,0.00032295738],"domain_scores_gemma":[0.99619716,0.0023919092,0.000050634015,0.00042367724,0.0005957252,0.00034089468],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004956493,0.0001034882,0.00037859316,0.00014861478,0.00023206255,0.000019893112,0.0002817979,0.000060469098,0.00042876817],"category_scores_gemma":[0.0072206566,0.000052442632,0.00009187014,0.0012803737,0.00097420206,0.00003037306,0.00015046138,0.0005158804,0.00000471867],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017967278,0.0028187197,0.9021454,0.00035385226,0.0002576073,0.000001975704,0.0019606245,1.7570797e-7,0.000007467132,0.00072212936,0.031762123,0.058173236],"study_design_scores_gemma":[0.0013750397,0.0075980253,0.98170376,0.00145441,0.000012732543,0.0000015495768,0.0051037837,0.0006630916,0.00030447764,0.00008640729,0.0016475614,0.0000491673],"about_ca_topic_score_codex":0.01463496,"about_ca_topic_score_gemma":0.011205134,"teacher_disagreement_score":0.079558395,"about_ca_system_score_codex":0.000108489505,"about_ca_system_score_gemma":0.0007354528,"threshold_uncertainty_score":0.99192667},"labels":[],"label_agreement":null}]}